0001466538--12-312022Q1falsehttp://fasb.org/us-gaap/2021-01-31#DebtAndCapitalLeaseObligationsP2YP2YP1Y00014665382022-01-012022-03-310001466538us-gaap:CommonClassAMemberexch:XNMS2022-01-012022-03-310001466538cown:A2033NotesMemberexch:XNMS2022-01-012022-03-3100014665382022-04-29xbrli:shares00014665382022-03-31iso4217:USD00014665382021-12-310001466538cown:PortfolioFundsMember2022-03-310001466538cown:PortfolioFundsMember2021-12-31iso4217:USDxbrli:shares0001466538us-gaap:ConvertiblePreferredStockMember2022-03-310001466538us-gaap:ConvertiblePreferredStockMember2021-12-310001466538us-gaap:CommonClassAMember2022-03-310001466538us-gaap:CommonClassAMember2021-12-310001466538us-gaap:CommonClassAMemberus-gaap:RestrictedStockMember2022-03-310001466538us-gaap:CommonClassAMemberus-gaap:RestrictedStockMember2021-12-310001466538us-gaap:CommonClassBMember2021-12-310001466538us-gaap:CommonClassBMember2022-03-3100014665382021-01-012021-03-310001466538us-gaap:MaterialReconcilingItemsMember2022-01-012022-03-310001466538us-gaap:CommonStockMember2021-12-310001466538us-gaap:CommonStockMember2020-12-310001466538us-gaap:CommonStockMember2022-01-012022-03-310001466538us-gaap:CommonStockMember2021-01-012021-03-310001466538us-gaap:CommonStockMember2022-03-310001466538us-gaap:CommonStockMember2021-03-310001466538us-gaap:PreferredStockMember2021-12-310001466538us-gaap:PreferredStockMember2020-12-310001466538us-gaap:PreferredStockMember2022-03-310001466538us-gaap:PreferredStockMember2021-03-310001466538us-gaap:ParentMember2021-12-310001466538us-gaap:ParentMember2020-12-310001466538us-gaap:TreasuryStockMember2021-12-310001466538us-gaap:TreasuryStockMember2020-12-310001466538us-gaap:TreasuryStockMember2022-01-012022-03-310001466538us-gaap:TreasuryStockMember2021-01-012021-03-310001466538us-gaap:TreasuryStockMember2022-03-310001466538us-gaap:TreasuryStockMember2021-03-310001466538us-gaap:AdditionalPaidInCapitalMember2021-12-310001466538us-gaap:AdditionalPaidInCapitalMember2020-12-310001466538us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001466538us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001466538us-gaap:AdditionalPaidInCapitalMember2022-03-310001466538us-gaap:AdditionalPaidInCapitalMember2021-03-310001466538us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001466538us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001466538us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001466538us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001466538us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001466538us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001466538us-gaap:RetainedEarningsMember2021-12-310001466538us-gaap:RetainedEarningsMember2020-12-310001466538us-gaap:RetainedEarningsMember2022-01-012022-03-310001466538us-gaap:RetainedEarningsMember2021-01-012021-03-310001466538us-gaap:RetainedEarningsMember2022-03-310001466538us-gaap:RetainedEarningsMember2021-03-310001466538us-gaap:ParentMember2022-03-310001466538us-gaap:ParentMember2021-03-310001466538cown:NonredeemableNoncontrollingInterestsMember2021-12-310001466538cown:NonredeemableNoncontrollingInterestsMember2020-12-310001466538cown:NonredeemableNoncontrollingInterestsMember2022-01-012022-03-310001466538cown:NonredeemableNoncontrollingInterestsMember2021-01-012021-03-310001466538cown:NonredeemableNoncontrollingInterestsMember2022-03-310001466538cown:NonredeemableNoncontrollingInterestsMember2021-03-3100014665382021-03-3100014665382020-12-31cown:segmentcown:division0001466538us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-03-310001466538us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310001466538cown:OperatingCompanyMembercown:DuringInvestmentPeriodMembersrt:MinimumMember2022-01-012022-03-31xbrli:pure0001466538cown:OperatingCompanyMembercown:DuringInvestmentPeriodMembersrt:MaximumMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:AfterInvestmentPeriodMembersrt:MinimumMembercown:HealthcareRoyaltyPartnersMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:AfterInvestmentPeriodMembersrt:MaximumMembercown:HealthcareRoyaltyPartnersMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:DuringInvestmentPeriodMembersrt:MinimumMembercown:OtherHealthcareRoyaltyPartnersMemberMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:DuringInvestmentPeriodMembersrt:MaximumMembercown:OtherHealthcareRoyaltyPartnersMemberMember2022-01-012022-03-310001466538cown:OperatingCompanyMemberus-gaap:HedgeFundsMember2022-01-012022-03-310001466538cown:CowenInsuranceMember2021-02-262021-02-260001466538cown:CowenInsuranceMember2022-01-012022-03-310001466538cown:CowenInsuranceMember2021-02-260001466538cown:CowenInsuranceMemberus-gaap:CustomerRelatedIntangibleAssetsMember2021-02-260001466538cown:CowenInsuranceMemberus-gaap:LicenseMember2021-02-260001466538cown:CowenInsuranceMember2022-03-310001466538cown:FacilityLeasesMember2022-03-310001466538cown:FacilityLeasesMember2021-12-310001466538cown:CollateralReinsuranceAgreementMember2022-03-310001466538cown:CollateralReinsuranceAgreementMember2021-12-310001466538cown:LetterOfCreditNYOffice1ExpiresApril2022Memberus-gaap:LetterOfCreditMember2022-03-310001466538cown:LetterOfCreditNYOffice3ExpiresOctober2022Memberus-gaap:LetterOfCreditMember2022-03-310001466538us-gaap:LetterOfCreditMembercown:LetterOfCreditNYOffice5ExpiresNovember2021Domain2022-03-310001466538us-gaap:LetterOfCreditMembercown:LetterOfCreditBostonOfficeExpiresMarch2028Member2022-03-310001466538cown:LetterofCreditSanFranciscoOfficeExpiresOctober2025Memberus-gaap:LetterOfCreditMember2022-03-310001466538us-gaap:CommonStockMember2022-03-310001466538us-gaap:CommonStockMember2021-12-310001466538us-gaap:PreferredStockMember2022-03-310001466538us-gaap:PreferredStockMember2021-12-310001466538cown:WarrantsAndRightsMember2022-03-310001466538cown:WarrantsAndRightsMember2021-12-310001466538us-gaap:USTreasuryAndGovernmentMember2022-03-310001466538us-gaap:USTreasuryAndGovernmentMember2021-12-310001466538us-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:ConvertibleDebtSecuritiesMember2022-03-310001466538us-gaap:ConvertibleDebtSecuritiesMember2021-12-310001466538us-gaap:LoansMember2022-03-310001466538us-gaap:LoansMember2021-12-310001466538cown:TradeClaimsMember2022-03-310001466538cown:TradeClaimsMember2021-12-310001466538us-gaap:PrivateEquityFundsMember2022-03-310001466538us-gaap:PrivateEquityFundsMember2021-12-310001466538us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-03-310001466538us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001466538us-gaap:ForeignExchangeForwardMember2022-03-310001466538us-gaap:ForeignExchangeForwardMember2021-12-310001466538us-gaap:SwapMember2022-03-310001466538us-gaap:SwapMember2021-12-310001466538us-gaap:OptionMember2022-03-31cown:contract0001466538us-gaap:OptionMember2021-12-310001466538us-gaap:InterestRateSwapMember2022-03-310001466538us-gaap:InterestRateSwapMember2021-12-310001466538cown:ReceivableonderivativescontractsatfairvalueMember2022-03-310001466538cown:ReceivableonderivativescontractsatfairvalueMember2021-12-310001466538us-gaap:FutureMember2022-03-310001466538us-gaap:FutureMember2021-12-310001466538us-gaap:PutOptionMember2022-03-310001466538us-gaap:PutOptionMember2021-12-310001466538cown:PayableforderivativescontractsatfairvalueMember2022-03-310001466538cown:PayableforderivativescontractsatfairvalueMember2021-12-310001466538us-gaap:OtherIncomeMember2022-01-012022-03-310001466538us-gaap:OtherIncomeMember2021-01-012021-03-310001466538cown:CarriedinterestMember2022-03-310001466538cown:CarriedinterestMember2021-12-310001466538us-gaap:EquityMethodInvestmentsMember2022-03-310001466538us-gaap:EquityMethodInvestmentsMember2021-12-310001466538srt:AffiliatedEntityMembercown:HealthcareRoyaltyPartnersMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:HealthcareRoyaltyPartnersMembercown:PortfolioFundsMember2021-12-310001466538cown:HealthcareRoyaltyPartnersIiMembersrt:AffiliatedEntityMembercown:PortfolioFundsMember2022-03-310001466538cown:HealthcareRoyaltyPartnersIiMembersrt:AffiliatedEntityMembercown:PortfolioFundsMember2021-12-310001466538cown:EclipseVenturesFundIL.P.Membercown:PortfolioFundsMember2022-03-310001466538cown:EclipseVenturesFundIL.P.Membercown:PortfolioFundsMember2021-12-310001466538cown:EclipseVentureFundIILPMembercown:PortfolioFundsMember2022-03-310001466538cown:EclipseVentureFundIILPMembercown:PortfolioFundsMember2021-12-310001466538cown:EclipseContinuityFundIL.P.Membercown:PortfolioFundsMember2022-03-310001466538cown:EclipseContinuityFundIL.P.Membercown:PortfolioFundsMember2021-12-310001466538cown:StarboardValueAndOpportunityFundLpMembersrt:AffiliatedEntityMembercown:PortfolioFundsMember2022-03-310001466538cown:StarboardValueAndOpportunityFundLpMembersrt:AffiliatedEntityMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:StarboardValueOpportunityFundLtdMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:StarboardValueOpportunityFundLtdMembercown:PortfolioFundsMember2021-12-310001466538cown:LagunitaBiosciencesLLCMemberMembercown:PortfolioFundsMember2022-03-310001466538cown:LagunitaBiosciencesLLCMemberMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:StarboardLeadersFundLPMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:StarboardLeadersFundLPMembercown:PortfolioFundsMember2021-12-310001466538cown:PortfolioFundsMembercown:Formation8PartnersFundIMember2022-03-310001466538cown:PortfolioFundsMembercown:Formation8PartnersFundIMember2021-12-310001466538cown:BDCFundICoinvest1LPMembercown:PortfolioFundsMember2022-03-310001466538cown:BDCFundICoinvest1LPMembercown:PortfolioFundsMember2021-12-310001466538cown:DifesaPartnersLPMembercown:PortfolioFundsMember2022-03-310001466538cown:DifesaPartnersLPMembercown:PortfolioFundsMember2021-12-310001466538cown:CowenSustainableInvestmentsILPMembersrt:AffiliatedEntityMembercown:PortfolioFundsMember2022-03-310001466538cown:CowenSustainableInvestmentsILPMembersrt:AffiliatedEntityMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:CowenHealthcareInvestmentsIILPMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:CowenHealthcareInvestmentsIILPMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:CowenHealthcareInvestmentsIIILPMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:CowenHealthcareInvestmentsIIILPMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:PortfolioFundsMembercown:CowenHealthcareInvestmentsIVLPMember2022-03-310001466538srt:AffiliatedEntityMembercown:PortfolioFundsMembercown:CowenHealthcareInvestmentsIVLPMember2021-12-310001466538srt:AffiliatedEntityMembercown:EclipseSPVILPMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:EclipseSPVILPMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:TriartisanESPartnersLLCMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:TriartisanESPartnersLLCMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:TriartisanPFCPartnersLLCMemberMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:TriartisanPFCPartnersLLCMemberMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:RamiusMergerFundLLCMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:RamiusMergerFundLLCMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:OtherPrivateInvestmentMembercown:PortfolioFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:OtherPrivateInvestmentMembercown:PortfolioFundsMember2021-12-310001466538srt:AffiliatedEntityMembercown:PortfolioFundsMembercown:OtherFundsMember2022-03-310001466538srt:AffiliatedEntityMembercown:PortfolioFundsMembercown:OtherFundsMember2021-12-310001466538cown:StarboardValueAndOpportunityFundLpMembersrt:AffiliatedEntityMembercown:PortfolioFundsMember2022-01-012022-03-310001466538srt:AffiliatedEntityMembercown:StarboardLeadersFundLPMembercown:PortfolioFundsMember2022-01-012022-03-310001466538srt:AffiliatedEntityMembercown:CowenHealthcareInvestmentsIILPMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:CowenHealthcareInvestmentsIILPMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:CowenHealthcareInvestmentsIIILPMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:CowenHealthcareInvestmentsIIILPMembercown:CarriedinterestMember2021-12-310001466538cown:CowenSustainableInvestmentsILPMembersrt:AffiliatedEntityMembercown:CarriedinterestMember2022-03-310001466538cown:CowenSustainableInvestmentsILPMembersrt:AffiliatedEntityMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:CowenSustainableInvestmentsOffshoreILPMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:CowenSustainableInvestmentsOffshoreILPMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:CSIIProdigyCoInvestmentLPMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:CSIIProdigyCoInvestmentLPMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:CSIPRTACoInvestmentLPMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:CSIPRTACoInvestmentLPMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:TriartisanTGIFPartnersLLCMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:TriartisanTGIFPartnersLLCMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:TriartisanESPartnersLLCMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:TriartisanESPartnersLLCMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:TriartisanPFCPartnersLLCMemberMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:TriartisanPFCPartnersLLCMemberMembercown:CarriedinterestMember2021-12-310001466538cown:RamiusMultiStrategyFundLPMembersrt:AffiliatedEntityMembercown:CarriedinterestMember2022-03-310001466538cown:RamiusMultiStrategyFundLPMembersrt:AffiliatedEntityMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:RamiusMergerFundLLCMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:RamiusMergerFundLLCMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:RCGIORenergysSarlMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:RCGIORenergysSarlMembercown:CarriedinterestMember2021-12-310001466538srt:AffiliatedEntityMembercown:OtherFundsMembercown:CarriedinterestMember2022-03-310001466538srt:AffiliatedEntityMembercown:OtherFundsMembercown:CarriedinterestMember2021-12-310001466538cown:StarboardValueLPMember2022-03-310001466538cown:StarboardValueLPMember2021-12-310001466538cown:HealthcareRoyaltyGPIIILLCMember2022-03-310001466538cown:HealthcareRoyaltyGPIIILLCMember2021-12-310001466538cown:HealthcareRoyaltyGpLlcMember2022-03-310001466538cown:HealthcareRoyaltyGpLlcMember2021-12-310001466538cown:HealthcareRoyaltyGpIiLlcMember2022-03-310001466538cown:HealthcareRoyaltyGpIiLlcMember2021-12-310001466538cown:HealthcareRoyaltyGPIVLLCMember2022-03-310001466538cown:HealthcareRoyaltyGPIVLLCMember2021-12-310001466538cown:RcgLongviewDebtFundIvManagementLlcMember2022-03-310001466538cown:RcgLongviewDebtFundIvManagementLlcMember2021-12-310001466538cown:HCROverflowFundGPLLCMember2022-03-310001466538cown:HCROverflowFundGPLLCMember2021-12-310001466538cown:HCRPMGSAccountManagementLLCMember2022-03-310001466538cown:HCRPMGSAccountManagementLLCMember2021-12-310001466538cown:HCRStaffordFundGPLLCMember2022-03-310001466538cown:HCRStaffordFundGPLLCMember2021-12-310001466538cown:EquityMethodInvesteeOtherMember2022-03-310001466538cown:EquityMethodInvesteeOtherMember2021-12-310001466538us-gaap:CommonStockMemberus-gaap:MaturityOvernightMember2022-03-310001466538us-gaap:CommonStockMemberus-gaap:MaturityUpTo30DaysMember2022-03-310001466538us-gaap:CommonStockMemberus-gaap:Maturity30To90DaysMember2022-03-310001466538us-gaap:MaturityOver90DaysMemberus-gaap:CommonStockMember2022-03-310001466538us-gaap:CorporateBondSecuritiesMemberus-gaap:MaturityOvernightMember2022-03-310001466538us-gaap:MaturityUpTo30DaysMemberus-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:Maturity30To90DaysMemberus-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:MaturityOver90DaysMemberus-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:CommonStockMemberus-gaap:MaturityOvernightMember2021-12-310001466538us-gaap:CommonStockMemberus-gaap:MaturityUpTo30DaysMember2021-12-310001466538us-gaap:CommonStockMemberus-gaap:Maturity30To90DaysMember2021-12-310001466538us-gaap:MaturityOver90DaysMemberus-gaap:CommonStockMember2021-12-310001466538us-gaap:CorporateBondSecuritiesMemberus-gaap:MaturityOvernightMember2021-12-310001466538us-gaap:MaturityUpTo30DaysMemberus-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:Maturity30To90DaysMemberus-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:MaturityOver90DaysMemberus-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2022-03-310001466538us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2021-12-310001466538cown:ConsolidatedFundsMember2022-01-012022-03-310001466538cown:EnterpriseLpMember2022-03-310001466538cown:EnterpriseLpMember2021-12-310001466538cown:LinkemMembercountry:ITcown:WirelessBroadbandMemberus-gaap:EquitySecuritiesMember2022-03-310001466538cown:LinkemMembercountry:ITcown:WirelessBroadbandMemberus-gaap:EquitySecuritiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2022-03-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommonStockMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ConvertibleDebtSecuritiesMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ConvertibleDebtSecuritiesMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ConvertibleDebtSecuritiesMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2022-03-310001466538cown:TradeClaimsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538cown:TradeClaimsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538cown:TradeClaimsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538cown:TradeClaimsMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:LoansMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LoansMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:LoansMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:LoansMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SwapMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommonStockMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMember2022-03-310001466538us-gaap:FutureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FutureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FutureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FutureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ForwardContractsMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SwapMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:SwapMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:OptionMember2022-03-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-03-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310001466538cown:QuartonMember2022-03-310001466538cown:PorticoMember2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommonStockMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ConvertibleDebtSecuritiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ConvertibleDebtSecuritiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ConvertibleDebtSecuritiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2021-12-310001466538cown:TradeClaimsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538cown:TradeClaimsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538cown:TradeClaimsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:TradeClaimsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:LoansMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LoansMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:LoansMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:LoansMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:PrivateEquityFundsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SwapMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:DerivativeFinancialInstrumentsAssetsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommonStockMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMembercown:WarrantsAndRightsMember2021-12-310001466538us-gaap:FutureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FutureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FutureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FutureMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ForwardContractsMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SwapMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:SwapMember2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:OptionMember2021-12-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001466538cown:QuartonMember2021-12-310001466538cown:PorticoMember2021-12-310001466538us-gaap:PreferredStockMember2021-12-310001466538us-gaap:PreferredStockMember2022-01-012022-03-310001466538us-gaap:PreferredStockMember2022-03-310001466538us-gaap:CommonStockMember2021-12-310001466538us-gaap:CommonStockMember2022-01-012022-03-310001466538us-gaap:CommonStockMember2022-03-310001466538us-gaap:ConvertibleDebtSecuritiesMember2021-12-310001466538us-gaap:ConvertibleDebtSecuritiesMember2022-01-012022-03-310001466538us-gaap:ConvertibleDebtSecuritiesMember2022-03-310001466538us-gaap:CorporateBondSecuritiesMember2021-12-310001466538us-gaap:CorporateBondSecuritiesMember2022-01-012022-03-310001466538us-gaap:CorporateBondSecuritiesMember2022-03-310001466538us-gaap:OptionMember2021-12-310001466538us-gaap:OptionMember2022-01-012022-03-310001466538us-gaap:OptionMember2022-03-310001466538us-gaap:PutOptionMember2021-12-310001466538us-gaap:PutOptionMember2022-01-012022-03-310001466538us-gaap:PutOptionMember2022-03-310001466538cown:WarrantsAndRightsMember2021-12-310001466538cown:WarrantsAndRightsMember2022-01-012022-03-310001466538cown:WarrantsAndRightsMember2022-03-310001466538cown:TradeClaimsMember2021-12-310001466538cown:TradeClaimsMember2022-01-012022-03-310001466538cown:TradeClaimsMember2022-03-310001466538us-gaap:PrivateEquityFundsMember2021-12-310001466538us-gaap:PrivateEquityFundsMember2022-01-012022-03-310001466538us-gaap:PrivateEquityFundsMember2022-03-310001466538cown:ContingentLiabilityPayableMember2021-12-310001466538cown:ContingentLiabilityPayableMember2022-01-012022-03-310001466538cown:ContingentLiabilityPayableMember2022-03-310001466538us-gaap:PreferredStockMember2020-12-310001466538us-gaap:PreferredStockMember2021-01-012021-03-310001466538us-gaap:PreferredStockMember2021-03-310001466538us-gaap:CommonStockMember2020-12-310001466538us-gaap:CommonStockMember2021-01-012021-03-310001466538us-gaap:CommonStockMember2021-03-310001466538us-gaap:ConvertibleDebtSecuritiesMember2020-12-310001466538us-gaap:ConvertibleDebtSecuritiesMember2021-01-012021-03-310001466538us-gaap:ConvertibleDebtSecuritiesMember2021-03-310001466538us-gaap:CorporateBondSecuritiesMember2020-12-310001466538us-gaap:CorporateBondSecuritiesMember2021-01-012021-03-310001466538us-gaap:CorporateBondSecuritiesMember2021-03-310001466538us-gaap:OptionMember2020-12-310001466538us-gaap:OptionMember2021-01-012021-03-310001466538us-gaap:OptionMember2021-03-310001466538us-gaap:PutOptionMember2020-12-310001466538us-gaap:PutOptionMember2021-01-012021-03-310001466538us-gaap:PutOptionMember2021-03-310001466538cown:WarrantsAndRightsMember2020-12-310001466538cown:WarrantsAndRightsMember2021-01-012021-03-310001466538cown:WarrantsAndRightsMember2021-03-310001466538us-gaap:LoansMember2020-12-310001466538us-gaap:LoansMember2021-01-012021-03-310001466538us-gaap:LoansMember2021-03-310001466538cown:TradeClaimsMember2020-12-310001466538cown:TradeClaimsMember2021-01-012021-03-310001466538cown:TradeClaimsMember2021-03-310001466538us-gaap:PrivateEquityFundsMember2020-12-310001466538us-gaap:PrivateEquityFundsMember2021-01-012021-03-310001466538us-gaap:PrivateEquityFundsMember2021-03-310001466538us-gaap:CorporateBondSecuritiesMember2020-12-310001466538us-gaap:CorporateBondSecuritiesMember2021-01-012021-03-310001466538us-gaap:CorporateBondSecuritiesMember2021-03-310001466538us-gaap:USGovernmentDebtSecuritiesMember2020-12-310001466538us-gaap:USGovernmentDebtSecuritiesMember2021-01-012021-03-310001466538us-gaap:USGovernmentDebtSecuritiesMember2021-03-310001466538cown:ContingentLiabilityPayableMember2020-12-310001466538cown:ContingentLiabilityPayableMember2021-01-012021-03-310001466538cown:ContingentLiabilityPayableMember2021-03-310001466538cown:ConsolidatedFundsMemberus-gaap:CommonStockMember2020-12-310001466538cown:ConsolidatedFundsMemberus-gaap:CommonStockMember2021-01-012021-03-310001466538cown:ConsolidatedFundsMemberus-gaap:CommonStockMember2021-03-310001466538cown:WarrantsAndRightsMembercown:ConsolidatedFundsMember2020-12-310001466538cown:WarrantsAndRightsMembercown:ConsolidatedFundsMember2021-01-012021-03-310001466538cown:WarrantsAndRightsMembercown:ConsolidatedFundsMember2021-03-310001466538cown:DiscountedCashFlowAndMarketApproachValuationTechniquesMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2022-03-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538cown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMemberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538srt:MaximumMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538srt:WeightedAverageMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538cown:DiscountedCashFlowAndMarketApproachValuationTechniquesMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2022-03-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:OptionMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMemberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538us-gaap:OptionMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538srt:WeightedAverageMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538cown:TradeClaimsMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538cown:TradeClaimsMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMember2022-03-310001466538cown:TradeClaimsMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538cown:WarrantsAndRightsMembercown:DiscountedCashFlowAndMarketApproachValuationTechniquesMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2022-03-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembercown:WarrantsAndRightsMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538cown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMemberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538cown:WarrantsAndRightsMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538cown:WarrantsAndRightsMembercown:BlackScholesModelMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2022-03-310001466538cown:WarrantsAndRightsMembercown:BlackScholesModelMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538srt:WeightedAverageMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2022-03-310001466538srt:WeightedAverageMembercown:WarrantsAndRightsMembercown:BlackScholesModelMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueInputsLevel3Memberus-gaap:OtherInvestmentsMember2022-03-310001466538us-gaap:FairValueInputsLevel3Member2022-03-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PutOptionMember2022-03-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PutOptionMember2022-03-310001466538us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PutOptionMember2022-03-310001466538srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PutOptionMember2022-03-310001466538us-gaap:MeasurementInputPriceVolatilityMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PutOptionMember2022-03-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueInputsLevel3Membercown:DiscountCashFlowAndMonteCarloTechniqueMember2022-03-310001466538cown:ContingentLiabilityPayableMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2022-03-310001466538cown:ContingentLiabilityPayableMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMembercown:MonteCarloMember2022-03-310001466538cown:ContingentLiabilityPayableMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membercown:MonteCarloMember2022-03-310001466538cown:ContingentLiabilityPayableMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Member2022-03-310001466538cown:ContingentLiabilityPayableMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membercown:MonteCarloMember2022-03-310001466538cown:DiscountedCashFlowAndMarketApproachValuationTechniquesMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2021-12-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMemberus-gaap:MarketApproachValuationTechniqueMember2021-12-310001466538srt:MaximumMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2021-12-310001466538srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538srt:WeightedAverageMembercown:CommonAndPreferredStockMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2021-12-31cown:times0001466538cown:TradeClaimsMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:TradeClaimsMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMember2021-12-310001466538cown:TradeClaimsMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:WarrantsAndRightsMembercown:DiscountedCashFlowAndMarketApproachValuationTechniquesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2021-12-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembercown:WarrantsAndRightsMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMemberus-gaap:MarketApproachValuationTechniqueMember2021-12-310001466538cown:WarrantsAndRightsMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2021-12-310001466538cown:WarrantsAndRightsMembercown:BlackScholesModelMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2021-12-310001466538cown:WarrantsAndRightsMembercown:BlackScholesModelMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538srt:WeightedAverageMembercown:WarrantsAndRightsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2021-12-310001466538srt:WeightedAverageMembercown:WarrantsAndRightsMembercown:BlackScholesModelMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:DiscountedCashFlowAndMarketApproachValuationTechniquesMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2021-12-310001466538us-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:OptionMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMemberus-gaap:MarketApproachValuationTechniqueMember2021-12-310001466538us-gaap:OptionMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2021-12-310001466538srt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538srt:WeightedAverageMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMember2021-12-310001466538us-gaap:FairValueInputsLevel3Memberus-gaap:OtherInvestmentsMember2021-12-310001466538us-gaap:FairValueInputsLevel3Member2021-12-310001466538us-gaap:FairValueMeasurementsRecurringMemberus-gaap:DerivativeFinancialInstrumentsLiabilitiesMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PutOptionMember2021-12-310001466538us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PutOptionMember2021-12-310001466538us-gaap:MeasurementInputPriceVolatilityMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueOptionPricingModelMemberus-gaap:FairValueInputsLevel3Memberus-gaap:PutOptionMember2021-12-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueInputsLevel3Membercown:DiscountCashFlowAndMonteCarloTechniqueMember2021-12-310001466538cown:ContingentLiabilityPayableMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMember2021-12-310001466538cown:ContingentLiabilityPayableMemberus-gaap:ValuationTechniqueDiscountedCashFlowMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:ContingentLiabilityPayableMemberus-gaap:FairValueInputsLevel3Membersrt:MinimumMembercown:MonteCarloMember2021-12-310001466538cown:ContingentLiabilityPayableMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membercown:MonteCarloMember2021-12-310001466538cown:ContingentLiabilityPayableMembersrt:WeightedAverageMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberus-gaap:FairValueInputsLevel3Member2021-12-310001466538cown:ContingentLiabilityPayableMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membercown:MonteCarloMember2021-12-310001466538us-gaap:FairValueInputsLevel1Member2022-03-310001466538us-gaap:FairValueInputsLevel1Member2021-12-310001466538us-gaap:FairValueInputsLevel2Member2022-03-310001466538us-gaap:FairValueInputsLevel2Member2021-12-310001466538us-gaap:NotesPayableOtherPayablesMember2022-03-310001466538us-gaap:NotesPayableOtherPayablesMember2021-12-310001466538us-gaap:ConvertibleDebtMembercown:A2022convertiblenoteMember2017-12-140001466538us-gaap:ConvertibleDebtMembercown:A2022convertiblenoteMember2020-12-310001466538us-gaap:ConvertibleDebtMembercown:A2022convertiblenoteMember2020-10-012020-12-310001466538us-gaap:ConvertibleDebtMembercown:A2022convertiblenoteMember2021-06-240001466538us-gaap:ConvertibleDebtMembercown:A2022convertiblenoteMemberus-gaap:CommonClassAMember2021-01-012021-06-300001466538us-gaap:ConvertibleDebtMembercown:A2022convertiblenoteMember2021-01-012021-06-300001466538us-gaap:ConvertibleDebtMembercown:A2022convertiblenoteMember2021-01-012021-03-310001466538us-gaap:SeniorNotesMembercown:A2024NotesMember2019-05-070001466538us-gaap:SeniorNotesMembercown:A2024NotesMember2019-09-300001466538us-gaap:SeniorNotesMembercown:A2024NotesMember2022-01-012022-03-310001466538us-gaap:SeniorNotesMembercown:A2024NotesMember2021-01-012021-03-310001466538us-gaap:SeniorNotesMembercown:A2033NotesMember2018-06-110001466538us-gaap:SeniorNotesMembercown:A2033NotesMember2020-09-300001466538us-gaap:SeniorNotesMembercown:A2033NotesMember2022-01-012022-03-310001466538us-gaap:SeniorNotesMembercown:A2033NotesMember2021-01-012021-03-310001466538us-gaap:SeniorNotesMembercown:A2027NotesMember2017-12-080001466538us-gaap:SeniorNotesMembercown:A2027NotesMember2017-12-140001466538us-gaap:SeniorNotesMembercown:A2027NotesMember2021-01-012021-03-310001466538us-gaap:SeniorNotesMembercown:A2027NotesMember2021-03-240001466538us-gaap:SeniorNotesMembercown:A2027NotesMember2022-01-012022-03-310001466538cown:TermLoanMembercown:A2028TermLoanMember2021-03-240001466538cown:TermLoanMembercown:A2028TermLoanMember2021-12-150001466538cown:TermLoanMembercown:A2028TermLoanMember2022-03-310001466538cown:TermLoanMembercown:A2028TermLoanMember2022-01-012022-03-310001466538cown:TermLoanMembercown:A2028TermLoanMember2021-01-012021-03-310001466538cown:InsuranceNoteMember2022-01-310001466538cown:InsuranceNoteMember2022-01-012022-03-310001466538cown:InsuranceNoteMember2022-03-310001466538cown:PurpleProtectAssetS91Member2020-09-300001466538cown:PurpleProtectAssetS91Member2021-04-012021-06-300001466538cown:PurpleProtectAssetS91Member2020-12-310001466538cown:PurpleProtectAssetS91Member2021-06-300001466538cown:PurpleProtectAssetS91Member2022-03-310001466538cown:TheMilitaryMutualLtdMember2022-03-310001466538cown:PurpleProtectAssetS91Member2022-01-012022-03-310001466538cown:PurpleProtectAssetS91Member2021-01-012021-03-310001466538cown:CorporateDebtMember2019-11-010001466538cown:CorporateDebtMember2022-03-310001466538cown:CorporateDebtMember2022-01-012022-03-310001466538us-gaap:SeniorNotesMember2022-03-310001466538cown:TermLoanMember2022-03-310001466538us-gaap:ConvertiblePreferredStockMember2015-05-192015-05-190001466538us-gaap:RetainedEarningsMemberus-gaap:ConvertiblePreferredStockMember2022-01-012022-03-310001466538us-gaap:RetainedEarningsMemberus-gaap:ConvertiblePreferredStockMember2021-01-012021-03-310001466538us-gaap:ConvertiblePreferredStockMember2015-05-1900014665382015-05-190001466538us-gaap:CallOptionMembersrt:MinimumMember2015-05-192015-05-1900014665382015-05-192015-05-190001466538srt:MinimumMember2015-05-192015-05-190001466538srt:MaximumMember2015-05-192015-05-19cown:class0001466538us-gaap:ConvertibleDebtMembercown:A2022convertiblenoteMember2018-06-260001466538us-gaap:ConvertibleDebtMemberus-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-3000014665382021-04-012021-06-3000014665382021-01-012021-12-310001466538us-gaap:DividendPaidMember2022-01-012022-03-310001466538cown:OperatingCompaniesMembercown:NonredeemableNoncontrollingInterestsMember2021-12-310001466538cown:OperatingCompaniesMembercown:NonredeemableNoncontrollingInterestsMember2020-12-310001466538cown:OperatingCompaniesMembercown:NonredeemableNoncontrollingInterestsMember2022-01-012022-03-310001466538cown:OperatingCompaniesMembercown:NonredeemableNoncontrollingInterestsMember2021-01-012021-03-310001466538cown:OperatingCompaniesMembercown:NonredeemableNoncontrollingInterestsMember2022-03-310001466538cown:OperatingCompaniesMembercown:NonredeemableNoncontrollingInterestsMember2021-03-310001466538cown:ConsolidatedFundsMembercown:NonredeemableNoncontrollingInterestsMember2021-12-310001466538cown:ConsolidatedFundsMembercown:NonredeemableNoncontrollingInterestsMember2020-12-310001466538cown:ConsolidatedFundsMembercown:NonredeemableNoncontrollingInterestsMember2022-01-012022-03-310001466538cown:ConsolidatedFundsMembercown:NonredeemableNoncontrollingInterestsMember2021-01-012021-03-310001466538cown:ConsolidatedFundsMembercown:NonredeemableNoncontrollingInterestsMember2022-03-310001466538cown:ConsolidatedFundsMembercown:NonredeemableNoncontrollingInterestsMember2021-03-310001466538cown:OperatingCompanyMembercown:UnderwritingFeesMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:UnderwritingFeesMember2021-01-012021-03-310001466538cown:OperatingCompanyMembercown:StrategicFinancialAdvisoryFeesMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:StrategicFinancialAdvisoryFeesMember2021-01-012021-03-310001466538cown:OperatingCompanyMembercown:PlacementandSalesAgentFeesMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:PlacementandSalesAgentFeesMember2021-01-012021-03-310001466538cown:OperatingCompanyMembercown:ExpenseReimbursementsfromClientsMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:ExpenseReimbursementsfromClientsMember2021-01-012021-03-310001466538cown:InvestmentBankingRevenueMembercown:OperatingCompanyMember2022-01-012022-03-310001466538cown:InvestmentBankingRevenueMembercown:OperatingCompanyMember2021-01-012021-03-310001466538cown:CommissionsMembercown:OperatingCompanyMember2022-01-012022-03-310001466538cown:CommissionsMembercown:OperatingCompanyMember2021-01-012021-03-310001466538cown:OperatingCompanyMembercown:TradeConversionMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:TradeConversionMember2021-01-012021-03-310001466538cown:OperatingCompanyMembercown:EquityandCreditResearchFeesMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:EquityandCreditResearchFeesMember2021-01-012021-03-310001466538cown:OperatingCompanyMembercown:BrokerageMember2022-01-012022-03-310001466538cown:OperatingCompanyMembercown:BrokerageMember2021-01-012021-03-310001466538cown:OperatingCompanyMember2022-01-012022-03-310001466538cown:OperatingCompanyMember2021-01-012021-03-310001466538cown:AssetCompanyMember2022-01-012022-03-310001466538cown:AssetCompanyMember2021-01-012021-03-310001466538cown:OutwardInsuranceMember2022-01-012022-03-310001466538cown:OutwardInsuranceMember2021-01-012021-03-310001466538cown:InwardReinsuranceMember2022-01-012022-03-310001466538cown:InwardReinsuranceMember2021-01-012021-03-310001466538cown:CowenInsuranceCoAndHollenfelsMember2022-01-012022-03-310001466538us-gaap:CashAndCashEquivalentsMember2022-03-310001466538us-gaap:USTreasuryBondSecuritiesMember2022-03-310001466538us-gaap:CashAndCashEquivalentsMember2021-12-310001466538us-gaap:USTreasuryBondSecuritiesMember2021-12-310001466538cown:CollateralReinsuranceAgreementReleasedSeptember302023Member2022-03-310001466538cown:CollateralReinsuranceAgreementReleasedMarch312021Member2022-03-310001466538cown:EquityPlansMembersrt:MinimumMemberus-gaap:EmployeeStockMember2022-01-012022-03-310001466538srt:MaximumMembercown:EquityPlansMemberus-gaap:EmployeeStockMember2022-01-012022-03-310001466538us-gaap:RestrictedStockMembercown:EquityPlansMembersrt:MinimumMember2022-01-012022-03-310001466538srt:MaximumMemberus-gaap:RestrictedStockMembercown:EquityPlansMember2022-01-012022-03-310001466538us-gaap:RestrictedStockMembercown:EquityPlansMember2022-03-310001466538cown:DeferredCashAwardMembercown:EquityPlansMember2022-01-012022-03-310001466538cown:DeferredCashAwardMembercown:EquityPlansMember2022-03-310001466538cown:EquityPlansMember2022-01-012022-03-310001466538cown:EquityPlansMember2021-01-012021-03-310001466538cown:RestrictedStockAndRestrictedStockUnitsRsusMembercown:EquityPlansMember2021-12-310001466538cown:RestrictedStockAndRestrictedStockUnitsRsusMembercown:EquityPlansMember2020-12-310001466538cown:RestrictedStockAndRestrictedStockUnitsRsusMembercown:EquityPlansMember2022-01-012022-03-310001466538cown:RestrictedStockAndRestrictedStockUnitsRsusMembercown:EquityPlansMember2021-01-012021-03-310001466538cown:RestrictedStockAndRestrictedStockUnitsRsusMembercown:EquityPlansMember2022-03-310001466538cown:RestrictedStockAndRestrictedStockUnitsRsusMembercown:EquityPlansMember2021-03-310001466538cown:EquityPlansMemberus-gaap:PerformanceSharesMember2019-04-012019-04-300001466538cown:EquityPlansMemberus-gaap:PerformanceSharesMember2021-02-012021-02-280001466538cown:EquityPlansMemberus-gaap:PerformanceSharesMember2020-07-012020-07-300001466538cown:EquityPlansMemberus-gaap:PerformanceSharesMember2016-03-012016-03-310001466538cown:EquityPlansMemberus-gaap:PerformanceSharesMember2022-01-012022-03-310001466538cown:March2016PerformanceAwardsMembercown:EquityPlansMemberus-gaap:PerformanceSharesMember2022-01-012022-03-310001466538cown:March2016PerformanceAwardsMemberus-gaap:ShareDistributionMembercown:EquityPlansMemberus-gaap:PerformanceSharesMember2022-01-012022-03-310001466538cown:March2016PerformanceAwardsMembercown:EquityPlansMemberus-gaap:PerformanceSharesMemberus-gaap:CashAndCashEquivalentsMember2022-01-012022-03-310001466538cown:EquityPlansMemberus-gaap:PerformanceSharesMembercown:April2019PerformanceAwardsMember2022-01-012022-03-310001466538us-gaap:ShareDistributionMembercown:EquityPlansMemberus-gaap:PerformanceSharesMembercown:April2019PerformanceAwardsMember2022-01-012022-03-310001466538cown:EquityPlansMemberus-gaap:PerformanceSharesMemberus-gaap:CashAndCashEquivalentsMembercown:April2019PerformanceAwardsMember2022-01-012022-03-310001466538srt:MinimumMemberus-gaap:PerformanceSharesMember2022-01-012022-03-310001466538srt:MaximumMemberus-gaap:PerformanceSharesMember2022-01-012022-03-310001466538us-gaap:RestrictedStockUnitsRSUMembercown:EquityPlansMembercown:NonEmployeeDirectorMember2021-01-012021-03-310001466538us-gaap:RestrictedStockUnitsRSUMembercown:EquityPlansMembercown:NonEmployeeDirectorMember2022-01-012022-03-310001466538us-gaap:RestrictedStockUnitsRSUMembercown:EquityPlansMembercown:NonEmployeeDirectorMember2022-03-310001466538us-gaap:RestrictedStockUnitsRSUMembercown:EquityPlansMembercown:NonEmployeeDirectorMember2021-12-310001466538cown:A2022EquityUnitIncentivePlanMember2022-03-010001466538cown:A2022EquityUnitIncentivePlanMember2022-01-012022-03-310001466538cown:A2022EquityUnitIncentivePlanMember2022-03-310001466538us-gaap:RestrictedStockUnitsRSUMembercown:EquityPlansMember2021-12-310001466538us-gaap:PerformanceSharesMember2022-01-012022-03-310001466538us-gaap:PerformanceSharesMember2021-01-012021-03-310001466538us-gaap:RestrictedStockMembercown:QuartonMember2022-01-012022-03-310001466538us-gaap:RestrictedStockMembercown:QuartonMember2021-01-012021-03-310001466538us-gaap:ConvertibleDebtMember2022-01-012022-03-310001466538us-gaap:ConvertibleDebtMember2021-01-012021-03-310001466538us-gaap:ConvertiblePreferredStockMember2022-01-012022-03-310001466538us-gaap:ConvertiblePreferredStockMember2021-01-012021-03-310001466538us-gaap:RestrictedStockMember2022-01-012022-03-310001466538us-gaap:RestrictedStockMember2021-01-012021-03-310001466538cown:FacilityLeasesMember2022-01-012022-03-310001466538cown:FacilityLeasesMember2021-01-012021-03-310001466538cown:EquipmentLeasesMember2022-03-310001466538cown:FacilityLeasesMember2022-03-310001466538cown:ServicePaymentsMember2022-03-310001466538cown:UnfundedCommitmentsMembercown:HealthcareRoyaltyPartnersMember2022-01-012022-03-310001466538cown:CommitmentToInvestMembercown:HealthcareRoyaltyPartnersMember2022-01-012022-03-310001466538cown:Formation8PartnersHardwareFundIL.P.Membercown:UnfundedCommitmentsMember2022-01-012022-03-310001466538cown:Formation8PartnersHardwareFundIL.P.Membercown:CommitmentToInvestMember2022-01-012022-03-310001466538cown:UnfundedCommitmentsMembercown:EclipseFundIIL.P.Member2022-01-012022-03-310001466538cown:CommitmentToInvestMembercown:EclipseFundIIL.P.Member2022-01-012022-03-310001466538cown:EclipseContinuityFundIL.P.Membercown:UnfundedCommitmentsMember2022-01-012022-03-310001466538cown:EclipseContinuityFundIL.P.Membercown:CommitmentToInvestMember2022-01-012022-03-310001466538cown:UnfundedCommitmentsMembercown:CowenHealthcareInvestmentsIIILPMember2022-01-012022-03-310001466538cown:CommitmentToInvestMembercown:CowenHealthcareInvestmentsIIILPMember2022-01-012022-03-310001466538cown:UnfundedCommitmentsMembercown:CowenHealthcareInvestmentsIVLPMember2022-01-012022-03-310001466538cown:CommitmentToInvestMembercown:CowenHealthcareInvestmentsIVLPMember2022-01-012022-03-310001466538cown:UnfundedCommitmentsMembercown:CowenSustainableInvestmentsILPMember2022-01-012022-03-310001466538cown:CommitmentToInvestMembercown:CowenSustainableInvestmentsILPMember2022-01-012022-03-310001466538cown:OperatingCompanyMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001466538cown:OperatingCompanyMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310001466538us-gaap:OperatingSegmentsMembercown:AssetCompanyMember2022-01-012022-03-310001466538us-gaap:OperatingSegmentsMembercown:AssetCompanyMember2021-01-012021-03-310001466538us-gaap:MaterialReconcilingItemsMember2021-01-012021-03-310001466538us-gaap:OperatingSegmentsMembercown:ConsolidatedFundsMembercown:AssetCompanyMember2022-01-012022-03-310001466538us-gaap:OperatingSegmentsMembercown:ConsolidatedFundsMembercown:AssetCompanyMember2021-01-012021-03-310001466538us-gaap:OperatingSegmentsMember2022-01-012022-03-310001466538us-gaap:OperatingSegmentsMember2021-01-012021-03-310001466538us-gaap:OperatingSegmentsMembercown:ConsolidatedFundsMember2022-01-012022-03-310001466538us-gaap:OperatingSegmentsMembercown:ConsolidatedFundsMember2021-01-012021-03-310001466538cown:ConsolidatedFundsMember2021-01-012021-03-310001466538cown:CowenAndCompanyMember2022-03-310001466538cown:CowenAndCompanyMember2022-01-012022-03-310001466538srt:MinimumMembercown:CowenAndCompanyMember2022-03-310001466538cown:OptionsClearingCorporationMembercown:CowenAndCompanyMember2022-03-310001466538cown:OptionsClearingCorporationMembercown:CowenAndCompanyMember2022-01-012022-03-310001466538cown:CowenFinancialProductsLLCMember2022-03-310001466538cown:ATMExecutionLLCMember2022-03-310001466538cown:WestminsterResearchMember2022-03-310001466538cown:CowenInternationalLimitedMembercown:UKFinancialConductAuthorityMember2022-03-310001466538cown:CowenExecutionServicesLtd.Membercown:UKFinancialConductAuthorityMember2022-03-310001466538cown:CowenandCompanyAsiaLimitedMember2022-03-310001466538cown:SpecialReserveAccountsMembercown:CowenAndCompanyMember2022-03-310001466538cown:PABReserveBankAccountsMembercown:CowenAndCompanyMember2022-03-310001466538cown:RCGInsuranceCompanyMember2022-03-310001466538srt:AffiliatedEntityMember2022-03-310001466538srt:AffiliatedEntityMember2021-12-310001466538cown:EmployeeLoansMember2022-03-310001466538cown:EmployeeLoansMember2021-12-310001466538cown:EmployeeLoansMembersrt:MinimumMember2022-01-012022-03-310001466538cown:EmployeeLoansMembersrt:MaximumMember2022-01-012022-03-310001466538cown:EmployeeLoansMember2022-01-012022-03-310001466538cown:EmployeeLoansMember2021-01-012021-03-310001466538cown:OtherFundsMember2022-03-310001466538cown:OtherFundsMember2021-12-310001466538cown:EmployeesMember2022-03-310001466538cown:EmployeesMember2021-12-310001466538cown:EmployeesMember2022-01-012022-03-310001466538cown:EmployeesMember2021-01-012021-03-310001466538cown:TriPartypledgelineMembercown:BMOHarrisBankMember2022-03-310001466538cown:PledgelineMembercown:BMOHarrisBankMember2022-03-310001466538cown:PledgelineMember2022-03-310001466538cown:SpikeLineMembercown:BMOHarrisBankMember2022-03-310001466538us-gaap:RevolvingCreditFacilityMembercown:MorganStanleyMember2022-03-310001466538us-gaap:SubsequentEventMember2022-04-212022-04-21

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2022
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 001-34516
Cowen Inc.
(Exact name of registrant as specified in its charter)
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
27-0423711
(I.R.S. Employer
Identification No.)
599 Lexington Avenue
New York, New York
(Address of Principal Executive Offices)
10022
(Zip Code)
(646) 562-1010
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class Trading SymbolName of Exchange on Which Registered
Class A Common Stock, par value $0.01 per share COWNThe Nasdaq Global Market
7.75% Senior Notes due 2033COWNLThe Nasdaq Global Market
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes    No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated filer
 
Accelerated filer
 
Non-accelerated filer

 
Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes     No 
As of April 29, 2022, there were 27,494,230 shares of the registrant's common stock outstanding.



Item No. Page No.




2

Table of Contents

Special Note Regarding Forward-Looking Statements
We have made statements in this Quarterly Report on Form 10-Q (including in "Management's Discussion and Analysis of Financial Condition and Results of Operations") that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking terms such as "may," "might," "will," "would," "could," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "project," "possible," "potential," "intend," "seek" or "continue," the negative of these terms and other comparable terminology or similar expressions. In addition, our management may make forward-looking statements to analysts, representatives of the media and others. These forward-looking statements represent only the Company's beliefs regarding future events (many of which, by their nature, are inherently uncertain and beyond our control) and are predictions only, based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from those expressed or implied by the forward-looking statements. In particular, you should consider the risks contained in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021 and the risks contained in Item 1A of this periodic report on Form 10-Q for the three months ended March 31, 2022.
Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. We undertake no obligation to update any of these forward-looking statements after the date of this filing to conform our prior statements to actual results or revised expectations.
Unaudited Condensed Consolidated Financial Statements are presented for the three months ended March 31, 2022 and 2021. The Consolidated Financial Statements as of December 31, 2021 were audited.



3

Table of Contents
PART I. FINANCIAL INFORMATION
Item 1. Unaudited Condensed Consolidated Financial Statements
Cowen Inc.
Condensed Consolidated Statements of Financial Condition
(dollars in thousands, except share and per share data)
(unaudited)
As of March 31, 2022As of December 31, 2021
Assets
Cash and cash equivalents$512,978 $914,343 
Cash collateral pledged52,865 47,494 
Segregated cash220,882 194,701 
Securities owned, at fair value ($1,704,831 and $1,764,853 were pledged to various parties)
2,763,514 2,660,742 
Securities purchased under agreements to resell19,621 — 
Receivable on derivative contracts, at fair value342,712 286,135 
Securities borrowed1,761,146 1,704,603 
Other investments ($131,766 and $137,986 at fair value, respectively)
237,628 274,111 
Deposits with clearing organizations, brokers and banks105,854 111,857 
Receivable from brokers, dealers and clearing organizations, net of allowance of $616 and $636, respectively
1,487,911 1,614,347 
Receivable from customers, net of allowance of $587 and $687, respectively
159,625 159,418 
Fees receivable, net of allowance of $828 and $886, respectively
128,136 145,809 
Due from related parties21,666 31,449 
Fixed assets, net of accumulated depreciation and amortization of $52,254 and $50,017, respectively
25,037 25,976 
Operating lease right-of-use assets95,430 93,655 
Goodwill234,005 234,005 
Intangible assets, net of accumulated amortization of $37,470 and $33,219, respectively
40,731 44,167 
Deferred tax asset, net19,608 21,765 
Other assets, net of allowance of $834 and $0 respectively
99,427 84,828 
Consolidated Funds  
Cash and cash equivalents23 296 
Other investments97,182 99,067 
Other assets46 46 
Total Assets$8,426,027 $8,748,814 
Liabilities, Temporary Equity and Permanent Equity  
Liabilities
Securities sold, not yet purchased, at fair value$974,867 $1,201,448 
Securities sold under agreements to repurchase229,192 63,469 
Payable for derivative contracts, at fair value46,814 60,163 
Securities loaned1,735,852 1,586,572 
Payable to brokers, dealers and clearing organizations587,540 586,553 
Payable to customers2,243,654 2,432,612 
Commission management payable126,968 102,990 
Compensation payable176,210 443,580 
Operating lease liabilities99,800 98,883 
Notes payable and other debt625,766 623,371 
Fees payable6,580 16,483 
Due to related parties27 — 
Accounts payable, accrued expenses and other liabilities241,110 236,088 
Consolidated Funds 
Due to related parties— 23 
Accounts payable, accrued expenses and other liabilities174 225 
Total Liabilities$7,094,554 $7,452,460 
4

Table of Contents
Cowen Inc.
Condensed Consolidated Statements of Financial Condition
(dollars in thousands, except share and per share data)
(unaudited)
As of March 31, 2022As of December 31, 2021
(continued)
Commitments and Contingencies (Note 22)
Redeemable Series A Convertible Preferred stock, par value $0.01 per share: 10,000,000 shares authorized, 120,750 shares issued and outstanding as of March 31, 2022 (aggregate liquidation preference of $120,750) and 10,000,000 shares authorized, 120,750 shares issued and outstanding as of December 31, 2021 (aggregate liquidation preference of $120,750)
$120,750 $120,750 
Permanent Equity
Class A common stock, par value $0.01 per share: 62,500,000 shares authorized, 56,835,283 shares issued and 27,614,903 outstanding as of March 31, 2022 and 62,500,000 shares authorized, 55,826,893 shares issued and 27,778,964 outstanding as of December 31, 2021, respectively (including 901,374 and 901,374 restricted shares, respectively)
334 334 
Class B common stock, par value $0.01 per share: 62,500,000 authorized, no shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively
— — 
Additional paid-in capital1,127,160 1,100,667 
Retained earnings491,189 461,982 
Accumulated other comprehensive income (loss)— (2)
Less: Class A common stock held in treasury, at cost, 29,220,380 and 28,047,929 shares as of March 31, 2022 and December 31, 2021, respectively
(583,535)(547,112)
Total Cowen Inc. Stockholders' Equity1,035,148 1,015,869 
Nonredeemable non-controlling interests175,575 159,735 
Total Permanent Equity$1,210,723 $1,175,604 
Total Liabilities, Redeemable Preferred Stock and Permanent Equity$8,426,027 $8,748,814 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5

Table of Contents
Cowen Inc.
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)
Three Months Ended March 31,
 20222021
Revenues 
Investment banking$101,542 $304,834 
Brokerage168,738 173,737 
Investment income (loss)
Securities principal transactions, net91,25263,965
Portfolio fund principal transactions, net (6,098)15,403
Carried interest allocations(17,067)96,769
Total investment income (loss)68,087 176,137 
Management fees16,769 25,742 
Incentive income633 2,258 
Interest and dividends46,335 59,388 
Insurance and reinsurance premiums11,321 7,117 
Other revenues, net(949)1,660 
Consolidated Funds 
Principal transactions, net(1,886)(3,349)
Interest and dividends
Total revenues410,592 747,526 
Interest and dividends expense46,524 57,641 
Total net revenues364,068 689,885 
Expenses 
Employee compensation and benefits187,178 388,196 
Brokerage and trade execution costs40,591 45,656 
Underwriting expenses259 6,915 
Professional, advisory and other fees13,682 15,460 
Service fees7,150 5,731 
Communications9,471 9,267 
Occupancy and equipment10,316 9,540 
Depreciation and amortization7,185 4,354 
Client services and business development6,569 6,848 
Insurance and reinsurance claims, commissions and amortization of deferred acquisition costs7,343 6,455 
Other expenses12,763 (3,340)
Consolidated Funds 
Professional, advisory and other fees42 110 
Other expenses63 161 
Total expenses302,612 495,353 
Other income (loss) 
Net gains (losses) on other investments5,580 12,645 
Bargain purchase gain, net of tax— 3,855 
Gain/(loss) on debt extinguishment — (4,538)
Total other income (loss)5,580 11,962 
Income (loss) before income taxes67,036 206,494 
Income tax expense (benefit)11,889 54,428 
Net income (loss) 55,147 152,066 
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds20,131 4,562 
Net income (loss) attributable to Cowen Inc.35,016 147,504 
Preferred stock dividends1,698 1,698 
Net income (loss) attributable to Cowen Inc. common stockholders$33,318 $145,806 
Weighted average common shares outstanding: 
Basic28,386 27,359 
Diluted (See Note 21)31,772 33,565 
Earnings (loss) per share:  
Basic$1.17 $5.33 
Diluted (See Note 21)$1.05 $4.34 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
6

Table of Contents

Cowen Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(dollars in thousands)
(unaudited)





 Three Months Ended March 31,
20222021
Net income (loss)$55,147 $152,066 
   Other comprehensive income (loss), net of tax:
Foreign currency translation
   Total other comprehensive income (loss), net of tax
Comprehensive income (loss)$55,149 $152,070 
    Less: Comprehensive income (loss) attributable to non-controlling interests 20,131 4,562 
Comprehensive income (loss) attributable to Cowen Inc. $35,018 $147,508 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.



7

Cowen Inc.
Condensed Consolidated Statements of Changes in Equity
(dollars in thousands, except share data)
(unaudited)
Three Months Ended March 31,
20222021
Permanent Equity Shares(in shares)
Common Shares Outstanding
Beginning balance27,778,964 26,845,628 
Restricted stock awards issued949,803 705,512 
Common stock issuance for partial settlement of contingent liability from prior acquisition58,587 56,801 
Purchase of treasury stock, at cost(1,172,451)(755,610)
Ending balance27,614,903 26,852,331 
Series A Convertible Preferred Shares Outstanding
Beginning balance— 120,750 
Ending balance 120,750 
Permanent Equity(in dollars)
Total Cowen Inc. Stockholders' Equity (beginning of period)$1,015,869 $969,497 
Class A Common stock
Beginning balance334 334 
Ending balance334 334 
Series A Convertible Preferred stock
Beginning balance— 
Ending balance 1 
Treasury stock
Beginning balance(547,112)(346,870)
Purchase of treasury stock, at cost(36,423)(26,904)
Ending balance(583,535)(373,774)
Additional Paid-in Capital
Beginning balance1,100,6671,130,138
Common stock issuance for partial settlement of contingent liability from prior acquisition1,881 2,202 
Amortization of share based awards24,612 19,037 
Ending balance$1,127,160 $1,151,377 
Accumulated Other Comprehensive Income (Loss)
Beginning balance$(2)$(7)
Foreign currency translation
Ending balance (3)
8

Three Months Ended March 31,
20222021
(in dollars)
Retained Earnings/ (Accumulated deficit)
Beginning balance461,982185,901 
Net income (loss) attributable to Cowen Inc.35,016147,504
Preferred stock dividends (See Note 13)
(1,698)(1,698)
Cash dividends to common stockholders (See Note 14)
(4,111)(2,777)
Ending balance491,189328,930
Total Cowen Inc. Stockholders' Equity (end of period) $1,035,148 $1,106,865 
Nonredeemable Non-controlling Interests
Beginning balance$159,735 $199,624 
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds20,1314,562
Capital contributions1,61022,515
Capital distributions(5,901)(18,773)
Deconsolidation of entity— (74,813)
Ending balance175,575133,115
Total Permanent Equity$1,210,723 $1,239,980 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
9

Table of Contents
Cowen Inc.
Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)
 Three Months Ended March 31,
 20222021
Cash flows from operating activities:  
Net income (loss)$55,147 $152,066 
Adjustments to reconcile net income (loss) to net cash provided by / (used in) operating activities:
Bargain purchase gain, net of tax— (3,855)
Depreciation and amortization7,185 4,354 
Amortization of debt issuance costs604 480 
Amortization of debt discount (premium)77 776 
Noncash lease expense(858)(362)
(Gain) / loss on extinguishment of debt— 3,890 
Share-based awards24,612 19,037 
Change in deferred taxes2,157 5,913 
Net loss (gain) on disposal of fixed assets101 — 
Contingent liability adjustment— (614)
Purchases of securities owned, at fair value(269,037)(269,073)
Proceeds from sales of securities owned, at fair value243,634 271,314 
Proceeds from sales of securities sold, not yet purchased, at fair value131,199 63,511 
Payments to cover securities sold, not yet purchased, at fair value(141,186)(58,346)
Proceeds from sales of other investments16,780 16,995 
Investment Income (loss) principal transactions, net(22,115)(158,833)
Consolidated Funds 
Proceeds from sales of securities owned, at fair value— 2,687 
Proceeds from other investments— 14,130 
Investment Income (loss) principal transactions, net1,886 3,143 
(Increase) decrease in operating assets: 
Securities owned, at fair value, held at broker-dealer(46,185)(1,112,154)
Receivable on derivative contracts, at fair value(56,577)(44,054)
Securities borrowed(56,543)(88,570)
Deposits with clearing organizations, brokers and banks6,003 22,874 
Receivable from brokers, dealers and clearing organizations126,436 (191,009)
Receivable from customers, net of allowance(207)(95,705)
Fees receivable, net of allowance17,673 (46,170)
Due from related parties9,783 440 
Other assets(14,597)(9,344)
Consolidated Funds 
Receivable on derivative contracts, at fair value— (2,917)
Other assets— 13 
Increase (decrease) in operating liabilities: 
Securities sold, not yet purchased, at fair value, held at broker-dealer(208,080)187,749 
Securities sold under agreement to repurchase165,723 (2,490)
Payable for derivative contracts, at fair value(13,348)(24,035)
Securities loaned149,280 607,531 
Payable to brokers, dealers and clearing organizations987 73,328 
Payable to customers(188,958)977,274 
Commission management payable23,978 22,634 
Compensation payable(279,653)(17,809)
Fees payable(9,903)(918)
Due to related parties27 48 
Accounts payable, accrued expenses and other liabilities14,907 39,591 
Consolidated Funds 
Due to related parties(23)— 
Accounts payable, accrued expenses and other liabilities(51)(359)
Net cash provided by / (used in) operating activities(309,142)363,161 
10

Cowen Inc.
Condensed Consolidated Statements of Cash Flows
(dollars in thousands)
(unaudited)
 Three Months Ended March 31,
 20222021
(continued)
Cash flows from investing activities: 
Securities purchased under agreement to resell(19,621)191 
Purchases of other investments(7,662)(29,117)
Purchase of business— 2,109 
Cash at deconsolidated entity — (5,620)
Proceeds from sales of other investments9,780 31,267 
Purchase of fixed assets and intangibles(2,914)(1,643)
Net cash provided by / (used in) investing activities(20,417)(2,813)
Cash flows from financing activities:  
Deferred debt issuance cost(112)(6,467)
Borrowings on notes and other debt4,019 301,490 
Repayments on notes and other debt(2,193)(139,737)
Purchase of treasury stock(24,140)(20,629)
Cash dividends paid(3,917)(2,313)
Preferred stock dividends paid(1,698)(1,698)
Contingent liability payment(8,195)(8,496)
Capital contributions by non-controlling interests in operating entities1,610 3,498 
Capital distributions to non-controlling interests in operating entities(5,901)(2,348)
Consolidated Funds 
Capital contributions by non-controlling interests in Consolidated Funds— 19,017 
Capital distributions to non-controlling interests in Consolidated Funds— (16,424)
Net cash provided by / (used in) financing activities(40,527)125,893 
Change in cash and cash equivalents(370,086)486,241 
Cash and cash equivalents, including cash collateral pledged and segregated cash, beginning of period1,156,834 941,470 
Cash and equivalents at end of period:
    Cash and cash equivalents 512,978 1,147,531 
    Cash collateral pledged52,865 110,303 
    Segregated cash220,882 168,942 
    Cash and cash equivalents, Consolidated Funds23 935 
Cash and cash equivalents, including cash collateral pledged and segregated cash, end of period$786,748 $1,427,711 
Supplemental information   
Cash paid during the year for interest$40,538 $65,259 
Cash paid during the year for taxes$12,980 $8,087 
Supplemental non-cash information  
Purchase of treasury stock, at cost, through net settlement (See Note 14)$12,283 $6,245 
Preferred stock dividends declared (See Note 14)
1,698 1,698 
Cash dividends declared (See Note 14)
4,111 2,777 
Net assets (liabilities) acquired upon acquisition (net of cash) — 3,107 
Net decrease in non-controlling interests in Consolidated Fund due to deconsolidation of Consolidated Fund (See Note 2)— 74,813 
Common stock issuance in relation to acquisitions1,881 2,202 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
11

Table of Contents

Cowen Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

Index
Notes to Unaudited Condensed Consolidated Financial Statements Page
  
  
  
  
  
  
  
  
 
 
 
  
  
 
  
  
  
  

12

Table of Contents
Cowen Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

1. Organization and Business
Cowen Inc., a Delaware corporation formed in 2009, is a diversified financial services firm that, together with its consolidated subsidiaries (collectively, "Cowen" or the "Company"), provides investment banking, research, sales and trading, prime brokerage, global clearing, securities financing, commission management services and investment management through its two business segments: the Operating Company ("Op Co") and the Asset Company ("Asset Co").
The Op Co segment consists of four divisions: the Investment Banking division, the Markets division, the Research division and the Cowen Investment Management ("CIM") division. The Company refers to the Investment Banking division, the Markets division and the Research division combined as its investment banking businesses. Op Co's investment banking businesses offer advisory and global capital markets origination, domain knowledge-driven research, sales and trading platforms for institutional investors, global clearing, commission management services and also a comprehensive suite of prime brokerage service. Sectors covered by Op Co's investment banking business include healthcare, technology, media and telecommunications, consumer, industrials, tech-enabled and business services, and energy. Op Co’s CIM division includes advisers to investment funds (including private equity structures and privately placed hedge funds) and registered funds. The Company has also invested capital in its insurance and reinsurance businesses.
The Asset Co segment consists of certain of the Company's private investments, private real estate investments and other legacy investment strategies. The focus of Asset Co is to drive future monetization of the invested capital of the segment.
2. Significant Accounting Policies
a.    Basis of presentation
These unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") as promulgated by the Financial Accounting Standards Board ("FASB") through the Accounting Standards Codification (the "Accounting Standards" or "ASC") as the source of authoritative accounting principles in the preparation of financial statements, and include the accounts of the Company, its operating and other subsidiaries, and entities in which the Company has a controlling financial interest or a general partner interest. All material intercompany transactions and balances have been eliminated on consolidation. Certain investment funds that are consolidated in these accompanying condensed consolidated financial statements, as further discussed below, are not subject to the consolidation provisions with respect to their own controlled investments pursuant to specialized industry accounting.
The accompanying condensed financial statements should be read in conjunction with the Company’s financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 (the "2021 Form 10-K"). Certain footnote disclosures included in the 2021 Form 10-K have been condensed or omitted from the accompanying condensed financial statements as they are not required for interim reporting under US GAAP or are insignificant to the interim reporting period.
b.    Principles of consolidation
The Company consolidates all entities that it controls through a majority voting interest or otherwise, including those investment funds in which the Company either directly or indirectly has a controlling financial interest. In addition, the Company consolidates all variable interest entities for which it is the primary beneficiary.
The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a Voting Operating Entity ("VOE") or a Variable Interest Entity ("VIE") under US GAAP.
Voting Operating Entities—VOEs are entities in which (i) the total equity investment at risk is sufficient to enable the entity to finance its activities independently, (ii) the equity holders at risk have the obligation to absorb losses, the right to receive residual returns and the right to direct the activities of the entity that most significantly impact the entity's economic performance and (iii) voting rights of equity holders are proportionate to their obligation to absorb losses or the right to receive returns.
Under US GAAP consolidation requirements, the usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. Accordingly, the Company consolidates all VOEs in which it owns a majority of the entity's voting shares or units.
13

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Variable Interest Entities—VIEs are entities that lack one or more of the characteristics of a VOE. In accordance with US GAAP, an enterprise must consolidate all VIEs of which it is the primary beneficiary. Under the US GAAP consolidation model for VIEs, an enterprise that (1) has the power to direct the activities of a VIE that most significantly impacts the VIE's economic performance, and (2) has an obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE, is considered to be the primary beneficiary of the VIE and thus is required to consolidate it.
The Company determines whether it is the primary beneficiary of a VIE upon its initial involvement with the VIE and reassesses whether it is the primary beneficiary on an ongoing basis as long as it has any continuing involvement with the VIE by performing a periodic qualitative and/or quantitative analysis of the VIE that includes a review of, among other things, its capital structure, contractual agreements between the Company and the VIE, the economic interests that create or absorb variability, related party relationships and the design of the VIE.
The VIEs the Company has invested in act as investment managers and/or investment companies that may be managed by the Company. The VIEs are financed through their operations and/or loan agreements with the Company.
In the ordinary course of business, the Company also sponsors various other entities that it has determined to be VIEs. These VIEs are primarily investment funds for which the Company serves as the general partner, managing member and/or investment manager with decision-making rights. The Company consolidates these investment funds when its variable interest is potentially significant to the entity. (see Note 6 for additional disclosures on VIEs).
Investment companies, which account for their investments under the specialized industry accounting guidance for investment companies prescribed under US GAAP, are not subject to the consolidation provisions for their investments. As of March 31, 2022 and December 31, 2021, the total assets of the consolidated VIEs were $332.4 million and $304.1 million, respectively, and total liabilities of the consolidated VIEs were $6.6 million and $9.8 million, respectively.
The Company consolidates investment funds for which it acts as the managing member/general partner and investment manager. At March 31, 2022, the Company consolidated Ramius Enterprise LP (“Enterprise LP”), an investment fund. At December 31, 2021, the Company consolidated the following investment funds: Enterprise LP and Cowen Private Investments LP ("Cowen Private").
During the first quarter of 2022, the Company deconsolidated Cowen Private as the fund was liquidated. During the first quarter of 2021, the Company deconsolidated Cowen Sustainable Investments I, LP ("CSI I LP") due to the Company's ownership being diluted through a capital equalization event.
Equity Method Investments—For operating entities over which the Company exercises significant influence but which do not meet the requirements for consolidation as outlined above, the Company uses the equity method of accounting. The Company's investments in equity method investees are recorded in other investments in the accompanying condensed consolidated statements of financial condition. The Company's share of earnings or losses from equity method investees is included in Net gains (losses) on other investments in the accompanying condensed consolidated statements of operations.
The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable. The difference between the carrying value of the equity method investment and its estimated fair value is recognized as an impairment charge when the loss in value is deemed other than temporary.
Other—If the Company does not consolidate an entity or apply the equity method of accounting, the Company accounts for its investment in such entity (primarily consisting of securities of such entity which are purchased and held principally for the purpose of selling them in the near term and classified as trading securities), at fair value with unrealized gains (losses) resulting from changes in fair value reflected within Investment income (loss) - Securities principal transactions, net or Investment income (loss) - portfolio fund investment income (loss) in the accompanying condensed consolidated statements of operations.
Retention of Specialized Accounting— The Consolidated Funds and certain other consolidated companies are investment companies and apply specialized industry accounting. The Company reports its investments on the condensed consolidated statements of financial condition at their estimated fair value, with unrealized gains (losses) resulting from changes in fair value reflected within Consolidated Funds - Principal transactions, net in the accompanying condensed consolidated statements of operations. Accordingly, the accompanying condensed consolidated financial statements reflect different accounting policies for investments depending on whether or not they are held through a consolidated investment company.
Certain portfolio fund investments qualify as equity method investments and are investment companies that apply specialized industry accounting. In applying equity method accounting guidance, the Company retains the specialized accounting of the investees and reports its investments on the condensed consolidated statements of financial condition at their estimated fair value, with unrealized gains (losses) resulting from changes in fair value reflected within Investment Income - portfolio fund principal transactions, net in the accompanying condensed consolidated statements of operations.
14

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
In addition, the Company's broker-dealer subsidiaries, Cowen and Company, LLC ("Cowen and Company"), Westminster Research Associates LLC ("Westminster"), Cowen Execution Services Limited ("Cowen Execution Ltd"), ATM Execution LLC ("ATM Execution"), Cowen and Company (Asia) Limited ("Cowen Asia"), and Cowen International Limited ("Cowen International Ltd"), apply the specialized industry accounting for brokers and dealers in securities, which the Company retains upon consolidation.
c.    Use of estimates
The preparation of the accompanying condensed consolidated financial statements in conformity with US GAAP requires the management of the Company to make estimates and assumptions that affect the fair value of securities and other investments, the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the accompanying condensed consolidated financial statements, as well as the accounting for goodwill and identifiable intangible assets and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates.
d.    Allowance for credit losses
ASC Topic 326, Financial Instruments – Credit Losses (“ASC 326”) prescribed the impairment model for certain financial assets measured at amortized cost by requiring a current expected credit loss ("CECL") methodology to estimate expected credit losses over the entire life of the financial asset, recorded at inception or purchase. Under the accounting update guidance, the Company has the ability to determine there are no expected credit losses in certain circumstances (e.g., based on collateral arrangements or based on the credit quality of the borrower or issuer).
The Company applies the guidance in ASC 326 to securities borrowed and fees and other receivables carried at amortized cost (including, but not limited to, receivables related to securities transactions, underwriting fees, strategic/financial advisory fees and placement and sales agent fees, management fees and incentive fees receivable).
The allowance for credit losses is based on the Company's expectation of the collectability of financial instruments, fees and other receivables utilizing the CECL framework. The Company considers factors such as historical experience, credit quality, age of balances and current and future economic conditions that may affect the Company’s expectation of the collectability in determining the allowance for credit losses. The Company’s expectation is that the credit risk associated with fees and other receivables is not significant until they are 90 days past due based on the contractual arrangement and expectation of collection in accordance with industry standards.
For securities borrowed, the Company applies a practical expedient to measure the allowance for credit losses based on the fair value of the collateral. If the fair value of the collateral held exceeds the amortized cost of the borrowing and the borrower is expected to continue to replenish the collateral as needed, the Company will not recognize an allowance. If the fair value of collateral is less than amortized cost and the borrower is expected to continue to replenish the collateral as needed, the Company applies the CECL model, utilizing a probability and loss given default methodology, only to the extent of the shortfall between the fair value of the collateral and amortized cost.
The credit loss expense related to the allowance for credit losses as well as any recoveries of amounts previously charged is reflected in other expenses in the accompanying condensed consolidated statements of operations.
e.    Valuation of investments and derivative contracts and other investments
US GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy are as follows:
Level 1Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
Level 2Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
Level 3Fair value is determined based on pricing inputs that are unobservable and includes situations where there is little, if any, market activity for the asset or liability. The determination of fair value for assets and liabilities in this category requires significant management judgment or estimation.
Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. Inputs may include price information, volatility statistics,
15

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
specific and broad credit data, liquidity statistics, and other factors. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company considers observable data to be that market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market. The categorization of a financial instrument within the hierarchy is based upon the pricing transparency of the instrument and does not necessarily correspond to the Company's perceived risk of that instrument. Inputs reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
The Company and its operating subsidiaries act as the manager for the Consolidated Funds. Both the Company and the Consolidated Funds hold certain investments which are valued by the Company, acting as the investment manager. The fair value of these investments is based on their proportional rights of the underlying portfolio company, and is generally estimated based on proprietary models developed by the Company, which include discounted cash flow analysis, public market comparables, and other techniques and may be based, at least in part, on independently sourced market information. The material estimates and assumptions used in these models include the timing and expected amount of cash flows, the appropriateness of discount rates used, and, in some cases, the ability to execute, timing of, and estimated proceeds from expected financings. Significant judgment and estimation impact the selection of an appropriate valuation methodology as well as the assumptions used in these models, and the timing and actual values realized with respect to investments could be materially different from values derived based on the use of those estimates. The valuation methodologies applied impact the reported value of the Company's investments and the investments held by the Consolidated Funds in the condensed consolidated financial statements. Certain of the Company's investments are relatively illiquid or thinly traded and may not be immediately liquidated on demand if needed. Fair values assigned to these investments may differ significantly from the fair values that would have been used had a ready market for the investments existed and such differences could be material.
The Company primarily uses the market approach to value its financial instruments measured at fair value. In determining an instrument's level within the hierarchy, the Company categorizes the Company's financial instruments into three categories: securities, derivative contracts and other investments. To the extent applicable, each of these categories can further be divided between those held long or sold short.
The Company has the option to measure certain financial assets and financial liabilities at fair value with changes in fair value recognized in earnings each period. The election is made on an instrument by instrument basis at initial recognition of an asset or liability or upon an event that gives rise to a new basis of accounting for that instrument.  The Company has elected the fair value option for certain of its investments held by its operating companies.  This option has been elected because the Company believes that it is consistent with the manner in which the business is managed, as well as the way that financial instruments in other parts of the business are recorded. 
Securities—Securities with values based on quoted market prices in active markets for identical assets are classified within level 1 of the fair value hierarchy. These securities primarily include active listed equities, certain U.S. government and sovereign obligations, Exchange Traded Funds ("ETFs"), mutual funds and certain money market securities.
Certain positions for which trading activity may not be readily visible, consisting primarily of convertible debt, corporate debt and loans and restricted equities, are stated at fair value and classified within level 2 of the fair value hierarchy. The estimated fair values assigned by management are determined in good faith and are based on available information considering trading activity, broker quotes, quotations provided by published pricing services, counterparties and other market participants, and pricing models using quoted inputs, and do not necessarily represent the amounts which might ultimately be realized. As level 2 investments include positions that are not always traded in active markets and/or are subject to transfer restrictions, valuations may be adjusted to reflect illiquidity and/or non-transferability.
Derivative Contracts—Derivative contracts can be exchange-traded or privately negotiated over-the-counter (“OTC”). Exchange-traded derivatives, such as futures contracts and exchange-traded option contracts, are typically classified within level 1 or level 2 of the fair value hierarchy depending on whether or not they are deemed to be actively traded. OTC derivatives, such as generic forwards, swaps and options, are classified as level 2 when their inputs can be corroborated by market data. OTC derivatives, such as swaps and options, with significant inputs that cannot be corroborated by readily available or observable market data are classified as level 3.
Other Investments—Other investments consist primarily of portfolio funds, carried interest and equity method investments, which are valued as follows:
i.    Portfolio Funds—Portfolio funds include interests in private investment partnerships, foreign investment companies and other collective investment vehicles which may be managed by the Company or its affiliates. The Company applies the practical expedient provided by the US GAAP fair value measurements and disclosures guidance relating to investments
16

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
in certain entities that calculate net asset value (“NAV”) per share (or its equivalent). The practical expedient permits an entity holding investments in certain entities that either are investment companies or have attributes similar to an investment company, and calculate NAV per share or its equivalent for which the fair value is not readily determinable, to measure the fair value of such investments on the basis of that NAV per share, or its equivalent, without adjustment. Investments which are valued using NAV per share as a practical expedient are not categorized within the fair value hierarchy.
ii. Carried Interest—For the private equity and debt fund products the Company offers, the Company is allocated incentive income by the investment funds based on the extent by which the investment funds performance exceeds predetermined thresholds. Carried interest allocations are generally structured from a legal standpoint as an allocation of capital in the Company’s capital account. The Company accounts for carried interest allocations by applying an equity ownership model. Accordingly, the Company accrues performance allocations quarterly based on the fair value of the underlying investments assuming hypothetical liquidation at book value.
iii. Equity Method Investments—For operating entities over which the Company exercises significant influence but which do not meet the requirements for consolidation as outlined above, the Company applies the equity method of accounting. The Company's investments in equity method investees are recorded in other investments in the accompanying condensed consolidated statements of financial condition. The Company's share of earnings or losses from equity method investees is included in Net gains (losses) on other investments in the accompanying condensed consolidated statements of operations.
See Notes 6 and 7 for further information regarding the Company's investments, including equity method investments and fair value measurements.
f.    Offsetting of derivative contracts
To reduce credit exposures on derivatives, the Company may enter into master netting agreements with counterparties that permit the Company the right, in the event of a default by a counterparty, to offset the counterparty’s rights and obligations under the agreement and to liquidate and offset any collateral against any net amount owed by the counterparty. Derivatives are reported on a net-by-counterparty basis (i.e., the net payable or receivable for derivative assets and liabilities for a given counterparty) in the condensed consolidated statements of financial condition when a legal right of offset exists under an enforceable netting agreement. Additionally, derivatives are reported net of cash collateral received and posted under enforceable credit support agreements in the condensed consolidated statements of financial position, provided a legal right of offset exists. See Note 6 for further information about offsetting of derivative financial instruments.
g.    Receivable from and payable to brokers
Receivable from brokers, dealers, and clearing organizations includes amounts receivable for securities failed to deliver by the Company to a purchaser by the settlement date, amounts receivable from broker-dealers and clearing organizations, commissions receivable from broker-dealers, and interest receivable from securities financing arrangements and are reported net of an allowance for credit losses.
Payable to brokers, dealers and clearing organizations includes amounts payable for securities failed to receive by the Company from a seller by the settlement date, amounts payable to broker-dealers and clearing organizations for unsettled trades, interest payable for securities financing arrangements, and payables of deposits held in proprietary accounts of brokers and dealers.
Receivables and payables with brokers, dealers and clearing organizations arising from unsettled regular-way transactions are presented net (assets less liabilities) across balances with the same counterparty. The Company's receivable from and payable to brokers, dealers and clearing organizations balances are held with multiple financial institutions.
h.    Receivable from and payable to customers
Receivable from customers includes amounts owed by customers on cash and margin transactions, recorded on a settlement-date basis and prepaid research, net of allowance for credit losses. For prepaid research, a prepaid research asset is established for research and related services disbursed in advance of anticipated client commission volumes.
Payable to customers primarily consists of amounts owed to customers relating to securities transactions not completed on settlement date, recorded on a settlement-date basis on the statement of financial condition, and other miscellaneous customer payables.
17

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Securities owned by customers, including those that collateralize margin, are not reflected as assets of the Company on the statement of financial condition. The Company holds these securities with the intention of settlement against customer orders and are held as collateral for customer receivables.
i.    Fees receivable
Fees receivable primarily relate to securities transactions and are reported net of an allowance for credit losses.  Fees receivable also include amounts due to the Company for underwriting fees, strategic/financial advisory fees and placement and sales agent fees. Additionally, management and incentive fees due to the Company are earned as the managing member, general partner and/or investment manager to the Company's investment funds and are recognized in accordance with appropriate revenue recognition guidance (see Note 2o for further reference).
j.    Securities financing arrangements
Securities borrowed and securities loaned are carried at the amounts of cash collateral advanced or received on a gross basis. The related rebates are recorded in the accompanying condensed consolidated statements of operations as interest and dividends income and interest and dividends expense. Securities borrowed transactions require the Company to deposit cash collateral with the lender. With respect to securities loaned, the Company receives cash or securities as collateral from the borrower. When the Company receives securities as collateral, and has concluded it (i) is the transferor and (ii) can pledge the securities to third parties, the Company recognizes the securities received as collateral at fair value in Securities owned, at fair value with the corresponding obligation to return the securities received as collateral at fair value in Securities sold, not yet purchased, at fair value. Securities received as collateral are not recognized when the Company either (i) is not the transferor or (ii) cannot pledge the securities to third parties. The initial collateral advanced or received approximates or is greater than the market value of securities borrowed or loaned. The Company monitors the market value of securities borrowed and loaned on a daily basis, with additional collateral obtained or returned, as necessary. Securities borrowed and loaned may also result in credit exposures for the Company in an event that the counterparties are unable to fulfill their contractual obligations. See Note 2d for further information.
Fees and interest received or paid are recorded in interest and dividends income and interest and dividends expense, respectively, on an accrual basis in the accompanying condensed consolidated statements of operations. Accrued interest income and expense are recorded in receivable from brokers, dealers and clearing organizations and payable to brokers, dealers and clearing organizations, respectively, on an accrual basis in the accompanying condensed consolidated statements of financial condition.
k.     Securities sold under agreements to repurchase
Securities purchased under agreement to resell and securities sold under agreements to repurchase ("repurchase agreements") are accounted for as collateralized financing transactions and are recorded at their contracted resale or repurchase amount plus accrued interest. A repo is a transaction in which a firm buys or sells financial instruments from/to a counterparty, typically in exchange for cash, and simultaneously enters into an agreement to resell or repurchase the same or substantially the same financial instruments to/from such counterparty at a stated price plus accrued interest at a future date. When the Company receives securities as collateral, and has concluded it (i) is the transferor and (ii) can pledge the securities to third parties, the Company recognizes the securities received as collateral at fair value in Securities owned, at fair value with the corresponding obligation to return the securities received as collateral at fair value in Securities sold, not yet purchased, at fair value. Securities received as collateral are not recognized when the Company either (i) is not the transferor or (ii) cannot pledge the securities to third parties. The initial collateral advanced approximates or is greater than the market value of securities purchased or sold in the transaction. The Company typically enters into repurchase transactions with counterparties that prefer repurchase transactions to securities borrowed and securities loaned transactions. The Company has executed master repurchase agreements with such counterparties and utilizes such counterparties to finance its own positions, or replace a securities lending transaction with a repurchase for matched book purposes. The Company monitors the market value of repurchases on a daily basis, with additional collateral obtained or returned, as necessary. Repurchases may also result in credit exposures for the Company in an event that the counterparties are unable to fulfill their contractual obligations. The Company mitigates its credit risk by continuously monitoring its credit exposure and collateral values by demanding additional collateral or returning excess collateral in accordance with the netting provisions available in the master repurchase contracts in place with the counterparties.
Interest paid is recorded in interest and dividends expense in accordance with US GAAP on repurchase agreement transactions on an accrual basis in the accompanying condensed consolidated statements of operations.



18

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
l.    Goodwill and intangible assets
Goodwill
Goodwill represents the excess of the purchase price consideration of acquired companies over the estimated fair value assigned to the individual assets acquired and liabilities assumed. Goodwill is allocated to the Company's reporting units at the date the goodwill is initially recorded. Once goodwill has been allocated to the reporting units, it generally no longer retains its identification with a particular acquisition but instead becomes identifiable with the reporting unit. As a result, all of the fair value of each reporting unit is available to support the value of goodwill allocated to the unit.
In accordance with US GAAP requirements for testing for impairment of goodwill, the Company tests goodwill for impairment on an annual basis or at an interim period if events or changed circumstances would more likely than not reduce the fair value of a reporting unit below its carrying amount. In testing for goodwill impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances led to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company concludes that fair value exceeds its carrying amount, then performing a quantitative impairment test is not necessary. If the Company concludes otherwise, the Company is required to perform a quantitative impairment test that requires a comparison of the fair value of the reporting unit to its carrying value, including goodwill. If the fair value of the reporting unit exceeds its carrying value, the related goodwill is not considered impaired and no further analysis is required. If the carrying value of the reporting unit exceeds its fair value, then the Company recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value.
Intangible assets
Intangible assets with finite lives are amortized over their estimated average useful lives. Intangible assets are tested for potential impairment whenever events or changes in circumstances suggest that an asset or asset group's carrying value may not be fully recoverable. An impairment loss, calculated as the difference between the estimated fair value and the carrying value of an asset or asset group, is recognized in the accompanying condensed consolidated statements of operations if the sum of the estimated undiscounted cash flows from the use or disposition of the asset or asset group is less than the corresponding carrying value. The Company continually monitors the estimated average useful lives of existing intangible assets.
m.    Temporary Equity
Temporary equity consists of Redeemable 5.625% Series A cumulative perpetual convertible preferred stock ("Series A Convertible Preferred Stock"). The Company has irrevocably elected to cash settle $1,000.00 of each conversion of any share of the Series A Convertible Preferred Stock. As the holders can exercise the conversion option on their shares of Series A Convertible Preferred Stock at any time and require cash payment upon conversion, the Company has classified the Series A Convertible Preferred Stock preferred stock in temporary equity.
n.    Non-controlling interests in consolidated subsidiaries
Non-controlling interests represent the pro rata share of the income or loss of the non-wholly owned consolidated entities attributable to the other owners of such entities. When non-controlling interest holders do not have redemption features that can be exercised at the option of the holder currently or contingent upon the occurrence of future events, their ownership has been classified as a component of permanent equity. Ownership which has been classified in permanent equity are non-controlling interests for which the holder does not have the unilateral right to redeem its ownership interests.
o.    Revenue recognition
The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers ("ASC Topic 606"), which requires that an entity recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company follows a five-step model to (a) identify the contract(s) with a customer, (b) identify the performance obligations in the contract, (c) determine the transaction price, (d) allocate the transaction price to the performance obligations in the contract, and (e) recognize revenue when (or as) the entity satisfies a performance obligation. In determining the transaction price, the Company includes variable consideration only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized would not occur when the uncertainty associated with the variable consideration is resolved. Significant judgments are required in the application of the five-step model including: when determining whether performance obligations are satisfied at a point in time or over time; how to allocate transaction prices where multiple performance obligations
19

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
are identified; when to recognize revenue based on the appropriate measure of the Company's progress under the contract; and whether constraints on variable consideration should be applied due to uncertain future events.
The Company's principal sources of revenue are generated within two segments. The Op Co segment generates revenue through five principal sources: investment banking revenue, brokerage revenue, management fees, investment income (loss) and incentive income. Investment income is excluded from ASC Topic 606. The Asset Co segment generates revenue through investment income (loss), management fees and incentive income. Revenue from contracts with customers includes management fees, incentive income, investment banking revenue and brokerage services revenue excluding principal transactions. ASC Topic 606 does not apply to revenue associated with financial instruments, interest income and expense, leasing and insurance contracts. The following is a description of principal activities, from which the Company generates its revenue. For more detailed information about reportable segments, see Note 23.
Investment banking
The Company earns investment banking revenue primarily from fees associated with public and private capital raising transactions and providing strategic advisory services. Investment banking revenues are derived primarily from public and private small- and mid-capitalization companies within the Company's sectors.     
Investment banking revenue consists of underwriting fees, strategic/financial advisory fees, expenses reimbursed from clients and placement and sales agent fees.    
Underwriting fees. The Company earns underwriting fees in securities offerings in which the Company acts as an underwriter, such as initial public offerings, follow-on equity offerings, debt offerings, and convertible securities offerings. Fee revenue relating to underwriting commitments is recorded at the point in time when all significant items relating to the underwriting process have been completed and the amount of the underwriting revenue has been determined. This generally is the point at which all of the following have occurred: (i) the issuer's registration statement has become effective with the SEC or the other offering documents are finalized; (ii) the Company has made a firm commitment for the purchase of securities from the issuer; (iii) the Company has been informed of the number of securities that it has been allotted; and (iv) the issuer obtains control and benefits of the offering; which generally occurs on trade date.
Underwriting fees are recognized gross of transaction-related expenses, and such amounts are adjusted to reflect actual expenses in the period in which the Company receives the final settlement, typically within 90 days following the closing of the transaction.
Strategic/financial advisory fees. The Company's strategic advisory revenue includes success fees earned in connection with advising companies, principally in mergers, acquisitions and restructuring transactions. The Company also earns fees for related advisory work such as providing fairness opinions. A significant portion of the Company's advisory revenue (i.e., success-related advisory fees) is considered variable consideration and recognized when it is probable that the variable consideration will not be reversed in a future period. The variable consideration is constrained until satisfaction of the performance obligation. The Company records strategic advisory revenues at the point in time, gross of related expenses, when the services for the transactions are completed or the contract is canceled under the terms of each assignment or engagement.
Placement and sales agent fees. The Company earns placement agency fees and sales agent commissions in non-underwritten transactions, such as private placements of loans and debt and equity securities, including private investment in public equity transactions ("PIPEs"), and as sales agent in at-the-market offerings of equity securities. The Company records placement revenues (which may be in cash and/or securities) at the point in time when the services for the transactions are completed under the terms of each assignment or engagement. The Company records sales agent commissions on a trade-date basis.
Expense reimbursements from clients.  Investment banking revenue includes expense reimbursements for transaction-related expenses, primarily consisting of legal, travel and other costs directly associated with the transaction.  Expense reimbursements associated with investment banking engagements are recognized in revenue at the point in time when the Company is contractually entitled to reimbursement. The related expenses are presented gross within their respective expense category in the accompanying condensed consolidated statements of operations.
Brokerage
Brokerage revenue consists of commissions, principal transactions, equity research fees and trade conversion revenue.
20

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Commissions. Commission revenue includes fees from executing and clearing client transactions and commission sharing arrangements. Trade execution and clearing services, when provided together, represent a single performance obligation as the services are not separately identifiable in the context of the contract. Commission revenues associated with combined trade execution and clearing services on a standalone basis, are recognized at a point in time on trade-date. Commission revenues are generally paid on settlement date and the Company records a receivable between trade-date and payment on settlement date. The Company permits institutional customers to allocate a portion of their commissions to pay for research products and other services provided by third parties. The amounts allocated for those purposes are commonly referred to as "soft dollar arrangements". The Company also offers institutional clients the ability to allocate a portion of their gross commissions incurred on trades executed with various brokers to pay for research products and other services provided by third parties by entering into commission sharing arrangements. The Company acts as an agent in the soft dollar and commission sharing arrangements as the customer controls the use of the soft dollars and directs payments to third-party service providers on its behalf. Accordingly, amounts allocated to soft dollar arrangements are netted against commission revenues and recorded on trade date. Commissions on soft dollar brokerage are recorded net of the related expenditures. The costs of commission sharing arrangements are recorded for each eligible trade and shown net of commission revenue.
Equity research fees. Equity research fees are paid to the Company for providing access to equity research. In the US, revenue is recognized once an arrangement exists, access to research has been provided and the customer has benefited from the research. As part of MiFID II, the international customers of the Company's broker-dealers have executed equity research contracts with its clients. The contracts either contain a fixed price for providing access to research or a price at the discretion of the customer with a contract minimum. Fixed equity research fees are recognized over the contract period as the customer is benefiting from the research throughout the contract term. When the equity research fees are based on the customer’s discretion with a contract minimum, the Company recognizes the contract minimum over the life of the contract as the customer benefits from the research provided and adjusts the revenue when the Company can estimate the amount of equity research fees over the contract minimum. Additionally, the Company earns variable consideration for attending client conferences and events. Revenue is recognized when the Company attends a client conference or event.
Trade conversion revenue. Trade conversion revenue includes fees earned from converting foreign securities into an American Depository Receipt ("ADR") and fees earned from converting an ADR into foreign securities on behalf of customers, and margins earned from facilitating customer foreign exchange transactions. Trade conversion revenue is recognized on a trade-date basis.
Investment Income
Investment income (loss) consists of securities principal transactions, net, portfolio fund principal transactions, net and carried interest allocations. Investment income is excluded from ASC Topic 606.
Securities principal transactions, net. Principal transactions, net includes realized gains and losses from transactions in financial instruments and unrealized gains and losses from ongoing changes in the fair value of the Company’s positions.
Principal transactions, net generated by the Company's broker-dealers include net trading gains and losses from the Company's market-making activities in over-the-counter equity and fixed income securities, trading of convertible securities, and trading gains and losses on inventory and other Company positions, which include securities previously received as part of investment banking transactions. In certain cases, the Company provides liquidity to clients by buying or selling blocks of shares of listed stocks without previously identifying the other side of the trade at execution, which subjects the Company to market risk. These positions are typically held for a short duration.
With respects to the Company's proprietary trading strategies, purchases and sales of securities, net of commissions, derivative contracts, and the related revenues and expenses are recorded on a trade-date basis with net trading gains and losses included as a component of Investment income - Securities principal transactions, net, in the accompanying condensed consolidated statements of operations.
Portfolio Fund principal transactions, net. Portfolio funds include interests in private investment partnerships, foreign investment companies and other collective investment vehicles which may be managed by the Company or its affiliates. The Company applies the practical expedient provided by the US GAAP fair value measurements and disclosures guidance relating to investments in certain entities that calculate net asset value (“NAV”) per share (or its equivalent). The practical expedient permits an entity holding certain investments that calculates NAV per share or its equivalent for which the fair value is not readily determinable and is considered an investment company under ASC 946 to measure the
21

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
fair value of such investments on the basis of that NAV per share, or its equivalent, without adjustment. Investments which are valued using NAV per share as a practical expedient are not categorized within the fair value hierarchy. Realized and unrealized gains (losses) resulting from changes in NAV per share are reflected within Investment income – portfolio fund principal transactions, net in the accompanying condensed consolidated statements of operations.
Carried interest allocations. The Company is allocated carried interest based on net profits (as defined in the respective investment management or partnership agreement) related to certain of the Company's private equity investment funds. For the private equity fund products the Company offers, the carried interest earned is typically up to 30% of the distributions made to investors after return of their contributed capital and generally a preferred return. The Company recognizes carried interest allocated to the Company under an equity ownership model as investment income - carried interest allocations in the accompanying condensed consolidated statements of operations accordance with ASC Topic 323, Investments - Equity Method and Joint Ventures. Under the equity method of accounting the Company recognizes its allocations of incentive income or carried interest within Investment Income - Carried interest allocations in the accompanying condensed consolidated statements of operations along with the allocations proportionate to the Company's ownership interests in the investment funds. Generally, carried interest is recognized after the investor has received a full return of its invested capital, plus a preferred return. However, for certain private equity structures, the Company is entitled to receive incentive fees earlier, provided that the investors have received their preferred return on a current basis or on an investor by investor basis. These private equity structures are generally subject to a potential clawback of these incentive fees upon the liquidation of the private equity structure if the investor has not received a full return of its invested capital plus the preferred return thereon.
Management fees
The Company earns management fees from investment funds and certain managed accounts for which it serves as the investment manager; such fees earned are typically based on committed and invested capital. The Company has determined that the primary drivers of management fees are committed and invested capital relating to private equity funds. The management fees are earned as the investment management services are provided and are not subject to reversals. The performance obligation related to the transfer of these services is satisfied over time because the customer is receiving and consuming the benefits as they are provided by the Company.
Management fees are generally paid on a quarterly basis and are prorated for capital inflows (or commitments) and redemptions (or distributions) and are recognized as revenue at that time as they relate specifically to the services provided in that period, which are distinct from the services provided in other periods. While some investors may have separately negotiated fees, in general the management fees are as follows:
Private equity funds. Management fees for the Company's private equity funds are generally charged at an annual rate of 1% to 2% of committed capital during the investment period (as defined in the relevant partnership agreement). After the investment period, management fees for these private equity funds are generally charged at an annual rate of 1% to 2% of the net asset value or the aggregate cost basis of the unrealized investments held by the private equity funds.  For certain other private equity funds (and managed accounts), the management fees range from 0.2% to 1% and there is no adjustment based on the investment period.  Management fees for the Company's private equity funds are generally paid on a quarterly basis.
Hedge funds. Management fees for the Company's hedge funds are generally charged at an annual rate of up to 2% of net asset value. Management fees are generally calculated monthly at the end of each month.
Incentive income
The Company earns incentive income based on net profits (as defined in the respective investment management or partnership agreement) related to certain of the Company's investment funds and managed accounts.  The incentive income is charged to the investment funds in accordance with their corresponding investment management or partnership agreement. For the hedge funds the Company offers, incentive income earned is typically up to 20% (in certain cases on performance in excess of a benchmark) of the net profits earned for the full year that are attributable to each fee-paying investor. 
The Company recognizes incentive income charged to the Company's hedge funds based on the net profits of the hedge funds. The Company recognizes such incentive income when the fees are no longer subject to reversal or are crystallized. For certain  hedge funds, the incentive fee crystallizes annually when the high-water mark for such hedge funds is reset, which delays recognition of the incentive fee until year end. In periods following a period of a net loss attributable to an investor, the Company generally does not earn incentive income on any future profits attributable to such investor until the accumulated net loss from prior periods is recovered, an arrangement commonly referred to as a "high-water mark." Generally, incentive income is earned after the investor has received a full return of its invested capital, plus a preferred return.
22

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Consolidated Funds – principal transaction, net
Purchases and sales of securities, net of commissions, derivative contracts, and the related revenues and expenses are recorded on a trade-date basis with net trading gains and losses included as a component of Consolidated Funds - Principal transactions, net in the accompanying condensed consolidated statements of operations.
Certain of the Companies Consolidated Funds invest in other investment funds for which the Company applies the practical expedient provided by the US GAAP fair value measurements and disclosures guidance relating to investments in certain entities that calculate net asset value (“NAV”) per share (or its equivalent). The practical expedient permits an entity holding investments in certain entities that either are investment companies or have attributes similar to an investment company, and calculate NAV per share or its equivalent for which the fair value is not readily determinable, to measure the fair value of such investments on the basis of that NAV per share, or its equivalent, without adjustment. Investments which are valued using NAV per share as a practical expedient are not categorized within the fair value hierarchy. Realized and unrealized gains (losses) resulting from changes in NAV per share are reflected within Consolidated Funds – Principal transaction, net.
Interest and dividends
Interest and dividends are earned by the Company from various sources. The Company receives interest and dividends primarily from securities finance activities and securities held by the Company for purposes of investing capital, investments held by its Consolidated Funds and its brokerage balances. Interest is recognized in accordance with US GAAP and market convention for the imputation of interest of the host financial instrument. Interest income is recognized on the debt of those issuers that is deemed collectible. Interest income and expense includes premiums and discounts amortized and accreted on debt investments based on criteria determined by the Company using the effective yield method, which assumes the reinvestment of all interest payments. Dividends are recognized on the ex-dividend date.
Insurance and reinsurance
Premiums for insurance and reinsurance contracts are earned over the coverage period. In most cases, premiums are recognized as revenues ratably over the term of the contract with unearned premiums computed on a monthly basis. For each of its contracts, the Company determines if the contract provides indemnification against loss or liability relating to insurance risk, in accordance with US GAAP. If the Company determines that a contract does not expose it to a reasonable possibility of a significant loss from insurance risk, the Company records the contract under the deposit method of accounting with any net amount receivable reflected as an asset in other assets, and any net amount payable reflected as a liability within accounts payable, accrued expenses and other liabilities on the condensed consolidated statements of financial condition.
The liabilities for losses and loss adjustment expenses are recorded at the estimated ultimate payment amounts, including reported losses.  Estimated ultimate payment amounts are based upon (1) reports of losses from policyholders, (2) individual case estimates and (3) estimates of incurred but unreported losses.
Provisions for losses and loss adjustment expenses are charged to earnings after deducting amounts recovered and estimates of recoverable amounts and are included in other expenses on the condensed consolidated statements of operations.
Costs of acquiring new policies, which vary with and are directly related to the production of new policies, have been deferred to the extent that such costs are deemed recoverable from future premiums or gross profits. Such costs include commissions and allowances as well as certain costs of policy issuance and underwriting and are included within other assets in the condensed consolidated statements of financial condition.
All of the items above are reported net of any Outward Reinsurance (see Note 18), which is determined as the portion of the Company’s premiums, liabilities for losses and loss adjustment expenses, provisions for losses and loss adjustment expenses, and costs of acquiring new policies that are ceded to providers of such Outward Reinsurance pursuant to their terms and conditions. These ceded amounts are calculated based on the same principles outlined above.
Interest and dividends expense
Interest and dividends expense relates primarily to securities finance activities, trading activity with respect to the Company's investments and interest expense on debt.
p.    Income taxes
The Company accounts for income taxes in accordance with US GAAP which requires the recognition of tax benefits or expenses based on the estimated future tax effects of temporary differences between the financial statement and tax basis of its assets and liabilities. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. Valuation allowances are established to reduce deferred tax assets to an amount that is more likely
23

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
than not to be realized. The Company evaluates its deferred tax assets for recoverability considering negative and positive evidence, including its historical financial performance, projections of future taxable income, future reversals of existing taxable temporary differences, and tax planning strategies. The Company records a valuation allowance against its deferred tax assets to bring them to a level that it is more likely than not to be utilized.
US GAAP clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements, requiring the Company to determine whether a tax position is more likely than not to be sustained upon examination, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For tax positions meeting the more likely than not threshold, the tax amount recognized in the financial statements is reduced by the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant taxing authority. The Company recognizes accrued interest and penalties related to its uncertain tax positions as a component of income tax expense.
In accordance with federal and state tax laws, the Company and its subsidiaries file consolidated federal, state, and local income tax returns as well as stand-alone state and local tax returns. The Company also has subsidiaries that are residents in foreign countries where tax filings have to be submitted on a stand-alone or combined basis. These subsidiaries are subject to taxes in their respective countries and the Company is responsible for and therefore reports all taxes incurred by these subsidiaries in the condensed consolidated statements of operations. The foreign jurisdictions where the Company owns subsidiaries and has tax filing obligations are the United Kingdom, Luxembourg, Malta, Germany, Switzerland, Israel, South Africa, Canada and Hong Kong.
q.    Recent pronouncements
In August 2020, the FASB issued guidance simplifying an issuer’s accounting for convertible instruments by eliminating two of the three models in ASC 470-20 that require separate accounting for embedded conversion features; separate accounting is still required in certain cases. The guidance also simplifies the settlement assessment that entities are required to perform to determine whether a contract qualifies for equity classification. The guidance requires entities to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of potential share settlement (if the effect is more dilutive) for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. The guidance requires new disclosures about events that occur during the reporting period and cause conversion contingencies to be met and about the fair value of a public business entity’s convertible debt at the instrument level. For public business entities, the guidance is effective for reporting periods beginning after December 15, 2021 and interim periods within those fiscal years with early adoption permitted. The Company adopted the guidance as of January 1, 2022 under the modified retrospective method. With the adoption of this guidance, the Company is required to include the portion of the Series A Convertible Preferred Stock that can be settled in Class A common stock (the amount in excess of $1,000.00 per share of the Series A Convertible Preferred Stock) in the diluted earnings per share calculation. See Note 21 for the calculation of diluted earnings per share.
In August 2018, the FASB issued guidance prescribing targeted improvements to financial services – insurance industry accounting guidance for long-duration contracts. The new guidance (i) prescribes the discount rate to be used in measuring the liability for future policy benefits for traditional and limited payment long-duration contracts, and requires assumptions for those liability valuations to be updated after contract inception, (ii) requires more market-based product guarantees on certain separate account and other account balance long-duration contracts to be accounted for at fair value, (iii) simplifies the amortization of deferred acquisition costs for virtually all long-duration contracts, and (iv) introduces certain financial statement presentation requirements, as well as significant additional quantitative and qualitative disclosures. For all entities, the guidance is effective for reporting periods beginning after December 15, 2022 and interim periods within those fiscal years with early adoption permitted. The Company is currently evaluating the impact of the new guidance.
3. Acquisition
Malta
On February 26, 2021 (the "Malta Acquisition Date"), the Company, through its indirect wholly owned subsidiary, Cowen Malta Holdings Ltd. (“Malta Holdings”), completed the acquisition of all of the outstanding equity interest of Axeria Insurance Limited (the “Malta Acquisition”), an insurance company organized under the laws of Malta whose principal business activity is to provide insurance coverage to third parties (see Note 18). Axeria Insurance Limited was renamed Cowen Insurance Company Ltd (“Cowen Insurance Co”) upon acquisition. The Malta Acquisition was completed for a combination of cash and deferred consideration. In the aggregate, the purchase price, assets acquired, and liabilities assumed were not significant and near-term impact to the Company and its consolidated results of operations and cash flows is not expected to be significant.
24

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
The aggregate estimated purchase price of the Malta Acquisition was $12.7 million. On the Malta Acquisition Date, the Company paid upfront consideration of $12.5 million, with additional deferred consideration of $0.2 million which was paid during the second quarter of 2021.
The Malta Acquisition was accounted for under the acquisition method of accounting in accordance with US GAAP. As such, the results of operations of the business acquired is included in the accompanying condensed consolidated statements of operations since the date of the Malta Acquisition and the assets acquired, liabilities assumed recorded at their fair values within their respective line items on the accompanying condensed consolidated statement of financial condition. The Company has recognized a bargain purchase gain of $5.2 million related to the Malta Acquisition and is shown net of associated tax of $1.3 million in the condensed consolidated statement of operations. The bargain purchase gain is primarily driven by the recognition of the customer relationships intangible asset and a contractual discount on the closing equity balance at the Malta Acquisition Date. Additionally, following the Malta Acquisition, the business acquired is included in the Cowen Investment Management reporting unit within the Operating Company segment.
The table below summarizes the purchase price allocation of net tangible and intangible assets acquired and liabilities assumed as of February 26, 2021:
(dollars in thousands)
Cash$14,844 
Securities owned, at fair value1,571 
Fixed assets30 
Intangible assets4,794 
Other assets12,828 
Compensation payable(17)
Other liabilities(16,099)
Total net identifiable assets acquired and liabilities assumed17,951 
Bargain purchase gain(5,216)
Total estimated purchase price$12,735 
As of the Malta Acquisition Date, the estimated fair value of the Company's intangible assets, which are primarily broker relationships, was $4.6 million and had a weighted average useful life of 10 years. The licenses of $0.2 million has indefinite life. Amortization expense for the three months ended March 31, 2022 was $0.1 million and for the three months ended March 31, 2021 was insignificant.
As of March 31, 2022, the estimated amortization expense related to these intangible assets in future periods is as follows:
 (dollars in thousands)
2022343 
2023458 
2024458 
2025458 
2026458 
Thereafter2,124 
$4,299 
In addition to the purchase price consideration, for the three months ended March 31, 2021, the Company had incurred acquisition-related expenses of $0.2 million, including financial advisory, legal and valuation services, which are included in professional, advisory and other fees in the accompanying condensed consolidated statements of operations.
4. Cash Collateral Pledged    
As of March 31, 2022 and December 31, 2021, the Company pledged cash collateral in the amount of $3.4 million and $3.4 million respectively, which relates to letters of credit issued to the landlords of the Company's premises in New York City, Boston and San Francisco. The Company also has pledged cash collateral for reinsurance agreements which amounted to $49.5 million, as of March 31, 2022, and $44.1 million, as of December 31, 2021, which are expected to be released periodically as per the terms of the reinsurance policy between March 31, 2022 and March 31, 2024 (see Notes 12 and 18).
As of March 31, 2022, the Company has the following irrevocable letters of credit, related to leased office space, for which there is cash collateral pledged, which the Company pays a fee on the stated amount of the letter of credit.
25

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
LocationAmountMaturity
 (dollars in thousands)
New York$209 April 2023
New York$1,325 October 2022
New York$1,226 August 2022
Boston$188 March 2023
San Francisco$454 October 2025
$3,402 
To the extent any letter of credit is drawn upon, interest will be assessed at the prime commercial lending rate. As of March 31, 2022 and December 31, 2021 there were no amounts due related to these letters of credit.
5. Segregated Cash
As of March 31, 2022 and December 31, 2021, cash segregated under federal regulations and other restricted deposits of $220.9 million and $194.7 million, respectively, consisted of cash deposited in Special Reserve Bank Accounts for the exclusive benefit of customers under SEC Rule 15c3-3 and cash deposited in Special Reserve Bank Accounts for the exclusive benefit of Proprietary Accounts of Broker-Dealers ("PAB") under SEC Rule 15c3-3 (see Note 24).
6. Investments of Operating Entities and Consolidated Funds
a.    Operating entities
Securities owned, at fair value
Securities owned, at fair value are held by the Company and are considered held for trading. Substantially all equity securities, which are not part of the Company's self-clearing securities finance activities, are pledged to external clearing brokers under terms which permit the external clearing broker to sell or re-pledge the securities to others subject to certain limitations.
As of March 31, 2022 and December 31, 2021, securities owned, at fair value consisted of the following:
As of March 31, 2022As of December 31, 2021
 (dollars in thousands)
Common stock$2,348,243 $2,428,820 
Preferred stock190,184 134,930 
Warrants and rights53,082 46,459 
Government bonds11,992 16,002 
Corporate bonds146,998 21,468 
Convertible bonds5,250 5,250 
Term loan 2,375 3,907 
Trade claims (*)4,840 3,496 
Private investments550 410 
$2,763,514 $2,660,742 
(*)The Company has elected the fair value option for securities owned, at fair value with a fair value of $4.8 million and $3.5 million of trade claims respectively, at March 31, 2022 and December 31, 2021.
Receivable on and Payable for derivative contracts, at fair value
The Company predominantly enters into derivative transactions to satisfy client needs and to manage its own exposure to market and credit risks resulting from its trading activities. The Company’s direct exposure to derivative financial instruments includes futures, currency forwards, equity swaps, interest rate swaps and options. The Company's derivatives trading activities
26

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
expose the Company to certain risks, such as price and interest rate fluctuations, volatility risk, credit risk, counterparty risk, foreign currency movements and changes in the liquidity of markets.
The Company's long and short exposure to derivatives is as follows:
Receivable on derivative contractsAs of March 31, 2022As of December 31, 2021
 Number of contracts / Notional ValueFair valueNumber of contracts / Notional ValueFair value
 (dollars in thousands)
Currency forwards$11,482 $109 $10,727 $80 
Equity swaps$2,077,076 388,875 $1,950,181 305,370 
Options (a)120,847 49,801 217,393 61,219 
Interest rate swap (c)$427,000 19,839 $285,000 1,208 
Netting - swaps (b)(115,912)(81,742)
$342,712 $286,135 
Payable for derivative contracts
As of March 31, 2022As of December 31, 2021
 Number of contracts / Notional ValueFair valueNumber of contracts / Notional ValueFair value
 (dollars in thousands)
Futures$2,567 $53 $9,378 $266 
Currency forwards$138,530 1,084 $149,575 1,346 
Equity swaps$825,229 152,265 $988,329 114,689 
Options (a)117,871 25,214 182,440 36,192 
Netting - swap (b)(131,802)(92,330)
$46,814 $60,163 
(a) Includes the volume of contracts for index, equity, commodity future and cash conversion options.
(b) Derivatives are reported on a net basis, by counterparty, when a legal right of offset exists under an enforceable netting agreement as well as net of cash collateral received or posted under enforceable credit support agreements. See Note 2f for further information on offsetting of derivative financial instruments.
(c) Interest rate swap offsetting the Company's floating rate debt on the Company's term loan. See Note 12
The following tables present the gross and net derivative positions and the related offsetting amount, as of March 31, 2022 and December 31, 2021. This table does not include the impact of over-collateralization.
Gross amounts offset on the Condensed Consolidated Statements of Financial Condition (a)
Net amounts included on the Condensed Consolidated Statements of Financial Condition
Gross amounts not offset in the Condensed Consolidated Statements of Financial Condition
Gross amounts recognizedFinancial instruments (a)Cash Collateral pledged (a)Net amounts
(dollars in thousands)
As of March 31, 2022
Receivable on derivative contracts, at fair value$458,624 $115,912 $342,712 $1,431 $256,061 $85,220 
Payable for derivative contracts, at fair value178,616 131,802 46,814 2,840 — 43,974 
As of December 31, 2021
Receivable on derivative contracts, at fair value$367,877 $81,742 $286,135 $1,421 $211,442 $73,272 
Payable for derivative contracts, at fair value152,493 92,330 60,163 2,839 — 57,324 
(a)Includes financial instruments subject to enforceable master netting provisions that are permitted to be offset to the extent an event of default has occurred.
The realized and unrealized gains/(losses) related to derivatives trading activities were $(37.8) million and $35.5 million for the three months ended March 31, 2022 and 2021, respectively, and are included in Investment income- Securities principal
27

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
transactions, net in the accompanying condensed consolidated statements of operations. The net gains (losses) on derivative contracts in the table above are one of a number of activities comprising the Company's business activities and are calculated before consideration of economic hedging transactions, which generally offset the net gains (losses) included above.
Pursuant to the various derivatives transactions discussed above, except for exchange traded derivatives and certain options, the Company is required to post/receive collateral. These amounts are recognized in receivable from brokers, dealers and clearing organizations and payable to brokers, dealers and clearing organizations respectively. As of March 31, 2022 and December 31, 2021, all derivative contracts were with major financial institutions.
Other investments
As of March 31, 2022 and December 31, 2021, other investments included the following:
As of March 31, 2022As of December 31, 2021
 (dollars in thousands)
Portfolio funds, at fair value (1)$131,766 $137,986 
Carried interest (2)70,281 88,925 
Equity method investments (3)35,581 47,200 
$237,628 $274,111 
(1) Portfolio funds, at fair value
The portfolio funds, at fair value as of March 31, 2022 and December 31, 2021, included the following:
As of March 31, 2022As of December 31, 2021
(dollars in thousands)
HealthCare Royalty Partners LP (a)(*)$791 $832 
HealthCare Royalty Partners II LP (a)(*)1,241 1,259 
Eclipse Ventures Fund I, L.P. (b)6,348 5,829 
Eclipse Ventures Fund II, L.P. (b)2,359 2,354 
Eclipse Continuity Fund I, L.P. (b)1,827 1,641 
Starboard Value and Opportunity Fund LP (c)(*)48,246 49,252 
Starboard Value and Opportunity Fund Ltd (c) (*)2,675 2,732 
Lagunita Biosciences, LLC (d)5,227 5,671 
Starboard Leaders Fund LP (e)(*)2,826 2,823 
Formation8 Partners Fund I, L.P. (f)19,949 20,992 
BDC Fund I Coinvest 1, L.P. (g) 1,250 1,250 
Difesa Partners, LP (h) 971 1,017 
Cowen Sustainable Investments I LP (i)(*)12,879 13,102 
Cowen Healthcare Investments II LP (i) (*)9,524 13,055 
Cowen Healthcare Investments III LP (i)(*)6,847 8,426 
Cowen Healthcare Investments IV LP (i)(*)1,987 1,071 
Eclipse SPV I, LP (j)(*)1,445 1,445 
TriArtisan ES Partners LLC (k)(*)1,805 1,805 
TriArtisan PFC Partners LLC (l)(*)1,177 1,112 
Ramius Merger Fund LLC (m)(*)1,760 1,692 
Other private investment (n)(*)294 303 
Other affiliated funds (o)(*)338 323 
$131,766 $137,986 
* These portfolio funds are affiliates of the Company.
The Company has no unfunded commitments regarding the portfolio funds held by the Company except as noted in Note 22.
(a)HealthCare Royalty Partners, L.P. and HealthCare Royalty Partners II, L.P. are private equity funds and therefore distributions will be made when cash flows are received from the underlying investments, typically on a quarterly basis.
28

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
(b)Each of Eclipse Ventures Fund I, L.P., Eclipse Ventures Fund II, L.P. and Eclipse Continuity Fund I, L.P. are venture capital funds which invests in early stage and growth stage hardware companies. Distributions will be made when the underlying investments are liquidated.
(c)Starboard Value and Opportunity Fund LP and Starboard Value and Opportunity Fund Ltd permits quarterly withdrawals upon 90 days' notice.
(d)Lagunita Biosciences, LLC, is a healthcare investment company that creates and grows early stage companies to commercialize impactful translational science that addresses significant clinical needs, is a private equity structure and therefore distributions will be made when the underlying investments are liquidated.
(e)Starboard Leaders Fund LP does not permit withdrawals, but instead allows terminations with respect to capital commitments upon 30 days' prior written notice at any time following the first anniversary of an investor's initial capital contribution.
(f)Formation8 Partners Fund I, L.P. is a private equity fund which invests in early stage and growth transformational information and energy technology companies. Distributions will be made when the underlying investments are liquidated.
(g)BDC Fund I Coinvest 1, L.P. is a private equity fund focused on investing in growth companies in industries disrupted by digitization. Distributions will be made when the underlying investments are liquidated.
(h)Difesa Partners, LP permits semi-annual withdrawals occurring on or after the anniversary of initial contribution upon 90 days written notice.
(i)Cowen Sustainable Investments I LP, Cowen Healthcare Investments II LP, Cowen Healthcare Investments III LP and Cowen Healthcare Investments IV LP are private equity funds.  Distributions are made from the fund when cash flows or securities are received from the underlying investments. Investors do not have redemption rights.
(j)Eclipse SPV I, L.P. is a co-investment vehicle organized to invest in a private company focused on software-driven automation projects.  Distributions will be made when the underlying investments are liquidated.
(k)TriArtisan ES Partners LLC is a co-investment vehicle organized to invest in a privately held nuclear services company. Distributions will be made when the underlying investment is liquidated.
(l)TriArtisan PFC Partners LLC is a co-investment vehicle organized to invest in a privately held casual dining restaurant chain. Distributions will be made when the underlying investment in liquidated.
(m)Ramius Merger Fund LLC permits monthly withdrawals on 45 days prior notice.
(n)Other private investment represents the Company's closed end investment in a portfolio fund that invests in a wireless broadband communication provider in Italy.
(o)The majority of these investment funds are affiliates of the Company or are managed by the Company and the investors can redeem from these funds as investments are liquidated.
(2)Carried interest
The Company applies an accounting policy election to recognize incentive income allocated to the Company under an equity ownership model in other investments in the accompanying condensed consolidated statements of financial condition (see Note 2o). Carried interest allocated to the Company from certain portfolio funds represents Cowen's general partner capital accounts from those funds. These balances are subject to change upon cash distributions, additional allocations or reallocations back to limited partners within the respective funds. All carried interest balances are earned from affiliates of the Company.
A portion of the Company's carried interest is granted to employees through profit sharing awards designed to more closely align compensation with the overall realized performance of the Company. These arrangements enable certain employees to earn compensation based on performance revenue earned by the Company and are recorded within compensation payable in the accompanying condensed consolidated statements of financial condition and employee compensation and benefits expense in the accompanying condensed consolidated statements of operation based on the probable and estimable payments under the terms of the awards. 
29

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
The carried interest as of March 31, 2022 and December 31, 2021, included the following:
As of March 31, 2022As of December 31, 2021
(dollars in thousands)
Cowen Healthcare Investments II LP$13,886 $23,327 
Cowen Healthcare Investments III LP11,510 18,523 
Cowen Sustainable Investments I LP6,725 7,436 
Cowen Sustainable Investments Offshore I LP8,114 9,196 
CSI I Prodigy Co-Investment LP2,241 2,436 
CSI PRTA Co- Investment LP8,682 9,535 
TriArtisan TGIF Partners LLC4,279 4,047 
TriArtisan ES Partners LLC3,389 3,401 
TriArtisan PFC Partners LLC10,408 9,394 
Ramius Multi-Strategy Fund LP555 587 
Ramius Merger Fund LLC 368 861 
RCG IO Renergys Sarl124 136 
Other affiliated funds— 46 
$70,281 $88,925 
(3) Equity method investments
Equity method investments include investments held by the Company in several operating companies. The operating agreement that governs the management of day-to-day operations and affairs of these entities stipulates that certain decisions require support and approval from other members in addition to the support and approval of the Company. As a result, all operating decisions made in these entities requires the support of both the Company and an affirmative vote of a majority of the other managing members who are not affiliates of the Company. As the Company does not possess control over any of these entities, the presumption of consolidation has been overcome pursuant to current Accounting Standards and the Company accounts for these investments under the equity method of accounting. Included in equity method investments are the investments in (a) HealthCare Royalty Partners General Partners (b) Starboard Value (and certain related parties) which serves as an operating company whose operations primarily include the day-to-day management (including portfolio management) of several activist investment funds and related managed accounts and (c) operating companies whose operations primarily include the day-to-day management of real estate entities. The Company recorded no impairment charges in relation to its equity method investments for the three months ended March 31, 2022 and 2021.
The Company elected to use the cumulative earnings approach for the distributions it receives from its equity method investments. Under the cumulative earnings approach, any distributions received up to the amount of cumulative earnings are treated as return on investment and classified in operating activities within the cash flows. Any excess distributions would be considered as return of investments and classified in investing activities.
The following table summarizes equity method investments held by the Company:
As of March 31, 2022As of December 31, 2021
(dollars in thousands)
Starboard Value LP$25,741 $36,889 
HealthCare Royalty GP III, LLC 1,830 1,957 
HealthCare Royalty GP, LLC 1,595 1,451 
HealthCare Royalty GP II, LLC 210 213 
HealthCare Royalty GP IV, LLC1,618 1,716 
RCG Longview Debt Fund IV Management, LLC331 331 
HCR Overflow Fund GP, LLC774 839 
 HCRP MGS Account Management, LLC 114 598 
HCR Stafford Fund GP, LLC3,119 2,955 
Other249 251 
$35,581 $47,200 
The Company's income from equity method investments was $5.6 million and $12.6 million and for the three months ended March 31, 2022 and 2021, respectively, and is included in net gains (losses) on other investments on the accompanying condensed consolidated statements of operations.
30

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Securities sold, not yet purchased, at fair value
Securities sold, not yet purchased, at fair value represent obligations of the Company to deliver a specified security at a contracted price and, thereby, create a liability to purchase that security at prevailing prices. The Company's liability for securities to be delivered is measured at their fair value as of the date of the condensed consolidated financial statements. However, these transactions result in off-balance sheet risk, as the Company's ultimate cost to satisfy the delivery of securities sold, not yet purchased, at fair value may exceed the amount reflected in the accompanying condensed consolidated statements of financial condition. As of March 31, 2022 and December 31, 2021, securities sold, not yet purchased, at fair value consisted of the following:
 As of March 31, 2022As of December 31, 2021
 (dollars in thousands)
Common stock$956,228 $1,192,396 
Corporate bonds1,349 37 
Preferred stock17,278 9,009 
Warrants and rights12 
$974,867 $1,201,448 
Securities purchased under agreements to resell/securities sold under agreements to repurchase and securities lending and borrowing transactions
The following tables present the contractual gross and net securities borrowing and lending agreements and securities sold under agreements to repurchase and the related offsetting amount as of March 31, 2022 and December 31, 2021.
Gross amounts not offset on the Condensed Consolidated Statements of Financial Condition
Gross amounts recognized, net of allowance
Gross amounts offset on the Condensed Consolidated Statements of Financial Condition (a)
Net amounts included on the Condensed Consolidated Statements of Financial Condition
Additional Amounts AvailableFinancial instrumentsCash Collateral pledged (b)Net amounts
(dollars in thousands)
As of March 31, 2022
Securities borrowed$1,761,146 $— $1,761,146 $— $1,661,310 $— $99,836 
Securities loaned1,735,852 — 1,735,852 — 1,706,171 — 29,681 
Securities purchased under agreements to resell19,621 — 19,621 — 21,035 — (1,414)
Securities sold under agreements to repurchase229,192 — 229,192 — 249,116 — (19,924)
As of December 31, 2021
Securities borrowed1,704,603 — 1,704,603 — 1,652,007 — 52,596 
Securities loaned1,586,572 — 1,586,572 — 1,592,140 — (5,568)
Securities sold under agreements to repurchase$63,469 $— $63,469 $— $74,443 $— $(10,974)
(a)Includes financial instruments subject to enforceable master netting provisions that are permitted to be offset to the extent an event of default has occurred.
(b)Includes the amount of cash collateral held/posted.
The following tables present gross obligations for securities loaned and securities sold under agreements to repurchase by remaining contractual maturity and class of collateral pledged as of March 31, 2022 and December 31, 2021:
31

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Open and OvernightUp to 30 days31 - 90 daysGreater than 90 daysTotal
(dollars in thousands)
As of March 31, 2022
Securities loaned
    Common stock$1,728,578 $— $— $— $1,728,578 
    Corporate bonds7,274 — — — 7,274 
Securities purchased under agreements to resell
     Corporate bonds19,621 — — — 19,621 
Securities sold under agreements to repurchase
    Common stock— 43,073 — — 43,073 
    Corporate bonds186,119 — — — 186,119 
As of December 31, 2021
Securities loaned
    Common stock$1,570,835 $— $— $— 1,570,835 
    Corporate bonds15,737 — — — 15,737 
Securities sold under agreements to repurchase
    Common stock— 20,906 42,563 — 63,469 
Variable Interest Entities
The total assets and liabilities of the variable interest entities for which the Company has concluded that it holds a variable interest, but for which it is not the primary beneficiary, are $9.1 billion and $692.4 million as of March 31, 2022 and $9.7 billion and $744.5 million as of December 31, 2021, respectively. The carrying value of the Company's exposure to loss for these variable interest entities as of March 31, 2022 was $155.1 million, and as of December 31, 2021 was $165.5 million, all of which is included in other investments, at fair value in the accompanying condensed consolidated statements of financial condition. Additionally, the Company's maximum exposure to loss for the variable interest entities noted above as of March 31, 2022 and December 31, 2021, was $224.7 million and $233.6 million, respectively.  The maximum exposure to loss often differs from the carrying value of exposure to loss of the variable interests. The maximum exposure to loss is dependent on the nature of the variable interests in the VIEs and is limited to the notional amounts of certain commitments and guarantees.
b.    Consolidated Funds
Other investments, at fair value
Investments in portfolio funds, at fair value
As of March 31, 2022 and December 31, 2021, investments in portfolio funds, at fair value, included the following:
As of March 31, 2022As of December 31, 2021
(dollars in thousands)
Investments of Enterprise LP$97,182 $99,067 
$97,182 $99,067 
Consolidated portfolio fund investments of Enterprise LP    
On May 12, 2010, the Company announced its intention to close its master fund, Ramius Enterprise Master Fund Ltd ("Enterprise Master"). Enterprise LP operated under a "master-feeder" structure up until January 1, 2019, when Enterprise Master distributed its capital to each feeder and was liquidated. As of March 31, 2022 and December 31, 2021, the consolidated investments in portfolio funds include Enterprise LP's investment in RCG Special Opportunities Fund, Ltd which is a portfolio fund that invests in a limited number of private equity investments directly as well as through affiliated portfolio funds.
Indirect Concentration of the Underlying Investments Held by Consolidated Funds
From time to time, either directly held by the Company, indirectly through the Company's consolidated entities or indirectly through its investments in the Consolidated Funds, the Company may maintain exposure to a particular issue or issuer (both long and/or short) which may account for 5% or more of the Company's equity. Based on information that is available to the Company as of March 31, 2022 and December 31, 2021, the Company assessed whether or not its interests in an issuer for which the
32

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Company's pro-rata share exceeds 5% of the Company's equity. There was one indirect concentration that exceeded 5% of the Company's equity as of March 31, 2022 and December 31, 2021, respectively.
Through its investments in a Consolidated Fund and combined with direct Company investments, the Company maintained exposure to a particular investment which accounted for 5% or more of the Company's equity.
Investment's percentage of the Company's stockholders' equity
IssuerSecurity TypeCountryIndustryPercentage of Stockholders' EquityMarket Value
(dollars in thousands)
As of March 31, 2022Linkem S.p.A.Equity and warrantsItalyWireless Broadband7.87 %$81,498 
As of December 31, 2021Linkem S.p.A.Equity and warrantsItalyWireless Broadband8.22 %$83,537 
7. Fair Value Measurements for Operating Entities and Consolidated Funds
The following table presents the assets and liabilities that are measured at fair value on a recurring basis on the accompanying condensed consolidated statements of financial condition by caption and by level within the valuation hierarchy as of March 31, 2022 and December 31, 2021:
 Assets at Fair Value as of March 31, 2022
 Level 1Level 2Level 3Netting (c)Total
  (dollars in thousands) 
Operating Entities
    Securities owned, at fair value 
Government bonds$11,992 $— $— $— $11,992 
Preferred stock20,483 — 169,701 — 190,184 
Common stock2,304,895 3,517 39,831 — 2,348,243 
Convertible bonds— — 5,250 — 5,250 
Corporate bonds28,892 115,680 2,426 — 146,998 
Trade claims— — 4,840 — 4,840 
Term loan— 2,375 — — 2,375 
Warrants and rights34,525 — 18,557 — 53,082 
Private investments— — 550 — 550 
    Receivable on derivative contracts, at fair value
Currency forwards— 109 — — 109 
Equity swaps— 388,875 — (115,912)272,963 
Options49,573 — 228 — 49,801 
Interest rate swap— 19,839 — — 19,839 
$2,450,360 $530,395 $241,383 $(115,912)$3,106,226 
Portfolio funds measured at net asset value (a)131,766 
Consolidated Funds' portfolio funds measured at net asset value (a)97,182 
Carried interest (a)70,281 
Equity method investments (a)35,581 
Total investments $3,441,036 
33

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
 Liabilities at Fair Value as of March 31, 2022
 Level 1Level 2Level 3Netting (c)Total
 (dollars in thousands)
Operating Entities
     Securities sold, not yet purchased, at fair value    
Common stock$858,685 $97,543 $— $— $956,228 
Corporate bonds— 1,349 — — 1,349 
Preferred stock17,278 — — — 17,278 
Warrants and rights12 — — — 12 
    Payable for derivative contracts, at fair value
Futures53 — — 53 
Currency forwards— 1,084 — — 1,084 
Equity swaps— 152,265 — (131,802)20,463 
Options22,135 — 3,079 — 25,214 
Accounts payable, accrued expenses and other liabilities
          Contingent consideration liability (b)— — 57,339 — 57,339 
$898,163 $252,241 $60,418 $(131,802)$1,079,020 
(a) In accordance with US GAAP, portfolio funds are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not classified in the fair value hierarchy. Carried interest and equity method investments presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the condensed consolidated statement of financial condition.
(b) In accordance with the terms of the purchase agreements for acquisitions that closed during the first quarter of 2019 (the acquisition of Quarton International AG "Quarton"), the fourth quarter of 2020 (the acquisition of MHT Partners, LP "MHT") and the fourth quarter of 2021 (the acquisition of Portico Capital Advisors "Portico"), the Company is required to pay to the sellers a portion of future net income and/or revenues of the acquired businesses, if certain targets are achieved through the periods ended through December 31, 2024. For all acquisitions the Company estimated the contingent consideration liabilities using a combination of Monte Carlo and Discounted Cash Flow methods which require the Company to make estimates and assumptions regarding the future cash flows and profits. Changes in these estimates and assumptions could have a significant impact on the amounts recognized. The undiscounted amounts for the Quarton acquisition can range from $12.5 million to $14.9 million. The undiscounted amounts for the MHT acquisition have no minimum or maximum as it is calculated based on revenue. The undiscounted amounts for the Portico acquisition can range from zero to $58.0 million.
(c) Derivatives are reported on a net basis, by counterparty, when a legal right of offset exists under an enforceable netting agreement as well as net of cash collateral received or posted under enforceable credit support agreements. See Note 2f for further information on offsetting of derivative financial instruments.
34

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
 Assets at Fair Value as of December 31, 2021
 Level 1Level 2Level 3Netting (c)Total
  (dollars in thousands) 
Operating Entities
    Securities owned, at fair value    
Government bonds$16,002 $— $— $— $16,002 
Preferred stock12,299 — 122,631 — 134,930 
Common stock2,396,041 121 32,658 — 2,428,820 
Convertible bonds— — 5,250 — 5,250 
Corporate bonds— 19,049 2,419 — 21,468 
Trade claims— — 3,496 — 3,496 
Term loan— 3,907 — — 3,907 
Private investments— — 410 — 410 
Warrants and rights31,056 — 15,403 — 46,459 
    Receivable on derivative contracts, at fair value
Currency forwards— 80 — — 80 
Equity swaps— 305,370 — (81,742)223,628 
Options60,985 — 234 — 61,219 
Interest rate swap— 1,208 — 1,208 
$2,516,383 $329,735 $182,501 $(81,742)$2,946,877 
Portfolio funds measured at net asset value (a)137,986 
Consolidated Funds' portfolio funds measured at net asset value (a)99,067 
Carried interest (a)88,925 
Equity method investments (a)47,200 
Total investments$3,320,055 
 Liabilities at Fair Value as of December 31, 2021
 Level 1Level 2Level 3Netting (c)Total
 (dollars in thousands)
Operating Entities
Securities sold, not yet purchased, at fair value    
Common stock$1,192,396 $— $— $— $1,192,396 
Corporate bonds— 37 — — 37 
Preferred stock9,009 — — — 9,009 
Warrants and rights— — — 
Payable for derivative contracts, at fair value
Futures266 — — — 266 
Currency forwards— 1,346 — — 1,346 
Equity swaps— 114,689 — (92,330)22,359 
Options32,773 — 3,419 — 36,192 
Accounts payable, accrued expenses and other liabilities
          Contingent consideration liability (b)— — 62,223 — 62,223 
$1,234,450 $116,072 $65,642 $(92,330)$1,323,834 
(a) In accordance with US GAAP, portfolio funds are measured at fair value using the net asset value per share (or its equivalent) as a practical expedient are not classified in the fair value hierarchy. Carried interest and equity method investments presented in the table above are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the condensed consolidated statement of financial condition.
(b) In accordance with the terms of the purchase agreements for acquisitions that closed during the first quarter of 2019 (the Quarton acquisition), the fourth quarter of 2020 (the MHT acquisition) and the fourth quarter of 2021 (the Portico acquisition), the Company is required to pay to the sellers a portion of future net income and/or revenues of the acquired businesses, if certain targets are achieved through the periods ended through December 31, 2024. For all acquisitions the
35

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Company estimated the contingent consideration liabilities using a combination of Monte Carlo and Discounted Cash Flow methods which require the Company to make estimates and assumptions regarding the future cash flows and profits. Changes in these estimates and assumptions could have a significant impact on the amounts recognized. The undiscounted amounts for the Quarton acquisition can range from $10.1 million to $25.0 million. The undiscounted amounts for the MHT acquisition have no minimum or maximum as it is calculated based on revenue. The undiscounted amounts for the Portico acquisition can range from zero  to $58.0 million.
(c) Derivatives are reported on a net basis, by counterparty, when a legal right of offset exists under an enforceable netting agreement as well as net of cash collateral received or posted under enforceable credit support agreements. See Note 2f for further information on offsetting of derivative financial instruments.
The following table includes a roll forward of the amounts for the three months ended March 31, 2022 and 2021 for financial instruments classified within level 3. The classification of a financial instrument within level 3 is based upon the significance of the unobservable inputs to the overall fair value measurement.
Three Months Ended March 31, 2022
Balance at December 31, 2021Transfers inTransfers outPurchases/(covers)(Sales)/shortsRealized and Unrealized gains/lossesBalance at March 31, 2022Change in unrealized gains/losses relating to instruments still held (1)
(dollars in thousands)
Operating Entities
Preferred stock$122,631 $— $— $3,441 $(1,100)$44,729 $169,701 $44,729 
Common stock32,658 — — 2,018 (33)5,188 39,831 5,188 
Convertible bonds5,250 — — — — — 5,250 — 
Corporate bond2,419 — — — — 2,426 
Options, asset234 — — — — (6)228 (6)
Options, liability3,419 — — — — (340)3,079 (340)
Warrants and rights15,403 — — 414 — 2,740 18,557 2,740 
Trade claims3,496 — — 1,666 (615)293 4,840 293 
Private investments410 — — 353 (250)37 550 37 
Contingent consideration liability62,223 — — — (10,076)5,192 57,339 5,192 
Three Months Ended March 31, 2021
Balance at December 31, 2020Transfers inTransfers outPurchases/(covers)(Sales)/shortsRealized and Unrealized gains/lossesBalance at March 31, 2021Change in unrealized gains/losses relating to instruments still held (1)
(dollars in thousands)
Operating Entities
Preferred stock$59,967 $— $— $1,859 $(4,651)$(698)$56,477 $(698)
Common stock23,786 — (5,353)(a)3,226 (1,387)2,434 22,706 1,679 
Convertible bonds6,040 — — 1,050 (3,930)(23)3,137 (23)
Corporate Bond, asset135 — — 70 (49)(20)136 (49)
Options, asset251 — — — — (10)241 (10)
Options, liability3,915 — — — — (618)3,297 (618)
Warrants and rights6,547 — — 3,406 (1,206)(823)7,924 (895)
Term Loan12,623 — — 322 — (521)12,424 (521)
Trade claim8,713 — — 1,378 (4,216)30 5,905 (1,021)
Private investments642 — — 443 — — 1,085 — 
Corporate bond, liability704 — — — (289)— 415 — 
Government bonds, liability1,500 — — — (1,278)300 522 87 
Contingent consideration liability37,952 — — (11,312)— (7,061)19,579 (7,061)
Consolidated Funds
Common stock2,951 — — — — — 2,951 — 
Warrants and rights5,806 — — — (670)193 5,329 (477)
(1) Unrealized gains/losses are reported in Investment income - Securities principal transactions, net in the accompanying condensed consolidated statements of operations.
36

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
(a) The entity in which the Company is invested completed an initial public offering.
Certain assets and liabilities are measured at fair value on a nonrecurring basis and therefore are not included in the tables above.
The Company recognizes all transfers and the related unrealized gain (loss) at the beginning of the reporting period.
Transfers between level 2 and 3 generally relate to whether significant relevant observable inputs are available for the fair value measurements or due to change in liquidity restrictions for the investments.
The following table includes quantitative information as of March 31, 2022 and December 31, 2021 for financial instruments classified within level 3. The table below quantifies information about the significant unobservable inputs used in the fair value measurement of the Company's level 3 financial instruments.
Quantitative Information about Level 3 Fair Value Measurements
Fair Value
March 31, 2022
Valuation TechniquesUnobservable InputsRangeWeighted Average
Level 3 Assets(dollars in thousands)
Common and preferred stocks$75,253 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
12.5% - 20%
6.25x - 6.75x
13%
6.5x
Options228 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
12.5% - 13.5%
6.25x - 6.75x
13%
6.5x
Trade claims2,138 Discounted cash flowsDiscount rate
50%
50%
Warrants and rights5,986 
Discounted cash flows
Guideline companies
Option pricing model
Discount rate
EBITDA Market Multiples
Volatility
12.5% - 13.5%
6.25x - 6.75x
73% - 103%
13.0%
6.5x
97.2%
Other level 3 assets (a)157,778 
Total level 3 assets $241,383 
Level 3 Liabilities
Options3,079 
Discounted cash flows
Option pricing model
Discount rate
Volatility
2.29%
35%
2.29%
35%
Contingent consideration liability57,339 
Discounted cash flows
Monte Carlo simulation
Discount rate
Volatility
8.6% - 16%
20% - 22%
12.3%
20.9%
Total level 3 liabilities$60,418 
Quantitative Information about Level 3 Fair Value Measurements
Fair Value at December 31, 2021Valuation TechniquesUnobservable InputsRangeWeighted Average
Level 3 Assets(dollars in thousands)
Common and preferred stocks$76,491 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
12.5% - 20%
6.25x - 6.75x
13%
6.5x
Trade claims2,376 Discounted cash flowsDiscount rate
40%
40%
Warrants and rights4,483 
Discounted cash flows
Guideline companies
Option pricing model
Discount rate
EBITDA Market Multiples
Volatility
12.5% - 13.5%
6.25x - 6.75x
90% - 100%
13%
6.5x
95%
Options234 
Discounted cash flows
Guideline companies
Discount rate
EBITDA Market Multiples
12.5% - 13.5%
6.25x - 6.75x
13%
6.5x
Other level 3 assets (a)98,917 
Total level 3 assets $182,501 
Level 3 Liabilities
Options3,419 Option pricing modelVolatility
35%
35%
Contingent consideration liability 62,223 
Discounted cash flows
Monte Carlo simulation
Discount rate
Volatility
7% - 15%
20% - 24%
12%
22%
Total level 3 liabilities$65,642 
(a)The quantitative disclosures exclude financial instruments for which the determination of fair value is based on prices from recent transactions.
37

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
The Company has established valuation policies, procedures and internal control infrastructure over the fair value measurement of financial instruments. In the event that observable inputs are not available, the control processes are designed to ensure that the valuation approach utilized is applicable, reasonable and consistently applied. Where a pricing model is used to determine fair value, these control processes include reviews of the methodology and inputs for both reasonableness and applicability. Consistent with best practices, recently executed comparable transactions and other observable market data are used for the purposes of validating both the model and the assumptions used to calculate fair value. Independent of trading and valuation functions, the Company’s Valuation Committee in conjunction with its Price Verification team, plays an important role in determining that financial instruments are appropriately valued and that fair value measurements are both reasonable and reliable. This is particularly important where prices or valuations that require inputs are less observable. The Valuation Committee is comprised of senior management, including non-investment professionals, who are responsible for overseeing and monitoring the pricing of the Company's investments.
The US GAAP fair value leveling hierarchy is designated and monitored on an ongoing basis. In determining the designation, the Company takes into consideration a number of factors including the observability of inputs, liquidity of the investment and the significance of a particular input to the fair value measurement. Designations, models, pricing vendors, third party valuation providers and inputs used to derive fair market value are subject to review by the valuation committee and the internal audit group. The Company reviews its valuation policy guidelines on an ongoing basis and may adjust them in light of improved valuation metrics and models, the availability of reliable inputs and information, and prevailing market conditions. The Company regularly reviews a profit and loss report, as well as other periodic reports, and analyzes material changes from period to period in the valuation of its investments as part of its control procedures. The Company also performs back testing on a regular basis by comparing prices observed in executed transactions to previous valuations.
The fair market value for level 3 securities may be highly sensitive to the use of industry-standard models, unobservable inputs and subjective assumptions. The degree of fair market value sensitivity is also contingent upon the subjective weight given to specific inputs and valuation metrics. The Company holds various equity and debt instruments where different weight may be applied to industry-standard models representing standard valuation metrics such as: discounted cash flows, market multiples, comparative transactions, capital rates, recovery rates and timing, and bid levels. Generally, changes in the weights ascribed to the various valuation metrics and the significant unobservable inputs in isolation may result in significantly lower or higher fair value measurements. Volatility levels for warrants and options are not readily observable and subject to interpretation. The interrelationship between unobservable inputs may vary significantly amongst level 3 securities as they are generally highly idiosyncratic. Significant increases (decreases) in any of those inputs in isolation can result in a significantly lower (higher) fair value measurement.
Other financial assets and liabilities
The following table presents the carrying values and fair values, at March 31, 2022 and December 31, 2021, of financial assets and liabilities and information on their classification within the fair value hierarchy which are not measured at fair value on a recurring basis. For additional information regarding the financial instruments within the scope of this disclosure, and the methods and significant assumptions used to estimate their fair value (see Note 2e).
 March 31, 2022December 31, 2021Fair Value Hierarchy
 Carrying AmountFair ValueCarrying AmountFair Value
  (dollars in thousands) 
Financial Assets 
Operating companies
Cash and cash equivalents$512,978 $512,978 $914,343 $914,343 Level 1
Cash collateral pledged52,865 52,865 47,494 47,494 Level 2
Segregated cash220,882 220,882 194,701 194,701 Level 1
Securities purchased under agreements to resell19,621 19,621 — — Level 2
Securities borrowed1,761,146 1,761,146 1,704,603 1,704,603 Level 2
Loans receivable5,041 5,041 (b)4,858 4,858 (b)Level 3
Consolidated Funds
Cash and cash equivalents23 23 296 296 Level 1
Financial Liabilities
Securities sold under agreements to repurchase229,192 229,192 63,469 63,469 Level 2
Securities loaned1,735,852 1,735,852 1,586,572 1,586,572 Level 2
Notes payable and other debt625,766 (c)644,238 (a)623,371 (c)655,229 (a)Level 2
(a)Notes payable and other debt are based on the last broker quote available.
38

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
(b)The fair market value of level 3 loans is calculated using discounted cash flows where applicable.
(c)The carrying amount of the notes payable and other debt includes an unamortized discount and unamortized premium of $2.7 million and $0.2 million as of March 31, 2022, respectively, and unamortized discount and unamortized premium of $2.8 million and $0.3 million as of December 31, 2021, respectively.
8. Deposits with Clearing Organizations, Brokers and Banks
Under the terms of agreements between the Company and some of its clearing organizations, brokers and banks, balances owed are collateralized by certain of the Company's cash and securities balances. As of March 31, 2022 and December 31, 2021, the Company had a total of $105.9 million and $111.9 million, respectively, in deposit accounts with clearing organizations, brokers and banks that could be used as collateral to offset losses incurred by the clearing organizations, brokers and banks, on behalf of the Company's activities, if such losses were to occur.
9. Receivable From and Payable To Brokers, Dealers and Clearing Organizations
Receivable from and payable to brokers, dealers and clearing organizations includes cash held at the clearing brokers, amounts receivable or payable for unsettled transactions, monies borrowed and proceeds from short sales equal to the fair value of securities sold, not yet purchased, at fair value, which are restricted until the Company purchases the securities sold short. Pursuant to the master netting agreements the Company entered into with its brokers, dealers and clearing organizations, these balances are presented net (assets less liabilities) across balances with the same counterparty. The Company's receivable from and payable to brokers, dealers and clearing organizations balances are held at multiple financial institutions.
As of March 31, 2022 and December 31, 2021, amounts receivable from brokers, dealers and clearing organizations include:
As of March 31, 2022As of December 31, 2021
 (dollars in thousands)
Broker-dealers$1,342,242 $1,533,713 
Securities failed to deliver91,561 17,851 
Clearing organizations44,450 56,075 
Securities borrowed/loaned interest receivable9,658 6,708 
$1,487,911 $1,614,347 
As of March 31, 2022 and December 31, 2021, amounts payable to brokers, dealers and clearing organizations include:
As of March 31, 2022As of December 31, 2021
 (dollars in thousands)
Broker-dealers$419,423 $483,112 
Securities failed to receive95,201 57,894 
Clearing organizations62,804 37,925 
Securities borrowed/loaned interest payable10,112 7,622 
$587,540 $586,553 
10. Receivable From and Payable To Customers
As of March 31, 2022 and December 31, 2021, receivable from customers of $159.6 million and $159.4 million, respectively, consist of amounts owed by customers relating to securities transactions not completed on settlement date and receivables arising from prepaid research.
As of March 31, 2022 and December 31, 2021, payable to customers of $2.2 billion and $2.4 billion, respectively, include amounts due on cash and margin transactions to the Company's clients, some of which have their assets held by a Company omnibus account, which are included within receivables from brokers, dealers and clearing organizations in the accompanying condensed consolidated statements of financial condition. In the omnibus structure, positions that are owned by Cowen International Ltd are fully cross collateralized by client funds, meaning that the Company does not have market risk. Additionally, Cowen International Ltd has no obligation to settle any trade that it deems inappropriate from a risk perspective, adding an important market and counterparty risk mitigating factor.
11. Commission Management Payable
The Company receives a gross commission from various brokers, which is then used to fund commission sharing and recapture arrangements, less the portion retained as income to the Company. Accrued commission sharing and commission
39

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
recapture payable of $127.0 million and $103.0 million, as of March 31, 2022 and December 31, 2021, respectively, are classified as commission management payable in the accompanying condensed consolidated statements of financial condition.
12. Convertible Debt and Notes Payable
As of March 31, 2022 and December 31, 2021, the Company's outstanding debt was as follows:
 As of March 31, 2022As of December 31, 2021
 (dollars in thousands)
Notes payable$174,139 $174,015 
Term loan
434,319 435,147 
Other notes payable15,857 12,537 
Finance lease obligations1,451 1,672 
$625,766 $623,371 
Convertible Debt
December 2022 Convertible Notes
The Company, on December 14, 2017, issued $135.0 million aggregate principal amount of 3.00% convertible senior notes due December 2022 (the “December 2022 Convertible Notes”). The December 2022 Convertible Notes have a final maturity date of December 15, 2022 unless earlier repurchased by the Company or converted by the holder in accordance with their terms prior to such date. The interest on the December 2022 Convertible Notes is payable semi-annually on December 15 and June 15 of each year. The December 2022 Convertible Notes are senior unsecured obligations of Cowen. The December 2022 Convertible Notes were issued with an initial conversion price of $17.375 per share of Cowen's Class A common stock. Pursuant to the indenture governing the December 2022 Convertible Notes, conversions of the December 2022 Convertible Notes will be settled by the delivery and/or payment, as the case may be, of Cowen’s Class A Common Stock, cash, or a combination thereof, at the Company's election.
The Company recognized the embedded cash conversion option at issuance date fair value, which also represents the initial unamortized discount on the December 2022 Convertible Notes of $23.4 million and is shown net in convertible debt in the accompanying condensed consolidated statements of financial condition. On June 26, 2018, the Company received shareholder approval for the Company to settle the December 2022 Convertible Notes entirely in Class A common stock. Upon receiving shareholder approval, the Company reclassified the separately recognized conversion option from a derivative liability to equity.
During December 2020, the Company repurchased and extinguished $46.9 million of the outstanding principal amount of the December 2022 Convertible Notes for cash consideration of $70.5 million. In conjunction with the partial extinguishment of the December 2022 Convertible Notes, the Company accelerated the pro rata unamortized discount of $3.6 million and capitalized debt issuance costs of $0.4 million. The Company allocated $29.6 million of the cash consideration paid to the extinguishment of the equity component of the December 2022 Convertible Notes. The Company recognized $2.7 million of gain on debt extinguishment.
On March 24, 2021, the Company issued a redemption notice announcing that the Company would redeem all of the December 2022 Convertible Notes, and provided holders the option to elect to settle the as-converted value of the December 2022 Convertible Notes as allowed under the terms of the December 2022 Convertible Notes. As a result of the Company’s call for redemption of the December 2022 Convertible Notes, the December 2022 Convertible Notes were convertible, at the option of the holder at any time prior to June 22, 2021, the second business day prior to the December 2022 Convertible Notes' Redemption Date. On June 24, 2021 (the "Redemption Date") the Company redeemed all of the outstanding principal amount of the December 2022 Convertible Notes. The redemption amount was determined based on the holders election to convert, which allowed for either 100.00% of the principal amount thereof plus accrued and unpaid interest on such principal amount up to June 15, 2021, to, but not including the Redemption Date of the December 2022 Convertible Notes, or the value of the Company's Class A common stock to be issued on conversion. The settlement method for the December 2022 Convertible Notes was $88.1 million in cash, (the outstanding principal amount of the December 2022 Convertible Notes) and 2,938,841 shares of the Company’s Class A common stock, (the remainder of the conversion obligation in excess of the principal amount). The conversion rate on the December 2022 Convertible Notes on the Redemption Date was 33.35 shares of the Company’s Class A common stock per $1,000.00 principal amount of December 2022 Convertible Notes converted. In conjunction with the redemption of the remaining December 2022 Convertible Notes, the Company accelerated the pro rata unamortized discount of $5.1 million and capitalized debt issuance costs of $0.5 million.
Amortization on the discount, included within interest and dividends expense in the accompanying condensed consolidated statements of operations is $0.8 million for the three months ended March 31, 2021, based on an effective interest rate of 7.13%.
40

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
The Company capitalized the debt issuance costs in the amount of $2.2 million, which is a direct deduction from the carrying value of the debt and was amortized over the life of the December 2022 Convertible Notes in interest and dividends expense in the accompanying condensed consolidated statements of operations. The Company recorded interest expense of $0.7 million for the three months ended March 31, 2021.
Notes Payable
May 2024 Notes
On May 7, 2019, the Company completed its private placement of $53.0 million aggregate principal amount of 7.25% senior notes due May 2024 (the "May 2024 Notes") with certain institutional investors. On September 30, 2019, the Company issued an additional $25.0 million of the same series of notes. The additional May 2024 Notes were purchased at a premium of $0.5 million, which is shown net in notes payable in the accompanying condensed consolidated statement of financial condition. To date the May 2024 Notes have maintained their initial private rating. Interest on the May 2024 Notes is payable semi-annually in arrears on May 6 and November 6. The Company recorded interest expense of $1.4 million and $1.4 million for the three months ended March 31, 2022 and 2021, respectively. The Company capitalized debt issuance costs of approximately $1.5 million in May 2019 and $0.6 million in September 2019, which is a direct deduction from the carrying value of the debt and will be amortized over the life of the May 2024 Notes in interest and dividends expense in the accompanying condensed consolidated statements of operations.
June 2033 Notes
On June 11, 2018, the Company completed its public offering of $90.0 million of 7.75% senior notes due June 2033 (the "June 2033 Notes") and subsequently the underwriters exercised in full their option to purchase an additional $10.0 million principal amount of the June 2033 Notes. Interest on the June 2033 Notes is payable quarterly in arrears on March 15, June 15, September 15 and December 15. The Company recorded interest expense of $1.9 million for the three months ended March 31, 2022 and 2021, respectively. The Company capitalized debt issuance costs of approximately $3.6 million which is a direct deduction from the carrying value of the debt and will be amortized over the life of the June 2033 Notes in interest and dividends expense in the accompanying condensed consolidated statements of operations.
December 2027 Notes
On December 8, 2017, the Company completed its public offering of $120.0 million of 7.35% senior notes due December 2027 (the "December 2027 Notes") and subsequently the underwriters exercised in full their option to purchase an additional $18.0 million principal amount of the December 2027 Notes. Interest on the December 2027 Notes is payable quarterly in arrears on March 15, June 15, September 15 and December 15. The Company recorded interest expense of $2.5 million for three months ended March 31, 2021. The Company capitalized debt issuance costs of approximately $5.0 million which is a direct deduction from the carrying value of the debt and will be amortized over the life of the December 2027 Notes in interest and dividends expense in the accompanying condensed consolidated statements of operations. The net proceeds of the offering, after deducting the underwriting discount and estimated offering expenses payable by the Company were used to redeem all of its 8.25% senior notes due October 2021 and for general corporate purposes.
On March 24, 2021, the Company delivered payment of and discharged all $138.0 million outstanding aggregate principal of the December 2027 Notes plus accrued and unpaid interest through the effective redemption date of April 23, 2021. In conjunction with the extinguishment of the December 2027 Notes , the Company accelerated the pro-rata capitalized debt issuance costs. During the three months ended March 31, 2021, the Company recognized $4.4 million of loss on debt extinguishment.
Term Loan
March 2028 Term Loan
On March 24, 2021, the Company borrowed $300 million of first lien term loan due March 24, 2028. On December 15, 2021, the Company borrowed an additional $150 million first lien term loan under the same terms and conditions as, and fungible with, the initial first lien term loan (collectively, the “March 2028 Term Loan”). The aggregate amount borrowed under the March 2028 Term Loan is $450 million. The March 2028 Term Loan bears interest at an annual rate equal to, at the option of the Company, either the (a) London Inter-bank Offered Rate ("LIBOR") (adjusted for reserves and subject to a floor of 0.75%) plus a margin of 3.25% or (b) an alternate base rate plus a margin of 2.25%. The Company is required to pay amortization of approximately 1.00% per annum of the original principal amount of the March 2028 Term Loan. Additionally, the Company has entered into an interest rate swap to offset the floating interest rate of the March 2028 Term Loan (See Note 6). The obligations of the Company for the March 2028 Term Loan are guaranteed by certain of the Company’s wholly-owned domestic subsidiaries (excluding its broker-dealer subsidiaries) (the “Guarantors”) and secured by substantially all of the assets of the Company and the
41

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Guarantors, subject in each case to certain customary exceptions. The terms of the March 2028 Term Loan contain customary affirmative and negative covenants, subject to certain customary exceptions, thresholds, qualifications and “baskets”. Proceeds from the March 2028 Term Loan were used to (i) satisfy and discharge and redeem the Company’s 2027 Senior Notes, (ii) redeem the Company’s December 2022 Convertible Notes that remained outstanding as of March 31, 2021 and pay the cash settlement amount in connection with the conversion of December 2022 Convertible Notes prior to that redemption date, and (iii) for the payment of fees, commissions, premiums, expenses and other transaction costs (including original issue discount or upfront fees) payable in connection with the transactions related thereto. As of March 31, 2022, the outstanding principal amount of the March 2028 Term Loan was $445.5 million.
Interest expense for the March 2028 Term Loan was $4.5 million and $0.2 million for the three months ended March 31, 2022 and 2021, based on an effective interest rate of 4.46%. In March 2021, the Company capitalized debt issuance costs of approximately $6.6 million and initial unamortized discount of $1.5 million related to the March 2028 Term Loan which is a direct deduction from the carrying value of the debt and will be amortized over the life of the March 2028 Term loan in interest and dividends expense in the accompanying condensed consolidated statements of operations. In December 2021, the Company capitalized debt issuance costs of approximately $2.7 million and unamortized discount of $1.5 million related to the additional borrowing of $150 million which is a direct deduction from the carrying value of the debt and will be amortized over the life of the March 2028 Term loan in interest and dividends expense in the accompanying condensed consolidated statements of operations.
The U.K. Financial Conduct Authority, which regulates LIBOR, has announced that all US Dollar LIBOR settings will either cease to be provided by any administrator or no longer be representative as of June 30, 2023. As the March 2028 Term Loan represents the Company’s only significant exposure to LIBOR as of March 31, 2022, the transition to an alternative Inter-bank Offer Rate is not expected to have a material impact on Company's consolidated financial statements.
Other Notes Payable
During January 2022, the Company borrowed $4.0 million to fund insurance premium payments. This note had an effective interest rate of 2.01% and was due in December 2022, with monthly payment requirements of $0.4 million. As of March 31, 2022, the outstanding balance note was $3.2 million. Interest expense for the three months ended March 31, 2022 was insignificant.
On September 30, 2020, the Company borrowed $72.0 million from Purple Protected Asset S-81 ("PPA S-81"), a Luxembourg entity unrelated to Cowen. The Company repaid $60.0 million of the PPA S-81 loan in June 2021. The loan is payable on September 30, 2023, had an initial interest rate of 1.4 times the Secured Overnight Financing Rate ("SOFR") plus 6.07% until December 31, 2020 and 1.4 times the SOFR plus 5.8% until June 30, 2021 and 3.65 times the SOFR plus 4.0% thereafter with quarterly interest payments. The loan obligation, as well as a loan issued by The Military Mutual Ltd (a United Kingdom company unrelated to Cowen) with principal of $28.4 million that was sold by Cowen Re to PPA S-81 at fair value for no gain or loss on September 30, 2020, are fully cash collateralized through a reinsurance policy provided by Cowen Re which is reflected in cash collateral pledged in the condensed consolidated statements of financial condition as of December 31, 2020 (see Notes 4 and 18). The Company capitalized debt issuance costs of approximately $1.7 million which is a direct deduction from the carrying value of the loan and will be amortized over the life of the loan in interest and dividends expense shown in the accompanying condensed consolidated statements of operations. The Company recorded interest expense of $0.5 million and $1.1 million for the three months ended March 31, 2022 and 2021, respectively, related to its loan payable to PPA S-81.
During November 2019, the Company borrowed $2.6 million to fund general corporate capital expenditures. This note had an effective interest rate of 6% and is due in November 2024, with monthly payment requirements of $0.1 million. As of March 31, 2022, the outstanding balance on this note was $1.5 million. Interest expense for the three months ended March 31, 2022 and 2021 was insignificant.
Finance Lease Obligations
The Company has entered into various finance leases for computer equipment. These finance lease obligations are included in notes payable and other debt in the accompanying condensed consolidated statements of financial condition.
For the three months ended March 31, 2022 and 2021, quantitative information regarding the Company's finance lease obligations reflected in the accompanying condensed consolidated statements of operations, the supplemental cash flow information and certain other information related to finance leases were as follows:
42

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Three Months Ended March 31,
20222021
(dollars in thousands)
Lease cost
Finance lease cost:
    Amortization of finance lease right-of-use assets$324 $309 
    Interest on lease liabilities$20 $34 
Other information
Cash paid for amounts included in the measurement of lease liabilities:
    Operating cash flows from finance leases$20 $34 
    Financing cash flows from finance leases$274 $332 
Weighted average remaining lease term - operating leases (in years)1.632.01
Weighted average discount rate - operating leases4.66 %4.89 %
Annual scheduled maturities of debt and minimum payments (of principal and interest) for all debt outstanding as of March 31, 2022, are as follows:
Notes Payable
Term Loan
Other Notes PayableFinance Lease
Obligation
 (dollars in thousands)
2022$11,468 $16,733 $3,752 $849 
202313,405 22,351 12,593 500 
202488,578 22,168 543 100 
20257,750 21,986 — 49 
20267,750 21,803 — 12 
Thereafter150,375 445,631 — — 
Subtotal279,326 550,672 16,888 1,510 
Less (a)(105,187)(116,353)(1,031)(59)
Total$174,139 $434,319 $15,857 $1,451 
(a)Amount necessary to reduce net minimum payments to present value calculated at the Company's implicit rate at inception. This amount also includes capitalized debt costs and the unamortized discount on the Company's convertible debt.
Letters of Credit
As of March 31, 2022, the Company has six irrevocable letters of credit, related to leased office space, for which there is cash collateral pledged, which the Company pays a fee on the stated amount of the letter of credit. The Company also has pledged cash collateral for reinsurance agreements (See Note 4).
To the extent any letter of credit is drawn upon, interest will be assessed at the prime commercial lending rate. As of March 31, 2022 and December 31, 2021, there were no amounts due related to these letters of credit.
13. Redeemable Preferred Stock
The Company is authorized to issue 10,000,000 shares of preferred stock, par value $0.01 per share. Subject to the rights of holders of any outstanding preferred stock, the number of authorized shares of preferred stock may be increased or decreased by the affirmative vote of the holders of a majority of the shares entitled to vote on such matters, but in no instance can the number of authorized shares be reduced below the number of shares then outstanding. The Company's amended and restated certificate of incorporation permits the Company to issue up to 10,000,000 shares of preferred stock in one or more series with such designations, titles, voting powers, preferences and rights and such qualifications, limitations and restrictions as may be fixed by the board of directors of the Company without any further action by the Company's stockholders. The Company's board of directors may increase or decrease the number of shares of any series of preferred stock following the issuance of that series of preferred stock, but in no instance can the number of shares of a series of preferred stock be reduced below the number of shares of the series then outstanding.
On May 19, 2015, the Company completed its offering of 120,750 shares of Series A Convertible Preferred Stock that provided $117.2 million of proceeds, net of underwriting fees and issuance costs of $3.6 million. Each share of the Series A
43

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Convertible Preferred Stock is entitled to dividends at a rate of 5.625% per annum, which will be payable, when and if declared by the board of directors of the Company, quarterly, in arrears, on February 15, May 15, August 15 and November 15 of each year. The Company may, at its option, pay dividends in cash, common stock or a combination thereof. The Company declared and paid a cash dividend in respect of the Series A Convertible Preferred Stock of $1.7 million for the three months ended March 31, 2022. The Company declared and accrued a cash dividend in respect of the Series A Convertible Preferred Stock of $1.7 million for the three months ended March 31, 2021. Each share of Series A Convertible Preferred Stock is non-voting and has a liquidity preference over the Company's Class A common stock and ranks senior to all classes or series of the Company's Class A common stock, but junior to all of the Company's existing and future indebtedness with respect to dividend rights and rights upon the Company's involuntary liquidation, dissolution or winding down.
Upon issuance, each share of Series A Convertible Preferred Stock was convertible, at the option of the holder, into a number of shares of the Company's Class A common stock equal to the liquidation preference of $1,000.00 divided by the conversion rate. The initial conversion rate (subsequent to the December 5, 2016 reverse stock split) is 38.0619 shares (which equates to $26.27 per share) of the Company's Class A common stock for each share of the Series A Convertible Preferred Stock. At any time on or after May 20, 2020, when the Company's capped call option expired, the Company was able to elect to convert all outstanding shares of the Series A Convertible Preferred Stock into shares of the Company's Class A common stock, cash or a combination thereof, at the Company's election, in each case, based on the then-applicable conversion rate, if the last reported sale price of the Company's Class A common stock equals or exceeds 150% of the then-current conversion price on at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days (including on the last trading day of such period) immediately prior to such election. At the time of conversion, the conversion rate may be adjusted based on certain events, including but not limited to the issuance of cash dividends or Class A common stock as dividends to the Company's Class A common shareholders or a share split or combination.
On December 31, 2021, the Company irrevocably elected that, upon the conversion of any share of the outstanding Series A Convertible Preferred Stock, the Company will settle $1,000.00 of its conversion obligation in cash. With respect to each conversion, to the extent the conversion obligation per share of Series A Convertible Preferred Stock is greater than $1,000.00, the Company may satisfy its conversion obligation in respect of such excess using any settlement method permitted under the Certificate of Designations. As the holders can exercise the conversion option on their shares of Series A Convertible Preferred Stock at any time and require cash payment upon conversion, the Company reclassified the Series A Convertible Preferred Stock to temporary equity at December 31, 2021.
14. Stockholder's Equity
The Company is authorized to issue 125,000,000 shares of common stock, which shall consist of 62,500,000 shares of Class A common stock, par value $0.01 per share, and 62,500,000 shares of Class B common stock, par value $0.01 per share. Subject to the rights of holders of any outstanding preferred stock, the number of authorized shares of common stock may be increased or decreased by the affirmative vote of the holders of a majority of the shares entitled to vote on such matters, but in no instance can the number of authorized shares be reduced below the number of shares then outstanding.
The certificate of incorporation of the Company provides for two classes of common stock, and for the conversion of each class into the other, to provide a mechanism by which holders of Class A common stock of the Company who may be limited in the amount of voting common stock of the Company they can hold pursuant to federal, state or foreign bank laws, to convert their shares into non-voting Class B common stock to prevent being in violation of such laws. Each holder of Class A common stock is entitled to one vote per share in connection with the election of directors and on all other matters submitted to a stockholder vote, provided, however, that, except as otherwise required by law, holders of Class A common stock are not entitled to vote on any amendment to the Company's amended and restated certificate of incorporation that relates solely to the terms of one or more outstanding series of the Company's preferred stock, if holders of the preferred stock series are entitled to vote on the amendment under the Company's certificate of incorporation or Delaware law. No holder of Class A common stock may accumulate votes in voting for directors of the Company.
No holder of Class B common stock is entitled to vote except as otherwise provided by law, provided however that the Company must obtain the consent of a majority of the holders of Class B common stock to effect any amendment, alteration or repeal of any provision of the Company's amended and restated certificate of incorporation or amended and restated by-laws that would adversely affect the voting powers, preferences or rights of holders of Class B common stock. Except as otherwise provided by law, Class B common stock shares will not be counted as shares held by stockholders for purposes of determining whether a vote or consent has been approved or given by the requisite percentage of shares.
Each share of Class A common stock is convertible at the option of the holder and at no cost into one share of Class B common stock, and each share of Class B common stock is convertible at the option of the holder and at no cost into one share of Class A common stock. The conversion ratios will be adjusted proportionally to reflect any stock split, stock dividend, merger,
44

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
reorganization, recapitalization or other change in the Class A common stock and Class B common stock. Upon conversion, converted shares resume the status of authorized and unissued shares.
Subject to the preferences of the holders of any of the Company's preferred stock that may be outstanding from time to time, each share of Class A common stock and Class B common stock will have an equal and ratable right to receive dividends and other distributions in cash, property or shares of stock as may be declared by the Company's board of directors out of assets or funds legally available for the payment of dividends and other distributions.
In the event of the liquidation, dissolution or winding up of the Company, subject to the preferences of the holders of any preferred stock of the Company that may be outstanding from time to time, holders of Class A common stock and Class B common stock will be entitled to share equally and ratably in the assets available for distribution to the Company's stockholders. There are no redemption or sinking fund provisions applicable to the Class A or the Class B common stock.
Embedded Cash Conversion Option on the December 2022 Convertible Notes
Upon issuance of the December 2022 Convertible Notes (see Note 12), the Company recognized the embedded cash conversion option at fair value of $23.4 million which was valued as of June 26, 2018 at $29.0 million. On June 26, 2018, the Company received shareholder approval for the Company to settle the December 2022 Convertible Notes entirely in Class A common stock. Upon receiving shareholder approval, the Company reclassified the separately recognized conversion option from a derivative liability to equity. The Company allocated $29.6 million of the cash consideration paid on the December 2020 partial extinguishment of the Convertible Notes (see Note 12) to this equity component. The Company redeemed all of the remaining December 2022 Convertible Notes on June 24, 2021.
Cash Dividends to Common Stockholders
During the first quarter of 2020, the Company began the declaration of a quarterly cash dividend payable on its common stock. During March 2021, the Company's Board of Directors declared a cash dividend of $0.08 per share of Class A common stock. During June 2021, September 2021 and December 2021, the Company's Board of Directors declared a cash dividend of $0.10 per share of Class A common stock. During March 2022, the Company's Board of Directors declared a cash dividend of $0.12 per share of Class A common stock. Dividends are payable on all outstanding shares of Class A common stock and on granted but unvested shares of Class A common stock under the Equity Plans on the date of record (See Note 19). During the three months ended March 31, 2022, the Company paid $3.9 million of cash dividends to its holders of Class A common stock.
Treasury Stock
Treasury stock of $583.5 million as of March 31, 2022, compared to $547.1 million as of December 31, 2021, resulted from $12.3 million acquired through repurchases of shares to cover employee minimum tax withholding obligations related to stock compensation vesting events under the Equity Plans or other similar transactions and $24.1 million purchased in connection with a share repurchase program.
The following represents the activity relating to the treasury stock held by the Company during the three months ended March 31, 2022:
Treasury Stock SharesCost
(dollars in thousands)
Average Cost per Share
Balance outstanding at December 31, 202128,047,929 $547,112 $19.51 
Shares purchased for minimum tax withholding under the 2010 and 2020 Equity Plans or other similar transactions374,149 12,283 32.83 
Purchase of treasury stock798,302 24,140 30.24 
Balance outstanding at March 31, 202229,220,380 $583,535 $19.97 








45

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
15. Non-Controlling Interests in Consolidated Subsidiaries and Investment Funds
Redeemable and nonredeemable non-controlling interests in consolidated subsidiaries and investment funds and the related net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds are comprised as follows:
 As of March 31, 2022As of March 31, 2021
 (dollars in thousands)
Nonredeemable non-controlling interests in consolidated subsidiaries and investment funds
Operating companies
    Beginning balance 126,105 83,818 
    Capital contributions1,610 3,498 
    Capital distributions(5,901)(2,348)
    Income (loss) attributable to non-controlling interests20,858 7,661 
    Ending balance142,672 92,629 
Consolidated Funds
    Beginning balance 33,630 115,806 
    Capital contributions— 19,017 
    Capital distributions— (16,425)
    Deconsolidation of entity— (74,813)
    Income (loss) attributable to non-controlling interests(727)(3,099)
    Ending balance32,903 40,486 
Total Nonredeemable non-controlling interests in consolidated subsidiaries and investment funds$175,575 $133,115 
16. Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income includes the after tax change in Other revenues in the accompanying condensed consolidated statement of operations. During the periods presented, the Company did not have material reclassifications out of other comprehensive income.
Three Months Ended March 31,
20222021
(dollars in thousands)
Beginning balance$(2)$(7)
Foreign currency translation
Ending balance$ $(3)

46

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
17. Revenue from Contracts with Customers
For the three months ended March 31, 2022 and 2021, the following tables presents revenues from contracts with customers disaggregated by fee type and segment.
Three Months Ended March 31,
20222021
(dollars in thousands)
Revenue from contracts with customersOperating Company
Investment banking
     Underwriting fees$17,583 $154,304 
     Strategic/financial advisory fees58,789 73,555 
     Placement and sales agent fees22,584 72,544 
     Expense reimbursements from clients2,586 4,431 
Total investment banking revenue101,542 304,834 
Brokerage
     Commissions152,483 159,681 
     Trade conversion revenue7,410 6,241 
     Equity research fees6,203 4,593 
Total brokerage revenue from customers166,096 170,515 
Management fees16,555 25,499 
Incentive income633 2,258 
Total revenue from contracts with customers - Op Co$284,826 $503,106 
Asset Company
Management fees214 243 
Incentive income— — 
Total revenue from contracts with customers - Asset Co214 243 
Total revenue from contracts with customers$285,040 $503,349 

18. Insurance and reinsurance
Cowen Insurance Co is a Malta based insurance company that reinsures a significant proportion of its portfolio (“Outward Reinsurance”). The Company's wholly owned Luxembourg subsidiary, Cowen Reinsurance S.A. (formerly Hollenfels Re S.A.) (“Cowen Re”) provides reinsurance to third party insurance and reinsurance companies (“Inward Reinsurance”). Cowen Insurance Co’s and Cowen Re's share of claims incurred and paid during the periods below, as well as the change in claims outstanding and claims incurred but not reported ("IBNR") during these periods, net of reinsurance, were as follows:
Three Months Ended March 31,
20222021
(dollars in thousands)
Incurred and paid claims
Insurance (net of Outward Reinsurance)$1,067 $744 
Inward Reinsurance3,011 3,904 
Total$4,078 $4,648 
Change in claims outstanding and claims IBNR
Insurance (net of Outward Reinsurance)$54 $(136)
Inward Reinsurance(589)(559)
Total$(535)$(695)
Cowen Insurance Co and Cowen Re utilize several methods to determine their claims IBNR. Cowen Insurance Co and Cowen Re generally employ an estimation methodology whereby historical average claims ratios over a period of up to 10 years are utilized, based on availability of data. In cases where current claims development contradicts historical results, Cowen Insurance Co and Cowen Re employ a method to average claims ratios derived through different actuarial calculation methods. If an event occurs that may give rise to significant future claims in excess of the amount calculated using the above-mentioned
47

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
methodologies, the impact of such an event is calculated using existing claims data and actuarial estimation methods to adjust Cowen Insurance Co's and Cowen Re's IBNR provision. During the three months ended March 31, 2022, claims liability and claim adjustment expenses were calculated using the above-mentioned methods consistent with prior years.
While Cowen Insurance Co and Cowen Re typically settle their premiums and claim payments on a quarterly basis, the frequency of claims in the underlying policies is impractical for Cowen Insurance Co and Cowen Re to obtain. Cowen Insurance Co and Cowen Re write contracts on both a proportional and non-proportional basis. The contracts contain inspection rights to allow the companies to inspect the policy documents that provide the source for the underlying data provided by the cedant. This negates the need for them to collect and hold the documents themselves which would be impracticable. Cowen Insurance Co and Cowen Re did not discount any of its reserves and did not cede any portion of its exposures during the three months ended March 31, 2022 and 2021.
From time to time, Cowen Insurance Co and Cowen Re may enter into insurance and reinsurance agreements that require it to post collateral of cash or U.S. government bonds to cover certain exposures as defined in the respective insurance and reinsurance agreements. As of March 31, 2022, Cowen Re had pledged $61.4 million of collateral towards such reinsurance obligations, of which $49.4 million was in cash and $12.0 million was in U.S. government bonds. As of March 31, 2021, total collateral pledged was $120.5 million, of which $106.8 million was cash and $13.7 million was U.S. government bonds. The collateral pledged as of March 31, 2022 was $1.4 million higher than the amounts pledged at December 31, 2021. This is due to cash movements required to maintain contracted minimum balances with cedants. Cowen Re expects $40.5 million of the cash collateral pledged to be released on September 30, 2023. The remaining collateral of $20.9 million is expected to be released periodically between March 31, 2022 and March 31, 2024 in accordance with the terms of the underlying insurance and reinsurance agreements. As of December 31, 2021, Cowen Insurance Co had no pledged collateral.
19. Share-Based Payments, Deferred Compensation and Employee Ownership Plans
The Company has issued share-based compensation under the 2010 and 2020 Equity Incentive Plan (the "Equity Plans"). The Equity Plans permit the grant of options, restricted shares, restricted stock units, and other equity-based awards to the Company's employees and directors. Stock options granted generally vest over two to five-year periods and expire seven years from the date of grant. Restricted shares and restricted share units issued, both of which are eligible to accrue dividend equivalents, may be immediately vested or may generally vest over a two-to five-year period. Awards are subject to the risk of forfeiture, inclusive of accrued dividend equivalents. As of March 31, 2022, there were 0.6 million shares available for future issuance under only the 2020 Equity Incentive Plan.
Under the Equity Plans, the Company awarded $49.1 million of deferred cash awards to its employees during the three months ended March 31, 2022. These awards vest over a four-year period and accrue interest at 0.70% per year. As of March 31, 2022, the Company had unrecognized compensation expense related to the Equity Plans' deferred cash awards of $89.8 million.
The Company measures compensation cost for equity classified share-based awards on grant date and amortizes the unearned compensation associated with such awards on a straight-line basis over the vesting period of the option or award, net of estimated forfeitures. In relation to awards under the Equity Plan, the Company recognized compensation expense of $21.6 million and $28.2 million for the three months ended March 31, 2022 and 2021, respectively. The income tax effect recognized for the Equity Plans was a benefit of $7.0 million and $10.8 million for the three months ended March 31, 2022 and 2021, respectively.
Restricted Stock Units Granted to Employees
Restricted shares and restricted stock units are referred to collectively as restricted stock. The following table summarizes the Company's restricted share and restricted stock unit activity for the three months ended March 31, 2022 and 2021:
Three Months Ended March 31, 2022Three Months Ended March 31, 2021
Nonvested Restricted Class A Common Shares and Class A Common Restricted Stock UnitsWeighted-Average
Grant Date
Fair Value
Nonvested Restricted Class A Common Shares and Class A Common Restricted Stock UnitsWeighted-Average
Grant Date
Fair Value
Beginning balance outstanding 4,595,342 $24.33 5,450,191 $17.56 
Granted1,919,504 31.98 1,593,941 34.85 
Vested(224,073)19.32 (291,062)16.11 
Canceled— — — — 
Forfeited(16,526)20.51 (8,134)20.22 
Ending balance outstanding 6,274,247 $26.86 6,744,936 $21.71 
48

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Included in the restricted share and restricted stock unit activity are performance-linked restricted stock units of 1,974,217 which were awarded from March 2016 through March 2022. Certain of the awards granted have the ability to be cash settled when the attained award exceeds a certain percentage of granted amount. The cash portion of the award has been bifurcated from the equity component and recorded as a compensation payable in the accompanying condensed consolidated statement of financial condition. Of the awards granted, 712,652 have vested and 320,681 have been canceled, as they did not meet the performance criteria, through March 31, 2022. Included in vested units are 233,333 units that had an attainable share value of 420,000, and were delivered in March 2021. Of this attainable share value 350,000 shares were settled in the issuance of the Company's Class A common stock and were delivered in March 2021 with the remaining 70,000 shares being settled in cash at the volume weighted average price on settlement date. Also included in vested units are 333,333 units that had an attainable share value of 666,666, due to reaching certain performance goals. Of this attainable value 528,800 shares were settled in the Company's Class A common stock and were delivered in March 2022 with the remaining 137,866 shares being settled in cash at the volume weighted average price of the Company's Class A common stock on settlement date. The remaining awards, included in the outstanding balance as of March 31, 2022, vest on December 2022, December 2023 and December 2024 and will be earned only to the extent that the Company attains specified market conditions relating to its volume-weighted average share price and total shareholder return in relation to certain benchmark indices and performance goals relating to aggregate net income and average return on shareholder equity. The actual number of attained shares ultimately earned could vary from zero, if performance goals are not met, to as much as 240% of the targeted award. Compensation expense is recognized to the extent that it is probable that the Company will attain the performance goals. The fair value of restricted stock is determined based on the number of shares granted and the quoted price of the Company's common stock on the date of grant.
As of March 31, 2022, there was $116.0 million of unrecognized compensation expense related to the Company's grant of nonvested restricted shares and restricted stock units to employees. Unrecognized compensation expense related to nonvested restricted shares and restricted stock units granted to employees is expected to be recognized over a weighted-average period of 2.14 years.
Restricted Shares and Restricted Stock Units Granted to Non-Employee Board Members
There were no restricted stock units awarded to non-employee board members during the three months ended March 31, 2022 and 2021. The Company delivered no units to non-employee board members during the three months ended March 31, 2022 and 2021. As of March 31, 2022 and 2021, there were 246,333 and 259,536 restricted stock units outstanding for non-employee board members, respectively.
Other Share Based Payments and Awards
In certain circumstances, the Company grants carried interest in consolidated managing member/general partner subsidiaries to third parties through the grant of equity awards in exchange for professional, advisory and other services. The equity awards are recorded within additional paid in capital in the accompanying condensed consolidated statements of financial condition and professional, advisory and other fees expense in the accompanying condensed consolidated statements of operations based on the fair value of the award granted and expensed over the terms of the award. In addition, the equity awards provide the third parties profit points aligned to the allocated carried interest distributions. Upon vesting of the awards, the third parties' allocation of carried interest is determined by applying an equity ownership model. Accordingly, the Company accrues carried interest allocations based on the fair value of the underlying investments assuming hypothetical liquidation at book value upon vesting as nonredeemable non-controlling interest.
On March 1, 2022, Cowen Digital Holdings LLC (“CDIG”) authorized 2,000,000 Class B Units, of which 1,487,500 Class B Units were issued to an affiliate, for which a subsidiary of the Company is the Managing Member, on behalf of the Company’s employees as incentive awards (the "Digital Awards") under the 2022 Equity Unit Incentive Plan. The Class B Units will, upon vesting, represent a 20% ownership of CDIG, a consolidated subsidiary of the Company upon vesting. Once the vesting conditions of the Digital Awards have been met, such awards will be presented as nonredeemable non-controlling interest in the accompanying condensed consolidated statements of financial condition. Half of the Digital Awards vest over a period of time and are tied to service (time based) and the other half vest when a qualifying event as stipulated in the Digital Award documents occurs (performance based). Once vested, Class B units will not be entitled to distributions unless and until a profit distribution hurdle has been met. The Company recognized compensation expense of $0.3 million related to the time based Digital Awards for the three months ended March 31, 2022. At March 31, 2022, there was $1.3 million of unrecognized compensation expense related to the time based Digital Awards which will be recognized over their five year vesting period. The fair value of time based Digital Awards is determined based on the fair market value of CDIG and its consolidated subsidiaries. The fair market value of CDIG and its consolidated subsidiaries is calculated utilizing recent transactions, discounted cash flows, and market multiples. The Digital Awards are then using a standard Black Scholes options pricing model. The primary input in determining the fair market value as of March 1, 2022 was recent/pending transactions in CDIG’s underlying investments. The expense related
49

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
to the performance based component of the Digital Awards will be recognized when the qualifying event is considered to be probable. The income tax effect recognized for the Digital Awards was a benefit of $0.1 million for the three months ended March 31, 2022.
20. Income Taxes
The taxable results of the Company’s U.S. operations are included in the consolidated income tax returns of Cowen, Inc. as well as stand-alone state and local tax returns. The Company has subsidiaries that are resident in foreign countries where tax filings are submitted on a stand-alone basis. These subsidiaries are subject to tax in their respective countries and the Company is responsible for and, thus, reports all taxes incurred by these subsidiaries. The countries where the Company owns subsidiaries that file tax returns are United Kingdom, Luxembourg, Malta, Germany, Switzerland, Israel, South Africa, Canada and Hong Kong.
The Company calculates its U.S. tax provision using the estimated annual effective tax rate methodology. The tax expense or benefit caused by an unusual or infrequent item is recorded in the quarter in which it occurs. To the extent that information is not available for the Company to fully determine the full year estimated impact of an item of income or tax adjustment, the Company calculates the tax impact of such item discretely. Accordingly, the Company uses the discrete methodology to calculate the tax impact of income attributable to redeemable non-controlling interests in consolidated subsidiaries and investment funds. Based on these methodologies, the Company’s effective income tax rate was 17.74% and 26.36% for the three months ended March 31, 2022 and 2021, respectively. During the three months ended March 31, 2022, the item whose tax impact was recorded discretely related primarily to stock compensation.
For the three months ended March 31, 2022, the effective tax rate differs from the statutory rate of 21% primarily due to income attributable to non-controlling interests in consolidated subsidiaries and investment funds, global intangible low-taxes income, foreign taxes, as well as other nondeductible expenses. For the three months ended March 31, 2021, the effective tax rate differs from the statutory rate of 21% primarily due to income attributable to noncontrolling interests in consolidated subsidiaries and investment funds, global intangible low-taxes income, stock compensation, as well as other nondeductible expenses.
The Company has no uncertain tax position liability as of March 31, 2022 and December 31, 2021.
The Company records deferred tax assets and liabilities for the future tax benefit or expense that will result from differences between the carrying value of its assets for income tax purposes and for financial reporting purposes, as well as for operating or capital loss and tax credit carryovers. A valuation allowance is recorded to bring the net deferred tax assets to a level that, in management's view, is more likely than not to be realized in the foreseeable future. This level will be estimated based on a number of factors, especially the amount of net deferred tax assets of the Company that are actually expected to be realized, for tax purposes, in the foreseeable future. As of March 31, 2022, the Company recorded a valuation allowance against deferred tax assets related to its foreign tax credits and foreign net operating losses.
The Company is subject to examination by the United States Internal Revenue Service as well as state, local and foreign tax authorities in jurisdictions where the Company has significant business operations, such as New York, United Kingdom, Luxembourg, Malta, and Germany.
The Company continues to permanently reinvest the capital and accumulated earnings of its subsidiaries in the United Kingdom, Malta, Germany, Switzerland, Israel, Canada, and Hong Kong.
21. Earnings Per Share
Basic earnings per share is calculated by dividing net income attributable to the Company's common stockholders by the weighted average number of shares of Class A common stock outstanding for the period. As of March 31, 2022, there were 27,614,903 shares of Class A common stock outstanding. As of March 31, 2022, the Company has included 246,803 fully vested, unissued restricted stock units and restricted shares in its calculation of basic earnings per share. As of December 31, 2021, there were 27,778,964 shares of Class A common stock outstanding. As of December 31, 2021, the Company has included 972,732 fully vested, unissued restricted stock units and restricted shares in its calculation of basic earnings per share.
Diluted earnings per common share are calculated by adjusting the weighted average outstanding shares to assume conversion of all potentially dilutive items. The Company uses the treasury stock method to reflect the potential dilutive effect of the unvested restricted shares and restricted stock units. In calculating the number of dilutive shares outstanding, the shares of common stock underlying unvested restricted shares and restricted stock units are assumed to have been delivered, for the entire period being presented. The number of performance-linked unvested restricted stock units that are included in the calculation are at the amount that could be earned using current payout rates. The assumed proceeds from the assumed vesting, delivery and exercising were calculated as the amount of compensation cost attributed to future services and not yet recognized.
50

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
The Company previously concluded that it had the intent and ability to settle the December 2022 Convertible Notes in cash and, as a result, the convertible notes did not have an impact on the Company's diluted earnings per share calculation. On March 24, 2021, the Company issued a redemption notice announcing that the Company would redeem all of the December 2022 Convertible Notes (See Note 12). On June 24, 2021, the Company cash settled the December 2022 Convertible Notes up to the principal amount of the December 2022 Convertible Notes and share settled through the delivery of shares of the Company’s Class A common stock for the remainder of the conversion obligation in excess of the principal amount. The shares of the Company’s Class A common stock issued are within basic earnings per share subsequent to June 24, 2021. Prior to that date, the Company has applied the if-converted method to the portion of the December 2022 notes above the principal amount that settled in shares upon a conversion in dilutive earnings per share.
On December 31, 2021, the Company irrevocably elected to cash settle $1,000.00 of its obligation in respect of each conversion of any share of the Series A Convertible Preferred Stock. Prior to this date, the Company could elect to settle the Series A Convertible Preferred Stock in shares, cash, or a combination of both. Effective January 1, 2022, Company adopted ASC 470-20, which requires the Company to use the if-converted method for all convertible instruments in the diluted earnings per share calculation and include the effect of potential share settlement (if the effect is more dilutive) for instruments that may be settled in cash or shares, except for certain liability-classified share-based payment awards. With the adoption of this guidance, the Company is required to include the portion of the Series A Convertible Preferred Stock that can be settled in Class A common stock (the amount in excess of $1,000.00 per share of the Series A Convertible Preferred Stock) in the diluted earnings per share calculation. As a result, the Series A Convertible Preferred Stock impacts the Company’s diluted earnings per share calculation for the March 31, 2022 (See Note 2).
The computation of earnings per share is as follows:
 Three Months Ended March 31,
 20222021
 (dollars and share data in thousands, except per share data)
Net income (loss) $55,147 $152,066 
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds20,131 4,562 
Net income (loss) attributable to Cowen Inc.35,016 147,504 
Preferred stock dividends1,698 1,698 
Net income (loss) attributable to Cowen Inc. common stockholders for basic earnings per share33,318 145,806 
Change in fair value of contingently issuable shares
41 — 
Net income (loss) attributable to Cowen Inc. common stockholders for diluted earnings per share$33,359 $145,806 
Shares for basic and diluted calculations: 
Weighted average shares used in basic computation 28,386 27,359 
Performance based restricted stock 374 445 
Contingently issuable common stock in connection with acquisitions82 — 
December 2022 Convertible Notes— 2,659 
Series A Convertible Preferred Stock708 — 
Restricted stock2,222 3,102 
Weighted average shares used in diluted computation31,772 33,565 
Earnings (loss) per share: 
Basic $1.17 $5.33 
Diluted$1.05 $4.34 
22. Commitments and Contingencies
Operating Lease Obligations
The Company has entered into leases for real estate and other facilities. These leases contain rent escalation clauses and options to extend the applicable lease term. The Company does not include renewal options in the lease term for calculating the Company's lease liability as the renewal options allow the Company operational flexibility and the Company is not reasonably certain to exercise these renewal options at this time. The Company records the expenses related to occupancy and equipment on
51

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
a straight-line basis over the lease term and these expenses are included in occupancy and equipment expense and client services and business development expense in the accompanying condensed consolidated statements of operations.
For the three months ended March 31, 2022 and 2021, quantitative information regarding the Company's operating lease obligations reflected in the accompanying condensed consolidated statements of operations were as follows:
Three Months Ended March 31,
20222021
(dollars in thousands)
Lease cost
Operating lease cost$6,614 $5,770 
Short-term lease cost141 33 
Variable lease cost 837 906 
Sublease income(155)(160)
Total lease costs$7,437 $6,549 
The following table summarizes the supplemental cash flow information and certain other information related to operating leases for the three months ended March 31, 2022 and 2021:
Three Months Ended March 31,
20222021
(dollars in thousands)
Other information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$9,814 $6,748 
Weighted average remaining lease term - operating leases (in years)5.544.56
Weighted average discount rate - operating leases4.13 %4.10 %
As of March 31, 2022, maturities of the outstanding operating lease liabilities for the Company were as follows:
Equipment Leases (operating)Real Estate and Other Facility Rental (a) (b)
 (dollars in thousands)
2022$366 $16,813 
2023381 25,476 
2024370 22,965 
2025370 12,312 
2026278 8,881 
Thereafter— 24,969 
Total operating leases1,765 111,416 
Less discount105 13,218 
Less short-term leases— 58 
Total lease liability$1,660 $98,140 
(a)The Company has entered into various agreements to sublease certain of its premises.
(b)During the three months ended March 31, 2022, the Company recognized an increase of $8.3 million of operating right-of-use assets and leases liabilities related to facility leases.
52

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
Other Commitments
As of March 31, 2022, future minimum annual service payments for the Company were as follows:
Service Payments
 (dollars in thousands)
2022$22,196 
202317,544 
20248,214 
20253,889 
20263,253 
Thereafter7,357 
Total service payment commitments$62,453 
Unfunded Commitments
The following table summarizes unfunded commitments as of March 31, 2022:
EntityUnfunded CommitmentsCommitment Term
(dollars in thousands)
HealthCare Royalty Partners funds (a)$6,451 2.8 years
Eclipse Ventures Fund I, L.P.$28 2.8 years
Eclipse Fund II, L.P.$18 3.8 years
Eclipse Continuity Fund I, L.P.$16 4.8 years
Cowen Healthcare Investments III LP$2,165 4.8 years
Cowen Healthcare Investments IV LP$5,784 5.8 years
Cowen Sustainable Investments I LP$14,643 7.8 years
(a) The Company is a limited partner of the HealthCare Royalty Partners funds (which are managed by Healthcare Royalty Management) and is a member of HealthCare Royalty Partners General Partners. The Company will make its pro-rata investment in the HealthCare Royalty Partners funds along with the other limited partners.
Litigation
In the ordinary course of business, the Company and its affiliates, subsidiaries and current and former officers, directors and employees (the "Company and Related Parties") are named as defendants in, or as parties to, various legal actions and proceedings. Certain of these actions and proceedings assert claims or seek relief in connection with alleged violations of securities, banking, anti-fraud, anti-money laundering, employment and other statutory and common laws. Certain of these actual or threatened legal actions and proceedings include claims for substantial or indeterminate compensatory or punitive damages, or for injunctive relief.
In the ordinary course of business, the Company and Related Parties are also subject to governmental and regulatory examinations, information gathering requests (both formal and informal), certain of which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. Certain of the Company's affiliates and subsidiaries are registered broker-dealers, futures commission merchants, investment advisers or other regulated entities and, in those capacities, are subject to regulation by various U.S., state and foreign securities, commodity futures and other regulators. In connection with formal and informal inquiries by these regulators, the Company receives requests and orders seeking documents and other information in connection with various aspects of the Company's regulated activities.
Due to the global scope of the Company's operations, and its presence in countries around the world, the Company and Related Parties may be subject to litigation, governmental and regulatory examinations, information gathering requests, investigations and proceedings (both formal and informal), in multiple jurisdictions with legal and regulatory regimes that may differ substantially, and present substantially different risks, from those to which the Company and Related Parties are subject in the United States.
The Company seeks to resolve all litigation and regulatory matters in the manner management believes is in the best interests of the Company and its shareholders, and contests liability, allegations of wrongdoing and, where applicable, the amount of damages or scope of any penalties or other relief sought as appropriate in each pending matter.
In accordance with US GAAP, the Company establishes reserves for contingencies when the Company believes that it is probable that a loss has been incurred and the amount of loss can be reasonably estimated. The Company discloses a contingency if there is at least a reasonable possibility that a loss may have been incurred and there is no reserve for the loss because the
53

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
conditions above are not met. The Company's disclosure includes an estimate of the reasonably possible loss or range of loss for those matters, for which an estimate can be made. Neither a reserve nor disclosure is required for losses that are deemed remote.
The Company appropriately reserves for certain matters where, in the opinion of management, the likelihood of liability is probable and the extent of such liability is reasonably estimable. Such amounts are included within accounts payable, accrued expenses and other liabilities in the accompanying condensed consolidated statements of financial condition. Estimates, by their nature, are based on judgment and currently available information and involve a variety of factors, including, but not limited to, the type and nature of the litigation, claim or proceeding, the progress of the matter, the advice of legal counsel, the Company's defenses and its experience in similar cases or proceedings as well as its assessment of matters, including settlements, involving other defendants in similar or related cases or proceedings. The Company may increase or decrease its legal reserves in the future, on a matter-by-matter basis, to account for developments in such matters. The Company accrues legal fees as incurred.
23. Segment Reporting
The Company has two reportable business segments: Op Co and Asset Co. The Op Co segment consists of Cowen Investment Management ("CIM"), Investment Banking, Markets and Research. The Asset Co segment consists of the Company's private investments, private real estate investments and other legacy investment strategies.
Segment Measures
The measure of profit or loss for these segments is Economic Income (Loss), which management uses to evaluate the financial performance of and make operating decisions for the segments including determining appropriate compensation levels. Expenses not directly associated with specific segments are allocated based on the most relevant measures applicable, including headcount, square footage and other factors.
In general, Economic Income (Loss) is an after tax measure (which represents the Company’s income tax expense or benefit calculated on Pre-tax Economic Income (Loss) once all currently available net operating losses have been utilized and is presented after preferred stock dividends. Economic Income (Loss) (i) includes management reclassifications which the Company believes provides additional insight into the performance of the Company’s core businesses and divisions (ii) eliminates the impact of consolidation for Consolidated Funds and (iii) excludes goodwill and certain other impairments, certain other transaction-related adjustments and/or reorganization expenses and certain costs associated with debt.
The Company does not disclose total asset information for its business segments as the information is not reviewed by the Chief Operating Decision Maker ("CODM"). The Op Co and Asset Co segments do not conduct inter-segment transactions.
The following table sets forth operating results for the Company's consolidated US GAAP net income (loss) and related reclassifications and adjustments necessary to reconcile to the Company's Economic Income (Loss) measure which represents the Company's Op Co and Asset Co segments' results:
 Three Months Ended March 31,
 20222021
 (dollars in thousands)
Economic Income
Op Co$36,297 $143,858 
Asset Co1,150 (1,476)
Adjustments applied to arrive at Net Income (loss)
Income attributable to non-controlling interest20,131 4,562 
Preferred stock dividends1,698 1,698 
Amortization of (discount)/premium on convertible debt(75)(776)
Acquisition related amounts(80)(238)
Contingent liability adjustments(5,133)6,798 
Debt extinguishment gain (loss) and accelerated debt costs— (4,538)
Bargain purchase gain— 3,855 
US GAAP Income tax expense(11,889)(54,428)
Economic income tax expense 13,048 52,751 
Net income (loss) $55,147 $152,066 
Economic Income (Loss) information provided and reviewed by the CODM includes (i) non-interest revenue, (ii) interest revenue, (iii) interest expense, (iv) depreciation and amortization expense and (v) income taxes presented on an Economic Income (Loss) basis by Segment. The following table sets forth the included segment information on a US GAAP basis with reconciliations to consolidated amounts.
54

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
 Three Months Ended March 31,
 20222021
 (dollars in thousands)
Op Co
     Non-Interest Revenue$367,652 $697,885 
     Interest Revenue 40,331 51,104 
           Total Revenues407,983 748,989 
     Interest Expense43,300 53,803 
     Depreciation and Amortization7,179 4,349 
     Income Taxes 11,832 55,085 
Asset Co
     Non-Interest Revenue2,599 (1,668)
     Interest Revenue203 
     Interest Revenue, Consolidated funds
           Total Revenues2,609 (1,463)
     Interest Expense 1,236 1,275 
     Depreciation and Amortization
     Income Taxes57 (657)
Total Segment
     Non-Interest Revenue *370,251 696,217 
     Interest Revenue 40,339 51,307 
     Interest Revenue, Consolidated funds
           Total Revenues$410,592 $747,526 
Interest and Dividend Expense (includes dividend expense of $2.0 million and $2.6 million for the three months ended March 31, 2022 and 2021, respectively)
46,524 57,641 
Depreciation and Amortization7,185 4,354 
Income Taxes11,889 54,428 
* Includes dividend revenue of $6.0 million and $8.1 million for the three months ended March 31, 2022 and 2021, respectively. In addition, includes dividend revenue, consolidated funds, of $0.0 million and $2.6 million for the three months ended March 31, 2022 and 2021, respectively.
24. Regulatory Requirements
Regulatory Capital
As registered broker-dealers with the United States Securities and Exchange Commission ("SEC"), Cowen and Company, ATM Execution and Westminster are subject to the Uniform Net Capital Rule 15c3-1, "SEA Rule 15c3-1," under the Securities Exchange Act ("SEA") of 1934, which requires the maintenance of minimum net capital. Each registered broker-dealer has elected to compute net capital under the alternative method permitted by that rule.
The Company acquired Portico, a registered broker-dealer on December 16, 2021. As a result of the acquisition, Portico's net assets were transferred into Cowen and Company. The Company applied to withdraw Portico's status as a FINRA registered broker-dealer on December 20, 2021 which was approved by the SEC on February 18, 2022.
Under the alternative method, Cowen and Company's minimum net capital requirement, as defined in (a)(4) of SEA Rule 15c3-1, is equal to the greater of $1.5 million or 2% of aggregate debits arising from customer transactions. ATM Execution, and Westminster are required to maintain minimum net capital, as defined in (a)(1)(ii) of SEA Rule 15c3-1, equal to the greater of $250,000 or 2% of aggregate debits arising from customer transactions. Advances to affiliates, repayment of borrowings, distributions, dividend payments, and other equity withdrawals are subject to certain notification and other provisions of SEA Rule 15c3-1 and other regulatory bodies.
Cowen and Company is also subject to certain net capital rule requirements under the Regulation 1.17 of the Commodity Futures Trading Commission ("CFTC") under Commodities Exchange Act (“CEA”) as an introducing broker. Under Regulation 1.17, Cowen and Company is required to maintain net capital equal to or in excess of $45,000 or the amount of net capital required by SEA Rule 15c3-1, whichever is greater. Additionally, as an options clearing member of the Options Clearing Corporation ("OCC") under OCC Rule 302, Cowen and Company is required to maintain net capital equal to the greater of $2.0
55

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
million or 2% of aggregate debit items. At March 31, 2022, Cowen and Company had $397.2 million of net capital in excess of its minimum requirements under SEA Rule 15c3-1.
The Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) was signed into law on July 21, 2010. The Dodd-Frank Act contains provisions that require the registration of all swap dealers, major swap participants, security-based swap dealers, and/or major security-based swap participants. Cowen Financial Products, Ltd ("Cowen Financial Products") registered only with the SEC with an effective date of November 1, 2021 as a securities-based swap dealer and is not using models to compute its net capital. Under the rules there is a minimum net capital requirement for, among others, an entity that acts as a dealer in security-based swaps, which is the greater of $20 million or 2% of risk margin amount The risk margin amount means the sum of (i) the total initial margin required to be maintained by the SEC securities-based swaps dealer at each clearing agency with respect to securities-based swaps transactions cleared for securities-based swap customers and (ii) the total initial margin amount calculated by the SEC securities-based swaps dealer swaps dealer with respect to non-cleared securities-based swaps under SEC rules. At March 31, 2022, Cowen Financial Products had $16.7 million of net capital in excess of its minimum requirements under SEA Rule 18a-1.
Cowen International Ltd and Cowen Execution Ltd are subject to the capital requirements of the U.K. Financial Conduct Authority ("FCA"), as defined, and must exceed the minimum capital requirement set forth by the FCA. On 1 January 2022, the FCA adopted the Investment Firms Prudential Regime ("IFPR"). This is a new prudential regime which applies to MiFID investment firms authorized and regulated by the FCA in the UK. The IFPR refocuses prudential requirements and expectations away from the risks firms face, to also consider and look to manage the potential harm firms can pose to consumers and markets. Cowen International Ltd and Cowen Execution Ltd will both be designated as Class 2 firms under the new regime and will have a minimum capital requirement equal to the higher of; the Permanent minimum capital requirement, their respective Fixed Overhead requirement, and their Risk Responsive Computation ("K-factors").
Cowen Asia, a previously established entity, was re-registered with regulatory approval on May 17, 2019. Cowen Asia is subject to the financial resources requirements of the Securities and Futures Commission ("SFC") of Hong Kong. Financial Resources must exceed the Total Financial Resources requirement of the SFC.
As of March 31, 2022, the regulatory net capital, minimum net capital requirement and excess net capital of U.S. regulated broker dealers and swap dealer together with the equivalent of capital requirements and compliance information for foreign broker dealers registered with the FCA and the SFC are presented as follows:
SubsidiaryNet CapitalMinimum Net Capital RequirementExcess Net Capital
 (dollars in thousands)
Cowen and Company$406,557 $9,343 $397,214 
ATM Execution$7,880 $250 $7,630 
Westminster$19,521 $250 $19,271 
Cowen Financial Products$36,658 $20,000 $16,658 
Cowen International Ltd (a)$51,109 $25,735 $25,374 
Cowen Execution Ltd (a)$17,900 $5,075 $12,825 
Cowen Asia (a)$2,045 $383 $1,662 
(a)The equivalent of Net Capital under FCA rules is referred as “capital resources” and under SFC rules is referred as “net liquid capital.” The equivalent of Minimum Net Capital Requirement under FCA rules is referred as “minimum capital resources requirement and under SFC rules is referred as “net liquid capital requirement."
Customer Protection
The Company's U.S. broker-dealers must also comply with the customer protection provisions under SEA Rule 15c3-3 which requires a computation of a reserve requirement for customer and maintenance of a deposit of cash or securities into a special reserve bank account for the exclusive benefit of customers; or claim an exemption pursuant to subparagraphs (k)(2)(i) or (k)(2)(ii) of that rule. Firms can rely on more than one exemption.
ATM Execution claims the (k)(2)(ii) exemption with regard to all of their customer accounts and transactions that are introduced on a fully-disclosed basis to their clearing agents for clearing, settlement and custody. Westminster claims the (k)(2)(i) exemption with regard to customer transactions and balances that are cleared, settled and custodied in bank accounts designated as Special Accounts for the Exclusive Benefit of Customers ("Special Bank Accounts"). Westminster also claims exemption for other business activities that are not covered under (k)(2)(i) contemplated by Footnote 74 of the SEC Release No. 34-70073 adopting amendments to 17 C.F.R. § 240.17a-5 for receiving transaction-based compensation in return for providing commission management services.
56

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
In accordance with the requirements of SEA Rule 15c3-3, Cowen and Company may be required to deposit in a Special Reserve Account cash or acceptable qualified securities for the exclusive benefit of customers. As of March 31, 2022, Cowen and Company had segregated approximately $51.8 million of cash to satisfy the customer reserve provision of SEA Rule 15c3-3.
As a clearing and carrying broker-dealer, Cowen and Company is required to compute a reserve requirement for proprietary accounts of broker-dealers ("PAB"), as defined in SEA Rule 15c3-3. Cowen and Company conducts PAB reserve computations in order to determine the amount it is required to deposit in its PAB Reserve Bank Accounts pursuant to SEA Rule 15c3-3. This allows each correspondent firm that uses Cowen and Company as its clearing broker-dealer to classify its PAB account assets held at Cowen and Company as allowable assets in the correspondent's net capital calculation. At March 31, 2022, Cowen and Company had $71.7 million of cash on deposit in PAB Reserve Bank Accounts. Cowen and Company and ATM Execution also maintain certain assets in PAB accounts held at their respective clearing brokers. Each treats its assets held in those PAB accounts at the respective clearing brokers as allowable assets for net capital purposes.
Cowen Financial Products, as a registered securities based swap dealer, claims Rule 18a-4(f) exemption under the Securities Exchange Act of 1934 (the “Act”) with regard to its swap counterparties on the basis that it has provided sufficient notice to its swap counterparties of their respective rights to require segregation of funds or other property used to secure uncleared security based swaps pursuant to section 3E(f)(1)(A)-(B) of the Act (15 U.S.C. 78c-5(f)(1)(A)). Any margin collateral received and held by the security based swap dealer with respect to uncleared security based swaps will not be subject to a segregation requirement. The notice outlines how a claim of those swap counterparties for the collateral would be treated in a bankruptcy or other formal liquidation proceeding of the security-based swap dealer.
Other Regulatory Requirements
Cowen Insurance Co and Cowen Re are individually required to maintain a solvency capital ratio as calculated by relevant European Commission directives and local regulatory rules in Malta and Luxembourg, respectively. Each company's individual solvency capital ratio calculated at the end of each quarter must exceed a minimum requirement. As of December 31, 2021, the last testing date for Cowen Re and Cowen Insurance Co, the solvency capital ratios of both Cowen Insurance Co and Cowen Re were in excess of the minimum requirements.
Based on minimum capital and surplus requirements pursuant to the laws of the state of New York that apply to captive insurance companies, RCG Insurance Company, Cowen's captive insurance company incorporated and licensed in the state of New York, was required to maintain capital and surplus of approximately $0.3 million as of March 31, 2022. RCG Insurance Company’s capital and surplus as of March 31, 2022 totaled $6.0 million.
25. Related Party Transactions
The Company and its affiliated entities are the managing member, general partner and/or investment manager to the Company's investment funds and certain managed accounts. Management fees and incentive income are primarily earned from affiliated entities. As of March 31, 2022 and December 31, 2021, $21.9 million and $16.6 million, respectively, included in fees receivable, are earned from related parties. The Company may, at its discretion, reimburse certain fees charged to the investment funds that it manages to avoid duplication of fees when such funds have an underlying investment in another affiliated investment fund. For the three months ended March 31, 2022 and 2021, the amounts which the Company reimbursed the investment funds it manages were immaterial. Fees receivable and fees payable are recorded at carrying value, which approximates fair value.
The Company may also make loans to employees or other affiliates, excluding executive officers of the Company. These loans are interest bearing and settle pursuant to the agreed-upon terms with such employees or affiliates, and are included in due from related parties in the accompanying condensed consolidated statements of financial condition. As of March 31, 2022 and December 31, 2021, loans to employees of $9.2 million and $8.8 million, respectively, were included in due from related parties on the accompanying condensed consolidated statements of financial condition. Of these amounts $3.8 million and $3.8 million, respectively, are related to forgivable loans. These forgivable loans provide for a cash payment up-front to employees, with the amount due back to the Company forgiven over a vesting period.  An employee that voluntarily ceases employment, or is terminated with cause, is generally required to pay back to the Company any unvested forgivable loans granted to them.  The forgivable loans are recorded as an asset to the Company on the date of grant and payment, and then amortized to compensation expense on a straight-line basis over the vesting period.  The vesting period on forgivable loans is generally one to three years. The Company recorded compensation expense of $0.8 million and $1.2 million for the three months ended March 31, 2022 and 2021, respectively. This expense is included in employee compensation and benefits in the accompanying condensed consolidated statements of operations. For the three months ended March 31, 2022 and 2021, the interest income was $0.1 million, for these related party loans and advances, and are included in interest and dividends in the accompanying condensed consolidated statements of operations.
57

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
The remaining balance included in due from related parties of $12.4 million and $22.6 million as of March 31, 2022 and December 31, 2021, respectively, relates to amounts due to the Company from affiliated investment funds and real estate entities due to expenses paid on their behalf.
Employees and certain other related parties invest on a discretionary basis within consolidated entities. These investments generally are subject to preferential management fee and performance fee arrangements. As of March 31, 2022 and December 31, 2021, such investments aggregated $58.3 million and $53.9 million, respectively, were included in non-controlling interests on the accompanying condensed consolidated statements of financial condition. Their share of the net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds aggregated $10.3 million and $10.1 million for the three months ended March 31, 2022 and 2021, respectively.
The Company may, at times, have unfunded commitment amounts pertaining to related parties. See Note 22 for amounts committed as of March 31, 2022.
26. Guarantees and Off-Balance Sheet Arrangements
Guarantees
US GAAP requires the Company to disclose information about its obligations under certain guarantee arrangements. Those standards define guarantees as contracts and indemnification agreements that contingently require a guarantor to make payments to the guaranteed party based on changes in an underlying security (such as an interest or foreign exchange rate, security or commodity price, an index or the occurrence or nonoccurrence of a specified event) related to an asset, liability or equity security of a guaranteed party. Those standards also define guarantees as contracts that contingently require the guarantor to make payments to the guaranteed party based on another entity's failure to perform under an agreement as well as indirect guarantees of the indebtedness of others.
In the normal course of its operations, the Company enters into contracts that contain a variety of representations and warranties which provide general indemnifications. The Company's maximum exposure under these arrangements is unknown as this would involve future claims that may be made against the Company that have not yet occurred. However, based on experience, the Company expects the risk of loss to be remote.
The Company indemnifies and guarantees certain service providers, such as clearing and custody agents, trustees and administrators, against specified potential losses in connection with their acting as an agent of, or providing services to, the Company or its affiliates. The Company also indemnifies some clients against potential losses incurred in the event specified third-party service providers, including sub-custodians and third-party brokers, improperly execute transactions. The maximum potential amount of future payments that the Company could be required to make under these indemnifications cannot be estimated. However, the Company believes that it is unlikely it will have to make significant payments under these arrangements and has not recorded any contingent liability in the condensed consolidated financial statements for these indemnifications.
The Company also provides representations and warranties to counterparties in connection with a variety of commercial transactions and occasionally indemnifies them against potential losses caused by the breach of those representations and warranties. The Company may also provide standard indemnifications to some counterparties to protect them in the event additional taxes are owed or payments are withheld, due either to a change in or adverse application of certain tax laws. These indemnifications generally are standard contractual terms and are entered into in the normal course of business. The maximum potential amount of future payments that the Company could be required to make under these indemnifications cannot be estimated. However, the Company believes it is unlikely it will have to make material payments under these arrangements and has not recorded any contingent liability in the accompanying condensed consolidated financial statements for these indemnifications.
The Company may maintain cash and cash equivalents at financial institutions in excess of federally insured limits. The Company has not experienced any material losses in such accounts and does not believe it is exposed to significant credit risks in relation to such accounts.
Off-Balance Sheet Arrangements
The Company has no material off-balance sheet arrangements, which have not been disclosed, as of March 31, 2022 and December 31, 2021. Through indemnification provisions in clearing agreements with clients, customer activities may expose the Company to off-balance-sheet credit risk. Pursuant to the clearing agreement, the Company is required to reimburse the Company's clearing broker, without limit, for any losses incurred due to a counterparty's failure to satisfy its contractual obligations. However, these transactions are collateralized by the underlying security, thereby reducing the associated risk to changes in the market value of the security through the settlement date.
58

Cowen Inc.
Notes to Unaudited Condensed Consolidated Financial Statements (Continued)
The Company's customer securities activities are transacted on a delivery versus payment, cash or margin basis. In delivery versus payment transactions, the Company is exposed to risk of loss in the event of the customers' or brokers' inability to meet the terms of their contracts.
In margin transactions, the Company extends credit to clients collateralized by cash and securities in their account. In the event the customers or brokers fail to satisfy their obligations, the Company may be required to purchase or sell securities at prevailing market prices in order to fulfill the obligations.
The Company's exposure to credit risk can be directly impacted by volatile securities markets, which may impair the ability of counterparties to satisfy their contractual obligations. The Company seeks to control its credit risk through a variety of reporting and control procedures, including establishing credit limits based upon a review of the customers' financial condition and credit ratings. The Company seeks to control the risk associated with its customer margin transactions by requiring customers to maintain margin collateral in compliance with various regulatory and internal guidelines. The Company also monitors required margin levels daily and, pursuant to its guidelines, requires customers to deposit additional collateral, or reduce positions, when necessary.
In addition, during the normal course of business, the Company has exposure to a number of risks including market risk, currency risk, credit risk, operational risk, liquidity risk and legal risk. As part of the Company's risk management process, these risks are monitored on a regular basis throughout the course of the year.
The Company enters into secured and unsecured borrowing agreements to obtain funding necessary to cover daily securities settlements with clearing corporations. At times, funding is required for unsettled customer delivery versus payment and riskless principal transactions, as well as to meet deposit requirements with clearing organizations. Secured arrangements are collateralized by the securities. The Company maintains uncommitted financing arrangements with large financial institutions, the details of which are summarized below as of March 31, 2022.
LenderContractual AmountAvailable AmountMaturity DateDescription
Pledge Lines(dollars in thousands)
      BMO Harris Bank$75,000 $75,000 NoneSecured Tri-Party Pledge Facility
       BMO Harris Bank150,000 150,000 NoneSecured Depository Trust Company Pledge Line
       Total225,000 225,000 
Spike Line
     BMO Harris Bank
     Canadian Imperial Bank
     of Commerce, in syndication
70,000 70,000 August 19, 2022Unsecured committed spike line facility to cover short term increases in National Securities Clearing Corporation margin deposit requirements
Revolving Credit Facility
     Morgan Stanley25,000 25,000 March 24, 2026Unsecured Corporate Revolver
Total Credit Lines$320,000 $320,000 

27. Subsequent Events
On April 21, 2022 the Board of Directors declared a quarterly cash dividend payable on its common stock of $0.12 per common share, payable on June 15, 2022, to stockholders of record on June 1, 2022.
The Company has evaluated events that have occurred after the balance sheet date but before the financial statements are issued and has determined that there were no other subsequent events requiring adjustment or disclosure in the condensed consolidated financial statements.

59

Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations
         The discussion contains forward-looking statements, which involve numerous risks and uncertainties, including, but not limited to, those described in the sections titled “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021 (the "2021 Form 10-K") and in Item 1A of this Quarterly Report on Form 10-Q, many of which risks are currently elevated by, and may or will continue to be elevated by, the COVID-19 pandemic. This Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the condensed consolidated financial statements and related notes of Cowen Inc. included elsewhere in this quarterly report. Actual results may differ materially from those contained in any forward-looking statements.
Overview
Cowen Inc., a Delaware corporation formed in 2009, is a diversified financial services firm that, together with its consolidated subsidiaries (collectively, "Cowen" or the "Company"), provides investment banking, research, sales and trading, prime brokerage, global clearing, securities financing, commission management services and investment management through its two business segments: the Operating Company ("Op Co") and the Asset Company ("Asset Co").
Operating Company
The Op Co segment consists of four divisions: the Cowen Investment Management ("CIM") division, the Investment Banking division, the Markets division (which includes sales and trading, prime brokerage, global clearing, securities financing and commission management services) and the Research division. The Company refers to the Investment Banking division, the Markets division and the Research division collectively as its investment banking businesses. Op Co's CIM division includes advisers to investment funds (including private equity structures and privately placed hedge funds), and registered funds. Op Co's investment banking businesses offer industry focused investment banking for growth-oriented companies including advisory and global capital markets origination, domain knowledge-driven research, sales and trading platforms for institutional investors, global clearing, commission management services and also a comprehensive suite of prime brokerage services.
The CIM division is the Company's investment management business, which operates primarily under the Cowen Investment Management name. CIM offers innovative investment products and solutions across the liquidity spectrum to institutional and private clients. The predecessor to this business was founded in 1994 and, through one of its subsidiaries, has been registered with the SEC as an investment adviser under the Investment Advisers Act of 1940, as amended (the "Advisers Act") since 1997. The Company's investment management business offers investors access to a number of strategies to meet their specific needs including healthcare investing, sustainable investing, healthcare royalties, merger arbitrage and activism. A portion of the Company’s capital is invested alongside the Company's investment management clients. The Company has also invested capital in its insurance and reinsurance businesses.
Op Co's investment banking businesses include investment banking, research, sales and trading, prime brokerage, global clearing, securities financing and commission management services provided primarily to companies and institutional investor clients. Sectors covered by Op Co's investment banking business include healthcare, technology, media and telecommunications, consumer, industrials, tech-enabled and business services, and energy. We provide research and brokerage services to over 6,000 domestic and international clients seeking to trade securities and other financial instruments, principally in our sectors. The investment banking businesses also offer a full-service suite of introduced prime brokerage services targeting emerging private fund managers. Historically, we have focused our investment banking efforts on small to mid-capitalization public companies as well as private companies. From time to time, the Company invests in private capital raising transactions of its investment banking clients.
Asset Company
The Asset Co segment consists of the Company's private investments, private real estate investments and other legacy investment strategies. The focus of Asset Co is to drive future monetization of the invested capital of the segment.
Certain Factors Impacting Our Business
Our Company's businesses and results of operations are impacted by the following factors:
Underwriting, private placement and strategic/financial advisory fees.  Our revenues from investment banking are directly linked to the underwriting fees we earn in equity and debt securities offerings in which the Company acts as an underwriter, private placement fees earned in non-underwritten transactions, sales commissions earned in at-the-market offerings and success fees earned in connection with advising both buyers and sellers, principally in mergers and acquisitions. As a result, the future performance of our investment banking business will depend on, among other things, our ability to secure lead manager and co-manager roles in clients' capital raising transactions as well as our ability to secure mandates as a client's strategic financial advisor.
60


Table of Contents
Liquidity.  As a clearing broker-dealer in the U.S., we are subject to cash deposit requirements with clearing organizations, brokers and banks that may be large in relation to our total liquid assets.
Equity research fees.  Equity research fees are paid to the Company for providing access to equity research. The Company also permits institutional customers to allocate a portion of their commissions to pay for research products and other services provided by third parties. Our ability to generate revenues relating to our equity research depends on the quality of our research and its relevance to our institutional customers and other clients.
Principal transactions. Principal transactions revenue includes net trading gains and losses from the Company's market-making activities and net trading gains and losses on inventory and other Company positions. In certain cases, the Company provides liquidity to clients buying or selling blocks of shares of listed stocks without previously identifying the other side of the trade at execution, which subjects the Company to market risk.
Commissions.  Our commission revenues depend for the most part on our customers' trading volumes and on the notional value of the non-U.S. securities traded by our customers.
Investment performance.  Our revenues from incentive income and carried interest allocations are linked to the performance of the investment funds and accounts that we manage. Performance also affects assets under management because it influences investors' decisions to invest assets in, or withdraw assets from, the investment funds and accounts managed by us.
Fee and allocation rates.  Our management fee revenues are linked to the management fee rates we charge as a percentage of contributed and invested capital. Our incentive income revenues are linked to the rates we charge as a percentage of performance-driven asset growth. Our incentive allocations are generally subject to "high-water marks," whereby incentive income is generally earned by us only to the extent that the net asset value of an investment fund at the end of a measurement period exceeds the highest net asset value as of the end of the earlier measurement period for which we earned incentive income. Our incentive allocations, in some cases, are subject to performance hurdles. Additionally, our revenues from management fees are directly linked to assets under management. Positive performance in our legacy funds increases assets under management which results in higher management fees.
Investment performance of our own capital.  We invest our own capital and the performance of such invested capital affects our revenues.  Investment income in the investment bank business includes gains and losses generated by the capital the Company invests in private capital raising transactions of its investment banking clients.  Our revenues from investment income are linked to the performance of the underlying investments.
External Factors Impacting Our Business
Our financial performance is highly dependent on the environment in which our businesses operate. We believe a favorable business environment is characterized by many factors, including a stable geopolitical climate, transparent financial markets, low inflation, low interest rates, low unemployment, strong business profitability and high business and investor confidence. Unfavorable or uncertain economic or market conditions can be caused by declines in economic growth, business activity or investor or business confidence, limitations on the availability (or increases in the cost of) credit and capital, increases in inflation or interest rates, exchange rate volatility, unfavorable global asset allocation trends, outbreaks of hostilities or other geopolitical instability, such as the ongoing war in Ukraine, corporate, political or other scandals that reduce investor confidence in the capital markets, global health crisis, such as the ongoing COVID-19 pandemic, or a combination of these or other factors. Until the COVID-19 pandemic subsides, we could experience reduced levels in certain of our investment banking activities, reduced revenues from incentive income in our investment management business and reduced investment income. Our businesses and profitability have been and may continue to be adversely affected by market conditions in many ways, including the following:
Our investment bank business has been, and may continue to be, adversely affected by market conditions. Increased competition continues to affect our investment banking and capital markets businesses. The same factors also affect trading volumes in secondary financial markets, which affect our brokerage business. Commission rates, market volatility, increased competition from larger financial firms and other factors also affect our brokerage revenues and may cause these revenues to vary from period to period.
Our investment management business can be adversely affected by unanticipated levels of requested redemptions. We experienced significant levels of requested redemptions during the 2008 financial crisis and, while the environment for investing in investment management products has since improved, it is possible that we could intermittently experience redemptions above historical levels, regardless of investment fund performance.
Our investment bank business focuses primarily on small to mid-capitalization and private companies in specific industry sectors. These sectors may experience growth or downturns independent of general economic and market conditions, or may face market conditions that are disproportionately better or worse than those impacting the economy and markets generally. In addition, increased government regulation has had, and may continue to have, a disproportionate effect on
61

Table of Contents
capital formation by smaller companies. Therefore, our investment bank business could be affected differently than overall market trends.
Our businesses, by their nature, do not produce predictable earnings. Our results in any period can be materially affected by conditions in global financial markets and economic conditions generally. We are also subject to various legal and regulatory actions that impact our business and financial results.
Recent Developments
On March 23, 2022, Cowen announced the public launch of the Company's digital asset division, Cowen Digital LLC. Based in Stamford, Connecticut, the new division offers full-service trade execution and custody solutions on a platform that provides institutional clients with secure and compliant access to the digital asset ecosystem. Custody solutions are provided through Cowen’s strategic partnership with Standard Custody & Trust, a subsidiary of PolySign Inc.
Basis of Presentation
The unaudited condensed consolidated financial statements of the Company in this Form 10-Q are prepared in accordance with US GAAP as promulgated by the Financial Accounting Standards Board ("FASB") through Accounting Standards Codification (the "Accounting Standards") as the source of authoritative accounting principles in the preparation of financial statements and include the accounts of the Company, its subsidiaries, and entities in which the Company has a controlling financial interest or a substantive, controlling general partner interest. All material intercompany transactions and balances have been eliminated in consolidation. Certain fund entities that are consolidated in the condensed consolidated financial statements, are not subject to these consolidation provisions with respect to their own investments pursuant to their specialized accounting.
The Company serves as the managing member/general partner and/or investment manager to affiliated fund entities which it sponsors and manages. Certain of these funds in which the Company has a substantive, controlling general partner interest are consolidated with the Company pursuant to US GAAP as described below (the "Consolidated Funds"). Consequently, the Company's condensed consolidated financial statements reflect the assets, liabilities, income and expenses of these funds on a gross basis. The ownership interests in these funds which are not owned by the Company are reflected as redeemable and non-redeemable non-controlling interests in consolidated subsidiaries in the condensed consolidated financial statements appearing elsewhere in this Form 10-Q. The management fees and incentive income earned by the Company from these funds are eliminated in consolidation.
Expenses
The Company's expenses consist of compensation and benefits, insurance and reinsurance costs, general, administrative and other, and Consolidated Funds expenses.
Compensation and Benefits.  Compensation and benefits is comprised of salaries, benefits, discretionary cash bonuses and equity-based compensation. Annual incentive compensation is variable, and the amount paid is generally based on a combination of employees' performance, their contribution to their business segment, and the Company's performance. Generally, compensation and benefits comprise a significant portion of total expenses, with annual incentive compensation comprising a significant portion of total compensation and benefits expenses.
Insurance and Reinsurance claims, commissions and amortization of deferred acquisition costs. Insurance and reinsurance-related expenses reflect loss and claim reserves, acquisition costs and other expenses incurred with respect to our insurance and reinsurance operations.
Operating, General and Administrative.  General, administrative and other expenses are primarily related to professional services, occupancy and equipment, business development expenses, communications, expenses associated with our reinsurance business and other miscellaneous expenses. These expenses may also include certain one-time charges and non-cash expenses.
Depreciation and Amortization.  Depreciation and amortization is comprised of depreciation expense for tangible assets and the amortization of intangible assets. The depreciation of assets capitalized under finance leases is included in depreciation and amortization expenses as well.
Consolidated Funds Expenses.  The Company's condensed consolidated financial statements reflect the expenses of the Consolidated Funds and the portion attributable to other investors is allocated to a non-controlling interest.
Income Taxes
The taxable results of the Company’s U.S. operations are subject to U.S. federal, state and local taxation as a corporation. The Company is also subject to foreign taxation on income it generates in certain countries.
The Company records deferred tax assets and liabilities for the future tax benefit or expense that will result from differences between the carrying value of its assets for income tax purposes and for financial reporting purposes, as well as for operating or
62


Table of Contents
capital loss and tax credit carryovers. A valuation allowance is recorded to bring the net deferred tax assets to a level that, in management’s view, is more likely than not to be realized in the foreseeable future. This level will be estimated based on a number of factors, especially the amount of net deferred tax assets of the Company that are actually expected to be realized, for tax purposes, in the foreseeable future. Deferred tax liabilities that cannot be realized in a similar future time period and thus that cannot offset the Company’s deferred tax assets are not taken into account when calculating the Company’s net deferred tax assets.
Temporary Equity
Temporary equity consists of Redeemable 5.625% Series A cumulative perpetual convertible preferred stock ("Series A Convertible Preferred Stock"). The Company has irrevocably elected to cash settle $1,000.00 of each conversion of any share of the Series A Convertible Preferred Stock. As the holders can exercise the conversion option on their shares of Series A Convertible Preferred Stock at any time and require cash payment upon conversion, the Company has classified the Series A Convertible Preferred Stock preferred stock in temporary equity.
Non-Redeemable Non-Controlling Interests
Non-controlling interests represent the pro rata share of the income or loss of the non-wholly owned consolidated entities attributable to the other owners of such entities. When non-controlling interest holders do not have redemption features that can be exercised at the option of the holder currently or contingent upon the occurrence of future events, their ownership has been classified as a component of permanent equity. Ownership which has been classified in permanent equity are non-controlling interests for which the holder does not have the unilateral right to redeem its ownership interests.
Investment Fund Performance and Assets Under Management
For the three months ended March 31, 2022, the Company's activist strategy had marginally negative results but outperformed its benchmark while its merger arbitrage strategies had positive results. The Company's healthcare royalty strategy is now making allocations from the strategy's fourth fund. The Company’s healthcare investments strategy is now deploying capital from its fourth fund. Finally, our sustainable investing strategy is now deploying capital, with three investments made as of March 31, 2022. The liquidation of certain multi-strategy hedge funds advised by the Company also continues.
As of March 31, 2022, the Company had assets under management of $15.6 billion.
Strategy Healthcare InvestmentsHealthcare RoyaltiesActivismMerger ArbitrageSustainable InvestmentsOther (a)
(dollars in millions)
AUM$1,074$3,556$8,387$311$1,367$884
Team
Private Equityüüü
Hedge Fundüü
Managed Accountüüüü
UCITSü
Otherü
(a) Other strategies include legacy funds and other private investment strategies.
The Company's Invested Capital
The Company invests a significant portion of its capital base to help drive results and facilitate the growth of the Op Co and Asset Co business segments. Within Op Co, management allocates capital to three primary investment categories: (i) broker-dealer capital and related trading strategies; (ii) liquid alternative trading strategies; and (iii) public and private healthcare strategies. Broker-dealer capital and related trading strategies include capital investments in the Company's broker-dealers as well as securities finance and special purpose acquisition company trading strategies to grow liquidity and returns within operating businesses.  Much of the Company's public and private healthcare strategies and liquid alternative trading strategies portfolios are invested alongside the Company's investment management clients. The Company's liquid alternative trading strategies include merger arbitrage and activist fund strategies. In addition, from time to time, the Company makes investments in private capital raising transactions of its investment banking clients.
The Company allocates capital to Asset Co's private investments. Asset Co's private investments include the Company's investment in Italian wireless broadband provider Linkem, private equity funds Formation8 and Eclipse and legacy real estate investments.
As of March 31, 2022, the Company's invested capital amounted to a net value of $842.8 million (supporting a long market value of $760.9 million), representing approximately 81% of Cowen's stockholders' equity presented in accordance with
63

Table of Contents
US GAAP. The table below presents the Company's invested equity capital by strategy and as a percentage of Cowen's stockholders' equity as of March 31, 2022. The total net values presented in the table below do not tie to Cowen's condensed consolidated statement of financial condition as of March 31, 2022 because they represent only some of the line items in the accompanying condensed consolidated statement of financial condition.
StrategyNet Value% of Stockholders' Equity
(dollars in millions)
Op Co
     Broker-dealer capital and related trading$613.5 59%
     Public and Private Healthcare28.1 3%
     Liquid Alternative Trading68.7 7%
     Other12.9 1%
Asset Co
     Private Investments119.6 12%
Total842.8 81%
Cowen Inc. Stockholders' Equity$1,035.1 
The allocations shown in the table above will change over time.
Results of Operations
To provide comparative information of the Company's operating results for the periods presented, a discussion of Economic Income (Loss) (which is a non-GAAP measure) of our Op Co and Asset Co segments follows the discussion of our total consolidated US GAAP results.
64


Table of Contents
Three Months Ended March 31, 2022 Compared with Three Months Ended March 31, 2021
Condensed Consolidated Statements of Operations
(unaudited)
 Three Months Ended March 31,Period to Period
 20222021$ Change% Change
 (dollars in thousands)
Revenues    
Investment banking$101,542 $304,834 $(203,292)(67)%
Brokerage168,738 173,737 (4,999)(3)%
Investment income (loss)
Securities principal transactions, net91,25263,96527,28743 %
Portfolio fund principal transactions, net (6,098)15,403(21,501)(140)%
Carried interest allocations(17,067)96,769(113,836)(118)%
Total investment income (loss)68,087 176,137 (108,050)(61)%
Management fees16,769 25,742 (8,973)(35)%
Incentive income633 2,258 (1,625)(72)%
Interest and dividends46,335 59,388 (13,053)(22)%
Insurance and reinsurance premiums11,321 7,117 4,204 59 %
Other revenues, net(949)1,660 (2,609)(157)%
Consolidated Funds revenues(1,884)(3,347)1,463 44 %
Total revenues410,592 747,526 (336,934)(45)%
Interest and dividends expense46,524 57,641 (11,117)(19)%
Total net revenues364,068 689,885 (325,817)(47)%
Expenses    
Employee compensation and benefits187,178 388,196 (201,018)(52)%
Insurance and reinsurance claims, commissions and amortization of deferred acquisition costs7,343 6,455 888 14 %
Operating, general, administrative and other expenses100,801 96,077 4,724 %
Depreciation and amortization expense7,185 4,354 2,831 65 %
Consolidated Funds expenses105 271 (166)(61)%
Total expenses302,612 495,353 (192,741)(39)%
Other income (loss)    
Net gains (losses) on other investments5,580 12,645 (7,065)(56)%
Bargain purchase gain, net of tax— 3,855 (3,855)NM
Gain/(loss) on debt extinguishment — (4,538)4,538 NM
Total other income (loss)5,580 11,962 (6,382)(53)%
Income (loss) before income taxes67,036 206,494 (139,458)(68)%
Income tax expense (benefit)11,889 54,428 (42,539)(78)%
Net income (loss) 55,147 152,066 (96,919)(64)%
Net income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment funds20,131 4,562 15,569 341 %
Net income (loss) attributable to Cowen Inc.35,016 147,504 (112,488)(76)%
Preferred stock dividends1,698 1,698 — — %
Net income (loss) attributable to Cowen Inc. common stockholders$33,318 $145,806 $(112,488)(77)%
Revenues
Investment Banking
Investment banking revenues decreased $203.3 million to $101.5 million for the three months ended March 31, 2022 compared with $304.8 million in the prior year period. During the three months ended March 31, 2022, the Company completed six underwriting transactions, 19 strategic advisory transactions and eight debt capital markets transactions. During the three months ended March 31, 2021, the Company completed 62 underwriting transactions, 21 strategic advisory transactions and five debt capital markets transactions.
65

Table of Contents
Brokerage
Brokerage revenues decreased $5.0 million to $168.7 million for the three months ended March 31, 2022 compared with $173.7 million in the prior year period. This was attributable to a decrease in institutional brokerage, primarily special situations and electronic commissions. Customer trading volumes across the industry (according to Bloomberg) decreased 12% for the quarter ended March 31, 2022 compared to the prior year period.
Investment Income (loss)
Securities principal transactions, net
Securities principal transactions, net increased $27.3 million to $91.3 million for the three months ended March 31, 2022 compared with $64.0 million in the prior year period. The increase in securities principal transactions, net was primarily attributable to an increase in the value of our digital investments offset partially by a decrease in our healthcare and merchant banking investments. Additionally, first quarter 2022 also included $18 million from a mark-to-market unrealized gain on an interest rate swap used to offset interest on floating-rate debt. We subsequently realized this gain in early April.
Portfolio fund principal transactions, net
Portfolio fund investment income (loss) decreased $21.5 million to a loss of $6.1 million for the three months ended March 31, 2022 compared with an income of $15.4 million in the prior year period. The decrease is primarily related to public positions in our healthcare and sustainable fund investments and a decrease in our activist fund investments.
Carried interest allocations
Carried interest allocations decreased $113.9 million to a loss of $17.1 million for the three months ended March 31, 2022 compared with an income of $96.8 million in the prior year period. The primary driver of the decrease was a decrease in allocations from our healthcare and sustainable funds.
Management Fees
Management fees decreased $8.9 million to $16.8 million for the three months ended March 31, 2022 compared with $25.7 million in the prior year period. This decrease in management fees was primarily related to management fees earned from new investors entering the Cowen Sustainable funds in the first quarter of 2021 when, during the quarter, the fund had multiple capital raises offset partially by an increase in the Cowen Healthcare investments funds.
Incentive Income
Incentive income decreased $1.6 million to $0.6 million for the three months ended March 31, 2022. This decrease was primarily related to a decrease in performance fees from our Cowen Sustainable and Cowen Healthcare investment funds. Due to revenue recognition standards, effective January 1, 2018, the Company recognizes the majority of incentive income allocated to the Company as carried interest allocations, included in investment income (loss).
Interest and Dividends
Interest and dividends decreased $13.1 million to $46.3 million for the three months ended March 31, 2022 compared with $59.4 million in the prior year period. Interest and dividends amounts are primarily attributable to securities finance activity. The decrease in the securities finance activity is due to lower customer demand which has created less matched book opportunities for international securities.
Insurance and Reinsurance Premiums
Insurance and reinsurance premiums increased $4.2 million to $11.3 million for the three months ended March 31, 2022 compared with $7.1 million in the prior year period. This increase is driven by an increase in premiums (net of reinsurance) in both our insurance and reinsurance entities.
Other Revenues, net
Other revenues decreased $2.6 million to a loss of $0.9 million for the three months ended March 31, 2022 compared with an income of $1.7 million in the prior year period. This primarily related to foreign currency exchange rate fluctuations from our non-USD transactions.


66


Table of Contents
Consolidated Funds Revenues
Consolidated Funds revenues increased $1.4 million to a loss of $1.9 million for the three months ended March 31, 2022 compared with a loss of $3.3 million in the prior year period. The increase is due to the losses in the prior period related the Enterprise LP fund primarily driven by foreign revaluation of our Linkem investment. The amounts shown under Consolidated Funds reflect the consolidated total performance for such investment funds, and the portion of those gains or losses that are attributable to other investors is allocated to non-controlling interests.
Interest and Dividends Expense
Interest and dividends expense decreased $11.1 million to $46.5 million for the three months ended March 31, 2022 compared with $57.6 million in the prior year period. Interest and dividends amounts are primarily attributable to securities finance activities. There was a decrease in the securities finance activity due to lower customer demand which has created less matched book opportunities for international securities.
Expenses
Employee Compensation and Benefits
Employee compensation and benefits expenses decreased $201.0 million to $187.2 million for the three months ended March 31, 2022 compared with $388.2 million in the prior year period. The decrease is primarily due to $336.9 million lower total revenues as well as a decrease of $6.4 million in other income (loss) during 2022 as compared to 2021 and thus resulting in a lower compensation and benefits accrual. The compensation to revenue ratio, including other income (loss), was 45% for the three months ended March 31, 2022, compared with 51% in the prior year period.
Insurance and Reinsurance Claims and Commissions
Insurance and reinsurance-related expenses increased $0.8 million to $7.3 million for the three months ended March 31, 2022 compared with $6.5 million the prior year period. The net increase derives from the insurance entity.
Operating, General, Administrative and Other Expenses
Operating, general, administrative and other expenses increased $4.7 million to $100.8 million for the three months ended March 31, 2022 compared with $96.1 million in the prior year period. The increase is primarily related to fair market value adjustments to the contingent consideration liabilities for previous acquisitions offset only partially by lower floor brokerage and trade execution costs and underwriting fees due to lower brokerage and investment banking revenues.
Depreciation and Amortization Expenses
Depreciation and amortization expenses increased $2.8 million to $7.2 million for the three months ended March 31, 2022 compared with $4.4 million in the prior year period. The increase is primarily related to two acquisitions which closed during 2021.
Consolidated Funds Expenses
Consolidated Funds expenses decreased $0.2 million to $0.1 million for the three months ended March 31, 2022 compared with $0.3 million in the prior year period. During the first quarter of 2022, the Company deconsolidated Cowen Private Investments LP as the fund was liquidated. During the first quarter of 2021, the Company deconsolidated Cowen Sustainable Investments I, LP due to the Company's ownership being diluted through a capital equalization event.The amounts shown under Consolidated Funds reflect the consolidated total performance for such investment funds, and the portion of those gains or losses that are attributable to other investors is allocated to non-controlling interests.
Other Income (Loss)
Other income (loss) decreased $6.4 million to $5.6 million for the three months ended March 31, 2022 compared with $12.0 million in the prior year period. The decrease in other income (loss), which primarily represents our equity method investments, was primarily attributable to a decrease in performance in our activist investments and also the bargain purchase gain on an acquisition from the first quarter of 2021, offset partially by a loss on debt extinguishment.
Income Taxes
Income tax expense decreased $42.5 million to $11.9 million for the three months ended March 31, 2022 compared with $54.4 million in the prior year period. This change is primarily attributable to the change in the Company’s income before income taxes for the respective periods.

67

Table of Contents
Net Income (Loss) Attributable to Non-controlling Interests
Net income (loss) attributable to non-controlling interests increased $15.5 million to $20.1 million for the three months ended March 31, 2022 compared with income of $4.6 million in the prior year period. The increase was primarily the result of gains in first quarter of 2022 related to higher valuation in the Company's digital investment. Non-controlling interests represent the pro rata share of the income or loss of the non-wholly owned consolidated entities attributable to the other owners of such entities.
Preferred Stock Dividends
On May 19, 2015, the Company completed its offering of 120,750 shares of the Company's 5.625% Series A cumulative perpetual convertible preferred stock. Each share of the Series A Convertible Preferred Stock is entitled to dividends at a rate of 5.625% per annum. The Company may, at its option, pay dividends in cash, common stock or a combination thereof. The Company accrued $1.7 million preferred stock dividends for the periods ended March 31, 2022 and 2021, respectively.
Segment Analysis, Economic Income (Loss) and related components
Economic Income (Loss) and related components
The Company presents supplemental financial measures that are not prepared in accordance with US GAAP. These non-GAAP financial measures include (i) Pre-tax Economic Income (Loss) (ii) Economic Income (Loss), (iii) Economic Operating Income (Loss), (iv) Economic Proceeds and related components, (v) Net Economic Proceeds and related components, (vi) Economic Expenses and related components and (vii) related per share measures. The Company believes that these non-GAAP financial measures, viewed in addition to, and not in lieu of, the Company’s reported US GAAP results, provide useful information to investors and analysts regarding its performance and overall results of operations as it presents investors and analysts with a supplemental operating view of the Company’s financials to help better inform their analysis of the Company’s performance.
These Non-GAAP financial measures are an integral part of the Company’s internal reporting to measure the performance of its business segments, allocate capital and other strategic decisions as well as assess the overall effectiveness of senior management. The Company believes that presenting these non-GAAP measures may provide expanded transparency into the Company’s business operations, growth opportunities and expense allocation decisions.
The Company’s primary non-GAAP financial measures of profit or loss are Pre-tax Economic Income (Loss), Economic Income (Loss) and Economic Operating Income (Loss). Pre-tax Economic Income (Loss) is a pre-tax measure which (i) includes management reclassifications which the Company believes provides additional insight on the performance of the Company’s core businesses and divisions; (ii) eliminates the impact of consolidation for Consolidated Funds; and excludes (iii) goodwill and intangible impairment, (iv) certain other transaction-related adjustments and/or reorganization expenses, as well as (v) certain costs associated with debt. Economic Income (Loss) is a similar measure, but after tax, which includes the Company’s income tax expense or benefit calculated on Pre-tax Economic Income (Loss) once all currently available net operating losses have been utilized (this occurred during tax year 2020) and is presented after preferred stock dividends. Economic Operating Income (Loss) is a similar measure to Economic Income (Loss), but before depreciation and amortization expenses. The Company believes that these non-GAAP financial measures provide analysts and investors transparency into the measures of profit and loss management uses to evaluate the financial performance of and make operating decisions for the segments including determining appropriate compensation levels. Additionally, the measures provide investors and analysts with additional insight into the activities of the Company’s core businesses, taking into account, among other things, the impact of minority investment stakes, securities borrowing and lending activities and expenses from investment banking activities on US GAAP reported results. The Company presents Pre-tax Economic Income (Loss) in addition to Economic Income (Loss) and Economic Operating Income (Loss) to provide insight to investors and analysts on how the Company manages its tax position over time.
In addition to Pre-tax Economic Income (Loss), Economic Income (Loss) and Economic Operating Income (Loss), the Company also presents Economic Proceeds, Net Economic Proceeds, Economic Expenses, as well as their related components. These measures include management reclassifications and the elimination of the impact of the consolidation for Consolidated funds as described above. These adjustments are meant to provide comparability to our peers as well as to provide investors and analysts with transparency into how the Company manages its operating businesses and how analysts and investors review and analyze the Company’s and its peers’ similar lines of businesses. For example, among others, within the Company’s Op Co business segment, investors and analysts typically review and analyze the performance of investment banking revenues net of underwriting expenses and excluding the impact of reimbursable expenses. Additionally, the performance of the Company’s Markets business is typically analyzed as a unit incorporating commissions, interest from securities financing transactions and gains and losses from proprietary and facilitation trading. The Company’s investment management business performance is analyzed and reviewed by investors and analysts through investment income, incentive income and management fees. The
68


Table of Contents
presentation of Economic Proceeds, Net Economic Proceeds, Economic Expenses as well as their related components align with these and other examples of how the Company’s business activities and performance are reviewed by analysts and investors in addition to providing simplification related to legacy businesses and investments for which the Company maintains long-term monetization strategies. Additionally, the Company manages its operating businesses to an Economic Compensation-to-Proceeds ratio. Presentation of Economic Compensation Expense and Economic Proceeds provides transparency in addition to the Company’s US GAAP Compensation Expense.
Reconciliations to comparable US GAAP measures are presented along with the Company’s Non-GAAP financial measures. The non-GAAP measures presented herein may not be comparable to similarly titled measures presented by other public companies and are not identical to corresponding measures used in our various agreements or public filings.
These Non-GAAP measures should not be considered in isolation or as a substitute for revenue, expenses, income (loss) before income taxes, net income, operating cash flows, investing and financing activities, or other income or cash flow statement data prepared in accordance with US GAAP. As a result of the adjustments made to arrive at these Non-GAAP measures described below, these Non-GAAP measures have limitations in that they do not take into account certain items included or excluded under US GAAP, including its consolidated funds.
For a reconciliation of US GAAP net income (loss) to Pre-tax Economic Income (Loss), Economic Income (Loss) and Economic Operating Income (Loss) for the periods presented and additional information regarding the reconciling adjustments discussed above, see the following section "Reconciliation of US GAAP (Unaudited) to Non-GAAP Measures".
The Company conducts its operations through two segments: Op Co and Asset Co. The Company's principle sources of revenues included in Economic Income (Loss) are derived from activities in the following business segments. The Op Co and Asset Co segments do not conduct inter-segment transactions.
The Op Co segment generates revenue through several principal sources: investment banking revenue, brokerage revenue, management fees, incentive income, and investment income earned from the Company's own capital.
The Asset Co segment generates revenue through management fees, incentive income and investment income from the Company’s own capital.
Three Months Ended March 31, 2022 Compared with Three Months Ended March 31, 2021
Total Economic Operating Income (Loss) was $42.8 million for the three months ended March 31, 2022, a decrease of $102.7 million compared to Economic Operating Income (Loss) of $145.6 million in the prior year period. Total Economic Income (Loss) was $37.4 million for the three months ended March 31, 2022 compared to Economic Income (Loss) of $142.4 million in the prior year period. Total Pre-tax Economic Income (Loss) was $52.2 million for the three months ended March 31, 2022, a decrease of $144.6 million compared to Pre-tax Economic Income (Loss) of $196.8 million in the prior year period.
Economic Proceeds included in total Economic Income (Loss) were $331.6 million for the three months ended March 31, 2022, a decrease of $355.8 million compared to $687.4 million in the prior year period. This was primarily related to a decrease in investment banking, incentive fees and brokerage revenues.
69

Table of Contents
Operating Company Segment
Economic Proceeds
 Three Months Ended March 31,Total Period-to-Period
 20222021$ Change% Change
 (dollars in thousands)
Economic Proceeds
Investment banking$98,697 $293,488 $(194,791)(66)%
Brokerage197,856 221,848 (23,992)(11)%
Management fees20,440 26,884 (6,444)(24)%
Incentive income (loss)(12,797)109,925 (122,722)(112)%
Investment income (loss)22,226 31,918 (9,692)(30)%
Other income (loss) economic proceeds3,819 1,164 2,655 228 %
Total: Economic Proceeds330,241 685,227 (354,986)(52)%
Economic Interest Expense / (Income)(8,509)5,943 (14,452)(243)%
Net Economic Proceeds$338,750 $679,284 $(340,534)(50)%
Economic Proceeds The Op Co segment economic proceeds included in Economic Income (Loss) were $330.2 million for the three months ended March 31, 2022, a decrease of $355.0 million compared to $685.2 million in the prior year period.
Investment Banking Economic Proceeds decreased $194.8 million to $98.7 million for the three months ended March 31, 2022 compared with $293.5 million in the prior year period. During the three months ended March 31, 2022, the Company completed six underwriting transactions, 19 strategic advisory transactions and eight debt capital markets transactions. During the three months ended March 31, 2021, the Company completed 62 underwriting transactions, 21 strategic advisory transactions and five debt capital markets transactions.
Brokerage Economic Proceeds decreased $23.9 million to $197.9 million for the three months ended March 31, 2022, compared with $221.8 million in the prior year period. This was attributable to a decrease in institutional brokerage, primarily special situations and electronic commissions. Customer trading volumes across the industry (according to Bloomberg) decreased 12% for the quarter ended March 31, 2022 compared to the prior year period.
Management Fees Economic Proceeds for the segment decreased $6.5 million to $20.4 million for the three months ended March 31, 2022 compared with $26.9 million in the prior year period. This decrease in management fees was primarily related to management fees earned from new investors entering the Cowen Sustainable funds in the first quarter of 2021 when, during the quarter, the fund had multiple capital raises offset partially by an increase in the Cowen Healthcare investments funds.
Incentive Income (Loss) Economic Proceeds for the segment decreased $122.7 million to a loss of $12.8 million for the three months ended March 31, 2022 compared with income of $109.9 million in the prior year period. This decrease was primarily related to a decrease in performance fees from our Cowen Sustainable and Cowen Healthcare investment funds.
Investment Income (Loss) Economic Proceeds for the segment decreased $9.7 million to $22.2 million for the three months ended March 31, 2022 compared with $31.9 million in the prior year period. The decrease primarily relates to a decrease in performance investments across most of our strategies including healthcare, merchant banking and portfolio hedge offset partially with gains from our digital investments.
Other Income (Loss) Economic Proceeds for the segment increased $2.6 million to $3.8 million for the three months ended March 31, 2022 compared with income of $1.2 million in the prior year period. The change is driven by a $3.3 million increase in the insurance result and a $1.8 million gain on derivatives offset by a $2.5 million loss on foreign exchange.
Economic Interest Expenses / (Income) were $(8.5) million for the three months ended March 31, 2022, a decrease of $14.4 million compared with $5.9 million in the prior year period. First quarter 2022 interest expense / (income) included an $18 million unrealized gain from a mark-to-market adjustment on an interest rate swap used to offset interest on floating-rate debt.
Net Economic Proceeds were $338.8 million for the three months ended March 31, 2022, a decrease of $340.5 million compared with $679.3 million in the prior year period.


70

Table of Contents

Economic Expenses
 Three Months Ended March 31,Total Period-to-Period
 20222021$ Change% Change
Economic Expenses(dollars in thousands)
Employee compensation and benefits$186,424 $385,578 $(199,154)(52)%
Non-Compensation Expense93,792 89,415 4,377 %
Depreciation & Amortization7,179 4,349 2,830 65 %
Non-Controlling Interest1,013 1,467 (454)(31)%
Total: Economic Expenses$288,408 $480,809 $(192,401)(40)%
Economic Expenses were $288.4 million for the three months ended March 31, 2022, a decrease of $192.4 million compared with $480.8 million in the prior year period.
Economic Compensation Expenses were $186.4 million compared to $385.6 million in the prior year period. The decrease was due to lower revenues. The economic compensation-to-proceeds ratio increased to 56.5% compared to 56.3% in the prior year period.
Economic Non-compensation Expenses Fixed non-compensation expense increased $5.2 million to $40.9 million for the three months ended March 31, 2022 compared with $35.7 million in the prior year period. The increase primarily related to an increase in professional and advisory fees and communication costs. Variable non-compensation expenses which primarily are comprised of expenses that are incurred as a direct result of the processing and soliciting of revenue generating activities, decreased $0.8 million to $52.9 million for the three months ended March 31, 2022 compared with $53.7 million in the prior year period. The decrease is related to decreased brokerage and trade execution costs and decreased variable professional and advisory fees, which includes employment agency fees and legal fees directly related to revenues.
Economic Depreciation and Amortization Expenses increased to $7.2 million for the three months ended March 31, 2022 compared with $4.3 million in the prior year period. The increase is primarily related to two acquisitions which closed during 2021.
Economic Non-controlling interests decreased by $0.5 million to $1.0 million for the three months ended March 31, 2022 compared with $1.5 million in the prior year period. Non-controlling interest represents the portion of the net income or loss attributable to certain non-wholly owned subsidiaries that is allocated to our partners in those subsidiaries.
Economic Income and Economic Operating Income
 Three Months Ended March 31,Total Period-to-Period
 20222021$ Change% Change
 (dollars in thousands)
Pre-tax Economic Income (Loss)$50,342 $198,475 $(148,133)(75)%
Economic income tax expense 12,585 53,191 (40,606)(76)%
Preferred stock dividends1,460 1,426 34 %
Economic Income (Loss) 36,297 143,858 (107,561)(75)%
Add back: Depreciation and amortization expense, net of taxes5,385 3,183 2,202 69 %
Economic Operating Income (Loss)$41,682 $147,041 $(105,359)(72)%
Preferred Stock Dividends. On May 19, 2015, the Company completed its offering of 120,750 shares of Series A Convertible Preferred Stock. Each share of the Series A Convertible Preferred Stock is entitled to dividends at a rate of 5.625% per annum. The Company may, at its option, pay dividends in cash, common stock or a combination thereof.
71

Table of Contents
Asset Co Segment
 Three Months Ended March 31,Total Period-to-Period
 20222021$ Change% Change
Economic Proceeds(dollars in thousands)
Brokerage(62)— (62)NM
Management fees$266 $316 $(50)(16)%
Incentive income (loss)(215)(1,214)999 (82)%
Investment income (loss)1,407 3,090 (1,683)54 %
Other income (loss) economic proceeds(1)(200)%
Total: Economic Proceeds1,397 2,191 (794)(36)%
Economic Interest Expense / (Income)(1,417)1,090 (2,507)(230)%
Net Economic Proceeds$2,814 $1,101 $1,713 156 %
Economic Proceeds The Asset Co segment proceeds included in Economic Income (Loss) were $1.4 million for the three months ended March 31, 2022, a decrease of $0.8 million compared with negative proceeds (due to losses) of $2.2 million in the prior year period.
Management Fees Economic Proceeds for the segment remained fairly flat at $0.3 million for the three months ended March 31, 2022 compared with the prior year period.
Incentive Income (Loss) Economic Proceeds for the segment increased $1.0 million to a loss of $0.2 million for the three months ended March 31, 2022 compared with a loss of $1.2 million in the prior year period. This increase was related to an increase in performance fees from the Company's multi-strategy business.
Investment Income (Loss) Economic Proceeds for the segment decreased $1.7 million to $1.4 million for the three months ended March 31, 2022, compared with income of $3.1 million in the prior year period. The decrease primarily to decreased performance of our multi-strategy funds.
Economic Interest Expenses / (Income) were $(1.4) million for the three months ended March 31, 2022, a decrease of $2.5 million compared with $1.1 million in the prior year period. First quarter 2022 interest expense included an allocation of a gain from a mark-to-market adjustment on an interest rate swap used to offset interest on floating-rate debt.
Net Economic Proceeds for the segment were proceeds of $2.8 million for the three months ended March 31, 2022, an increase of $1.7 million compared with $1.1 million in the prior year period.

Economic Expenses
 Three Months Ended March 31,Total Period-to-Period
 20222021$ Change% Change
 (dollars in thousands)
Economic Expenses
Employee compensation and benefits$951 $2,819 $(1,868)(66)%
Non-Compensation Expense(79)85 (108)%
Depreciation & Amortization20 %
Total: Economic Expenses$963 $2,745 $(1,782)(65)%
Economic Expenses were $1.0 million for the three months ended March 31, 2022, a decrease of $1.7 million compared to $2.7 million in the prior year period.
Economic Compensation Expenses were $1.0 million for the three months ended March 31, 2022, a decrease of $1.8 million compared to $2.8 million in the prior year period. The decrease was due to lower total economic proceeds related to investment income (loss).
Economic Non-compensation Expenses Fixed non-compensation expense increased $0.1 million for the three months ended March 31, 2022 compared with the prior year period. The increase is primarily related to professional, advisory and other fees. Variable non-compensation expenses, which remained consistent for the three months ended March 31, 2022 compared with the prior year period, are comprised of expenses that are incurred as a direct result of the processing and soliciting of revenue generating activities.
72

Table of Contents
Economic Depreciation and Amortization Expenses remained consistent for the three months ended March 31, 2022 compared to the prior year period and relates to costs allocated from general company assets.
Economic Income and Economic Operating Income
 Three Months Ended March 31,Total Period-to-Period
 20222021$ Change% Change
 (dollars in thousands)
Pre-tax Economic Income (Loss)$1,851 $(1,644)$3,495 (213)%
Economic income tax expense 463 (440)903 (205)%
Preferred stock dividends238 272 (34)(13)%
Economic Income (Loss) 1,150 (1,476)2,626 (178)%
Add back: Depreciation and amortization expense, net of taxes67 %
Economic Operating Income (Loss)$1,155 $(1,473)$2,628 (178)%
Preferred Stock Dividends. On May 19, 2015, the Company completed its offering of 120,750 shares of Series A Convertible Preferred Stock. Each share of the Series A Convertible Preferred Stock is entitled to dividends at a rate of 5.625% per annum. The Company may, at its option, pay dividends in cash, common stock or a combination thereof.
73

Table of Contents
Reconciliation of US GAAP to Non-GAAP Measures for the three months ended March 31, 2022 and 2021
The following tables reconciles total US GAAP Revenues to total Economic Proceeds for the three months ended March 31, 2022 and 2021:
(unaudited)
Year Ended March 31, 2022

(Dollar amounts in thousands)
Investment BankingBrokerageInvestment Income Management FeesIncentive IncomeInterest and DividendsReinsurance Premiums Other Revenues, netConsolidated Funds RevenuesOther Income (Loss)Total
Total US GAAP Revenues and Other Income (Loss)$101,542 $168,738 $68,087 $16,769 $633 $46,335 $11,321 $(949)$(1,884)$5,580 $416,172 
Management Presentation Reclassifications:
Underwriting expensesa(259)— — — — — — — — — (259)
Reimbursable client expensesb(2,586)— — — — — — (311)— — (2,897)
Securities financing interest expensec— (1,247)— — — (29,805)— — — — (31,052)
Fund start-up costs, distribution and other feesd— — — (371)— — — (678)— — (1,049)
Certain equity method investmentse— — — 4,256 3,592 — — — — (5,756)2,092 
Carried interestf— — 17,067 — (16,900)— — — — — 167 
Proprietary trading, interest and dividendsg— 8,818 (62,084)— (337)(5,882)— 1,780 — 16,157 (41,548)
Insurance related activities expensesh— — — — — — (11,321)3,978 — — (7,343)
Facilitation trading gains and lossesi— 21,485 1,877 — — (10,648)— — — (15,981)(3,267)
Total Management Presentation Reclassifications:(2,845)29,056 (43,140)3,885 (13,645)(46,335)(11,321)4,769 — (5,580)(85,156)
Fund Consolidated Reclassificationsl— — (1,314)52 — — — — 1,884 — 622 
Total Economic Proceeds$98,697 $197,794 $23,633 $20,706 $(13,012)$— $— $3,820 $— $— $331,638 
74

Table of Contents
(unaudited)
Year Ended March 31, 2021
(Dollar amounts in thousands)
Investment BankingBrokerageInvestment Income Management FeesIncentive IncomeInterest and DividendsReinsurance Premiums Other Revenues, netConsolidated Funds RevenuesOther Income (Loss)Total
Total US GAAP Revenues and Other Income (Loss)$304,834 $173,737 $176,137 $25,742 $2,258 $59,388 $7,117 $1,660 $(3,347)$11,962 $759,488 
Management Presentation Reclassifications:
Underwriting expensesa(6,915)— — — — — — — — — (6,915)
Reimbursable client expensesb(4,431)— — — — — — (288)— — (4,719)
Securities financing interest expensec— 1,435 — — — (41,801)— — — — (40,366)
Fund start-up costs, distribution and other feesd— (157)— (4,074)— — — (637)— — (4,868)
Certain equity method investmentse— — — 3,480 9,643 — — — — (10,830)2,293 
Carried interestf— — (96,769)— 97,039 — — — — — 270 
Proprietary trading, interest and dividendsg— 16,100 (32,726)— (326)(4,096)— (234)— 11,153 (10,129)
Insurance related activities expensesh— — — — — — (7,117)662 — — (6,455)
Facilitation trading gains and lossesi— 30,733 (8,967)— — (13,491)— — — (12,968)(4,693)
Total Management Presentation Reclassifications:(11,346)48,111 (138,462)(594)106,356 (59,388)(7,117)(497)— (12,645)(75,582)
Fund Consolidated Reclassificationsl— — (2,667)2,052 97 — — — 3,347 — 2,829 
Income Statement Adjustments:
Acquisition related amountsn— — — — — — — — — (3,855)(3,855)
Debt extinguishment lossp— — — — — — — — — 4,538 4,538 
Total Income Statement Adjustments:— — — — — — — — — 683 683 
Total Economic Proceeds$293,488 $221,848 $35,008 $27,200 $108,711 $— $— $1,163 $— $— $687,418 










75

Table of Contents
The following table reconciles total US GAAP interest and dividends expense to total Economic Interest Expense for the three months ended March 31, 2022 and 2021:
(unaudited)
Year Ended March 31,
(Dollar amounts in thousands)
20222021
Total US GAAP Interest & Dividend Expense$46,524 $57,641 
Management Presentation Reclassifications:
Securities financing interest expensec(31,052)(40,366)
Fund start-up costs, distribution and other feesd(895)(538)
Proprietary trading gains and lossesg(21,161)(4,235)
Facilitation trading gains and lossesi(3,267)(4,693)
Total Management Presentation Reclassifications:(56,375)(49,832)
Income Statement Adjustments:
Amortization of discount/(premium) on debtm(75)(776)
Total Income Statement Adjustments:(75)(776)
Total Economic Interest Expense$(9,926)$7,033 
The following tables reconcile total US GAAP Expenses and non-controlling interests to total Economic Expenses for the three months ended March 31, 2022 and 2021:
(unaudited)
Year Ended March 31, 2022Year Ended March 31, 2021
(Dollar amounts in thousands)
Employee Compensation and BenefitsNon-compensation US GAAP ExpensesNet income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment fundsTotalEmployee Compensation and BenefitsNon-compensation US GAAP ExpensesNet income (loss) attributable to non-controlling interests in consolidated subsidiaries and investment fundsTotal
Total US GAAP$187,178 $115,434 $20,131 $322,743 $388,196 $107,157 $4,562 $499,915 
Management Presentation Reclassifications:
Underwriting expensesa— (259)— (259)— (6,915)— (6,915)
Reimbursable client expensesb— (2,897)— (2,897)— (4,719)— (4,719)
Fund start-up costs, distribution and other feesd— (154)— (154)— (4,330)— (4,330)
Certain equity method investmentse— 2,092 — 2,092 — 2,293 — 2,293 
Carried interestf— 167 — 167 — 270 — 270 
Proprietary trading, interest and dividends
g— 471 (20,858)(20,387)— 1,768 (7,662)(5,894)
Insurance related activities expensesh— (7,343)— (7,343)— (6,455)— (6,455)
Associated partner/banker compensationj546 (546)— — 548 (548)— — 
Management company non-Controlling interestk(349)(664)1,013 — (347)(1,120)1,467 — 
Total Management Presentation Reclassifications:197 (9,133)(19,845)(28,781)201 (19,756)(6,195)(25,750)
Fund Consolidated Reclassificationsl— (105)727 622 — (271)3,100 2,829 
Income Statement Adjustments:
Acquisition related amountsn— (80)— (80)— (238)— (238)
Contingent liability adjustmentsn— (5,133)— (5,133)— 6,798 — 6,798 
Total Income Statement Adjustments:— (5,213)— (5,213)— 6,560 — 6,560 
Total Economic Expenses$187,375 $100,983 $1,013 $289,371 $388,397 $93,690 $1,467 $483,554 
76

Table of Contents
The following table reconciles US GAAP Net Income (loss) Attributable to Cowen Inc. Common Stockholders to Pre-tax Economic Income (Loss), Economic Income (loss), and Economic Operating Income (loss) for the three months ended March 31, 2022 and 2021:
(unaudited)
Year Ended March 31,
(Dollar amounts in thousands)
20222021
US GAAP Net income (loss) attributable to Cowen Inc. common stockholders$33,318 $145,806 
Income Statement Adjustments:
US GAAP Income tax expense (benefit)o11,889 54,428 
Amortization of discount (premium) on debt    m75 776 
Debt extinguishment gain (loss) and/or accelerated debt costsp— 4,538 
Bargain purchase gainn— (3,855)
Contingent liability adjustmentsn5,133 (6,798)
Acquisition related amountsn80 238 
Preferred stock dividendsq1,698 1,698 
Pre-tax Economic Income (Loss)52,193 196,831 
Economic income tax expense (13,048)(52,751)
Preferred stock dividends(1,698)(1,698)
Economic Income (Loss) $37,447 $142,382 
Add back: Depreciation and amortization expense, net of taxes5,390 3,186 
Economic Operating Income (Loss)$42,837 $145,568 

77

Table of Contents
Management Reclassifications
Management reclassification adjustments and fund consolidation reclassification adjustments have no effect on Economic Operating Income (Loss). These adjustments are reclassifications to change the location of certain line items.
aUnderwriting expenses: Economic Proceeds presents investment banking revenues net of underwriting expenses.
bReimbursable client expenses: Economic Proceeds presents expenses reimbursed from clients and affiliates within their respective expense category but is included as a part of revenues under US GAAP.
cSecurities financing interest expense: Brokerage within Economic Proceeds included net securities borrowed and securities loaned activities which are shown gross in interest income and interest expense for US GAAP.
dFund start-up costs, distribution and other fees: Economic Proceeds and Economic Interest Expense are net of fund start-up costs and distribution fees paid to agents and other debt service costs.
eCertain equity method investments: Economic Proceeds and Economic Expenses recognize the Company's proportionate share of management and incentive fees and associated share of expenses on a gross basis for equity method investments within the activist business, real estate operating entities and the healthcare royalty business. The Company applies the equity method of accounting to these entities and accordingly the results from these businesses are recorded within Other Income (Loss) for US GAAP.
fCarried interest: The Company applies an equity ownership model to carried interest which is recorded in Investment income - Carried interest allocation for US GAAP. The Company presents carried interest as Incentive Income Economic Proceeds.
gProprietary trading, interest and dividends: Economic Proceeds presents interest and dividends from the Company's proprietary trading in investment income.
hInsurance related activities expenses: Economic Proceeds presents underwriting income from the Company's insurance and reinsurance related activities, net of expenses, within other revenue. The costs are recorded within expenses for US GAAP reporting.
iFacilitation trading gains and losses: Economic Brokerage Proceeds presents gains and losses on investments held as part of the Company's facilitation and trading business within brokerage revenues as these investments are directly related to the markets business activities while these are presented in Investment income - Securities principal transactions, net for US GAAP reporting.
jAssociated partner/banker compensation reclassification: Economic Compensation Expense presents certain payments to associated banking partners as compensation rather than non-compensation expenses.
kManagement company non-controlling interest: Economic Expenses non-controlling interest represents only operating entities that are not wholly owned by the Company. The Company also presents non-controlling interests within total expenses for Economic Income (Loss).
Fund Consolidation Reclassifications
lThe impacts of consolidation and the related elimination entries of the Consolidated Funds are not included in Economic Income (Loss). Adjustments to reconcile to US GAAP Net Income (Loss) included elimination of incentive income and management fees earned from the Consolidated Funds and addition of investment fund expenses excluding management fees paid, investment fund revenues and investment income (loss).
Income Statement Adjustments
mPre-tax Economic Income (Loss) excludes the amortization of discount (premium) on debt.
nPre-tax Economic Income (Loss) excludes acquisition related adjustments (including bargain purchase gain and contingent liability adjustments).
oPre-tax Economic Income (Loss) excludes US GAAP income taxes.
pPre-tax Economic Income (Loss) excludes gain/(loss) on debt extinguishment and accelerated debt costs.
qPre-tax Economic income (Loss) excludes preferred stock dividends.
78

Table of Contents
Liquidity and Capital Resources
We continually monitor our liquidity position. The working capital needs of the Company's business have been met through current levels of equity capital, current cash and cash equivalents, and anticipated cash generated from our operating activities, including management fees, incentive income, returns on the Company's own capital, investment banking fees and brokerage commissions. The Company expects that its primary working capital liquidity needs over the next twelve months will be:
to pay our operating expenses, primarily consisting of compensation and benefits, interest on debt and other general and administrative expenses; and
to provide capital to facilitate the growth of our existing business.
Based on our historical results, management's experience, our current business strategy and current assets under management, the Company believes that its existing cash resources will be sufficient to meet its anticipated working capital and capital expenditure requirements for at least the next twelve months. However, the Company’s assessment could be affected by various risks and uncertainties, including but not limited to, the effects of the COVID-19 pandemic. Our cash reserves include cash, cash equivalents and assets readily convertible into cash such as our securities held in inventory. Securities inventories are stated at fair value and are generally readily marketable. As of March 31, 2022, we had cash and cash equivalents of $513.0 million and net liquid investment assets of $1.1 billion, which includes cash and cash equivalents and short-term investments held by foreign subsidiaries as of March 31, 2022 of $114.2 million. The Company continues to permanently reinvest the capital and accumulated earnings of its subsidiaries in the United Kingdom, Malta, Germany, Switzerland, Israel, Canada, and Hong Kong.
The timing of cash bonus payments to our employees may significantly affect our cash position and liquidity from period to period. While our employees are generally paid salaries semi-monthly during the year, cash bonus payments, which can make up a significant portion of total compensation, are generally paid by March 15th.
As a clearing member firm providing services to certain of our brokerage customers, we are subject to cash deposit requirements with clearing organizations, brokers and banks that may be large in relation to total liquid assets and may fluctuate significantly based upon the nature and size of customers' trading activity and market volatility. At March 31, 2022, the Company had security deposits totaling $105.9 million with clearing organizations in the U.S. for the settlement of equity trades. In the normal course of our U.S. settlement activities, we may also need to temporarily finance customer securities positions from short settlements or delivery failures.
The Company may incur additional indebtedness or raise additional capital under certain circumstances to respond to market opportunities and challenges. Current market conditions may make it more difficult or costly to borrow additional funds or raise additional capital.
Unfunded commitments
The following table summarizes unfunded commitments as of March 31, 2022:
EntityUnfunded CommitmentsCommitment term
(dollars in thousands)
HealthCare Royalty Partners funds (a)$6,451 2.8 years
Eclipse Ventures Fund I, L.P.$28 2.8 years
Eclipse Fund II, L.P.$18 3.8 years
Eclipse Continuity Fund I, L.P.$16 4.8 years
Cowen Healthcare Investments III LP$2,165 4.8 years
Cowen Healthcare Investments IV LP$5,784 5.8 years
Cowen Sustainable Investments I LP$14,643 7.8 years
(a) The Company is a limited partner of the HealthCare Royalty Partners funds (which are managed by Healthcare Royalty Management) and is a member of HealthCare Royalty Partners General Partners. The Company will make its pro-rata investment in the HealthCare Royalty Partners funds along with the other limited partners.
Due to the nature of the securities business and our role as a market-maker and execution agent, the amount of our cash and short-term investments, as well as operating cash flow, may vary considerably due to a number of factors, including the dollar value of our positions as principal, whether we are net buyers or sellers of securities, the dollar volume of executions by our customers and clearinghouse requirements, among others. Certain regulatory requirements constrain the use of a portion of our liquid assets for financing, investing or operating activities. Similarly, due to the nature of our business lines, the capital necessary to maintain current operations and our current funding needs subject our cash and cash equivalents to different requirements and uses.
79

Table of Contents
Preferred Stock and Purchase of Capped Call Option
On May 19, 2015, the Company completed its offering of 120,750 shares of Series A Convertible Preferred Stock that provided $117.2 million of proceeds, net of underwriting fees and issuance costs of $3.6 million. Each share of the Series A Convertible Preferred Stock is entitled to dividends at a rate of 5.625% per annum, which will be payable, when and if declared by the board of directors of the Company, quarterly, in arrears, on February 15, May 15, August 15 and November 15 of each year. The Company may, at its option, pay dividends in cash, common stock or a combination thereof. The Company declared and paid a cash dividend in respect of the Series A Convertible Preferred Stock of $1.7 million for the three months ended March 31, 2022. The Company declared and accrued a cash dividend in respect of the Series A Convertible Preferred Stock of $1.7 million for the three months ended March 31, 2021
Each share of Series A Convertible Preferred Stock is non-voting and has a liquidity preference over the Company's Class A common stock and ranks senior to all classes or series of the Company's Class A common stock, but junior to all of the Company's existing and future indebtedness with respect to dividend rights and rights upon the Company's involuntary liquidation, dissolution or winding down.
Upon issuance, each share of Series A Convertible Preferred Stock was convertible, at the option of the holder, into a number of shares of the Company's Class A common stock equal to the liquidation preference of $1,000 divided by the conversion rate. The initial conversion rate (subsequent to the December 5, 2016 reverse stock split) is 38.0619 shares (which equates to $26.27 per share) of the Company's Class A common stock for each share of the Series A Convertible Preferred Stock. At any time on or after May 20, 2020, when the Company's capped call option expired, the Company was able to elect to convert all outstanding shares of the Series A Convertible Preferred Stock into shares of the Company's Class A common stock, cash or a combination thereof, at the Company's election, in each case, based on the then-applicable conversion rate, if the last reported sale price of the Company's Class A common stock equals or exceeds 150% of the then-current conversion price on at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days (including on the last trading day of such period) immediately prior to such election. At the time of conversion, the conversion rate may be adjusted based on certain events, including but not limited to the issuance of cash dividends or Class A common stock as dividends to the Company's Class A common shareholders or a share split or combination.
On December 31, 2021, the Company irrevocably elected that, upon the conversion of any share of the outstanding Series A Convertible Preferred Stock, the Company will settle $1,000.00 of its conversion obligation in cash. With respect to each conversion, to the extent the conversion obligation per share of Series A Convertible Preferred Stock is greater than $1,000.00, the Company may satisfy its conversion obligation in respect of such excess using any settlement method permitted under the Certificate of Designations. As the holders can exercise the conversion option on their shares of Series A Convertible Preferred Stock at any time and require cash payment upon conversion, the Company reclassified the Series A Convertible Preferred Stock to temporary equity at December 31, 2021.
Regulation
Regulatory Capital
As registered broker-dealers with the United States Securities and Exchange Commission ("SEC"), Cowen and Company, ATM Execution and Westminster are subject to the Uniform Net Capital Rule 15c3-1, "SEA Rule 15c3-1," under the Securities Exchange Act ("SEA") of 1934, which requires the maintenance of minimum net capital. Each registered broker-dealer has elected to compute net capital under the alternative method permitted by that rule.
The Company acquired Portico, a registered broker-dealer on December 16, 2021. As a result of the acquisition, Portico's net assets were transferred into Cowen and Company. The Company applied to withdraw Portico's status as a FINRA registered broker-dealer on December 20, 2021 which was approved by the SEC on February 18, 2022.
Under the alternative method, Cowen and Company's minimum net capital requirement, as defined in (a)(4) of SEA Rule 15c3-1, is equal to the greater of $1.5 million or 2% of aggregate debits arising from customer transactions. ATM Execution, and Westminster are required to maintain minimum net capital, as defined in (a)(1)(ii) of SEA Rule 15c3-1, equal to the greater of $250,000 or 2% of aggregate debits arising from customer transactions. Advances to affiliates, repayment of borrowings, distributions, dividend payments, and other equity withdrawals are subject to certain notification and other provisions of SEA Rule 15c3-1 and other regulatory bodies.
Cowen and Company is also subject to certain net capital rule requirements under the Regulation 1.17 of the Commodity Futures Trading Commission ("CFTC") under Commodities Exchange Act (“CEA”) as an introducing broker. Under Regulation 1.17, Cowen and Company is required to maintain net capital equal to or in excess of $45,000 or the amount of net capital required by SEA Rule 15c3-1, whichever is greater. Additionally, as an options clearing member of the Options Clearing Corporation ("OCC") under OCC Rule 302, Cowen and Company is required to maintain net capital equal to the greater of $2.0
80

Table of Contents
million or 2% of aggregate debit items. At March 31, 2022, Cowen and Company had $397.2 million of net capital in excess of its minimum requirements under SEA Rule 15c3-1.
The Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) was signed into law on July 21, 2010. The Dodd-Frank Act contains provisions that require the registration of all swap dealers, major swap participants, security-based swap dealers, and/or major security-based swap participants. Cowen Financial Products, Ltd ("Cowen Financial Products") registered only with the SEC with an effective date of November 1, 2021 as a securities-based swap dealer and is not using models to compute its net capital. Under the rules there is a minimum net capital requirement for, among others, an entity that acts as a dealer in security-based swaps, which is the greater of $20 million or 2% of risk margin amount The risk margin amount means the sum of (i) the total initial margin required to be maintained by the SEC securities-based swaps dealer at each clearing agency with respect to securities-based swaps transactions cleared for securities-based swap customers and (ii) the total initial margin amount calculated by the SEC securities-based swaps dealer swaps dealer with respect to non-cleared securities-based swaps under SEC rules. At March 31, 2022, Cowen Financial Products had $16.7 million of net capital in excess of its minimum requirements under SEA Rule 18a-1.
Cowen International Ltd and Cowen Execution Ltd are subject to the capital requirements of the U.K. Financial Conduct Authority ("FCA"), as defined, and must exceed the minimum capital requirement set forth by the FCA. On 1 January 2022, the FCA adopted the Investment Firms Prudential Regime ("IFPR"). This is a new prudential regime which applies to MiFID investment firms authorized and regulated by the FCA in the UK. The IFPR refocuses prudential requirements and expectations away from the risks firms face, to also consider and look to manage the potential harm firms can pose to consumers and markets. Cowen International Ltd and Cowen Execution Ltd will both be designated as Class 2 firms under the new regime and will have a minimum capital requirement equal to the higher of; the Permanent minimum capital requirement, their respective Fixed Overhead requirement, and their Risk Responsive Computation ("K-factors").
Cowen Asia, a previously established entity, was re-registered with regulatory approval on May 17, 2019. Cowen Asia is subject to the financial resources requirements of the Securities and Futures Commission ("SFC") of Hong Kong. Financial Resources must exceed the Total Financial Resources requirement of the SFC.
As of March 31, 2022, the regulatory net capital, minimum net capital requirement and excess net capital of U.S. regulated broker dealers and swap dealer together with the equivalent of capital requirements and compliance information for foreign broker dealers registered with the FCA and the SFC are presented as follows:
SubsidiaryNet Capital (a)Net Capital Requirement (b)Excess Net Capital
 (dollars in thousands)
Cowen and Company$406,557 $9,343 $397,214 
ATM Execution$7,880 $250 $7,630 
Westminster$19,521 $250 $19,271 
Cowen Financial Products$36,658 $20,000 $16,658 
Cowen International Ltd (a)$51,109 $25,735 $25,374 
Cowen Execution Ltd (a)$17,900 $5,075 $12,825 
Cowen Asia (a)$2,045 $383 $1,662 
(a)The equivalent of Net Capital under FCA rules is referred as “capital resources” and under SFC rules is referred as “net liquid capital.” The equivalent of Minimum Net Capital Requirement under FCA rules is referred as “minimum capital resources requirement and under SFC rules is referred as “net liquid capital requirement."
Customer Protection
The Company's U.S. broker-dealers must also comply with the customer protection provisions under SEA Rule 15c3-3 which requires a computation of a reserve requirement for customer and maintenance of a deposit of cash or securities into a special reserve bank account for the exclusive benefit of customers; or claim an exemption pursuant to subparagraphs (k)(2)(i) or (k)(2)(ii) of that rule. Firms can rely on more than one exemption.
ATM Execution claims the (k)(2)(ii) exemption with regard to all of their customer accounts and transactions that are introduced on a fully-disclosed basis to their clearing agents for clearing, settlement and custody. Westminster claims the (k)(2)(i) exemption with regard to customer transactions and balances that are cleared, settled and custodied in bank accounts designated as Special Accounts for the Exclusive Benefit of Customers ("Special Bank Accounts"). Westminster also claims exemption for other business activities that are not covered under (k)(2)(i) contemplated by Footnote 74 of the SEC Release No. 34-70073 adopting amendments to 17 C.F.R. § 240.17a-5 for receiving transaction-based compensation in return for providing commission management services.
81

Table of Contents
In accordance with the requirements of SEA Rule 15c3-3, Cowen and Company may be required to deposit in a Special Reserve Account cash or acceptable qualified securities for the exclusive benefit of customers. As of March 31, 2022, Cowen and Company had segregated approximately $51.8 million of cash to satisfy the customer reserve provision of SEA Rule 15c3-3.
As a clearing and carrying broker-dealer, Cowen and Company is required to compute a reserve requirement for proprietary accounts of broker-dealers ("PAB"), as defined in SEA Rule 15c3-3. Cowen and Company conducts PAB reserve computations in order to determine the amount it is required to deposit in its PAB Reserve Bank Accounts pursuant to SEA Rule 15c3-3. This allows each correspondent firm that uses Cowen and Company as its clearing broker-dealer to classify its PAB account assets held at Cowen and Company as allowable assets in the correspondent's net capital calculation. At March 31, 2022, Cowen and Company had $71.7 million of cash on deposit in PAB Reserve Bank Accounts. Cowen and Company and ATM Execution also maintain certain assets in PAB accounts held at their respective clearing brokers. Each treats its assets held in those PAB accounts at the respective clearing brokers as allowable assets for net capital purposes.
Cowen Financial Products, as a registered securities based swap dealer, claims Rule 18a-4(f) exemption under the Securities Exchange Act of 1934 (the “Act”) with regard to its swap counterparties on the basis that it has provided sufficient notice to its swap counterparties of their respective rights to require segregation of funds or other property used to secure uncleared security based swaps pursuant to section 3E(f)(1)(A)-(B) of the Act (15 U.S.C. 78c-5(f)(1)(A)). Any margin collateral received and held by the security based swap dealer with respect to uncleared security based swaps will not be subject to a segregation requirement. The notice outlines how a claim of those swap counterparties for the collateral would be treated in a bankruptcy or other formal liquidation proceeding of the security-based swap dealer.
Other Regulatory Requirements
Cowen Insurance Co and Cowen Re are individually required to maintain a solvency capital ratio as calculated by relevant European Commission directives and local regulatory rules in Malta and Luxembourg, respectively. Each company's individual solvency capital ratio calculated at the end of each quarter must exceed a minimum requirement. As of December 31, 2021, the last testing date for Cowen Re and Cowen Insurance Co, the solvency capital ratios of both Cowen Insurance Co and Cowen Re were in excess of the minimum requirements.
Based on minimum capital and surplus requirements pursuant to the laws of the state of New York that apply to captive insurance companies, RCG Insurance Company, Cowen's captive insurance company incorporated and licensed in the state of New York, was required to maintain capital and surplus of approximately $0.3 million as of March 31, 2022. RCG Insurance Company’s capital and surplus as of March 31, 2022 totaled $6.0 million.
Cash Flows Analysis
The Company's primary sources of cash are derived from its operating activities, realized returns on its own invested capital and borrowings on debt. The Company's primary uses of cash include compensation and general and administrative expenses.
Operating Activities.    Net cash used in operating activities of $309.1 million for the three months ended March 31, 2022 was primarily related to (i) a decrease in compensation payable, (ii) a decrease in purchases of securities owned, at fair value only partially offset by an increase in proceeds from sales of securities owned, at fair value, (iii) a decrease in securities sold, but not yet purchased, at fair value, held at broker dealer only partially offset by an increase in securities loaned and securities sold under agreement to repurchase and (iv) decrease in payable to customers. Net cash provided by operating activities of $363.1 million for the three months ended March 31, 2021 was primarily related to (i) an increase in stock loan, (ii) an increase in payable to customers and (iii) net income only partially offset by a decrease in securities owned, at fair value, held at broker dealer.
Investing Activities.    Net cash used in investing activities of $20.4 million for the three months ended March 31, 2022 was primarily related to securities purchased under agreement to resell. Net cash provided by investing activities of $2.8 million for the three months ended March 31, 2021 was primarily related to the proceeds from sales of other investments offset only partially by purchases of other investments.
Financing Activities.    Net cash used in financing activities for the three months ended March 31, 2022 of $40.5 million was primarily related to (i) purchase of treasury stock (net of re-issue), (ii) decrease in contingent liability and (iii) decrease in capital distributions to non-controlling interests. Net cash provided by financing activities for the three months ended March 31, 2021 of $125.9 million was primarily related to an (i) increase in borrowings on notes and other debt offset by decrease in repayments on notes and other debt.


82

Table of Contents
Debt
Convertible Debt
December 2022 Convertible Notes
The Company, on December 14, 2017, issued $135.0 million aggregate principal amount of 3.00% convertible senior notes due December 2022 (the “December 2022 Convertible Notes”). The December 2022 Convertible Notes have a final maturity date of December 15, 2022 unless earlier repurchased by the Company or converted by the holder in accordance with their terms prior to such date. The interest on the December 2022 Convertible Notes is payable semi-annually on December 15 and June 15 of each year. The December 2022 Convertible Notes are senior unsecured obligations of Cowen. The December 2022 Convertible Notes were issued with an initial conversion price of $17.375 per share of Cowen's Class A common stock. Pursuant to the indenture governing the December 2022 Convertible Notes, conversions of the December 2022 Convertible Notes will be settled by the delivery and/or payment, as the case may be, of Cowen’s Class A Common Stock, cash, or a combination thereof, at the Company's election.
The Company recognized the embedded cash conversion option at issuance date fair value, which also represents the initial unamortized discount on the December 2022 Convertible Notes of $23.4 million and is shown net in convertible debt in the accompanying condensed consolidated statements of financial condition. On June 26, 2018, the Company received shareholder approval for the Company to settle the December 2022 Convertible Notes entirely in Class A common stock. Upon receiving shareholder approval, the Company reclassified the separately recognized conversion option from a derivative liability to equity.
During December 2020, the Company repurchased and extinguished $46.9 million of the outstanding principal amount of the December 2022 Convertible Notes for cash consideration of $70.5 million. In conjunction with the partial extinguishment of the December 2022 Convertible Notes, the Company accelerated the pro rata unamortized discount of $3.6 million and capitalized debt issuance costs of $0.4 million. The Company allocated $29.6 million of the cash consideration paid to the extinguishment of the equity component of the December 2022 Convertible Notes. The Company recognized $2.7 million of gain on debt extinguishment.
On March 24, 2021, the Company issued a redemption notice announcing that the Company would redeem all of the December 2022 Convertible Notes, and provided holders the option to elect to settle the as-converted value of the December 2022 Convertible Notes as allowed under the terms of the December 2022 Convertible Notes. As a result of the Company’s call for redemption of the December 2022 Convertible Notes, the December 2022 Convertible Notes were convertible, at the option of the holder at any time prior to June 22, 2021, the second business day prior to the December 2022 Convertible Notes' Redemption Date. On June 24, 2021 (the "Redemption Date") the Company redeemed all of the outstanding principal amount of the December 2022 Convertible Notes. The redemption amount was determined based on the holders election to convert, which allowed for either 100.00% of the principal amount thereof plus accrued and unpaid interest on such principal amount up to June 15, 2021, to, but not including the Redemption Date of the December 2022 Convertible Notes, or the value of the Company's Class A common stock to be issued on conversion. The settlement method for the December 2022 Convertible Notes was $88.1 million in cash, (the outstanding principal amount of the December 2022 Convertible Notes) and 2,938,841 shares of the Company’s Class A common stock, (the remainder of the conversion obligation in excess of the principal amount). The conversion rate on the December 2022 Convertible Notes on the Redemption Date was 33.35 shares of the Company’s Class A common stock per $1,000.00 principal amount of December 2022 Convertible Notes converted. In conjunction with the redemption of the remaining December 2022 Convertible Notes, the Company accelerated the pro rata unamortized discount of $5.1 million and capitalized debt issuance costs of $0.5 million.
Amortization on the discount, included within interest and dividends expense in the accompanying condensed consolidated statements of operations is $0.8 million for the three months ended March 31, 2021, based on an effective interest rate of 7.13%. The Company capitalized the debt issuance costs in the amount of $2.2 million, which is a direct deduction from the carrying value of the debt and was amortized over the life of the December 2022 Convertible Notes in interest and dividends expense in the accompanying condensed consolidated statements of operations. The Company recorded interest expense of $0.7 million for the three months ended March 31, 2021.
Notes Payable
May 2024 Notes
On May 7, 2019, the Company completed its private placement of $53.0 million aggregate principal amount of 7.25% senior notes due May 2024 (the "May 2024 Notes") with certain institutional investors. On September 30, 2019, the Company issued an additional $25.0 million of the same series of notes. The additional May 2024 Notes were purchased at a premium of $0.5 million, which is shown net in notes payable in the accompanying condensed consolidated statement of financial condition. To date the May 2024 Notes have maintained their initial private rating. Interest on the May 2024 Notes is payable semi-annually in arrears
83

Table of Contents
on May 6 and November 6. The Company recorded interest expense of $1.4 million and $1.4 million for the three months ended March 31, 2022 and 2021, respectively. The Company capitalized debt issuance costs of approximately $1.5 million in May 2019 and $0.6 million in September 2019, which is a direct deduction from the carrying value of the debt and will be amortized over the life of the May 2024 Notes in interest and dividends expense in the accompanying condensed consolidated statements of operations.
June 2033 Notes
On June 11, 2018, the Company completed its public offering of $90.0 million of 7.75% senior notes due June 2033 (the "June 2033 Notes") and subsequently the underwriters exercised in full their option to purchase an additional $10.0 million principal amount of the June 2033 Notes. Interest on the June 2033 Notes is payable quarterly in arrears on March 15, June 15, September 15 and December 15. The Company recorded interest expense of $1.9 million and $1.9 million for the three months ended March 31, 2022 and 2021, respectively. The Company capitalized debt issuance costs of approximately $3.6 million which is a direct deduction from the carrying value of the debt and will be amortized over the life of the June 2033 Notes in interest and dividends expense in the accompanying condensed consolidated statements of operations.
December 2027 Notes
On December 8, 2017, the Company completed its public offering of $120.0 million of 7.35% senior notes due December 2027 (the "December 2027 Notes") and subsequently the underwriters exercised in full their option to purchase an additional $18.0 million principal amount of the December 2027 Notes. Interest on the December 2027 Notes is payable quarterly in arrears on March 15, June 15, September 15 and December 15. The Company recorded interest expense of $2.5 million for three months ended March 31 2021. The Company capitalized debt issuance costs of approximately $5.0 million which is a direct deduction from the carrying value of the debt and will be amortized over the life of the December 2027 Notes in interest and dividends expense in the accompanying condensed consolidated statements of operations. The net proceeds of the offering, after deducting the underwriting discount and estimated offering expenses payable by the Company were used to redeem all of its 8.25% senior notes due October 2021 and for general corporate purposes.
On March 24, 2021, the Company delivered payment of and discharged all $138.0 million outstanding aggregate principal of the December 2027 Notes plus accrued and unpaid interest through the effective redemption date of April 23, 2021. In conjunction with the extinguishment of the December 2027 Notes , the Company accelerated the pro-rata capitalized debt issuance costs. During the three months ended March 31, 2021, the Company recognized $4.4 million of loss on debt extinguishment.
Term Loan
March 2028 Term Loan
On March 24, 2021, the Company borrowed $300 million of first lien term loan due March 24, 2028. On December 15, 2021, the Company borrowed an additional $150 million first lien term loan under the same terms and conditions as, and fungible with, the initial first lien term loan (collectively, the “March 2028 Term Loan”). The aggregate amount borrowed under the March 2028 Term Loan is $450 million. The March 2028 Term Loan bears interest at an annual rate equal to, at the option of the Company, either the (a) London Inter-bank Offered Rate ("LIBOR") (adjusted for reserves and subject to a floor of 0.75%) plus a margin of 3.25% or (b) an alternate base rate plus a margin of 2.25%. The Company is required to pay amortization of approximately 1.00% per annum of the original principal amount of the March 2028 Term Loan. Additionally, the Company has entered into an interest rate swap to offset the floating interest rate of the March 2028 Term Loan (See Note 6). The obligations of the Company for the March 2028 Term Loan are guaranteed by certain of the Company’s wholly-owned domestic subsidiaries (excluding its broker-dealer subsidiaries) (the “Guarantors”) and secured by substantially all of the assets of the Company and the Guarantors, subject in each case to certain customary exceptions. The terms of the March 2028 Term Loan contain customary affirmative and negative covenants, subject to certain customary exceptions, thresholds, qualifications and “baskets”. Proceeds from the March 2028 Term Loan were used to (i) satisfy and discharge and redeem the Company’s 2027 Senior Notes, (ii) redeem the Company’s December 2022 Convertible Notes that remained outstanding as of March 31, 2021 and pay the cash settlement amount in connection with the conversion of December 2022 Convertible Notes prior to that redemption date, and (iii) for the payment of fees, commissions, premiums, expenses and other transaction costs (including original issue discount or upfront fees) payable in connection with the transactions related thereto. As of March 31, 2022, the outstanding principal amount of the March 2028 Term Loan was $445.5 million.
Interest expense for the March 2028 Term Loan was $4.5 million and $0.2 million for the three months ended March 31, 2022 and 2021, based on an effective interest rate of 4.46%. In March 2021, the Company capitalized debt issuance costs of approximately $6.6 million and initial unamortized discount of $1.5 million related to the March 2028 Term Loan which is a direct deduction from the carrying value of the debt and will be amortized over the life of the March 2028 Term loan in interest and dividends expense in the accompanying condensed consolidated statements of operations. In December 2021, the Company
84

Table of Contents
capitalized debt issuance costs of approximately $2.7 million and unamortized discount of $1.5 million related to the additional borrowing of $150 million which is a direct deduction from the carrying value of the debt and will be amortized over the life of the March 2028 Term loan in interest and dividends expense in the accompanying condensed consolidated statements of operations.
The U.K. Financial Conduct Authority, which regulates LIBOR, has announced that all US Dollar LIBOR settings will either cease to be provided by any administrator or no longer be representative as of June 30, 2023. As the March 2028 Term Loan represents the Company’s only significant exposure to LIBOR as of March 31, 2022, the transition to an alternative Inter-bank Offer Rate is not expected to have a material impact on Company's consolidated financial statements.
Other Notes Payable
During January 2022, the Company borrowed $4.0 million to fund insurance premium payments. This note had an effective interest rate of 2.01% and was due in December 2022, with monthly payment requirements of $0.4 million. As of March 31, 2022, the outstanding balance note was $3.2 million. Interest expense for the three months ended March 31, 2022 was insignificant.
On September 30, 2020, the Company borrowed $72.0 million from Purple Protected Asset S-81 ("PPA S-81"), a Luxembourg entity unrelated to Cowen. The Company repaid $60.0 million of the PPA S-81 loan in June 2021. The loan is payable on September 30, 2023, had an initial interest rate of 1.4 times the Secured Overnight Financing Rate ("SOFR") plus 6.07% until December 31, 2020 and 1.4 times the SOFR plus 5.8% until June 30, 2021 and 3.65 times the SOFR plus 4.0% thereafter with quarterly interest payments. The loan obligation, as well as a loan issued by The Military Mutual Ltd (a United Kingdom company unrelated to Cowen) with principal of $28.4 million that was sold by Cowen Re to PPA S-81 at fair value for no gain or loss on September 30, 2020, are fully cash collateralized through a reinsurance policy provided by Cowen Re which is reflected in cash collateral pledged in the condensed consolidated statements of financial condition as of December 31, 2020 (see Notes 4 and 18). The Company capitalized debt issuance costs of approximately $1.7 million which is a direct deduction from the carrying value of the loan and will be amortized over the life of the loan in interest and dividends expense shown in the accompanying condensed consolidated statements of operations. The Company recorded interest expense of $0.5 million and $1.1 million for the three months ended March 31, 2022 and 2021, respectively, related to its loan payable to PPA S-81.
During November 2019, the Company borrowed $2.6 million to fund general corporate capital expenditures. This note had an effective interest rate of 6% and is due in November 2024, with monthly payment requirements of $0.1 million. As of March 31, 2022, the outstanding balance on this note was $1.5 million. Interest expense for the three months ended March 31, 2022 and 2021 was insignificant.
Finance Lease Obligations
The Company has entered into various finance leases for computer equipment. These finance lease obligations are included in notes payable and other debt in the accompanying condensed consolidated statements of financial condition.
For the three months ended March 31, 2022 and 2021, quantitative information regarding the Company's finance lease obligations reflected in the accompanying condensed consolidated statements of operations, the supplemental cash flow information and certain other information related to finance leases were as follows:
Three Months Ended March 31,
20222021
(dollars in thousands)
Lease cost
Finance lease cost:
    Amortization of finance lease right-of-use assets$324 $309 
    Interest on lease liabilities20 34 
Weighted average remaining lease term - operating leases (in years)1.632.01
Weighted average discount rate - operating leases4.66 %4.89 %
Letters of Credit
As of March 31, 2022, the Company has the following irrevocable letters of credit, related to leased office space, for which there is cash collateral pledged, which the Company pays a fee on the stated amount of the letter of credit. The Company also has pledged cash collateral for reinsurance agreements which amounted to $49.5 million, as of March 31, 2022, and $44.1 million, as
85

Table of Contents
of December 31, 2021, which are expected to be released periodically as per the terms of the reinsurance policy between March 31, 2022 and March 31, 2024.
.
LocationAmountMaturity
 (dollars in thousands)
New York$209 April 2023
New York$1,325 October 2022
New York$1,226 August 2022
Boston$188 March 2023
San Francisco$454 October 2025
$3,402 
To the extent any letter of credit is drawn upon, interest will be assessed at the prime commercial lending rate. As of March 31, 2022 and December 31, 2021 there were no amounts due related to these letters of credit.
Contractual Obligations
The following tables summarize the Company's contractual cash obligations as of March 31, 2022:
Total< 1 Year1-3 Years3-5 YearsMore Than
5 Years
 (dollars in thousands)
Equipment, Service and Facility Leases    
Real Estate and Other Facility Rental$111,416 $16,813 $48,441 $21,193 $24,969 
Service Payments62,453 22,196 25,758 7,142 7,357 
Operating Equipment Leases1,765 366 751 648 — 
   Total175,634 39,375 74,950 28,983 32,326 
Debt    
Notes Payable279,326 11,468 101,983 15,500 150,375 
Term Loan550,672 16,733 44,519 43,789 445,631 
Finance Lease Obligation1,510 849 600 61 — 
Other Notes Payable16,888 3,752 13,136 — — 
   Total$848,396 $32,802 $160,238 $59,350 $596,006 
Minimum payments for all debt outstanding
Annual scheduled maturities of debt and minimum payments for all debt outstanding as of March 31, 2022, are as follows:
Notes Payable
Term Loan
Other Notes PayableFinance Lease
Obligation
 (dollars in thousands)
2022$11,468 $16,733 $3,752 $849 
202313,405 22,351 12,593 500 
202488,578 22,168 543 100 
20257,750 21,986 — 49 
20267,750 21,803 — 12 
Thereafter150,375 445,631 — — 
Subtotal279,326 550,672 16,888 1,510 
Less (a)(105,187)(116,353)(1,031)(59)
Total$174,139 $434,319 $15,857 $1,451 
(a)Amount necessary to reduce net minimum payments to present value calculated at the Company's implicit rate at inception. This amount also includes capitalized debt costs and the unamortized discount on the Company's convertible debt.
Off-Balance Sheet Arrangements
We have no material off-balance sheet arrangements as of March 31, 2022. However, through indemnification provisions in our clearing agreements, customer activities may expose us to off-balance-sheet credit risk. Pursuant to the clearing agreements,
86

Table of Contents
we are required to reimburse our clearing broker, without limit, for any losses incurred due to a counterparty's failure to satisfy its contractual obligations. However, these transactions are collateralized by the underlying security, thereby reducing the associated risk to changes in the market value of the security through the settlement date.
Cowen and Company and ATM Execution are members of various securities exchanges and clearing organizations. Under the standard membership agreement, members are required to guarantee the performance of other members and, accordingly, if another member becomes unable to satisfy its obligations to the various securities exchanges and clearing organizations, all other members would be required to meet the shortfall. The Company's liability under these arrangements is not quantifiable. Accordingly, no contingent liability is carried in the accompanying condensed consolidated statements of financial condition for these arrangements.
Cowen and Company temporarily loans securities to other brokers in connection with its securities lending activities. Cowen and Company receives cash as collateral for the securities loaned. Increases in securities prices may cause the market value of the securities loaned to exceed the amount of cash received as collateral. In the event that counterparty to these transactions does not return the loaned securities, Cowen and Company may be exposed to the risk of acquiring the securities at prevailing market prices in order to satisfy its client obligations. Cowen and Company controls this risk by requiring credit approvals for counterparties, by monitoring the market value of securities loaned on a daily basis, and by requiring additional cash as collateral or returning collateral when necessary.
Cowen and Company temporarily borrows securities from other brokers in connection with its securities borrowing activities. Cowen and Company deposits cash as collateral for the securities borrowed. Decreases in securities prices may cause the market value of the securities borrowed to fall below the amount of cash deposited as collateral. In the event that counterparty to these transactions does not return collateral, Cowen and Company may be exposed to the risk of selling the securities at prevailing market prices. Cowen and Company controls this risk by requiring credit approvals for counterparties, by monitoring the collateral values on a daily basis, and by depositing additional collateral with counterparties or receiving cash when deemed necessary.
Critical Accounting Policies and Estimates
Critical accounting policies are those that require the Company to make significant judgments, estimates or assumptions that affect amounts reported in its condensed consolidated financial statements or the notes thereto. The Company bases its judgments, estimates and assumptions on current facts, historical experience and various other factors that the Company believes to be reasonable and prudent. Actual results may differ materially from these estimates.
The following is a summary of what the Company believes to be its most critical accounting policies and estimates.
Consolidation
The Company's condensed consolidated financial statements include the accounts of the Company, its subsidiaries, and entities in which the Company has a controlling financial interest, including the Consolidated Funds, in which the Company has a controlling general partner interest. All material intercompany transactions and balances have been eliminated in consolidation. The Company's investment funds are not subject to these consolidation provisions with respect to their investments pursuant to their specialized accounting.
The Company's condensed consolidated financial statements reflect the assets, liabilities, revenues, expenses and cash flows of the Consolidated Funds on a gross basis. The management fees and incentive income earned by the Company from the Consolidated Funds were eliminated in consolidation; however, the Company's allocated share of net income from these investment funds was increased by the amount of this eliminated income. Hence, the consolidation of these investment funds had no net effect on the Company's net earnings. The Company consolidates all entities that it controls through a majority voting interest or otherwise, including those investment funds in which the Company either directly or indirectly has a controlling financial interest. In addition, the Company consolidates all variable interest entities for which it is the primary beneficiary.
The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a Voting Operating Entity ("VOE") or a Variable Interest Entity ("VIE") under US GAAP.
Voting Operating Entities—VOEs are entities in which (i) the total equity investment at risk is sufficient to enable the entity to finance its activities independently, (ii) the equity holders at risk have the obligation to absorb losses, the right to receive residual returns and the right to direct the activities of the entity that most significantly impact the entity's economic performance and (iii) voting rights of equity holders are proportionate to their obligation to absorb losses or the right to receive returns.
87

Table of Contents
Under US GAAP consolidation requirements, the usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. Accordingly, the Company consolidates all VOEs in which it owns a majority of the entity's voting shares or units.
Variable Interest Entities—VIEs are entities that lack one or more of the characteristics of a VOE. In accordance with US GAAP, an enterprise must consolidate all VIEs of which it is the primary beneficiary. Under the US GAAP consolidation model for VIEs, an enterprise that (1) has the power to direct the activities of a VIE that most significantly impacts the VIE's economic performance, and (2) has an obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE, is considered to be the primary beneficiary of the VIE and thus is required to consolidate it. The Company determines whether it is the primary beneficiary of a VIE upon its initial involvement with the VIE and reassesses whether it is the primary beneficiary on an ongoing basis as long as it has any continuing involvement with the VIE by performing a periodic qualitative and/or quantitative analysis of the VIE that includes a review of, among other things, its capital structure, contractual agreements between the Company and the VIE, the economic interests that create or absorb variability, related party relationships and the design of the VIE.
The VIEs the Company has invested in act as investment managers and/or investment companies that may be managed by the Company. The VIEs are financed through their operations and/or loan agreements with the Company.
In the ordinary course of business, the Company also sponsors various other entities that it has determined to be VIEs. These VIEs are primarily investment funds for which the Company serves as the general partner, managing member and/or investment manager with decision-making rights. The Company consolidates these investment funds when its variable interest is potentially significant to the entity (see Note 6 for additional disclosures on VIEs).
The Company consolidates investment funds for which it acts as the managing member/general partner and investment manager. At March 31, 2022, the Company consolidated Ramius Enterprise LP (“Enterprise LP”), an investment fund. At December 31, 2021, the Company consolidated the following investment funds: Enterprise LP and Cowen Private Investments LP ("Cowen Private").
During the first quarter of 2022, the Company deconsolidated Cowen Private as the fund was liquidated. During the first quarter of 2021, the Company deconsolidated Cowen Sustainable Investments I, LP ("CSI I LP") due to the Company's ownership being diluted through a capital equalization event.
Equity Method InvestmentsFor operating entities over which the Company exercises significant influence but which do not meet the requirements for consolidation as outlined above, the Company uses the equity method of accounting. The Company's investments in equity method investees are recorded in other investments in the accompanying condensed consolidated statements of financial condition. The Company's share of earnings or losses from equity method investees is included in Net gains (losses) on other investments in the accompanying condensed consolidated statements of operations.
The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable. The difference between the carrying value of the equity method investment and its estimated fair value is recognized as an impairment charge when the loss in value is deemed other than temporary.
Other—If the Company does not consolidate an entity or apply the equity method of accounting, the Company accounts for its investment in such entity (primarily consisting of securities of such entity which are purchased and held principally for the purpose of selling them in the near term and classified as trading securities), at fair value with unrealized gains (losses) resulting from changes in fair value reflected within Investment income (loss) - Securities principal transactions, net or Investment income (loss) - portfolio fund investment income (loss) in the accompanying condensed consolidated statements of operations.
Retention of Specialized Accounting— The Consolidated Funds and certain other consolidated companies are investment companies and apply specialized industry accounting. The Company reports its investments on the condensed consolidated statements of financial condition at their estimated fair value, with unrealized gains (losses) resulting from changes in fair value reflected within Consolidated Funds - Principal transactions, net in the accompanying condensed consolidated statements of operations. Accordingly, the accompanying condensed consolidated financial statements reflect different accounting policies for investments depending on whether or not they are held through a consolidated investment company.
Certain portfolio fund investments qualify as equity method investments and are investment companies that apply specialized industry accounting. In applying equity method accounting guidance, the Company retains the specialized accounting of the investees and reports its investments on the condensed consolidated statements of financial condition at their estimated fair value, with unrealized gains (losses) resulting from changes in fair value reflected within Investment Income - portfolio fund principal transactions, net in the accompanying condensed consolidated statements of operations.
88

Table of Contents
In addition, the Company's broker-dealer subsidiaries and security-based swap dealer apply the specialized industry accounting for brokers and dealers in securities, which the Company retains upon consolidation.
Valuation of investments and derivative contracts
US GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy are as follows:
Level 1Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
Level 2Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
Level 3Fair value is determined based on pricing inputs that are unobservable and includes situations where there is little, if any, market activity for the asset or liability. The determination of fair value for assets and liabilities in this category requires significant management judgment or estimation.
Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. Inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, and other factors. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The Company considers observable data to be that market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant market. The categorization of a financial instrument within the hierarchy is based upon the pricing transparency of the instrument and does not necessarily correspond to the Company's perceived risk of that instrument. Inputs reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
The Company and its operating subsidiaries act as the manager for the Consolidated Funds. Both the Company and the Consolidated Funds hold certain investments which are valued by the Company, acting as the investment manager. The fair value of these investments is based on their proportional rights of the underlying portfolio company, and is generally estimated based on proprietary models developed by the Company, which include discounted cash flow analysis, public market comparables, and other techniques and may be based, at least in part, on independently sourced market information. The material estimates and assumptions used in these models include the timing and expected amount of cash flows, the appropriateness of discount rates used, and, in some cases, the ability to execute, timing of, and estimated proceeds from expected financings. Significant judgment and estimation impact the selection of an appropriate valuation methodology as well as the assumptions used in these models, and the timing and actual values realized with respect to investments could be materially different from values derived based on the use of those estimates. The valuation methodologies applied impact the reported value of the Company's investments and the investments held by the Consolidated Funds in the condensed consolidated financial statements. Certain of the Company's investments are relatively illiquid or thinly traded and may not be immediately liquidated on demand if needed. Fair values assigned to these investments may differ significantly from the fair values that would have been used had a ready market for the investments existed and such differences could be material.
The Company primarily uses the market approach to value its financial instruments measured at fair value. In determining an instrument's level within the hierarchy, the Company categorizes the Company's financial instruments into three categories: securities, derivative contracts and other investments. To the extent applicable, each of these categories can further be divided between those held long or sold short.
The Company has the option to measure certain financial assets and financial liabilities at fair value with changes in fair value recognized in earnings each period. The election is made on an instrument by instrument basis at initial recognition of an asset or liability or upon an event that gives rise to a new basis of accounting for that instrument.  The Company has elected the fair value option for certain of its investments held by its operating companies.  This option has been elected because the Company believes that it is consistent with the manner in which the business is managed, as well as the way that financial instruments in other parts of the business are recorded. 
Securities—Securities with values based on quoted market prices in active markets for identical assets are classified within level 1 of the fair value hierarchy. These securities primarily include active listed equities, certain U.S. government and sovereign obligations, Exchange Traded Funds ("ETFs"), mutual funds and certain money market securities.
89

Table of Contents
Certain positions for which trading activity may not be readily visible, consisting primarily of convertible debt, corporate debt and loans and restricted equities, are stated at fair value and classified within level 2 of the fair value hierarchy. The estimated fair values assigned by management are determined in good faith and are based on available information considering trading activity, broker quotes, quotations provided by published pricing services, counterparties and other market participants, and pricing models using quoted inputs, and do not necessarily represent the amounts which might ultimately be realized. As level 2 investments include positions that are not always traded in active markets and/or are subject to transfer restrictions, valuations may be adjusted to reflect illiquidity and/or non-transferability.
Derivative contracts—Derivative contracts can be exchange-traded or privately negotiated over-the-counter (“OTC”). Exchange-traded derivatives, such as futures contracts and exchange-traded option contracts, are typically classified within level 1 or level 2 of the fair value hierarchy depending on whether or not they are deemed to be actively traded. OTC derivatives, such as generic forwards, swaps and options, are classified as level 2 when their inputs can be corroborated by market data. OTC derivatives, such as swaps and options, with significant inputs that cannot be corroborated by readily available or observable market data are classified as level 3.
Other investments—Other investments consist primarily of portfolio funds, carried interest and equity method investments, which are valued as follows:
i.    Portfolio funds—Portfolio funds include interests in private investment partnerships, foreign investment companies and other collective investment vehicles which may be managed by the Company or its affiliates. The Company applies the practical expedient provided by the US GAAP fair value measurements and disclosures guidance relating to investments in certain entities that calculate net asset value (“NAV”) per share (or its equivalent). The practical expedient permits an entity holding investments in certain entities that either are investment companies or have attributes similar to an investment company, and calculate NAV per share or its equivalent for which the fair value is not readily determinable, to measure the fair value of such investments on the basis of that NAV per share, or its equivalent, without adjustment. Investments which are valued using NAV per share as a practical expedient are not categorized within the fair value hierarchy.
ii. Carried Interest—For the private equity and debt fund products the Company offers, the Company is allocated incentive income by the investment funds based on the extent by which the investment funds performance exceeds predetermined thresholds. Carried interest allocations are generally structured from a legal standpoint as an allocation of capital in the Company’s capital account. The Company accounts for carried interest allocations by applying an equity ownership model. Accordingly, the Company accrues performance allocations quarterly based on the fair value of the underlying investments assuming hypothetical liquidation at book value.
iii. Equity Method Investments—For operating entities over which the Company exercises significant influence but which do not meet the requirements for consolidation as outlined above, the Company applies the equity method of accounting. The Company's investments in equity method investees are recorded in other investments in the accompanying condensed consolidated statements of financial condition. The Company's share of earnings or losses from equity method investees is included in Net gains (losses) on other investments in the accompanying condensed consolidated statements of operations.
Goodwill and Intangible Assets
Goodwill
Goodwill represents the excess of the purchase price consideration of acquired companies over the estimated fair value assigned to the individual assets acquired and liabilities assumed. Goodwill is allocated to the Company's reporting units at the date the goodwill is initially recorded. Once goodwill has been allocated to the reporting units, it generally no longer retains its identification with a particular acquisition, but instead becomes identifiable with the reporting unit. As a result, all of the fair value of each reporting unit is available to support the value of goodwill allocated to the unit.
In accordance with US GAAP requirements for testing for impairment of goodwill, the Company tests goodwill for impairment on an annual basis or at an interim period if events or changed circumstances would more likely than not reduce the fair value of a reporting unit below its carrying amount. In testing for goodwill impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances led to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company concludes that fair value exceeds its carrying amount, then performing a quantitative impairment test is not necessary. If the Company concludes otherwise, the Company is required to perform a quantitative impairment test that requires a comparison of the fair value of the reporting unit to its carrying value, including goodwill. If the fair value of the reporting unit exceeds its carrying value, the related goodwill is not considered impaired and no further analysis is required. If the
90

Table of Contents
carrying value of the reporting unit exceeds its fair value, then the Company recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value.
Intangible assets
Intangible assets with finite lives are amortized over their estimated average useful lives. Intangible assets are tested for potential impairment whenever events or changes in circumstances suggest that an asset or asset group's carrying value may not be fully recoverable. An impairment loss, calculated as the difference between the estimated fair value and the carrying value of an asset or asset group, is recognized in the accompanying condensed consolidated statements of operations if the sum of the estimated undiscounted cash flows from the use or disposition of the asset or asset group is less than the corresponding carrying value. The Company continually monitors the estimated average useful lives of existing intangible assets.
Legal Reserves
The Company estimates potential losses that may arise out of legal and regulatory proceedings and records a reserve and takes a charge to income when losses with respect to such matters are deemed probable and can be reasonably estimated, in accordance with US GAAP. These amounts are reported in other expenses, net of recoveries, in the condensed consolidated statements of operations. See Note 22 in our accompanying condensed consolidated financial statements for the quarter ended March 31, 2022 for further discussion.
Recently adopted and future adoption of accounting pronouncements
        For a detailed discussion, see Note 2q "Recent pronouncements" in our accompanying condensed consolidated financial statements for the three months ended March 31, 2022.
Item 3.    Quantitative and Qualitative Disclosures about Market Risk
During the three months ended March 31, 2022, there were no material changes in our quantitative and qualitative disclosures about market risks from those disclosed in our 2021 Form 10-K. For a more detailed discussion concerning our market risk, see Item 7A "Quantitative and Qualitative Disclosures about Market Risk" in our 2021 Form 10-K.
Item 4.    Controls and Procedures
Our management, with the participation of the Chief Executive Officer and the Chief Financial Officer (the principal executive officer and principal financial officer, respectively), evaluated our disclosure controls and procedures as of March 31, 2022.
Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that, as of March 31, 2022, our disclosure controls and procedures are effective to provide a reasonable assurance that information required to be disclosed by the Company in the reports filed or submitted by it under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer of the Company, as appropriate, to allow timely decisions regarding required disclosure.
There have been no changes in our internal controls over financial reporting that occurred during the three months ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting for such period.
PART II. OTHER INFORMATION
Item 1.    Legal Proceedings    
In the ordinary course of business, the Company and its affiliates, subsidiaries and current and former officers, directors and employees (the "Company and Related Parties") are named as defendants in, or as parties to, various legal actions and proceedings. Certain of these actions and proceedings assert claims or seek relief in connection with alleged violations of securities, banking, anti-fraud, anti-money laundering, employment and other statutory and common laws. Certain of these actual or threatened legal actions and proceedings include claims for substantial or indeterminate compensatory or punitive damages, or for injunctive relief.
In the ordinary course of business, the Company and Related Parties are also subject to governmental and regulatory examinations, information gathering requests (both formal and informal), certain of which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. Certain of our affiliates and subsidiaries are registered broker-dealers, futures commission merchants, investment advisers or other regulated entities and, in those capacities, are subject to regulation by
91

Table of Contents
various U.S., state and foreign securities, commodity futures and other regulators. In connection with formal and informal inquiries by these regulators, we receive requests and orders seeking documents and other information in connection with various aspects of our regulated activities.
Due to the global scope of our operations, and presence in countries around the world, the Company and Related Parties may be subject to litigation, governmental and regulatory examinations, information gathering requests, investigations and proceedings (both formal and informal), in multiple jurisdictions with legal and regulatory regimes that may differ substantially, and present substantially different risks, from those to which the Company and Related Parties are subject in the United States.
The Company seeks to resolve all litigation and regulatory matters in the manner management believes is in the best interests of the Company and its shareholders, and contests liability, allegations of wrongdoing and, where applicable, the amount of damages or scope of any penalties or other relief sought as appropriate in each pending matter.
In accordance with US GAAP, the Company establishes reserves for contingencies when the Company believes that it is probable that a loss has been incurred and the amount of loss can be reasonably estimated. The Company discloses a contingency if there is at least a reasonable possibility that a loss may have been incurred and there is no reserve for the loss because the conditions above are not met. The Company's disclosure includes an estimate of the reasonably possible loss or range of loss for those matters, for which an estimate can be made. Neither a reserve nor disclosure is required for losses that are deemed remote.
The Company appropriately reserves for certain matters where, in the opinion of management, the likelihood of liability is probable and the extent of such liability is reasonably estimable. Such amounts are included within accounts payable, accrued expenses and other liabilities in the accompanying condensed consolidated statements of financial condition. Estimates, by their nature, are based on judgment and currently available information and involve a variety of factors, including, but not limited to, the type and nature of the litigation, claim or proceeding, the progress of the matter, the advice of legal counsel, the Company's defenses and its experience in similar cases or proceedings as well as its assessment of matters, including settlements, involving other defendants in similar or related cases or proceedings. The Company may increase or decrease its legal reserves in the future, on a matter-by-matter basis, to account for developments in such matters. The Company accrues legal fees as incurred.
Item 1A.    Risk Factors
The discussion of our business and operations should be read together with the risk factors contained in Item 1A of our 2021 Form 10-K for the fiscal year ended December 31, 2021.
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
As of March 31, 2022, the Company's Board of Directors has a share repurchase program that, since its inception, has authorized the Company to purchase up to $466.4 million of Cowen Class A common stock from time to time through a variety of methods, including in the open market or through privately negotiated transactions, in accordance with applicable securities laws. The specific timing and amount of repurchases will vary depending on various factors, including, among others, market conditions and competing needs for the use of our capital.  We may elect to conduct future share repurchases through open market purchases, private transactions or automatic share repurchase programs under SEC Rule 10b5-1. During the three months ended March 31, 2022, the Company repurchased 798,302 shares, at an average price of $30.24 per share, of Cowen Class A common stock through the share repurchase program.
The table below sets forth the information with respect to purchases made by or on the behalf of the Company or any "affiliated purchaser" (as defined in Rule 10b-18(a)(3) under the Exchange Act, as amended), of our common stock during the three months ended March 31, 2022. Board approval of repurchases is based on dollar amount. As a result, the Company cannot estimate the number of shares that may yet be purchased.
92

Table of Contents
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsApproximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
Month 1 (January 1, 2022 – January 31, 2022)
Common stock repurchases(1)379,002 $33.23 379,002 $43,526,497 
Employee transactions(2)— — — — 
Other (3)— — — — 
Total379,002 $33.23 379,002 
Month 2 (February 1, 2022 – February 28, 2022)
Common stock repurchases(1)30,000 $29.55 30,000 $42,639,886 
Employee transactions(2)— — — — 
Other (3)— — — — 
Total30,000 $29.55 30,000 
Month 3 (March 1, 2022 – March 31, 2022)
Common stock repurchases(1)389,300 $27.38 389,300 $31,979,581 
Employee transactions(2)374,149 32.83 — — 
Other (3)— — — — 
Total763,449 $30.05 389,300 
Total (January 1, 2022 – March 31, 2022)
Common stock repurchases(1)798,302 $30.24 798,302 $— 
Employee transactions(2)374,149 32.83 — — 
Other (3)— — — — 
Total1,172,451 $31.07 798,302 
(1)    The Company's Board of Directors have authorized the repurchase, subject to market conditions, of up to $466.4 million of the Company's outstanding Class A common stock.
(2)    Represents shares of the Company's Class A common stock withheld in satisfaction of tax withholding obligations upon the vesting of equity awards or other similar transactions.
(3)    Represents shares of common stock distributed to the Company from an escrow account established to satisfy the Company's indemnification claims arising under the terms of the purchase agreement entered into in connection with the Company's acquisition of Convergex Group, LLC.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable.
Item 5. Other Information
None.
93

Table of Contents
Item 6.    Exhibits
Exhibit No.Description
101.INSXBRL INSTANCE DOCUMENT
101.SCHXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
101.CALXBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
101.DEFXBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
101.LABXBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
101.PREXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
104 Cover Page Interactive Data File - (formatted as inline XBRL and contained in Exhibit 101)

* Signifies management contract or compensatory plan or arrangement.
94

Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
COWEN INC.
  By:/s/ JEFFREY M. SOLOMON
  Name:Jeffrey M. Solomon
 Title:Chair and Chief Executive Officer (Principal Executive Officer)
  By:/s/ STEPHEN A. LASOTA
  Name:Stephen A. Lasota
Date:May 2, 2022 Title:Chief Financial Officer (principal financial officer and principal accounting officer)


Exhibit 10.1
RESTRICTED STOCK UNIT AND DEFERRED CASH AWARD AGREEMENT
THIS RESTRICTED STOCK UNIT AND DEFERRED CASH AWARD AGREEMENT (this “Agreement”) is made by and between Cowen Inc. (the “Company”), and [insert name], (the “Grantee”), as of February 1, 2022 (the “Grant Date”).
RECITALS
WHEREAS, the Company desires to grant to the Grantee the restricted stock units award (the “RSU Award”) and deferred cash award (the “Deferred Cash Award”) described herein (collectively, the “Awards”), subject to the terms of the Cowen Inc. 2020 Equity and Incentive Plan, as amended in 2021 (the “Plan”);
WHEREAS, the RSU Award shall consist of a grant of restricted stock units of Cowen Inc. in accordance with the terms and subject to the conditions set forth in this Agreement and the Plan;
WHEREAS, the Deferred Cash Award shall consist of a grant of deferred cash in accordance with the terms and subject to the conditions set forth in this Agreement and the Plan;
WHEREAS, the Grantee has accepted the grant of the Awards and hereby agrees to the terms and conditions hereinafter stated; and
WHEREAS, the capitalized terms used but not defined herein shall have the respective meanings given to them in the Plan;
NOW, THEREFORE, in consideration of the foregoing recitals and of the promises and conditions herein contained, it is agreed as follows:
ARTICLE I
Section 1.1 -Grant of Restricted Stock Units.
The RSU Award granted to the Grantee by the Company as of the Grant Date consists of [insert] restricted stock units (“RSUs”) pursuant to the terms and subject to the conditions and restrictions of this Agreement and the Plan. Each RSU constitutes an unfunded and unsecured promise of the Company to deliver (or cause to be delivered) to the Grantee upon settlement, subject to the terms of this Agreement, one share of Stock. Until such settlement and delivery, the Grantee has only the rights of a general unsecured creditor, and no rights as a shareholder of the Company, provided that, whenever a normal cash dividend is paid on shares of Stock, the Company shall credit to the Grantee an amount of cash equal to the product of the per-share amount of the dividend paid times the number of then unsettled RSUs. Such credited amounts shall be paid to the Grantee when and only to the extent the Stock underlying the RSU is transferred to the Grantee in accordance with this Agreement.
Section 1.2 -Grant of Deferred Cash.
The Deferred Cash Award granted to the Grantee by the Company as of the Grant Date consists of the right to receive [insert] dollars ($[insert]) in deferred cash, less applicable taxes and payroll deductions and subject to the conditions and restrictions of this Agreement and the Plan (“Deferred Cash”). Until the Company pays the Grantee Deferred Cash under this Agreement, all funds shall continue to be part of the general funds of the Company, and title to and beneficial ownership of any assets, whether cash or investments, which the Company may, in its sole discretion, set aside or earmark to meet its obligations hereunder shall at all times
1


Exhibit 10.1
remain in the Company until paid to the Grantee. The Grantee shall not under any circumstances acquire any property interest in any specific assets of the Company.
Section 1.3 -Vesting and Settlement of Awards.
(a)Normal Vesting and Settlement Schedule. The RSU Award shall vest and be settled as follows: (i) twelve and one half percent (12.5%) on September 1, 2022; (ii) twelve and one half percent (12.5%) on June 1, 2023; (iii) twenty-five percent (25%) on June 1, 2024; (iv) twenty-five percent (25%) on June 1, 2025; and (v) twenty-five percent (25%) on June 1, 2026; and the Deferred Cash will vest as follows: (vi) twelve and one half percent (12.5%) on August 15, 2022; (vii) twelve and one half percent (12.5%) on May 15, 2023; (viii) twenty-five percent (25%) on May 15, 2024; (ix) twenty-five percent (25%) on May 15, 2025; and (x) twenty-five percent (25%) on May 15, 2026 (each a “Vesting Date”, and collectively, the “Vesting Dates”), provided that (A) as of each Vesting Date the Grantee is employed in Good Standing by the Employer; and (B) with respect to the settlement of RSUs, the Grantee satisfies the Tax Withholding Amount (defined below). Vested Deferred Cash will be settled and paid via payroll by the first regularly schedule payroll after the Vesting Date.
(b)Interest on Deferred Cash. For each period of time in which a portion of the Deferred Cash Award remains unvested, and has not been forfeited, the Grantee shall be entitled to interest on the unvested amount at a rate equal to 70 basis points per annum. Any interest accrued with respect to the Deferred Cash Award as of a given Vesting Date shall be paid in full when the vested Deferred Cash is settled. In the event that the Grantee forfeits the right to receive any unvested Deferred Cash, the Grantee also forfeits any then-accrued and unpaid interest.
(c)Vesting and Settlement in the Event of a Qualifying Termination. Any unvested Awards shall vest and be settled in full due to a Qualifying Termination, provided that (i) the Grantee (or Grantee’s executor or estate as applicable) satisfies the Tax Withholding Amount related the settlement of the RSU Award; and (ii) the Grantee (or Grantee’s executor or estate as applicable) executes, delivers, and does not revoke a general release of claims in favor of the Company and its Affiliates, in a form requested by the Company, within seven (7) days (or such longer period as required by law for the release to become effective, but in no event longer than fifty-two (52) days). For purposes of vesting and settlement under this Section, the vesting date shall be the date Grantee’s employment terminates, and the settlement date will be within sixty (60) days thereafter. If the settlement under this Section could occur in more than one taxable year depending on the date Grantee executes and returns the general release, then, regardless of the year in which Grantee executes and returns the general release, the settlement date will be the later of (y) January 1 of the next calendar year; or (z) the next payroll date that is at least ten (10) business days after the general release becomes irrevocable. If the Grantee (or Grantee’s executor or estate as applicable) does not execute and deliver the general release within the time permitted (or if the Grantee (or Grantee’s executor or estate as applicable) revokes the general release if permitted by law), all unvested Awards will be forfeited as of the date of termination of employment.
(d)Vesting and Settlement in the Event of a Qualifying Retirement. Any unvested Awards shall vest on the date of the Grantee’s Qualifying Retirement and shall be settled at such times set forth in Section 1.3(a) above, provided that (i) the Grantee satisfies the Tax Withholding Amount related the settlement of the RSU Award; (ii) the Grantee executes, delivers, and does not revoke a general release of claims in favor of the Company and its Affiliates, in a form requested by the Company, within seven (7) days (or such longer period as required by law for the release to become effective, but in no event longer than fifty (50) days); and (iii) prior to each settlement date after Grantee’s Retirement Date, Grantee has provided the Company with a notarized affidavit in a form requested by the Company, which will include, but
2


Exhibit 10.1
not be limited to, affirming whether Grantee is in compliance with this Agreement, whether the Grantee is engaged in a Competitive Activity, and disclosing Grantee’s then current employer, if any. In the event that the Grantee engages in any Competitive Activity prior to an applicable settlement date, the Grantee shall forfeit for no consideration all unsettled Awards that vested pursuant to this Section. Notwithstanding anything herein to the contrary, for purposes of vesting and settlement under this Section, the vesting date shall be the date Grantee’s employment terminates, and the settlement date will be the later of the date the general release becomes irrevocable and the settlement date set forth in Section 1.3(a) above. If the Grantee does not execute and deliver the general release within the time permitted (or if the Grantee) revokes the general release if permitted by law), all unvested Awards will be forfeited as of the date of termination of employment.
(e)Vesting and Settlement Provision in Employment Agreement. In the event that the Grantee is a party to an employment agreement with compensation terms in effect as of the Grant Date (“Employment Agreement”) that provides for accelerated vesting of any equity-based or deferred cash awards upon any event not specified in this Section, the vesting terms of such Employment Agreement shall control and the Awards will vest in accordance with the terms of such Employment Agreement upon the occurrence of such event and shall be settled within sixty (60) days of vesting, provided the Grantee has satisfied any Tax Withholding Amount related to such vesting.
Section 1.4 -Forfeiture.
Except as set forth above, if the Grantee’s employment with the Employer is terminated, then any unvested Awards shall immediately be forfeited to the Company (and in the case of a voluntary resignation, such forfeiture shall occur as of the commencement of the Notice Period, as defined below), and neither the Grantee nor any of the Grantee’s successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such then-unvested Awards. Additionally, if the Company reasonably determines, in its sole discretion, that the Grantee has violated the Notice of Termination Section of this Agreement, the Restrictive Covenants Section of this Agreement, or other notice obligations or restrictive covenants to which Grantee is otherwise subject, or commits an act or omission which would qualify as Cause (defined below) (any of these violations, a “Breach”), then any unvested Awards shall immediately be forfeited to the Company as of the date of the Company’s determination, and neither the Grantee nor any of the Grantee’s successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such unvested Awards.
Section 1.5 -Taxes.
The Grantee agrees to pay promptly, at the time the Grantee recognizes taxable income or wages in respect of the Awards, the minimum amount equal to the federal, state, and local taxes and withholdings the Company determines are required to be withheld under applicable tax laws with respect to the Awards (the “Tax Withholding Amount”), and subject to the conditions and restrictions of this Agreement and the Plan. In the case of a Qualifying Retirement, FICA taxes (e.g., social security and Medicare) are due on all vested but unsettled RSUs. With respect to the Deferred Cash, the Deferred Cash paid to the Grantee will be reduced by the Tax Withholding Amount. With respect to RSUs, payment of the Tax Withholding Amount may be effected through (a) payment by the Grantee to the Company in cash or cash equivalents; (b) at the discretion of the Company, and in accordance with Company policy, either (x) the Company withholding the number of shares of Stock with an aggregate fair market value on the date of vesting equal to the Tax Withholding Amount; or (y) selling shares to cover the Tax Withholding Amount on the open market; or (c) at the discretion of the Company, any combination of these methods. If the Grantee does not pay the Tax Withholding Amount in accordance with the terms of this Section within forty-five (45) days after the Vesting Date, at the election of the Company,
3


Exhibit 10.1
any then-vested, but unsettled, RSUs having an aggregate value equal to the Tax Withholding Amount (as determined by the Company in its sole discretion) shall immediately be forfeited to the Company and neither the Grantee nor any of the Grantee’s successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such RSUs.
ARTICLE II
Section 2.1 - Definitions. Notwithstanding the definitions set forth in this Section, if the Grantee is subject to an Employment Agreement that defines “Cause,” “Disability,” or “Good Standing,” such term will have the meaning set forth in the Employment Agreement, as amended by any subsequent deferred compensation award agreements.
(a)Affiliate” means, with respect to any entity, any other entity that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such entity.
(b)Cause” means when the Employer, in its sole discretion in good faith, determines that: (i) the Grantee has breached any material provision of the Plan; this Agreement; Grantee’s Employment Agreement, offer letter, Terms and Conditions of Employment, or any deferred compensation award agreement including, but not limited to, the Notice of Termination Section or Restrictive Covenants Section below or in Grantee’s Employment Agreement or Terms and Conditions of Employment; (ii) the Grantee has been indicted for, convicted of, pled guilty or nolo contendere to, or committed any felony, or has been convicted of or pled guilty or nolo contendere to any other crime (whether or not related to the Grantee’s duties for the Employer or any Affiliate) with the exception of minor traffic offenses; (iii) the Grantee has committed an act of fraud, dishonesty, gross negligence, or substantial misconduct in his performance of his duties or responsibilities; (iv) the Grantee has violated or has failed to comply with the internal policies of the Employer or any Affiliate, including its policies against discrimination, harassment or retaliation, or the rules and regulations of any regulatory or self-regulatory organization with jurisdiction over the Employer or any Affiliate; (v) the Grantee has failed to perform a material duty of Grantee’s position including, by way of example and not of limitation, Grantee’s insubordination, or failure or refusal to follow an instruction reasonably given by Grantee’s superiors in the course of employment; and (vi) the Grantee has committed an act which results in negative publicity to the Company, regardless of whether such act occurred within the performance of his or her duties or responsibilities.
(c)Competitive Activity” means, directly or indirectly, on behalf of a Competitor engaging in any activity which is the same as or reasonably similar to: (1) the positions Grantee has held with the any Cowen Inc. Company, (2) the activities Grantee has performed for any Cowen Inc. Company, (3) the activities Grantee gained knowledge of by virtue of his or her work for a Cowen Inc. Company; or (4) any activity engaged in by any department, division, or other group Grantee has managed on behalf of a Cowen Inc. Company. Competitive Activity includes being involved in any manner as an employee, stockholder, owner, officer, director, partner, agent, consultant, independent contractor, registered representative or in any other corporate or representative capacity. Competitive activity applies within the United States; provided, however, that if Grantee’s activities or position are located in, involve contact with or Grantee conducts business with countries other than the United States, it includes those countries, as permitted by law.
(d)Competitor” includes any company, partnership, entity or person which is currently competitive with, or is preparing to be competitive with, a Cowen Inc. Company.
(e)Cowen Inc. Company” includes Cowen Inc. and its subsidies, affiliates and joint ventures including, but not limited to, Cowen Investment Management LLC, Cowen and
4


Exhibit 10.1
Company, LLC, Kyber Data Science LLC, Cowen Digital LLC, ATM Execution LLC, Westminster Research Associates, Cowen Execution Services Limited, Cowen International Limited, and each of their subsidiaries, affiliates and joint ventures.
(f)Disability” means that the Grantee (i) is unable to engage in any substantial gainful activity, with or without reasonable accommodation, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months; or (ii) is, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering employees of the Employer or any Affiliate.
(g)Employer” means the Company or the Affiliate of the Company that employs the Grantee.
(h)“Good Standing” means that Grantee remains actively employed and (i) has not been given notice of the termination of Grantee’s employment; (ii) has not given notice of resignation or resigned, other than notice of a Qualifying Retirement; and (iii) is not currently suspended or under investigation for conduct that could, in the Company’s good faith determination, result in a termination for Cause.
(i)“Length of Service” means Grantee’s completed years of service with any Cowen Inc. Company as reflected in Cowen’s human resources management system (currently Workday);
(j)Qualifying Retirement” means the Grantee’s voluntary resignation that satisfies each of the following conditions: (i) as of the date Grantee provides resignation notice: (A) Grantee is at least fifty-eight (58) years of age, (B) Grantee’s Length of Service is at least five (5) years; and (C) Grantee’s age plus Length of Service equals at least sixty-eight (68) years; (ii) Grantee has provided the Employer with at least six (6) months prior written notice of the Grantee’s intention to voluntarily resign in order to retire (such notice to specify, among other things as may be required by the Employer, the intended Retirement Date); (iii) the Grantee continues to use his or her best efforts in the performance of his or her duties and responsibilities, including hiring Grantee’s replacement if requested by the Company, through Grantee’s Retirement Date; (vi) Grantee remains in Good Standing with the Employer through Grantee’s Retirement Date, and (v) Cause does not exist from the time the resignation notice is provided by the Grantee through the Grantee’s Retirement Date.
(k)“Qualifying Termination” means termination of the Grantee’s employment due to (i) termination by the Employer without Cause; or (ii) Grantee’s death or Disability.
(l)Retirement Date” means the date Grantee’s employment terminates due to a voluntary resignation due to a Qualifying Retirement.
Section 2.2 - Notice of Termination.
Other than for a Qualifying Retirement, Grantee shall not voluntarily resign without first giving advanced written notice of the effective date of Grantee’s resignation. The length of Grantee’s notice period (“Notice Period”) and the amount of advanced written resignation notice is based on Grantee’s corporate title and business division on the date Grantee provides resignation notice as follows:
5


Exhibit 10.1
Corporate TitleLength of Notice Period
Managing Director4 months
Director3 months
Investment Banking - Vice President, Associate and Analyst2 months
Markets - Vice President, Associate and Analyst2 months
Research – Vice President and Associate2 months
All other titles (less senior than Director) not otherwise listed on this chart2 months

This Notice of Termination Section expressly supersedes any shorter Notice Periods set forth in any offer letter, Terms and Conditions of Employment, or deferred compensation award agreement; provided, however, that if Grantee has agreed to a longer Notice Period pursuant to an offer letter, Terms and Conditions of Employment, or deferred compensation award agreement, the longer length of time governs. If the Grantee has an Employment Agreement in effect as of the Grant Date that contains a Notice Obligation, then that provision governs.
Grantee must deliver written notice of resignation pursuant to this Section to Grantee’s manager with a copy to the Head of Human Resources by hand, e-mail, or mail with proof of delivery (such as certified mail, UPS, or FedEx). If Grantee is resigning to take another position, Grantee agrees to identify the new employer in the written resignation notice. Unless Grantee receives prior written consent from the head of Grantee’s Division, Grantee agrees not to send out a “goodbye” e-mail or other written communication, either internally to employees or externally, announcing Grantee’s resignation or departure. The obligations in this Section are Grantee’s “Notice Obligations”.
During the Notice Period, Grantee continues to be an employee. Grantee will continue to receive Grantee’s base salary or draw on a normal payroll cycle and remain eligible for benefits through the last day of employment. Grantee will not be eligible to receive any bonus, incentive compensation or paid time off. Grantee will forfeit any deferred compensation as of the date Grantee provides resignation notice. As an employee, Grantee may not perform services for another employer during the Notice Period, and Grantee continues to be bound by all fiduciary duties and policies and procedures. During the Notice Period, the Employer or the Company may (i) require Grantee to transition duties and responsibilities; or (ii) withdraw any powers vested in, or duties assigned to, Grantee. The Employer and the Company also retain the right, in their sole discretion, to waive the Notice Period in whole or in part or to place Grantee on paid leave for all or part of the Notice Period. If the Employer or the Company waives or shortens the Notice Period, Grantee will only receive base salary/draw and benefits through Grantee’s termination date.
6


Exhibit 10.1
Section 2.3 - Restrictive Covenants.
(a)Employee Non-Solicitation. Grantee agrees that during employment (including any Notice Period) and for a period of one (1) year after the date of the termination of Grantee’s employment for any reason, Grantee will not, without the Company's prior written consent, directly or indirectly: (a) solicit or induce, or cause others to solicit or induce, any employees of a Cowen Inc. Company (defined below) to leave the Company or in any way modify their relationship with the Company; (b) hire or cause others to hire any employees of a Cowen Inc. Company; or (c) encourage or assist in the hiring process of any Cowen Inc. Company employee or in the modification of any such employee's relationship the Cowen Inc. Company, or cause others to participate, encourage or assist in the hiring process of any employees of a Cowen Inc. Company.
(b)Non-Competition Obligation. In order to safeguard the Employer’s and the Company’s Protectable Interests (as defined below), Grantee agrees that if he or she has a Front Office position, during Grantee’s employment and Post-employment Period after Grantee’s employment terminates, Grantee will not, without prior written consent of the Company’s Head of Human Resources, directly or indirectly, on behalf of a Competitor, engage in Competitive Activity (the restriction under this Paragraph, the “Non-competition Obligation”). The length of the post-employment Non-Competition Obligation will be equal to the length of Grantee’s Notice Obligation as of the date of Grantee’s termination of employment (the “Post-employment Period”). For example, if Grantee has a 3-month Notice Obligation, the length of Grantee’s Post-employment Period is three (3) months. The post-employment Non-competition Obligation does not apply if Grantee’s employment is terminated by the Company without Cause. If Grantee fully complies with Grantee’s Notice Obligations, the length of Grantee’s Post-employment Period will be reduced by the number of days Grantee remains on payroll during the Notice Period (for example, if Grantee’s Employer holds Grantee to Grantee’s full Notice Period, Grantee will not have any further Post-employment Period if Grantee fully complies with the Notice Obligations). Grantee acknowledges that this Non-Competition Obligation is in addition to any client non-solicitation obligation set forth in any offer letter, Terms and Conditions of Employment, or deferred compensation award agreement, and that such agreements are amended to add this Non-Competition Obligation; provided, however, that if Grantee has agreed to a longer post-employment non-competition period in an offer letter or Terms and Conditions of Employment, the longer length of time governs. If the Grantee has an Employment Agreement in effect as of the Grant Date, then that Employment Agreement governs.
(c)Non-Disclosure of Confidential or Proprietary Information. The Grantee shall not at any time, whether during Grantee’s employment or following the termination of Grantee’s employment, directly or indirectly, publish, disclose or furnish to any entity, firm, corporation or person, except as otherwise required by law or as required as part of Grantee’s position with the Company, any Confidential or Proprietary Information with respect to any aspect of its operations, business or clients. "Confidential or Proprietary Information" shall mean any secret, confidential or proprietary information of a Cowen Inc. Company that is not generally known to the public to which you gain access by reason of your employment and includes, but is not limited to, information relating to all principals, officers, and employees, all present or potential clients and investors; work product developed by and research conducted by a Cowen Inc. Company; research reports, models, and notes; business and marketing plans; sales, trading and financial data and strategies; legal and/or regulatory matters; operational costs; pitch books and presentation materials; client and investor lists; client contact and account information; pipelines; investor information; budgets; engagement letters; all current and prospective client confidential information; financial models; and internal procedures, manuals and guidebooks. This Paragraph does not prohibit any disclosure: (i) made for the purpose of reporting a suspected violation of law or claiming retaliation for reporting a violation of law in confidence to (A) the Equal Employment Opportunity Commission, the National Labor Relations Board, the
7


Exhibit 10.1
Occupational Safety and Health Administration, the Securities and Exchange Commission, FINRA, or any other federal, state or local government, agency or commission (“Government Agency”), (B) your attorney, or (C) in a sealed court document; (ii) made in cooperation with an investigation by a Government Agency; or (iii) required pursuant to a subpoena or other legal process; provided, however, with respect to a disclosure under (iii), other than to a Government Agency, that Grantee agrees to give the Company prompt written notice of the disclosure so that the Company may seek a protective order or waive Grantee’s compliance with this paragraph. Upon termination of Grantee’s employment for any reason, or at any other time requested by the Employer or the Company, Grantee agrees to immediately return all Confidential or Proprietary Information in Grantee’s possession, custody or control, and upon request of the Employer or the Company, agrees to execute an affidavit confirming Grantee’s compliance with this obligation.
(d)Non-Disparagement. The Grantee shall not at any time, whether during the Grantee’s employment or following any termination thereof, and shall not cause or induce others to, defame or disparage the Company or any Affiliate, or the directors, officers or employees of the Company or any Affiliate. Grantee agrees not to take any action which is intended, or would reasonably be expected, to harm the reputation of a Cowen Inc. Company, or which would reasonably be expected to lead to negative publicity to a Cowen Inc. Company.
(e)Company Property. All records, files, memoranda, reports, customer information, client and investor lists, documents, Work Made for Hire (defined below) and equipment relating to the business of the Company or any Affiliate that the Grantee prepares or possesses, or with which the Grantee comes into contact, in either case while the Grantee is an employee of the Company or any Affiliate, shall remain the property of the Company or such Affiliate. The Grantee agrees that upon the Grantee’s termination of employment for any reason, the Grantee shall provide to the Company and any Affiliate, as applicable, all documents, papers, files, and other material in the Grantee’s possession and under the Grantee’s control that are connected with or derived from the Grantee’s services to the Company or any Affiliate.
(f)Intellectual Property. Grantee agrees that the following, without limitation, belongs to and shall be the sole intellectual property of the Company: all inventions, improvements, products, designs, specifications, original works of authorship, trademarks, service marks, trade dress, discoveries, formulas, algorithms, processes, models, software or computer programs (including any modifications), data processing systems, analyses, data, techniques, trade secrets, know-how, ideas, creations, or work product (regardless of whether it contains Confidential or Proprietary Information or trade secrets), and any applications and registrations thereto, conceived, developed, made or improved on by Grantee: (i) in the course of employment with or work for a Cowen Inc. Company; or (ii) with the use of a Cowen Inc. Company’s time, material or facilities in any way related to or pertaining to or connected with the present or anticipated business, development, work or research of a Cowen Inc. Company (“Work Made for Hire”). The Company shall exclusively own all rights, title and interest in any Work Made for Hire, and shall be the author for all purposes under copyright law. Grantee hereby assigns such Work Made for Hire to the Company and agrees, without further compensation or consideration, to immediately take such actions to effect such assignment as may be requested by the Cowen Inc. Company. If any intellectual property is not deemed a Work Made for Hire, or if Grantee, by operation of law, is deemed to obtain any rights to the Work Made for Hire, Grantee shall irrevocably assign to the Company, without further compensation or consideration, your entire right, title, and interest in and to the intellectual property. Grantee further agrees not to impermissibly reproduce, copy, display, distribute, forward, plagiarize, or use (whether in hardcopy or electronically, including via e-mail) any Third Party Copyrighted Materials in violation of any license, subscription agreement, or law. “Third Party Copyrighted Materials” are copyrighted works, other than those of a Cowen Inc. Company including, but are not limited to, printed articles from publications; electronic articles and reports in online publications; database content; websites; streaming media; musical compositions, mobile apps;
8


Exhibit 10.1
online videos; movies; sound recordings, including in digital form such as downloads and streams; images; presentations; training materials; manuals; documentation; computer programs, software programs, and blogs.
(g)Compliance with Company Policies. The Grantee agrees to comply fully with the applicable internal policies of the Company and the Employer including, but not limited to, those contained in the Company’s and the Employer’s Employee Handbook, Code of Business Conduct and Ethics, and compliance policies and procedures. The Company’s right to modify these policies does not affect Grantee’s duty to comply with these policies at all times.
(h)Cooperation. The Grantee agrees to cooperate fully with the Company and the Employer at any time, whether during the Grantee’s employment or following any termination thereof, taking into account the requirements of any subsequent employment by the Grantee, on all matters relating to the Grantee’s employment, which cooperation shall be provided without additional consideration or compensation and shall include, without limitation, being available to serve as a witness and be interviewed and making available any books, records, and other documents within the Grantee’s control, provided, however, that the Grantee need not take any action hereunder that would constitute a violation of law or obligation to any third party (except to the extent such obligation arises due to any action taken by the Grantee with the intention to circumvent the operation of this Section or cause a waiver of attorney-client privilege). Without limiting the generality of the foregoing, the Grantee shall cooperate fully and truthfully in connection with any (1) past, present, or future suit, action, claim, or other proceeding; (2) inquiry, proceeding, or investigation by or before any governmental authority; (3) arbitration, mediation, or other alternative dispute resolution process, in each case involving the Company, the Employer, or any Affiliates; and (4) internal investigation. In connection with the Grantee’s providing such cooperation, the Company or the Employer, as applicable, shall reimburse the Grantee for reasonable, pre-approved expenses in connection with such cooperation.
(i)Publicity Consent. In connection with Grantee’s employment, Grantee grants the Cowen Inc. Companies the right to use his or her name, likeness, image, portrait, voice, and appearance for business purposes including, but not limited to, videos, audio recordings, photographs, publications, advertisements, news releases, websites, and any promotional materials (the “Materials”). Grantee acknowledges that he or she has no right, title, or interest in and to the Materials, and voluntarily waives the right to inspect or approve the use of the Materials. Grantee releases the Cowen Inc. Companies from all claims under federal, state and local law arising out of the Cowen Inc. Companies’ use of the Materials.
(j)Grantee Representations Supporting Restrictive Covenants. Grantee acknowledges and recognizes the highly competitive nature of the Employer’s and the Company’s business, that the Employer will invest time and resources into Grantee’s training and education in furtherance of Grantee’s position, and that by virtue of Grantee’s position, Grantee will have access to the Employer’s and the Company’s Confidential and Proprietary Information and trade secrets (collectively, “Protectable Interests”). Grantee understands that the restrictive covenants contained in this Agreement may limit Grantee’s ability to earn a livelihood in a position similar to or involving the same activities Grantee perform for the Employer, but Grantee acknowledges that Grantee will receive compensation and other benefits, including training and access to Confidential and Proprietary Information, sufficient to justify these restrictions. Grantee further acknowledges that given Grantee’s education, skills, and abilities, Grantee does not believe that the restrictive covenants in this Agreement will prevent Grantee from earning a livelihood. Grantee recognizes that the Company would not award the RSUs and Deferred Cash pursuant to this Agreement if Grantee was not willing to agree to the restrictive covenants contained in this Agreement.
9


Exhibit 10.1
Section 2.4 - Breach/Injunctive Relief.
In the event of a Breach, in addition to being entitled to exercise all rights granted by law, including recovery of damages, the Company and the Employer will be entitled to specific performance of its rights under this Agreement. The Grantee acknowledges that the Company shall suffer irreparable harm in the event of a Breach or prospective Breach, and that monetary damages would not be adequate relief. Accordingly, the Company shall be entitled to seek injunctive relief in any federal or state court of competent jurisdiction located in New York County, or in any state in which the Grantee resides. The Grantee further agrees that the Company and the Employer shall be entitled to recover all costs and expenses (including attorneys’ fees and expenses) incurred in connection with the enforcement of the Company’s rights hereunder including, but not limited to, with respect to a Breach.
Section 2.5 - Offset.
In the event that the Grantee voluntarily terminates employment or if the Grantee’s employment is terminated, for any reason or no reason, the Company may offset, to the fullest extent permitted by law, any amounts of money or other property due to the Company from the Grantee, or advanced or loaned to the Grantee by the Company, from any money or property owed to the Grantee or the Grantee’s estate by the Company as a result of such termination of employment, except to the extent such withholding or offset is not permitted under Section 409A of the Code (“Section 409A”), without the imposition of additional taxes or penalties on the Grantee.
Section 2.6 - Governing Law.
This Agreement shall be governed by and construed in accordance with the laws of the State of New York other than its laws regarding conflicts of law (to the extent that the application of the laws of another jurisdiction would be required thereby), other than the agreement to arbitrate set forth in Section 2.14, which is governed by and construed in accordance with the Federal Arbitration Act (“FAA”). Grantee consents that any arbitration with respect to this Agreement or Grantee’s employment will be brought in the New York County. To the extent that Grantee or the Company is permitted to commence a court action, Grantee consents to venue and personal jurisdiction in the state and federal courts in New York County, and Grantee waives any right to a jury trial in any such action.
Section 2.7 - Interpretation of Agreement.
Subject to the Plan, the Company shall have final authority to interpret and construe this Agreement and to make any and all determinations under them, and its decision shall be binding and conclusive upon the Grantee and the Grantee’s legal representative in respect of any questions arising under this Agreement.
Section 2.8 - Notices.
Any notice, other than notice by the Company relating to the Tax Withholding Amount and a resignation notice by Grantee, to be given under the terms of this Agreement shall be in writing and addressed to the Company at 599 Lexington Avenue, New York, New York 10022, Attention: General Counsel, and to the Grantee at the Grantee’s last known home address provided by Grantee to the Company as of the date of notice or at such other address as either party may hereafter designate in writing to the other by like notice. Notice by the Company relating to the Tax Withholding Amount may be sent to the Grantee via e-mail.
10


Exhibit 10.1
Section 2.9 - Effect of Agreement/Acknowledgment/Brokerage Account Requirement
Except as otherwise provided hereunder, this Agreement shall be binding upon and shall inure to the benefit of any successor or successors of the Company. This Agreement shall only become effective and binding on the Company in the event that Grantee shall within forty-five (45) days after the Grant Date: (i) return this signed Agreement to the Company’s Human Resources Department; and (ii) open and activate a brokerage account with the Company’s stock plan administrator.
Section 2.10 - Complete Agreement/Severability.
This Agreement may not be amended or modified in any manner (including by waiver) except by an instrument in writing signed by both parties hereto. The waiver by either party of compliance with any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement or of any subsequent breach of such party of a provision of this Agreement. Any provision of this Agreement held legally invalid or unenforceable shall not affect the enforceability of the remaining provisions. If any court or arbitrator determines that the Notice Period or restrictive covenants, or any part thereof, are invalid or unenforceable, it is the intention of the parties that these Sections shall not be terminated but shall be deemed to be amended to the extent required to make them valid and enforceable.
Section 2.11 - No Right to Continued Employment.
Nothing in this Agreement shall be deemed to confer on the Grantee any right to continued employment with the Company, Employer or any Affiliate.
Section 2.12 - Section 409A.
The intent of the parties is that payments under this Agreement comply with Section 409A of the Code, to the extent subject thereto, and accordingly, to the maximum extent permitted, this Agreement shall be interpreted and administered to be in compliance therewith. Notwithstanding anything contained herein to the contrary, the Grantee shall not be considered to have terminated employment with the Company for purposes of any payments under this Agreement which are subject to Section 409A of the Code until the Grantee has incurred a “separation from service” from the Company within the meaning of Section 409A of the Code. Each amount to be paid under this Agreement shall be construed as a separate identified payment for purposes of Section 409A of the Code. Without limiting the foregoing and notwithstanding anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section 409A of the Code, amounts that would otherwise be payable pursuant to this Agreement or any other arrangement between the Grantee and the Company during the six (6) month period immediately following the Grantee’s separation from service shall instead be paid on the first business day after the date that is six (6) months following the Grantee’s separation from service (or, if earlier, the Grantee’s date of death). The Company makes no representation that any or all of the payments described in this Agreement will be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section 409A of the Code from applying to any such payment. In the event that any provision of this Agreement would cause this Agreement fail to comply with Section 409A, to the extent subject thereto, such provision may be deemed null and void, and the Company and the Grantee agree to amend or restructure this Agreement to the extent necessary and appropriate to avoid adverse tax consequences under Section 409A.
11


Exhibit 10.1
Section 2.13 - Entire Agreement.
Except as otherwise specified herein, this Agreement constitutes the entire agreement of the parties with respect to the Awards and supersedes in its entirety all prior undertakings, agreements, correspondence, and term sheets of or between the Company and the Grantee with respect to the Awards.
Section 2.14 - Arbitration.
(a)Any and all disputes with the Company, the Employer, or any Affiliate arising out of or relating to this Agreement or to the Grantee’s employment will be submitted to and resolved exclusively by the Financial Industry Regulatory Association (“FINRA”) in accordance with its rules, unless Grantee is not registered or is not subject to FINRA’s jurisdiction, then by the American Arbitration Association (“AAA”) pursuant to the AAA’s Employment Arbitration Rules and Mediation Procedures. In the event of arbitration before the AAA, the arbitrator’s fees and the administrative costs associated with holding the arbitration hearing (e.g., set-up and calendaring, room costs, etc.) will be paid by the Company; however, Grantee will be responsible for paying Grantee’s attorney’s fees, witness fees, and all other personal legal expenses related to Grantee’s legal representation. In agreeing to arbitrate Grantee’s claims, Grantee recognizes that Grantee is waiving Grantee’s right to a trial in court and by a jury. The arbitration award shall be binding upon Grantee, the Company, the Employer, and any Affiliate and judgment upon the award may be entered in a court of competent jurisdiction. This arbitration provision applies to, but is not limited to, statutory discrimination, harassment, and retaliation claims under federal, state and local law.
(b)Grantee agrees to waive any right to bring, participate in, or recover any relief from a class, collective or other representative action against the Company or its Affiliates to the maximum extent permitted by law. If Grantee is included in a class, collective or other representative action, Grantee will take all steps necessary to opt-out of the action or refrain from opting-in. A court must decide any issue concerning the validity of this waiver, and an arbitrator does not have the authority to consider it or to allow Grantee to serve as a representative of others in arbitration pursuant to this Section. If for any reason a court finds this waiver unenforceable, the class, collective or representative claim may only be heard in court and not arbitrated, and to the fullest extent permitted by law, Grantee waives the right to a jury for any such claims. Grantee retains the right to challenge the validity of this waiver.
(c)This arbitration provision does not apply to: (i) a claim for injunctive relief permitted under this Agreement, any Employment Agreement, offer letter, Terms and Conditions of Employment, or deferred compensation award agreement, for which jurisdiction shall be reserved in the federal and/or state courts in New York County, with the parties consenting to personal jurisdiction; (ii) any claim arising under Sarbanes-Oxley; and (iii) claims prohibited by law from being arbitrated.
IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by a duly authorized officer, and the Grantee has hereunto set the Grantee’s hand on the date indicated below.
COWEN INC.

Signed:                                 
    [insert name]             Date
12

Exhibit 10.2
PERFORMANCE SHARES AWARD AGREEMENT
This PERFORMANCE SHARES AWARD AGREEMENT (this “Agreement”) is made by and between Cowen Inc. (the “Company”), and (insert name) (the “Grantee”), effective March 1, 2022 (the “Grant Date”).
RECITALS
WHEREAS, the Company desires to grant to the Grantee an award of restricted stock units tied to certain performance measures described herein (the “Award”), subject to the terms of the Cowen Inc. 2020 Equity and Incentive Plan, as amended in 2021 (the “Plan”);
WHEREAS, the Award shall consist of a grant of restricted stock units (the “RSUs”) in accordance with the terms and subject to the vesting conditions set forth in this Agreement and the Plan; and
WHEREAS, the capitalized terms used but not defined herein shall have the respective meanings given to them in the Plan.
NOW, THEREFORE, it is agreed as follows:
ARTICLE I

GRANT OF RESTRICTED STOCK UNITS
Section 1.1 -Grant of Restricted Stock Units.
Pursuant to the terms and conditions and restrictions of this Agreement and the Plan, the Award granted to the Grantee by the Company as of the Grant Date consists of a target award of (insert amount) (insert amount) RSUs (the “Target RSUs”).
The actual number of RSUs that become vested and settled (each, an “Attained RSU”) shall be based on the attainment of the performance metrics (the “Performance Metrics”) provided in, and calculated under, Section 1.2.

Each RSU constitutes an unfunded and unsecured promise of the Company to deliver (or cause to be delivered) to the Grantee upon settlement, subject to the terms of this Agreement, one share of Stock. Until such settlement and delivery, the Grantee has only the rights of a general unsecured creditor, and no rights as a shareholder of the Company, provided that, whenever a normal cash dividend is paid on shares of Stock, the Company shall credit to the Grantee an amount of cash equal to the product of the per-share amount of the dividend paid multiplied by the number of Attained RSUs as of the applicable Vesting Date (the “Dividend Equivalent Amount”). Such credited amounts shall be paid to the Grantee when and only to the extent the Stock underlying an Attained RSU is transferred to the Grantee in accordance with Section 1.2 below.

Section 1.2 -Vesting and Settlement of Awards.
(a)Normal Vesting and Settlement Schedule. The Grantee shall become vested in the Target RSUs upon December 31, 2024 (the “Vesting Date”), subject to the calculation of the Performance Metrics with respect to the three-year performance period of calendar years 2022, 2023, and 2024 (the “Performance Period”).



Exhibit 10.2
Vesting on the Vesting Date shall be conditioned on the following: (1) the Grantee remains actively employed by the Company as of the Vesting Date; or (2) as otherwise provided in Section 1.2(c), 1.2(d) and 1.2(e). The Attained RSUs will be settled as follows: (i) any Attained RSUs up to a Payout Rate (defined below) of one hundred and twenty percent (120%) will be settled in Cowen Inc. stock on March 10, 2025 (the “Settlement Date”); and (ii) any Attained RSUs above a Payout Rate of one hundred and twenty percent (120%) will be settled in undeferred cash via payroll on March 31, 2025, with the value of an Attained RSU calculated based on the volume weighted average price of Cowen Inc. stock on the Settlement Date. For the avoidance of doubt, the calculation of the Attained RSUs will be performed after the Vesting Date, but no later than the Settlement Date, once data necessary to analyze the Performance Metrics becomes available for the full Performance Period.

(b)Performance Metrics Calculation. With respect to the Target RSUs, the number of Attained RSUs shall be determined in accordance with this Section 1.2(b).

With respect to the Performance Period, as of the Vesting Date, the number of Preliminary RSUs shall be equal to the product of the Target RSUs and the applicable percentage in the table below (the “Payout Rate”) based on the Company’s AROCE (as defined in Section 2.1) with respect to the Performance Period.

AROCE Performance/Payout Scale (“ROCE Payout Scale”)
Performance Level*AROCEPayout Rate
Below ThresholdBelow 8%0% payout
Threshold8%50% payout
Above Threshold / Below Target10%75% payout
Target12.5%100% payout
Above Target15%125% payout
Above Target / Below Maximum17.5%150% payout
Maximum (capped)Greater than 20%200% payout
* Performance between the Threshold and the Maximum will be interpolated

The number of Attained RSUs shall be equal to the product of (A) the Preliminary RSUs and (B) the applicable Modifier indicated in the table below determined based on the Company’s TSR (as defined in Section 2.1) during such Performance Period versus the TSR of the companies comprising the S&P SmallCap 600 Financial Sector Index (the “Index”) as of the first day of each Performance Period for the same period:
TSR Modifier
Relative TSR Position
Modifier*
25th percentile and below
0.8
50th percentile
1.0
75th percentile and above
1.2
* The relative TSR will be interpolated between the 25th percentile and below and the 75th percentile. The relative TSR position will be calculated using the following formula where N is the total number of companies in the Index including Cowen and R is Cowen’s ranking compared to the Index: N-R / N-1

- 2 -

Exhibit 10.2
(i)The companies comprising the Index may be changed with respect to any Performance Period as follows:
(1)In the event of a merger, acquisition or business combination transaction of a company included in the Index (an “Index Company”) with or by another Index Company, the surviving entity shall remain a company included in the Index and the company that did not survive will be excluded from the Index.
(2)In the event of a merger of an Index Company with an entity that is not a company included in the Index (a “Non-Index Company”), or the acquisition or business combination transaction by or with an Index Company, or with a Non-Index Company, in each case where the Index Company is the surviving entity and remains publicly traded, the surviving entity shall remain a company included in the Index.
(3)In the event of a merger or acquisition or business combination transaction of an Index Company, by or with a Non-Index Company, a “going private” transaction involving an Index Company or the liquidation of an Index Company, where the Index Company is not the surviving entity or is otherwise no longer publicly traded, the company will be excluded from the Index.
(4)In the event of a bankruptcy of an Index Company, such company shall remain included in the Index and will have an assigned TSR of -100%.
(5)In the event of a stock distribution from an Index Company consisting of the shares of a new publicly-traded company (a “spin-off”), if, following such stock distribution, the company making the distribution remains in the Index, then such company shall remain included in the Index and the stock distribution shall be treated as a dividend from the Index Company based on the closing price of the shares of the spun-off company on its first day of trading. The performance of the shares of the spun-off company shall not thereafter be tracked for purposes of calculating TSR. If, following such stock distribution, the company making the distribution is no longer included in the Index, then such company and the related stock distribution shall not thereafter be tracked for purposes of calculating TSR.
(6)Companies that are added to the Index after the beginning of the applicable Performance Period will not be tracked for purposes of calculating TSR for the Index. Companies that are removed from the Index after the beginning of the applicable Performance Period will nonetheless continue to be considered companies included in the Index for purposes of calculating TSR.

(c)Vesting and Settlement in the Event of a Qualifying Termination. If, prior to the Vesting Date, the Grantee experiences a Qualifying Termination, then provided that the Grantee executes, delivers and does not revoke a Release of Claims, the Attained RSUs shall be determined in accordance with Section 1.2(b) as if the Grantee had continued to be actively
- 3 -

Exhibit 10.2
employed by the Company through the Vesting Date. Such Attained RSUs will be settled on the Settlement Date.
(d)Vesting and Settlement in the Event of a Termination of Employment Due to Death or Disability. Notwithstanding any provision in this Agreement to the contrary, if, prior to the Vesting Date, the Grantee’s employment terminates due to his death or Disability, the Target RSUs shall vest and be settled in full within sixty (60) days after the Grantee’s employment terminates, provided, that the Grantee or his executor or estate, as applicable, executes, delivers and does not revoke a Release of Claims. For purposes of vesting under this Section, the Vesting Date shall be the date Grantee’s employment terminates.
(e)Vesting and Settlement in the Event of a Change in Control. Notwithstanding any provision of this Agreement to the contrary, if, prior to the Vesting Date, the Company experiences a Change in Control, the Performance Metrics set forth in subsection (b) will no longer apply to any unvested Target RSUs. Instead, after a Change in Control, the Target RSUs shall vest on the Vesting Date, without regard to the Performance Metrics, as long as the Grantee remains actively employed by the Company on the Vesting Date, or in the event of a Qualifying Termination, Death or Disability, any unvested Target RSUs shall vest as of the date Grantee’s employment terminates and shall be settled in full within sixty (60) days after the Grantee’s employment terminates; provided, that the Grantee or his executor or estate, as applicable, executes, delivers and does not revoke a Release of Claims.

Section 1.3 -Forfeiture.
Except as provided in Section 1.2, upon the Grantee’s Termination of Employment, any unvested RSUs shall immediately be forfeited to the Company, and neither the Grantee nor any of the Grantee’s successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such then forfeited RSUs.
Section 1.4 -Taxes.
The Company agrees to withhold from the settlement of any portion of the Award, the minimum amount required by the federal, state, and local taxes and withholdings the Company determines are required to be withheld under applicable tax laws with respect to the Award (the “Tax Withholding Amount”), and subject to the conditions and restrictions of this Agreement and the Plan. Payment of the Tax Withholding Amount shall be effected by the Company as follows: (i) with respect to Attained RSUs settled in Stock: (x) withholding the number of shares of Stock with an aggregate Fair Market Value equal to the Tax Withholding Amount, (y) selling shares to cover the Tax Withholding Amount on the open market or (z) any combination of these methods; and (ii) with respect to Attained RSUs settled in undeferred cash, the amount paid to the Grantee will be reduced by the Tax Withholding Amount. “Fair Market Value” of an Attained RSU will be calculated based on the closing price of Cowen Inc. stock on March 10, 2025.
ARTICLE II

MISCELLANEOUS
Section 2.1 - Definitions. Notwithstanding the definitions set forth in this Section, if Grantee is subject to an employment agreement, effective as of the Grant Date, that defines
- 4 -

Exhibit 10.2
“Cause,” “Disability,” “Good Reason,” and “Release of Claims”, or that contains criteria for retirement, such terms shall have the meaning set forth in that employment agreement.
(a)Accumulated Shares” means, for a given trading day, the sum of (i) one (1) share and (ii) the cumulative number of shares of the company’s common stock purchasable with dividends declared on the company’s common stock to that point during the Performance Period, assuming same day reinvestment of such dividends at the closing price on the ex-dividend date.
(b)Adjusted Economic Operating Income” means, with respect to each fiscal year during a Performance Period, the Company’s Economic Operating Income, as adjusted for the following: (i) expenses greater than one million dollars ($1,000,000) associated with strategic initiatives undertaken by the Company shall be amortized over a five (5) year period as opposed to being expensed in the period in which they are incurred, (ii) adjustments resulting from changes in an existing, or application of a new, accounting principle that is not applied on a fully retrospective basis shall be excluded; (iii) a change in the Company’s statutory corporate tax rate to a rate other than those in effect as of the date of this Award Agreement; and (iv) other extraordinary items of income or loss may be excluded at the discretion of the Compensation Committee of the Board of Directors of the Company.
(c)Affiliate” means, with respect to any entity, any other entity that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such entity.
(d)AROCE” means the Company’s average return on common equity on an after-tax basis for the Performance Period which will be determined by (i) taking the sum of the Company’s Adjusted Economic Operating Income less the payment of dividends on the Company’s outstanding preferred stock during each of the fiscal years during the Performance Period divided by the average Common Equity of the Company during each such fiscal year (with the average Common Equity for each fiscal year calculated by adding the Common Equity at the beginning of such fiscal year and the Common Equity at the end of such fiscal year and dividing by two) and (ii) dividing such sum by three.
(e)Cause” means when Cowen or its Affiliate employing Grantee, in its sole discretion in good faith, determines that: (i) the Grantee has breached any material provision of the Plan; Grantee’s employment agreement, offer letter, terms and conditions of employment, or any deferred compensation award agreement; (ii) the Grantee has been indicted for, convicted of, pled guilty or nolo contendere to, or committed any felony, or has been convicted of or pled guilty or nolo contendere to any other crime (whether or not related to the Grantee’s duties for Cowen or any Affiliate) with the exception of minor traffic offenses; (iii) the Grantee has committed an act of fraud, dishonesty, gross negligence, or substantial misconduct in his performance of his duties or responsibilities; (iv) the Grantee has violated or has failed to comply with the internal policies of Cowen or any Affiliate, including its policies against discrimination, harassment or retaliation, or the rules and regulations of any regulatory or self-regulatory organization with jurisdiction over the Employer or any Affiliate, as applicable to Grantee; (v) the Grantee has failed to perform a material duty of Grantee’s position including, by way of example and not of limitation, Grantee’s insubordination, or failure or refusal to follow an instruction reasonably given by Grantee’s superiors in the course of employment; and (vi) the Grantee has committed an act which results in negative publicity to the Company, regardless of whether such act occurred within the performance of his or her duties or responsibilities.

(f)“Closing Average Period” means the 20 trading days immediately preceding the end of the applicable Performance Period.
- 5 -

Exhibit 10.2
(g)“Closing Average Share Value” means the average Share Value over the trading days in the Closing Average Period.
(h)Common Equityis common equity of the Company.
(i)Disability” means that the Grantee (i) is unable to engage in any substantial gainful activity, with or without reasonable accommodation, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months; or (ii) is, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering employees of Cowen or any Affiliate.
(j)Economic Operating Income” means, with respect to a fiscal year, the total of the Company’s “Economic Operating Income” as reported in the Company’s Annual Report, filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended.

(k)Good Standing” means that Grantee remains actively employed and (i) has not been given notice of the termination of Grantee’s employment; (ii) has not given notice of resignation or resigned, other than notice of a Qualifying Retirement; and (iii) is not currently suspended or under investigation for conduct that could, in the Company’s good faith determination, result in a termination for Cause.

(l)“Opening Average Period” means the 20 trading days preceding the applicable Performance Period.
(m)“Opening Average Share Value” means the average Share Value over the trading days in the Opening Average Period.
(n)Qualifying Retirement” means the Grantee’s voluntary resignation that satisfies each of the following conditions: (i) as of the date Grantee provides resignation notice: (A) Grantee is at least fifty-eight (58) years of age, (B) Grantee’s Length of Service is at least five (5) years; and (C) Grantee’s age plus Length of Service equals at least sixty-eight (68) years; (ii) Grantee has provided the Employer with at least six (6) months prior written notice of the Grantee’s intention to voluntarily resign in order to retire (such notice to specify, among other things as may be required by the Employer, the intended Retirement Date); (iii) the Grantee continues to use his or her best efforts in the performance of his or her duties and responsibilities, including hiring Grantee’s replacement if requested by the Company, through Grantee’s Retirement Date; (vi) Grantee remains in Good Standing with the Employer through Grantee’s Retirement Date, and (v) Cause does not exist from the time the resignation notice is provided by the Grantee through the Grantee’s Retirement Date.

(o)Qualifying Termination means the Grantee’s Termination of Employment due to (i) termination by the Company without “Cause”; (ii) termination of the Grantee’s employment due to a resignation for “Good Reason” if applicable to Grantee pursuant to an employment agreement effective as of the Grant Date; or (iii) a Qualifying Retirement.
(p)Release of Claimsmeans a general release of claims in favor of the Company and its Affiliates, in a form requested by the Company, returnable within twenty-one (21) days (or such longer period as required by law for the release to become effective, but in no event longer than fifty (50) days).
- 6 -

Exhibit 10.2
(q)“Share Value” means, with respect to a given trading day, the closing price of the company’s common stock multiplied by the Accumulated Shares for such trading day. Each Index Company’s “common stock” shall mean that series of common stock that is publicly traded on a registered U.S. exchange or, in the case of a non-U.S. company, an equivalent non-U.S. exchange. For purposes of calculating TSR, the value on any given trading day of any Index Company shares traded on a foreign exchange will be converted to U.S. dollars.
(r)Termination of Employment” means a “separation from service,” as defined under Section 409A of the Code.
(s)“TSR” means, for the Company and each Index Company, the company’s total shareholder return, expressed as a percentage, which will be calculated by dividing (i) the Closing Average Share Value by (ii) the Opening Average Share Value and subtracting one from the quotient.
Section 2.2 - Award Subject to Plan Provisions
This Award is made pursuant to the Plan, the terms of which are incorporated herein by reference, and in all respects shall be interpreted in accordance with the Plan. The Award is subject to interpretations, regulations and determinations concerning the Plan established from time to time by the Committee in accordance with the provisions of the Plan including, but not limited to, provisions pertaining to (a) rights and obligations with respect to withholding taxes, (b) the registration, qualification or listing of the shares issued under the Plan, (c) changes in capitalization of the Company and (d) other requirements of applicable law.
Section 2.3 - Governing Law.
This Agreement shall be governed by and construed in accordance with the laws of the State of New York other than its laws regarding conflicts of law (to the extent that the application of the laws of another jurisdiction would be required thereby).
Section 2.4 - Interpretation of Agreement.
Subject to the Plan, the Board shall have the final authority to interpret and construe in good faith this Agreement pursuant to the terms of the Plan and to make any and all determinations under them, and its decision shall be binding and conclusive upon the Grantee and the Grantee’s legal representative in respect of any questions arising under this Agreement.
Section 2.5 - Notices.
Any notice, other than notice by the Company relating to the Tax Withholding Amount pursuant to Section 1.4 above, to be given under the terms of this Agreement shall be in writing and addressed to the Company at 599 Lexington Avenue, New York, New York 10022, Attention: Head of Human Resources, and to the Grantee at the Grantee’s last known home address provided by the Grantee to the Company as of the date of notice or at such other address as either party may hereafter designate in writing to the other by like notice. Notice by the Company relating to the Tax Withholding Amount pursuant to Section 1.4 may be sent to the Grantee via e-mail.
Section 2.6 - Effect of Agreement.
Except as otherwise provided hereunder, this Agreement shall be binding upon and shall inure to the benefit of any successor or successors of the Company. This Agreement shall become effective and binding on the Company when signed by a duly authorized signatory of the
- 7 -

Exhibit 10.2
Company. The Grantee agrees to acknowledge receipt of the Agreement by signing and delivering this Agreement to the Company’s Human Resources Department within fifteen (15) days of the Grant Date.
Section 2.7 - Complete Agreement/Severability.
This Agreement may not be amended or modified in any manner (including by waiver) except by an instrument in writing signed by both parties hereto. The waiver by either party of compliance with any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement or of any subsequent breach of such party of a provision of this Agreement. Any provision of this Agreement held legally invalid or unenforceable shall not affect the enforceability of the remaining provisions.
Section 2.8 - No Right to Continued Employment.
Nothing in this Agreement shall be deemed to confer on the Grantee any right to continued employment with the Company or any Affiliate.
Section 2.9 - Section 409A.
This Agreement is intended to comply with the requirements of Section 409A of the Code, and shall be interpreted accordingly. Any settlement or payment otherwise required to be made hereunder to the Grantee at any date as a result of the Grantee’s Termination of Employment shall be delayed for such period of time to the extent necessary to meet the requirements of Section 409A(a)(2)(B)(i) of the Code (the “Delay Period). In the event that any provision of this Agreement would cause this Agreement to fail to comply with Section 409A of the Code, such provision may be deemed null and void, and the Company and the Grantee agree to amend or restructure this Agreement to the extent necessary and appropriate to avoid adverse tax consequences under Section 409A.
Section 2.10 - Entire Agreement.
Except as otherwise specified herein, this Agreement constitutes the entire agreement of the parties with respect to the subject matter hereof and supersedes in its entirety all prior undertakings, agreements, correspondence, and term sheets of or between the Company and the Grantee with respect to the subject matter hereof.

- 8 -

Exhibit 10.2
IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by a duly authorized officer.

COWEN INC.

Signed:                             
    
            
Acknowledged:

Signed:                             
    [insert name]            Date
- 9 -
Exhibit 10.3
COWEN DIGITAL HOLDINGS
2022 EQUITY UNIT INCENTIVE PLAN
Article I
PURPOSE OF PLAN
The Cowen Digital Holdings 2022 Equity Unit Incentive Plan (this “Plan”) is designed to (a) promote the long-term financial interests and growth of Cowen Digital Holdings LLC (the “Company”) and its Affiliates by attracting and retaining management and other personnel with the training, experience and ability to enable them to make a substantial contribution to the success of the Company; (b) motivate management personnel by means of growth-related incentives to achieve long-range goals; and (c) further the alignment of interests of Participants with those of the members of the Company through opportunities for equity and cash incentives in the Company.
Article II
DEFINITIONS
Terms that are capitalized but not defined herein shall have the meanings prescribed by the ManagementCo LLC Agreement (as defined below); and any term that is capitalized and not defined herein or in the ManagementCo LLC Agreement shall have the meaning prescribed by the Company LLC Agreement (as defined below). As used in this Plan, the following words shall have the following meanings:
Award” means Upstairs Class B Units, Phantom Units, or a Cash Award granted to a Participant pursuant to this Plan.
Award Agreement” means a written document, in a form approved by the Committee that is executed by the Company or MangementCo and a Participant and sets forth the terms, conditions, and limitations applicable to an Award.
Board” means the Board of Managers of the Company.
Cash Award” means an award granted under the Plan (other than Upstairs Class B Units or Phantom Units) that provides an opportunity to receive one or more cash payments subject to satisfying performance objectives and vesting and other conditions as determined by the Committee and set forth in the applicable Award Agreement.
Cause” means, with respect to a Participant and in the absence of an Award Agreement or an individual employment, consulting, or similar written agreement between the Participant and the Company or any of its Affiliates in effect as of the grant date for an applicable Award Agreement (a “Participant Agreement”) otherwise defining Cause, (a) the Participant’s breach of any material provision of the Plan, an Award Agreement, or any other agreement involving the Company or an Affiliate; (b) the Participant’s indictment for, conviction of, plea of guilty or nolo contendere to, or commission of a felony, or conviction of, or plea of guilty or nolo contendere to any other crime (whether or not related to the Participant’s duties for the Service Recipient or any Affiliate); (c) the Participant’s commission of any act of fraud, dishonesty, gross negligence, or substantial misconduct in his or her performance of his or her duties or responsibilities; (d) the Participant’s violation of or failure to comply with the internal policies of the Service Recipient or any Affiliate, including its policies against discrimination, harassment or retaliation, or the rules and regulations of any regulatory or self-regulatory organization with jurisdiction over the Service Recipient or any Affiliate; (e) the Participant’s failure to perform a material duty of the Participant’s position including the Participant’s insubordination, or failure or refusal to follow any instruction reasonably given by the Participant’s superiors in the course of employment; or



Exhibit 10.3
(f) the Participant’s commission of any act which results in negative publicity to the Company, regardless of whether such act occurred within the performance of his or her duties or responsibilities. If, subsequent to a Participant’s Termination for any reason other than by the Service Recipient for Cause, it is discovered that the Participant’s employment or service could have been terminated for Cause, such Participant’s employment or service shall, at the discretion of the Committee, be deemed to have been terminated by the Service Recipient for Cause for all purposes under the Plan, and the Participant shall be required to repay to the Company all amounts received by him or her in respect of any Award to the extent exceeding the amount the Participant would have been entitled to receive had had such Termination been by the Service Recipient for Cause. If an Award Agreement or Participant Agreement defines Cause, “Cause” shall have the meaning provided in such agreement.

Committee” means the committee described in Article III. If such a committee has not been appointed by the Board, the Board shall be deemed to be the Committee for purposes of this Plan.
Company” means Cowen Digital Holdings LLC.
Company LLC Agreement” means the limited liability company agreement of the Company as in effect and amended from time to time.
Fair Market Value” means (a) with respect to the Company or ManagementCo, the fair market value of the Company or ManagementCo (as applicable), as determined by the Board using the reasonable application of a reasonable valuation method, and (b) with respect to any Upstairs Class B Unit, the value per unit, as determined by the Board and subject to the terms of the applicable Award Agreement. Except as otherwise set forth in any Award Agreement, Fair Market Value shall be determined in good faith by the Board and such determination shall be final and binding.
ManagementCo” means CDIG Management Co. LLC, a Delaware limited liability company.
ManagementCo LLC Agreement” means the limited liability company agreement of ManagementCo as in effect and amended from time to time.
Participant” means an employee, director, member, consultant, or other service provider of the Company or any of its Affiliates who is selected by the Board or the Committee to participate in this Plan.
Phantom Unit” means a right to receive payments in an amount that is determined by reference to the value of a Class B Unit or an Upstairs Class B Units. Each Phantom Unit shall be subject to vesting, payment, and other terms and conditions that are determined by the Committee and set forth in the applicable Award Agreement. Without limiting the generality of the foregoing, the payment terms for each Phantom Unit shall be structured to qualify for an exemption from Section 409A of the Code (e.g., the “short-term deferral” rule) or to comply with the requirements to avoid tax under Section 409A of the Code.
Service Recipient” means, with respect to a Participant, the Company or Affiliate of the Company that employs the Participant or, for a Participant who is not an employee, is the principal recipient of the Participant’s services. Following a Termination, the Service Recipient means the Company or Affiliate that most recently employed the Participant or was most recently the principal recipient of the Participant’s services.

2


Exhibit 10.3
Termination” means the termination of a Participant’s employment or service, as applicable, with the Service Recipient and its Affiliates. Unless otherwise determined by the Committee, if the Service Recipient ceases to be an Affiliate of the Company (by reason of sale, divestiture, spin-off, or other similar transaction), and the Participant’s employment or service is not transferred to an Affiliate of the Company, such Participant shall be deemed to have had a Termination hereunder as of the date of the consummation of such transaction. To the extent used in connection with the time of payment or settlement of any Award that is subject to Section 409A of the Code, Termination shall mean the Participant’s “separation from service” within the meaning of Section 409A.

Upstairs Class B Unit” means an Upstairs Class B Unit of ManagementCo as defined in the ManagementCo LLC Agreement.

Article III
ADMINISTRATION
3.1Generally. This Plan shall be administered by the Board or a committee consisting of one or more members of the Board. The members of the Committee shall be selected by the Board. During any period of time in which this Plan is administered by the Board, all references in this Plan or any Award Agreement to the Committee shall be deemed to refer to the Board.
3.2Power of the Committee. Except as otherwise provided in an Award Agreement, the Committee shall have full power and authority to administer and interpret this Plan, Awards granted under this Plan, and each Award Agreement, including the powers to (a) exercise all of the powers granted to it under this Plan; (b) construe, interpret, and implement this Plan and any Award Agreement; (c) prescribe, amend, and rescind rules and regulations relating to this Plan, including rules governing its own operations; (d) make all determinations necessary or advisable in administering this Plan, Awards, and any Award Agreements; (e) resolve any ambiguity, correct any defect, exercise discretion, supply any omission, and reconcile any inconsistency in this Plan, each Award, and each Award Agreement; (f) amend this Plan, each Award, and each Award Agreement (to the extent permitted by Article IX or the Award Agreement, as applicable); (g) determine the Service Providers who will be Participants; (h) grant Awards under this Plan and determine the terms and conditions of such Awards, consistent with the this Plan; (i) delegate such powers and authority to such Persons as it deems appropriate, provided that any such delegation is consistent with applicable law and any guidelines as may be established by the Board from time to time; and (j) waive any forfeiture, vesting, or other conditions under any Awards. The reasonable, good faith determination of the Committee on all matters relating to this Plan, each Award Agreement, and each Award shall be final, binding, and conclusive upon all Persons.
3.3Professional Assistance; Committee Actions. The Committee may employ counsel, consultants, accountants, appraisers, brokers, and other Persons at the expense of the Company. The Board, Committee, Company, and the officers of the Company shall be entitled to rely upon the advice, opinions, and valuations, as applicable, of any such Persons. Except as otherwise provided in an Award Agreement, all actions taken and all interpretations and determinations made by the Committee in good faith shall be final and binding upon all Participants, the Company, and all other interested Persons.
3


Exhibit 10.3
Article IV
AWARDS
4.1Grant of Awards. The Committee has sole discretion to grant Awards under the Plan and to determine the amounts, terms, conditions, and limitations of such Awards, consistent with the terms of this Plan. The amount, terms, conditions, and limitations of each Award under this Plan shall be set forth in an Award Agreement. Without limiting the generality of the foregoing, such terms and conditions may include restrictive covenants and a requirement that the Participant execute a release of claims as a condition of vesting, settlement, and/or payment of all or any portion of the Award.
4.2LLC Agreement. As a condition to the grant of Upstairs Class B Units, the applicable Participant will be required to become a party to the ManagementCo LLC Agreement (and, if applicable, his or her spouse shall execute a spousal joinder agreement in the form provided by the Company or ManagementCo), and any other grant of equity shall be conditioned on the Participant becoming a party to the applicable entity’s governing documents. In addition, each Award is conditioned on the Participant executing such documents and instruments as are reasonably and customarily required by the Company to evidence compliance with applicable federal and state securities and “blue sky” laws, or as otherwise reasonably requested by the Company. All Upstairs Class B Units acquired under this Plan will be held subject to, and in compliance with, the terms and conditions of the ManagementCo LLC Agreement.
Article V
UPSTAIRS CLASS B UNITS SUBJECT TO THIS PLAN; LIMITATIONS AND CONDITIONS
5.1Units Available for Awards. Subject to Article VII, the ManagementCo LLC Agreement allows the issuance of Upstairs Class B Units under this Plan, subject to not exceeding a number of units permitted by the ManagementCo LLC Agreement (“Plan Unit Reserve”). Phantom Units and Cash-Based Awards shall not count toward the Plan Unit Reserve; provided that if a Phantom Unit or Cash-Based Award is paid or settled in the form of Upstairs Class B Units, such Upstairs Class B Units shall count toward the Plan Unit Reserve. Unless restricted by applicable law, to the extent that an Award is forfeited, expired, repurchased, terminated, and/or canceled, the Upstairs Class B Units underlying such Award shall immediately become available for new Awards.
5.2Terms of Awards. At the time an Award is made or amended or the terms or conditions of an Award are changed, the Committee may provide for limitations or conditions (including vesting terms and conditions) on such Award in accordance with this Plan.
5.3Transfer Restrictions. Other than as specifically provided in the ManagementCo LLC Agreement or the applicable Award Agreement, no Award or benefit under this Plan shall be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, or charge, and any attempt to do so shall be void. Unless otherwise determined by the Committee and permitted by the ManagementCo LLC Agreement or applicable Award Agreement, no Award shall be transferable or assignable by the Participant other than by will or by the laws of descent and distribution.
5.4Rights as Members. Other than as specifically provided in the ManagementCo LLC Agreement, the Company LLC Agreement, or the Award Agreement, Participants shall not be, and shall not have any of the rights or privileges of, members of ManagementCo or the Company in respect of any Awards settled, convertible or exchangeable into Upstairs Class B Units, unless and until book entry representing such Upstairs Class B Units has been made and
4


Exhibit 10.3
the Participant has been admitted as a member pursuant to the ManagementCo LLC Agreement or Company LLC Agreement, as applicable.
5.5Coordination with Other Benefit Plans. Absent express provisions to the contrary in an applicable retirement, severance, or other benefit plan or arrangement, no Award under this Plan, and no amount payable in respect of any Award, (a) shall be deemed compensation for purposes of computing benefits or contributions under any retirement, severance, or other benefit plan of the Company or its Affiliates or (b) shall affect any benefits under any other benefit plan of any kind now or subsequently in effect under which the availability or amount of benefits is related to level of compensation.
Article VI
TRANSFERS AND LEAVES OF ABSENCE
For purposes of this Plan, unless the Committee determines otherwise: (1) a transfer of a Participant’s service to another Affiliate of the Company, without an intervening period of separation, shall not be deemed a Termination, and (2) a Participant who is on an approved leave of absence shall be deemed to have remained in the service of the Service Recipient during such leave of absence.
Article VII
ADJUSTMENTS FOR CHANGES IN CAPITALIZATION AND REORGANIZATION EVENTS
7.1Unit Change. In the event of an equity dividend, equity split, reverse equity split, separation, spinoff, reorganization, extraordinary dividend of cash or other property, equity combination, or recapitalization, reclassification, reorganization, merger, consolidation, conversion, split-up, spin-off, combination or exchange, or similar event affecting the capital structure of ManagementCo or the Company (each, a “Unit Change”), the Committee may, in all cases subject to the ManagementCo LLC Agreement and Company LLC Agreement, as applicable, adjust any or all of (a) the number and kind of Upstairs Class B Units subject to this Plan, as set forth in Section 5.1, and available for or covered by Awards; (b) the performance goals (if any) affecting the vesting or payment of such Awards; (c) the Repurchase Price per Repurchase Unit, to the extent not tied to Fair Market Value of the Repurchase Unit (each as defined in Article VIII hereof); and (d) any other provisions of Awards affected by such Unit Change as it deems, in good faith, to be required, equitable, or otherwise appropriate to effect the intent of the Awards.
7.2Reorganization Event. In the event of a merger, consolidation, acquisition of property or shares, Unit rights offering, liquidation, disaffiliation (including a Sale of the Company), spinoff, exchange, or similar transaction or event (each, a “Reorganization Event”), the Committee shall in its discretion and in such manner and on such terms and conditions as it, in good faith, deems appropriate, and in all cases subject to the ManagementCo LLC Agreement and Company LLC Agreement, as applicable, make such substitutions or adjustments as it deems appropriate and equitable to the outstanding Awards. Without limiting the generality of the foregoing, in the event of a Reorganization Event the Committee may take any one or more of the following actions:
(a)the Committee may provide, either by the terms of the agreement governing such transaction or by action taken prior to the occurrence of such transaction or event, for either (i) the cancellation of all or any portion of the outstanding Awards for an amount of cash or other property or a combination thereof having an aggregate value equal to the amount, if any, that could have been realized and/or attained in respect of such Awards (or portions thereof) as a result of a Reorganization Event had such Awards (or portion thereof) been
5


Exhibit 10.3
fully vested, as determined by the Committee in its sole discretion; provided, that, if the Committee determines in good faith that a Participant would not realize and/or attain any amounts in respect of such Awards (or portions thereof) as a result of the Reorganization Event had such Awards (or portion thereof) been fully vested at the time of the Reorganization Event, then the Committee may, in its sole discretion, cancel such Award for no consideration effective as of the effective date of the Reorganization Event, or (ii) the replacement of an Award, whether vested or unvested, with other rights or property, including cash or a new equity award such as an option, stock appreciation right, or full-value equity award, selected by the Committee in its sole discretion, which replacement award may be subject to vesting or the lapsing of restrictions, as applicable, on terms not substantially less favorable in the aggregate to the affected Participant than the terms of the Award for which such replacement award is substituted;
(b)the Committee may provide, either by the terms of such Award or by action taken prior to the occurrence of such transaction or event, that upon such event, such Award be assumed by the successor or survivor entity, or a parent or subsidiary thereof, or shall be substituted for by similar awards covering the securities of the successor or survivor entity, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of securities subject to such Award, any Profits Interest Hurdle and/or any performance goals governing the vesting and/or payment of such Awards; and
(c)the Committee may make adjustments in the number and type of Upstairs Class B Units and Phantom Units subject to outstanding Awards, or in the terms and conditions of any Awards (including the Profits Interest Hurdle, repurchase price, vesting, payment schedule, and/or the performance goals, if any, governing the vesting or value of such Awards), and the criteria included in, outstanding Awards and the related agreements and Awards which may be granted in the future.
7.3Fractional Units. Any adjustment provided under this Article VII may, in the Committee’s discretion, provide for the cash payment of any fractional Upstairs Class B Unit and/or Phantom Unit that might otherwise become subject to an Award.
7.4Other Distributions. The Committee may in its discretion also make adjustments of the type described in this Article VII to take into account distributions to Members or any other event if the Committee determines that adjustments are appropriate to avoid distortions in the operation of this Plan and to preserve the value of Awards made hereunder.
7.5Other Units. References in this Plan to Upstairs Class B Units shall be construed to include any securities resulting from any adjustment described in this Article VII.
Article VIII
COMPANY REPURCHASE OPTION
8.1General. Unless otherwise expressly provided in a Participant’s Award Agreement and without limitation of any repurchase or other transfer terms set forth in the ManagementCo LLC Agreement and Company LLC Agreement, as applicable, the provisions of this Article VIII shall apply to all Awards granted under the Plan.
8.2Right of Repurchase. If a Participant (i) experiences a Termination that results in cessation of vesting (as determined by the applicable Award Agreement) or (ii) breaches any non-competition, non-solicitation, no-hire, non-disparagement, intellectual property, confidential or proprietary information, or similar restrictive covenant or obligation in favor of the Company or any of its Affiliates (a “Triggering Event”), then in each case the Participant will no longer be eligible for further vesting of any Award, and the Company shall have the right to cause the ManagementCo to acquire from the Participant (or the Participant’s estate), in accordance with
6


Exhibit 10.3
this Section, any or all of the Units previously issued to the Participant under any Award under the Plan, to the extent not forfeited (the “Repurchase Right”). For each Upstairs Class B Unit that is repurchased by the ManagementCo, a Class B Unit of the Company shall be sold to the Company for the same price.
8.3Exercise of Repurchase Right. The Company may cause the ManagementCo to exercise the Repurchase Right by delivering a written notice to the Participant indicating the number of Units to be repurchased (the “Repurchase Units”) and the aggregate purchase price therefor (the “Repurchase Notice”). The Repurchase Right may be exercised for a period of twelve (12) months following the occurrence of any Triggering Event (as applicable, the “Repurchase Right Exercise Period”).
8.4Repurchase Price. The amount payable by the ManagementCo for each Repurchase Unit to be repurchased shall be as follows:
(a)In the event of Termination for Cause (including a determination that Cause existed before the Termination) or breach by the Participant, before the first anniversary of the Termination, of a restrictive covenant under the Award Agreement, the amount payable shall be $0.01 per Repurchase Unit (subject to adjustment in the event of a Unit Change or Reorganization Event).
(b)In the absence of an event described in subsection (a), above, the amount payable shall be the Fair Market Value of the Repurchase Units to be repurchased, unless otherwise expressly provided in the applicable Award Agreement.
The aggregate amounts payable under this Section 8.4 shall be the “Repurchase Price”.
8.5Closing of Repurchase. Subject to Section 8.7 hereof, the closing of the Repurchase Right shall take place at the offices of the Company, or at such other location (including a virtual location) designated by the Company, within thirty (30) days after the delivery of the Repurchase Notice. At the closing, the Participant shall execute and deliver to the Company instruments of transfer, in form and substance satisfactory to the Company (which may be electronic), sufficient to transfer the purchased Units to the ManagementCo free and clear of all liens, restrictions, security interests and encumbrances. In the event of any continued failure and/or refusal by a Participant to execute and deliver any instruments of transfer described above in this Section 8.5 within one hundred eighty (180) days following delivery of the Repurchase Notice, the Participant will be deemed to be in material breach of the Plan and the Award Agreement and deemed to waive and release all claims and rights in respect of the Repurchase Units or the Repurchase Price, and the Repurchase Units shall be forfeited, terminated, and canceled for no consideration. Thereafter, the underlying Upstairs Class B Units shall immediately become available for new Awards under the Plan in accordance with Section 5.1 of the Plan.
8.6Payment of Repurchase Price. Except as provided by the Committee in an Award Agreement, if the Repurchase Right is exercised, the Repurchase Price shall be paid in cash at the time of repurchase or by issuance of a promissory note equal to the Repurchase Price (less any portion of such Repurchase Price paid in cash); provided that such promissory note shall have a maturity date no more than three (3) years from the closing date of such repurchase, shall bear simple interest at a fixed rate equal to the applicable federal rate of interest then in effect (compounded annually), and shall be payable as to interest and principal on the maturity date.
8.7Delay of Repurchase. Notwithstanding anything contained in this Article VIII to the contrary, in the event that any repurchase described herein would result in a default under any applicable financing documents of any member of the Company or any of its Affiliates or would
7


Exhibit 10.3
otherwise be prohibited by applicable law or would result in adverse accounting results for the Company or its Affiliates (as applicable, a “Prohibition Event”), commencement of the applicable Repurchase Right Exercise Period shall be delayed until the Prohibition Event ceases to exist. Without limiting the foregoing, the Company shall be permitted to assign the Repurchase Right.
8.8    Participant Representations; Release of Claims. In connection with any repurchase of Repurchase Units pursuant to this Article VIII, the Company and the ManagementCo will be entitled to receive customary representations and warranties from the Participant regarding the repurchase of such Units as may be reasonably requested by the Company or the ManagementCo including the representation that the Participant has good and marketable title to such Units to be transferred and is free and clear of all liens, claims and other encumbrances. Without limiting the generality of the foregoing, subject to the terms of the applicable Award Agreement, the Committee may condition the Participant’s right to receive payment of the Repurchase Price on the Participant timely executing, delivering, and not revoking a general release of claims in favor of the Company and its Affiliates, in such form as may be requested by the Company. In the event of any failure and/or refusal by a Participant to timely execute and deliver any release described above in this Section 8.8, the Participant will be deemed to be in material breach of the Plan and Award Agreement and to waive and release all claims and rights in respect of the Repurchase Units and the Repurchase Price, and the Repurchase Units shall be forfeited, terminated, and canceled for no consideration. Thereafter, the underlying Upstairs Class B Units shall immediately become available for new Awards under the Plan in accordance with Section 5.1 of the Plan.
Article IX
AMENDMENT AND TERMINATION
9.1Awards. The Committee may amend outstanding Awards at any time and for any reason; provided that no such action shall modify an Award in a manner adverse to the applicable Participant without the Participant’s consent, except to the extent such modification is provided for or contemplated in the terms of the Award or this Plan (including, for the avoidance of doubt, pursuant to Article VII) or for the purpose of complying with applicable law or ensuring that the Upstairs Class B Units constitute “profits interests” within the meaning of Revenue Procedure 93-27, 1993-2 C.B. 343 and Revenue Procedure 2001-43, 2001-2 C.B. 191.
9.2Plan. The Board may amend, suspend, or terminate this Plan at any time and for any reason; provided that no such action shall affect an outstanding Award in a manner adverse to the applicable Participant without the Participant’s consent, except to the extent such action is provided for or contemplated in the terms of the Award, this Plan (including, for the avoidance of doubt, pursuant to Article VII), the Management Co LLC Agreement or Company LLC Agreement, as applicable, or for the purpose of complying with applicable law.
Article X
GOVERNING LAW
10.1Generally. This Plan, the legal relations between the parties, and the adjudication and the enforcement thereof shall be governed by and interpreted and construed in accordance with the laws of the State of Delaware applicable to agreements made and to be performed entirely within the State of Delaware, without regard to the conflict of law provisions thereof that could otherwise result in the application of the laws of any other jurisdiction.
10.2Non-U.S. Participants. If an Award is granted to a Person who is subject to the laws of jurisdictions other than those of the United States, such Award may have special terms
8


Exhibit 10.3
and conditions for the purpose of complying with non-U.S. laws or otherwise as deemed to be necessary or desirable by the Committee.
Article XI
TAXES
11.1Section 409A of the Code. It is intended that all Awards under this Plan and any Award Agreement be exempt from, or comply with the requirements to avoid tax under, Section 409A of the Code. This Plan and each Award Agreement shall be interpreted accordingly. In the case of an Award that constitutes a “nonqualified deferred compensation plan” subject to Section 409A of the Code, with respect to any provision providing for payment in connection with a Participant’s Termination, no termination of employment shall be deemed a Termination for purposes of such Award unless it is a “separation from service” under Section 409A of the Code. To the extent applicable, as determined in the sole discretion of the Committee with and upon advice of counsel, each amount or benefit payable pursuant to this Plan and any Award Agreement shall be deemed a separate payment for purposes of Section 409A of the Code, and in no event may a Participant, directly or indirectly, designate the calendar year of any payment to be made under this Plan or any Award Agreement. If a Participant is a “specified employee” (as determined under the Company’s administrative procedure for such determinations, in accordance with Section 409A of the Code) at the time of the Participant’s termination of employment, any payments under this Plan or any Award Agreement that are deemed to be non-qualified deferred compensation subject to Section 409A of the Code and that are payable (whether in cash, Units, or other property) in connection with the Participant’s separation from service shall not be paid or begin payment until the earlier of the Participant’s death and the first day following the six-month anniversary of the Participant’s separation from service.
11.2Tax Withholding. The ManagementCo, Company or any Affiliate or designee thereof shall be entitled to withhold any amounts that it determines to be required under federal, state, local and/or foreign tax rules in respect of any Award, and may take such action as it deems appropriate to ensure compliance with such withholding requirements. Without limiting the generality of the foregoing withholding may be collected by (a) requiring the Participant to pay or provide for payment of the applicable withholding amount, (b) deducting the applicable withholding amount from any amount otherwise payable to the Participant in cash (whether related to the Award or otherwise), or (c) if approved by the Committee, withholding Upstairs Class B Units having a Fair Market Value of the withholding amount. Regardless of the amount withheld or reported in respect of any Award or payment, each Participant is solely responsible for all taxes in respect of his or her Award(s) (including taxes on imputed income) except to the extent applicable law directly imposes a tax on the employer (i.e., in respect of an employee, the employer’s share of employment taxes). If any amounts are withheld and paid over to the appropriate taxing authority pursuant to this Section 11.2, such amounts shall be treated as having been paid to the Participant.
Article XII
MISCELLANEOUS
12.1ERISA. This Plan is not subject to the Employee Retirement Income Security Act of 1974, as amended.
12.2No Right of Employment or Service. Nothing contained herein, in any Award Agreement, or in any Award shall confer on any employee, director, or consultant any right to be continued in the employ or service of the Company or any Affiliates or affect any employee’s status as an at-will employee; nor shall anything contained herein, in any Award Agreement or an Award affect any rights which the Company or its Affiliates may have to change a person’s
9


Exhibit 10.3
compensation or other benefits or terminate such person’s employment or association with the Company or its Affiliates for any reason (with or without Cause, with or without compensation) at any time.
12.3Unfunded Plan. Unless the Committee determines otherwise, no benefit or promise under this Plan shall be secured by any specific assets of the Company or any of its Affiliates, nor shall any assets of the Company or any of its Affiliates be designated as attributable or allocated to the satisfaction of the Company’s obligations under this Plan.
12.4Non-Uniform Determinations. The Committee’s determinations under this Plan need not be uniform and may be made by it selectively among Persons who receive or are eligible to receive Awards (whether or not such Persons are similarly situated). Without limiting the generality of the foregoing, the Committee shall be entitled, among other things, to make non-uniform and selective determinations, and to enter into non-uniform and selective Award Agreements, as to the Persons to receive Awards under this Plan and the terms and provisions of Awards under this Plan.
12.5Electronic Delivery. Any reference herein to a “written” agreement or document or “writing” will include any agreement or document delivered electronically or posted on the Company’s intranet (or other shared electronic medium controlled or authorized by the Company to which the Participant has access) to the extent permitted by applicable law.
12.6Clawback/Recoupment Policy. Notwithstanding anything contained herein to the contrary, all Awards granted under this Plan shall be and remain subject to the Company’s and Affiliates’ incentive compensation clawback and recoupment policies as may be adopted, in effect, or amended from time to time. No such policy adoption or amendment shall in any event require the prior consent of any Participant. If an Award is subject to more than one such policy, the policy with the most restrictive clawback or recoupment provisions shall govern such Award, subject to applicable law.
12.7Section Headings; Construction. The section headings contained herein are for the purpose of convenience only and are not intended to define or limit the contents of the sections. All words used in this Plan shall be construed to be of such gender or number, as the circumstances require. Unless otherwise expressly provided, the words “include” and “including” shall not limit the preceding words or terms, and the word “or” is not exclusive.
12.8Severability. In the event any provision of this Plan or any Award Agreement shall be held by a court of competent jurisdiction to be illegal, invalid or unenforceable for any reason, the illegality, invalidity or unenforceability shall not affect the remaining provisions of this Plan and such Award Agreement and such illegal, invalid or unenforceable provision shall be deemed modified as if such provision had not been included.
12.9Survival of Terms; Conflicts. The provisions of this Plan shall survive the termination of this Plan to the extent consistent with, or necessary to carry out, the purposes thereof. Each Award Agreement remains subject to the terms of this Plan; provided, however, in the event of any conflict between specific provisions of this Plan and an Award Agreement, the Award Agreement shall control.
*    *    *    *    *

10

Exhibit 10.4
Form of Award Agreement
THE INTERESTS IN CDIG MANAGEMENT CO. LLC AWARDED PURSUANT TO THIS AGREEMENT HAVE NOT BEEN REGISTERED WITH, OR APPROVED OR DISAPPROVED BY, ANY FEDERAL OR STATE SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY. SUCH INTERESTS ARE SUBJECT TO RESTRICTIONS ON TRANSFER AND MAY NOT BE TRANSFERRED EXCEPT AS PERMITTED UNDER FEDERAL AND STATE SECURITIES LAWS, AND THE MANAGEMENTCO LLC AGREEMENT.
COWEN DIGITAL HOLDINGS
2022 EQUITY UNIT INCENTIVE PLAN
UPSTAIRS CLASS B UNIT AWARD AGREEMENT
This UPSTAIRS CLASS B UNIT AWARD AGREEMENT (this “Agreement”), by and between CDIG Management Co. LLC (the “Company”) and the individual named on the signature page hereto (“Participant”) is made as of the date set forth on such signature page hereto (the “Grant Date”) under the Cowen Digital Holdings 2022 Equity Unit Incentive Plan (the “Plan”).
WHEREAS, the Committee has determined that it would be in the best interest of the Company to grant Participant a number of Upstairs Class B Units on the terms and subject to the conditions set forth in this Agreement, the Plan, and the ManagementCo LLC Agreement.
NOW, THEREFORE, to implement the foregoing and in consideration of the mutual representations, warranties, covenants and agreements contained herein, the parties hereto agree as follows:
1.Definitions. Capitalized terms not defined in this Agreement shall have the meanings ascribed to such terms in the Plan or in the Limited Liability Company Agreement of the Company, dated as of ___________, as amended or supplemented from time to time (the “ManagementCo LLC Agreement”).
1.1Board” means the Board of Managers of Holdings.
1.2Competitive Activity” means, directly or indirectly, on behalf of a Competitor engaging in any activity which is the same as or reasonably similar to: (a) the positions Participant has held or the activities Participant has performed in relation to the business of Cowen Digital Holdings LLC, including its direct and indirect investments (collectively the “CDIG Business”); (b) the activities Participant gained knowledge of by virtue of his or her work for the CDIG Business; or (c) any activity engaged in by any department, division, or other group Participant has managed on behalf of, or in connection with, the CDIG Business. Competitive Activity includes being involved in any manner as an employee, stockholder, owner, officer, director, partner, agent, consultant, independent contractor, registered representative or in any other corporate or representative capacity. Competitive activity applies within the United States; provided, however, that if Participant’s activities or position are located in, involve contact with or Participant conducts business with countries other than the United States, it includes such countries, as permitted by applicable law.
1.3Competitor” includes any limited liability company, corporation, partnership, entity or person which is currently competitive with, or is preparing to be competitive with, the CDIG Business.



Exhibit 10.4
1.4Good Standing” means Participant remains actively employed and (i) has not been given notice of the termination of Participant’s employment, (ii) has not given notice or resignation or resigned, and (iii) is not currently suspended or under investigation for conduct that could, in the Company’s good faith determination, result in a termination for Cause; provided that if Participant is party to an employment agreement in effect as of the Grant Date that includes a definition of “Good Standing,” the definitions set forth in such other agreement shall control for purposes of this Agreement.
1.5Group Company” means any of the Company and each of its Affiliates.
1.6Qualifying Retirement” means Participant’s voluntary resignation that satisfies each of the following conditions: (i) as of the date Participant provides resignation notice: (A) Participant is at least fifty-eight (58) years of age, (B) Participant has at least five (5) years of service; and (C) Participant’s age plus length of service equals at least sixty-eight (68) years; (ii) Participant has provided the Service Recipient with at least six (6) months’ prior written notice of Participant’s intention to voluntarily resign in order to retire (such notice to specify, among other things as may be required by the Service Recipient, the intended Retirement Date); (iii) Participant continues to use his or her best efforts in the performance of his or her duties and responsibilities, including hiring Participant’s replacement if requested by the Service Recipient, through Participant’s Retirement Date; (vi) Participant remains in Good Standing with the Service Recipient through Participant’s Retirement Date, and (v) Cause does not exist from the time the resignation notice is provided by Participant through Participant’s Retirement Date.
1.7Retirement Date” means the date of Participant’s Termination due to a Qualifying Retirement.
2.Issuance of Award.
2.1Grant. Participant is hereby granted, effective as of the Grant Date, the number of Upstairs Class B Units set forth on the signature page hereto (the “Award”). Each Upstairs Class B Unit granted hereunder shall have the Profits Interest Hurdle set forth on the signature page hereto; provided that the Profits Interest Hurdle is subject to adjustment in accordance with the Plan and the ManagementCo LLC Agreement. The Upstairs Class B Units granted hereunder shall be treated as a separate “Profits Interest” in the Company within the meaning of Revenue Procedure 93-27, 1993-2 C.B. 343 and Revenue Procedure 2001-43, 2001-2 C.B. 191, issued by the Internal Revenue Service and the Company shall takes such actions as are necessary or advisable to effect such intent.
2.2Admission as a Member. If Participant is not a Member of the Company as of the Grant Date, concurrent with the execution of this Agreement and as a condition to the grant of the Award, Participant shall be admitted as a Member of the Company by (a) executing and delivering to the Company the Joinder in the form attached hereto as Exhibit A and (b) if applicable, delivering a Spousal Consent in the form attached hereto as Exhibit B executed by Participant’s spouse. Thereupon, Participant shall have all of the rights of a Member of the Company holding Upstairs Class B Units, subject to the terms and conditions of the ManagementCo LLC Agreement, the Plan and this Agreement. The Company and Participant acknowledge and agree that the Upstairs Class B Units are hereby issued to Participant for the performance of services to or for the benefit of the Company and its Affiliates. The Award is made pursuant to all of the provisions of the Plan and the ManagementCo LLC Agreement, which are incorporated herein by this reference, and is intended, and shall be interpreted in a manner, to comply therewith. Participant acknowledges that the Upstairs Class B Units granted hereunder serve in satisfaction of any commitments or expectations in respect of any such interests.
-2-

Exhibit 10.4
2.3Section 83(b) Election. Exhibit C hereto sets forth a form of election under Section 83(b) of the U.S. Internal Revenue Code of 1986, as amended (the “Code”) and the Treasury regulations thereunder (the “Section 83(b) Election”), and within 20 days after the Grant Date, Participant shall provide the Company with a copy of a completed Section 83(b) Election. Participant shall timely (within 30 days of the Grant Date) file such election with the Internal Revenue Service and shall thereafter notify the Company that Participant has made such timely filing. The Company makes no representations to Participant in respect of the tax consequences of the Section 83(b) Election (including in respect of the adequacy of the form of Section 83(b) Election) and Participant should consult his or her tax advisor regarding the consequences of the Section 83(b) Election, as well as the receipt, vesting, holding and sale of Upstairs Class B Units.
2.4Closing Conditions. Notwithstanding anything in this Agreement to the contrary, Participant shall have no rights under this Award (and this Award Agreement shall be null and void) unless: (a) Participant is an employee in Good Standing of the Company or one of its Affiliates on the Grant Date; (b) the representations under Section 4 of this Agreement are true and correct as of the Grant Date; (c) Participant is not in material breach of any agreement, obligation or covenant under this Agreement; and (d) Participant has executed and delivered to the Company, no later than 30 days after the Grant Date, this Agreement together with such other documents as may be required under the ManagementCo LLC Agreement, the Plan, and/or this Agreement, or as otherwise may reasonably be required or requested by the Company.
3.Vesting and Forfeiture.
3.1Units.
(a)Ten percent (10%) of the Upstairs Class B Units granted hereunder shall become vested on each of the first five (5) annual anniversaries of the Vesting Start Date set forth on the signature page hereto, in all cases, subject to Participant’s continued employment in Good Standing with the Company or an Affiliate through the applicable vesting date.
(b)Fifty percent (50%) of the Upstairs Class B Units granted hereunder shall become vested upon the first to occur of (i) a Sale of Holdings, (ii) an IPO, or (iii) a distribution to the holders of publicly traded stock of Cowen Inc. (COWN) of a majority of the voting common units of the Company, in each case subject to Participant’s continued employment in Good Standing with the Company or an Affiliate through the date of such event.
3.2Acceleration Upon Certain Events. All unvested Upstairs Class B Units shall immediately vest in full upon an event described in Section 3.1(b), above, subject to Participant’s continued employment in Good Standing with the Company or an Affiliate through the date of such event.
3.3Termination; Forfeiture; Company Repurchase Option.
(a)All unvested Upstairs Class B Units that do not become vested before Participant’s Termination shall be forfeited immediately upon such Termination, without consideration therefor; provided that if Participant has experienced a Qualified Retirement, the unvested Upstairs Class B Units shall continue to vest as of Participant’s Retirement Date, subject to Participant’s compliance with the covenants Section 5 hereof (Restrictive Covenants) for 12 months after Participant’s Qualified Retirement and (ii) Participant executing no later than 52 days after receipt, and not revoking, a release of claims in favor of the Company and its Affiliates, in a form that is acceptable to the Company.
-3-

Exhibit 10.4
(b)Following Termination, Participant shall retain all vested Upstairs Class B Units (if any), subject to (i) Participant’s compliance with the covenants Section 5 hereof (Restrictive Covenants) for 12 months after the Termination, (ii) Participant executing no later than 52 days after receipt, and not revoking, a release of claims in favor of the Company and its Affiliates, in a form that is acceptable to the Company, and (iii) the Company’s repurchase rights under Section 8 of the Plan.
(c)The provisions of Section 8 of the Plan (Company Repurchase Option, which includes a right to repurchase at less than fair market value under certain circumstances, including termination for Cause or non-compliance with restrictive covenants) shall apply with respect to all vested Upstairs Class B Units.
4.Investment Representations and Covenants of Participant.
4.1Upstairs Class B Units Unregistered. Participant acknowledges and represents that Participant has been advised by the Company that:
(a)Neither this Agreement nor the Upstairs Class B Units have been or will be registered with the Securities and Exchange Commission or under any state securities law. The Upstairs Class B Units must be held indefinitely and Participant must continue to bear the economic risk of the investment in the Upstairs Class B Units unless the offer and sale of such Upstairs Class B Units are subsequently registered under the U.S. Securities Act of 1933, as amended from time to time, including the rules and regulations thereunder, and all applicable state securities laws or an exemption from such registration is available (or as otherwise provided in the ManagementCo LLC Agreement);
(b)There is no established market for the Upstairs Class B Units, and it is not anticipated that there will be any public market for the Upstairs Class B Units in the foreseeable future;
(c)A restrictive legend in the form set forth below and the legends set forth in the ManagementCo LLC Agreement shall be placed on the certificates, if any, representing the Upstairs Class B Units:
THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN REPURCHASE OPTIONS AND OTHER PROVISIONS SET FORTH IN THE AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF CDIG MANAGEMENT CO. LLC AS AMENDED AND MODIFIED FROM TIME TO TIME, A COPY OF WHICH MAY BE OBTAINED BY THE HOLDER HEREOF AT THE ISSUER’S PRINCIPAL PLACE OF BUSINESS WITHOUT CHARGE; and
(d)A notation shall be made in the appropriate records of the Company indicating that the Upstairs Class B Units are subject to restrictions on transfer and, if the Company should at some time in the future engage the services of a securities transfer agent, appropriate stop-transfer instructions will be issued to such transfer agent with respect to the Upstairs Class B Units.
-4-

Exhibit 10.4
4.2Additional Investment Representations. Participant represents and warrants that:
(a)Participant’s financial situation is such that Participant can afford to bear the economic risk of holding the Upstairs Class B Units for an indefinite period of time, Participant has adequate means for providing for Participant’s current needs and personal contingencies, and Participant can afford to suffer a complete loss of Participant’s investment in the Upstairs Class B Units;
(b)Participant’s knowledge and experience in financial and business matters are such that Participant is capable of evaluating the merits and risks of the investment in the Upstairs Class B Units;
(c)Participant understands that the Upstairs Class B Units are a speculative investment that involves a high degree of risk of loss of Participant’s investment therein, there are substantial restrictions on the transferability of the Upstairs Class B Units and, on the Grant Date and for an indefinite period thereafter, there will be no public market for the Upstairs Class B Units and, accordingly, it may not be possible for Participant to liquidate Participant’s investment in case of emergency, if at all;
(d)Participant understands that the terms of this Agreement, the Plan, and the ManagementCo LLC Agreement provide that, if Participant ceases to be an employee of the Company or any of its Affiliates, or violates the applicable Restrictive Covenants, the Company has the right to repurchase the Upstairs Class B Units at a price that may, under certain circumstances, be less than the Fair Market Value thereof or Participant may forfeit the Upstairs Class B Units;
(e)Participant understands and has taken cognizance of all of the risk factors related to the acquisition of the Upstairs Class B Units and, other than as set forth in this Agreement, no representations or warranties have been made to Participant or Participant’s representatives concerning the Upstairs Class B Units or the Company or their prospects or other matters;
(f)Participant has been advised to consult Participant’s own legal, tax and financial advisors concerning this transaction and Participant has consulted with such advisors, if any, as Participant has seen fit in connection with this transaction;
(g)Participant has been given the opportunity to examine all documents and to ask questions of, and to receive answers from, the Company and its representatives concerning the Company and its Affiliates, the ManagementCo LLC Agreement, the Company’s organizational documents, and the terms and conditions of the acquisition of the Upstairs Class B Units, and to seek to obtain any additional information that Participant deems necessary;
(h)Participant understands the federal, state and local income and, to the extent applicable to Participant, non-U.S. tax consequences of the granting of the Upstairs Class B Units to Participant, the issuance of the Upstairs Class B Units to Participant, and the subsequent receipt of distributions, if any, in respect of the Upstairs Class B Units; and
(i)All information that Participant has provided to the Company and the Company’s representatives concerning Participant and Participant’s financial position is complete and correct as of the date of this Agreement.
-5-

Exhibit 10.4
5.Restrictive Covenants.
5.1Non-Competition Obligation. To safeguard Participant’s and the Company’s Protectable Interests (as defined below), Participant agrees that during Participant’s employment and Post-Employment Period (as defined below) after Participant’s employment terminates, Participant will not, without the prior written consent of the Company, directly or indirectly, on behalf of a Competitor, engage in Competitive Activity (the restriction under this Paragraph, the “Non-Competition Obligation”). The duration of the post-employment Non-Competition Obligation will be twelve (12) months following Participant’s Termination (the “Post-Employment Period”). Participant acknowledges that this Non-Competition Obligation is in addition to any Restrictive Covenants set forth in any agreement between Participant and a Group Company, and that such agreements are amended to add this Non-Competition Obligation; provided, however, that (i) if Participant’s work location immediately before Termination is a California office, Participant is not bound by the Non-Competition Obligation for the Post-Employment Period, and (ii) if Participant has agreed to a longer post-employment non-competition period in any agreement between Participant and a Group Company, the longer length of time governs.
5.2Employee Non-Solicitation. Participant agrees that during employment and the Post-Employment Period, Participant will not, without the Company's prior written consent, directly or indirectly: (a) solicit or induce, or cause others to solicit or induce, any employees of a Group Company to leave the applicable Group Company or in any way modify their relationship with the applicable Group Company; (b) hire or cause others to hire any employees of a Group Company; or (c) encourage or assist in the hiring process of any Group Company employee or in the modification of any such employee's relationship the Group Company, or cause others to participate, encourage or assist in the hiring process of any employees of a Group Company.
5.3Non-Disclosure of Confidential or Proprietary Information. Participant shall not at any time, whether during Participant’s employment or following the termination of Participant’s employment, directly or indirectly, publish, disclose or furnish to any entity, firm, corporation or person, except as otherwise required by law or as required as part of Participant’s position with the Company, any Confidential or Proprietary Information with respect to any aspect of its operations, business or clients. “Confidential or Proprietary Information” shall mean any secret, confidential or proprietary information of a Group Company that is not generally known to the public to which Participant gains access by reason of Participant’s employment and includes information relating to all principals, officers, and employees, all present or potential clients and investors; work product developed by and research conducted by a Group Company; research reports, models, and notes; business and marketing plans; sales, trading and financial data and strategies; legal and/or regulatory matters; operational costs; pitch books and presentation materials; client and investor lists; client contact and account information; pipelines; investor information; budgets; engagement letters; all current and prospective client confidential information; financial models; and internal procedures, manuals and guidebooks. This Section 5.3 does not prohibit any disclosure: (i) made for the purpose of reporting a suspected violation of law or claiming retaliation for reporting a violation of law in confidence to (A) the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission, FINRA, or any other federal, state or local government, agency or commission (“Government Agency”), (B) Participant’s attorney, or (C) in a sealed court document; (ii) made in cooperation with an investigation by a Government Agency; or (iii) required pursuant to a subpoena or other legal process; provided, however, with respect to a disclosure under (iii), other than to a Government Agency, that Participant agrees to give the Company prompt written notice of the disclosure so that the Company may seek a protective order or waive Participant’s compliance with this paragraph. Upon Participant’s Termination for any reason, or at any other time requested by the
-6-

Exhibit 10.4
Service Recipient or the Company, Participant agrees to immediately return all Confidential or Proprietary Information in Participant’s possession, custody or control, and upon request of the Service Recipient or the Company, agrees to execute an affidavit confirming Participant’s compliance with this obligation.
5.4Non-Disparagement. Participant shall not at any time, whether during Participant’s employment or following any Termination, and shall not cause or induce others to, defame or disparage the Company or any Affiliate, or the directors, officers or employees of the Company or any Affiliate. Participant agrees not to take any action which is intended, or would reasonably be expected, to harm the reputation of a Group Company, or which would reasonably be expected to lead to negative publicity to a Group Company.
5.5Company Property. All records, files, memoranda, reports, customer information, client and investor lists, documents, Work Made for Hire (defined below) and equipment relating to the business of the Company or any Affiliate that Participant prepares or possesses, or with which Participant comes into contact, in either case while Participant is an employee of the Company or any Affiliate, shall remain the property of the Company or such Affiliate. Participant agrees that upon Participant’s Termination for any reason, Participant shall provide to the Company and any Affiliate, as applicable, all documents, papers, files, and other material in Participant’s possession and under Participant’s control that are connected with or derived from Participant’s services to the Company or any Affiliate.
5.6Intellectual Property. Participant agrees that the following, without limitation, belongs to and shall be the sole intellectual property of the Company: all inventions, improvements, products, designs, specifications, original works of authorship, trademarks, service marks, trade dress, discoveries, formulas, algorithms, processes, models, software or computer programs (including any modifications), data processing systems, analyses, data, techniques, trade secrets, know-how, ideas, creations, or work product (regardless of whether it contains Confidential or Proprietary Information or trade secrets), and any applications and registrations thereto, conceived, developed, made or improved on by Participant: (i) in the course of employment with or work for a Group Company; or (ii) with the use of a Group Company’s time, material or facilities in any way related to or pertaining to or connected with the present or anticipated business, development, work or research of a Group Company (“Work Made for Hire”). The Company shall exclusively own all rights, title and interest in any Work Made for Hire, and shall be the author for all purposes under copyright law. Participant hereby assigns such Work Made for Hire to the Company and agrees, without further compensation or consideration, to immediately take such actions to effect such assignment as may be requested by a Group Company. If any intellectual property is not deemed a Work Made for Hire, or if Participant, by operation of law, is deemed to obtain any rights to the Work Made for Hire, Participant shall irrevocably assign to the Company, without further compensation or consideration, Participant’s entire right, title, and interest in and to the intellectual property. Participant further agrees not to impermissibly reproduce, copy, display, distribute, forward, plagiarize, or use (whether in hardcopy or electronically, including via e-mail) any Third Party Copyrighted Materials in violation of any license, subscription agreement, or law. “Third Party Copyrighted Materials” are copyrighted works, other than those of a Group Company including printed articles from publications; electronic articles and reports in online publications; database content; websites; streaming media; musical compositions, mobile apps; online videos; movies; sound recordings, including in digital form such as downloads and streams; images; presentations; training materials; manuals; documentation; computer programs, software programs, and blogs.
-7-

Exhibit 10.4
5.7Compliance with Company Policies. Participant agrees to comply fully with the applicable internal policies of the Company and the Service Recipient. The Company’s right to modify these policies does not affect Participant’s duty to comply with these policies at all times.
5.8Participant Representations Supporting Restrictive Covenants. Participant acknowledges and recognizes the highly competitive nature of the Service Recipient’s and the Company’s businesses, that the Service Recipient will invest time and resources into Participant’s training and education in furtherance of Participant’s position, and that by virtue of Participant’s position, Participant will have access to the Service Recipient’s and the Company’s Confidential and Proprietary Information and trade secrets (collectively, “Protectable Interests”). Participant understands that the restrictive covenants contained in this Agreement may limit Participant’s ability to earn a livelihood in a position similar to or involving the same activities Participant perform for the Service Recipient, but Participant acknowledges that Participant will receive compensation and other benefits, including training and access to Confidential and Proprietary Information, sufficient to justify these restrictions. Participant further acknowledges that given Participant’s education, skills, and abilities, Participant does not believe that the restrictive covenants in this Agreement will prevent Participant from earning a livelihood; and Participant acknowledges that he or she has the right, and has had an opportunity, to consult an attorney with respect to these provisions. Participant recognizes that the Company would not award the Upstairs Class B Units pursuant to this Agreement if Participant was not willing to agree to the restrictive covenants contained in this Agreement. Participant agrees and acknowledges that nothing in this Section 5 shall in any way affect, limit or modify Participant’s liabilities or obligations under any employment agreement, consulting agreement, management services agreement, confidentiality agreement, noncompetition agreement, non-solicitation agreement or any similar agreement with the Company or any of its Subsidiaries.
5.9Breach/Injunctive Relief. In the event of a breach of this Section 5, in addition to being entitled to exercise all rights granted by law, including recovery of damages, the Company and the Service Recipient will be entitled to specific performance of its rights under this Agreement. Participant acknowledges that the Company shall suffer irreparable harm in the event of a Breach or prospective Breach, and that monetary damages would not be adequate relief. Accordingly, the Company shall be entitled to seek injunctive relief in any federal or state court of competent jurisdiction located in New York, or in any state in which Participant resides. Participant further agrees that the Company and the Service Recipient shall be entitled to recover all costs and expenses (including attorneys’ fees and expenses) incurred in connection with the enforcement of the Company’s rights hereunder including with respect to a Breach. For the avoidance of doubt, although a breach occurring more than 12 months after Participant’s Termination shall not result in forfeiture of vested Upstairs Class B Units, the Company and its Affiliates retain all rights under law and in equity to enforce their rights (including to recover damages for breach) under this Section 5 even after the 12-month period has elapsed.
6.Cooperation. Participant agrees to cooperate fully with the Company and the Service Recipient at any time, whether during Participant’s employment or following any termination thereof, taking into account the requirements of any subsequent employment by Participant, on all matters relating to Participant’s employment, which cooperation shall be provided without additional consideration or compensation and shall include being available to serve as a witness and be interviewed and making available any books, records, and other documents within Participant’s control, provided, however, that Participant need not take any action hereunder that would constitute a violation of law or obligation to any third party (except to the extent such obligation arises due to any action taken by Participant with the intention to circumvent the operation of this Section 6 or cause a waiver of attorney-client privilege). Without limiting the generality of the foregoing, Participant shall cooperate fully and truthfully in connection with any (a) past, present, or future suit, action, claim, or other proceeding; (b)
-8-

Exhibit 10.4
inquiry, proceeding, or investigation by or before any governmental authority; (c) arbitration, mediation, or other alternative dispute resolution process, in each case involving the Company, the Service Recipient, or any Affiliates; and (d) internal investigation.
7.Miscellaneous.
7.1Notices. Unless otherwise provided herein, all notices and other communications hereunder shall be in writing and shall be deemed given and received (a) if delivered in person, on the date delivered, (b) if transmitted by facsimile (provided that receipt is confirmed by telephone), on the date sent, or (c) if delivered by an express courier, on the second Business Day after mailing, to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):
If to the Company:
Cowen Digital Holdings LLC
c/o Cowen Inc.
599 Lexington Avenue, 20
th Floor
New York, NY 10022
Attention:    General Counsel
If to Participant:
To the most recent address of Participant set forth in the personnel records of the Company.
7.2Amendments and Waivers.
(a)Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the case of a waiver, by the party against whom the waiver is to be effective; provided that, the foregoing notwithstanding, this Agreement may be amended by the Company unilaterally to cure any ambiguity or correct or supplement any provision herein which may be inconsistent with any other provision herein, the Plan or the ManagementCo LLC Agreement or to correct any errors or omissions so that this Agreement shall accurately reflect the agreement between the Company and the Participant, and to make any updates of a ministerial or non-material nature. No unilateral amendment may adversely affect Participant, except to the extent provided for or contemplated in the terms of this Agreement or the Plan (including, for the avoidance of doubt, pursuant to Article VII or IX thereof).
(b)No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.
7.3Successors and Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.
7.4Governing Law. Other than Section 5 (Restrictive Covenants) and Section 7.5 (Arbitration), this Agreement, the legal relations between the parties and the adjudication and the enforcement thereof, shall be governed by and interpreted and construed in accordance with the
-9-

Exhibit 10.4
laws of the State of Delaware applicable to agreements made and to be performed entirely within the State of Delaware, without regard to the conflict of law provisions thereof that could result in the application of the laws of any other jurisdiction. Section 7.5 (Arbitration) shall be governed by and construed in accordance with the Federal Arbitration Act. Section 5 (Restrictive Covenants) shall be governed by and interpreted and construed in accordance with the laws of the State of New York, without regard to the conflict of law provisions thereof that could result in the application of the laws of any other jurisdiction; provided that to the extent Participant’s work location is a California office, California law and jurisdiction shall replace New York under this Agreement during such period to the extent required by law.
7.5Arbitration.
(a)Any and all disputes with the Company or any Affiliate arising out of or relating to this Agreement or Participant’s employment will be submitted to and resolved exclusively by the Financial Industry Regulatory Association (“FINRA”) in accordance with its rules, unless Participant is not registered or is not subject to FINRA’s jurisdiction, in which case such disputes will be submitted to and exclusively resolved by American Arbitration Association (“AAA”) pursuant to the AAA’s employment Arbitration Rules and Mediation Procedures. In the event of arbitration before the AAA, the arbitrator’s fees and the administrative costs associated with holding the arbitration hearing (e.g., set-up and calendaring, room costs, etc.) will be paid by the Company; provided, however, that Participant will be responsible for paying Participant’s attorney’s fees, witness fees, and all other personal legal expenses related to Participant’s legal representation. In agreeing to arbitrate Participant’s claims, Participant recognizes that Participant is waiving Participant’s right to a trial in court and by a jury. The arbitration award shall be binding upon Participant, the Company, and any Affiliate and judgment upon the award may be entered in a court of competent jurisdiction. This arbitration provision applies to, but is not limited to, statutory discrimination, harassment, and retaliation claims under federal, state, and local law.
(b)Participant agrees to waive any and all rights to bring, participate, or recover any relief from a class, collective or other representative action against the Company and/or its Affiliates to the maximum extern permitted by law. If Participant is included in a class, collective or other representative action, Participant will take all steps necessary to opt-out of the action or refrain from opting-in. A court must decide any issue concerning the validity of this waiver, and an arbitrator does not have the authority to consider it or to allow Participant to serve as a representative of others in arbitration pursuant to this Section 7.5. If for any reason a court finds this waiver unenforceable, the class, collective or representative claim may only be heard in court and not arbitrated, and to the fullest extent permitted by law, Participant waives the right to a jury for any such claims. Participant retains the right to challenge the validity of this waiver.
(c)This arbitration provision does not apply to: (i) a claim for injunctive relief permitted under the ManagementCo LLC Agreement, the Plan, this Agreement or any agreement between Participant and the Company, for which jurisdiction shall be reserved in the federal and/or state courts in New York, with the parties consenting to personal jurisdiction; (ii) any claim arising under Sarbanes-Oxley; and (iii) claims prohibit by law from being arbitrated.
7.6Counterparts; Third-Party Beneficiaries. This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures hereto were upon the same instrument. This Agreement shall become effective as to a particular Participant when such Participant shall have received a counterpart hereof signed by the Company. No provision of this Agreement shall confer upon any person other than the parties hereto any rights or remedies hereunder.
-10-

Exhibit 10.4
7.7Entire Agreement. This Agreement, together with the Plan and the ManagementCo LLC Agreement, constitutes the entire agreement between the parties with respect to the subject matter of this Agreement and supersedes all prior agreements and understandings, both oral and written, between the parties with respect to the subject matter of this Agreement.
7.8Section Headings; Construction. The section headings contained herein are for the purpose of convenience only and are not intended to define or limit the contents of the sections. All words used in this Agreement shall be construed to be of such gender or number, as the circumstances require. Unless otherwise expressly provided, the word “including” does not limit the preceding words or terms and the word “or” is not exclusive.
7.9Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be deemed to be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision were so excluded and shall be enforced in accordance with its terms to the maximum extent permitted by law. If for any reason one or more of the provisions contained in this Agreement or in any other instrument referred to herein, shall, for any reason, be held to be invalid, illegal, or unenforceable in any respect, then to the maximum extent permitted by law, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement or any other such instrument. Furthermore, a determination in any jurisdiction that this Agreement, in whole or in part, is invalid, illegal, or unenforceable shall not in any way affect or impair the validity, legality, or enforceability of this Agreement in any other jurisdiction.
7.10Interpretation. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.
7.11Offset. In the event that Participant experiences a Termination, for any reason or no reason, the Company may offset, to the fullest extent permitted by law (and without triggering tax under Section 409A of the Code), any amounts of money or other property due to the Company from Participant, or advanced or loaned to Participant by the Company, from any money or property owed to Participant or Participant’s estate by the Company as a result of such Termination.
7.12Participant’s Employment . Nothing contained in this Agreement shall be deemed to obligate the Company or any of its Affiliates to employ Participant in any capacity whatsoever or to prohibit or restrict the Company or any of its Affiliates from terminating the employment of Participant at any time or for any reason whatsoever, with or without Cause.
7.13Tax Withholding. All compensation in respect of this Award is subject to withholding for taxes in such amounts and at such times as the Company determines to be required by law. Without limiting the generality of the foregoing, the Company shall be entitled to withhold (based on the Fair Market Value) a number of Units having an aggregate Fair Market Value equal to the applicable withholding amount. All amounts (if any) that are withheld and paid over to the appropriate taxing authority pursuant to this Section 7.13 shall be treated as having been paid to Participant. Regardless of the amount withheld or reported, Participant is solely responsible for all taxes in respect of this Award except the employer’s share of employment taxes (if any). If a taxing authority subsequently determines that withholding should have been made with respect to this Award (or any amount payable with respect thereto) and the Company or any of its Affiliates is required to pay any portion of Participant’s taxes that were not withheld, Participant shall reimburse the Company or Affiliate (as applicable) for the full amount paid by the Company or Affiliate in respect of such withholding, and the Company and ManagementCo shall be entitled to deduct and withhold the full amount of such required
-11-

Exhibit 10.4
reimbursement (to the extent not paid by Participant) from subsequent distributions and payments to Participant. Participant’s obligations under this Section 7.13 will survive the transfer, forfeiture, withdrawal, or other disposition by Participant of the whole or any portion of its interest in the Company, the death or legal disability of Participant and the termination, dissolution, liquidation and winding up of the Company, and the Company will be treated as continuing in existence for purposes of this Section 7.13.
7.14Incorporation, Recapitalization and/or Reorganization. If, in connection with a Reorganization Event, Participant receives securities or other consideration in respect of Participant’s Upstairs Class B Units, the rights and obligations set forth in this Agreement, and the Plan shall continue to apply to such securities or other consideration, mutatis mutandis. Participant agrees to take such actions and execute such documents (in Participant’s capacity as a member of the Company) as may be requested by the Company to give effect to any such event, including executing operating agreements, unitholder agreements or similar agreements, or joinders thereto.
* * * * *

-12-


IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above.
CDIG MANAGEMENT CO. LLC
By:        
Name:
Title:

PARTICIPANT
Name:    __________________________
Date:    __________________________
Address:        

    

    
NUMBER OF UPSTAIRS CLASS B UNITS GRANTED:        [●]
PROFITS INTEREST HURDLE:                    [●]
GRANT DATE:                            [●]
VESTING START DATE:                        [●]


Signature:     ______________________



Exhibit 31.1
Certification
I, Jeffrey M. Solomon, certify that:
1.     I have reviewed this Quarterly Report on Form 10-Q of Cowen Inc:
2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.     The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)     Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:May 2, 2022 /s/ JEFFREY M. SOLOMON
Name: Jeffrey M. Solomon
Title:    Chief Executive Officer
             (principal executive officer)



Exhibit 31.2

Certification
I, Stephen A. Lasota, certify that:
1.     I have reviewed this Quarterly Report on Form 10-Q of Cowen Inc:
2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.     The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)     Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:May 2, 2022 /s/ STEPHEN A. LASOTA
Name:  Stephen A. Lasota
Title:    Chief Financial Officer (principal financial officer and principal accounting officer)




Exhibit 32

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Cowen Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer's knowledge:
1.    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date:May 2, 2022 /s/ JEFFREY M. SOLOMON
Name:  Jeffrey M. Solomon
Title:    Chief Executive Officer        
            (principal executive officer)
     
  /s/ STEPHEN A. LASOTA
Name:  Stephen A. Lasota
Title:    Chief Financial Officer (principal financial
             officer and principal accounting officer)

*  The foregoing certification is being furnished solely pursuant to 18 U.S.C Section 1350 and is not being filed as part of the Report or as a separate disclosure document